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Abstract 
 
The Pd-, Cu- and Pd/Cu-mediated direct functionalisation of C2-H bonds at 1,3-X,N-
heterocycles (where X = S, O, N) and indole-containing biomolecules has been 
investigated. Such processes are useful in the synthesis and labeling of complex 
molecules, and represent an improvement on traditional Pd-mediated cross-coupling.  
 
A study of the mechanism of C2-H bond functionalisation of 1,3-X,N-heterocycles 
(specifically benzimidazole, benzothiazole and benzoxazole) with Pd/Cu catalyst 
systems has indicated a key role for Pd0 nanoparticles. Nanoparticles have been 
demonstrated to form in situ when molecular PdII pre-catalysts are employed, and have 
been characterized by transmission electron microscopy (TEM). The catalytic activity of 
these nanoparticles has been shown to vary with reaction environment (e.g. the use of 
different reaction vessels). Pre-synthesised, well-defined Pd0 nanoparticles supported 
on polyvinylpyrolidone (PVP) are effective catalysts for these processes and increase 
reaction reliability.  It is proposed that Cu N-heterocarbene (NHC) intermediates play a 
key role in these processes. A model system {(1,3-
dibenzyl)benzoimidazolylidenecopper(I) bromide} has been synthesised using an 
electrochemical method. The reaction of this model with PhI within and without the 
presence of PdII results in arylated product. Whilst conducting these studies, the novel 
compound bis{(1,3-dibenzyl)benzimidazolium}dicopper(I)tetrabromide was isolated. 
 
The C-H bond functionalisation of benzoxazole with a Pd/(1,10-phenanthroline) 
catalyst and PhI(OAc)2 aryl source has been studied in detail. Pd
0 nanoparticles have 
isolated and characterized from this reaction. It has also been demonstrated that 
PhI(OAc)2 rapidly degrades to PhI under the reaction conditions.  
 
The indole-based amino acid tryptophan is fluorescent, and modifying this fluorescence 
is of interest. A mild and selective C2-H bond functionalisation reaction for this amino 
acid has been developed, both as a single residue and within peptides. NMR 
spectroscopy, ReactIR® and other techniques have been used to build up a 
mechanistic picture of this reaction, with is proposed to proceed via a Pd0/II manifold. 
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CHAPTER 1: 
INTRODUCTION 
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1.1 Pd-Mediated C-X/C-H Bond Functionalisation 
1.1.1 Pd-Mediated C-X Bond Functionalisation  
Over the past forty years, Pd-catalysed cross-coupling chemistry has revolutionised the 
way C-C bonds are formed in the synthesis of complex organic molecules.1 The first 
example of Pd cross-coupling, the Mizoroki-Heck reaction, was initially published 
independently by Mizoroki and Heck in the early ‘seventies.2,3 Using Pd catalysts, it 
became possible to cross-couple aryl, benzyl or vinyl halides with a terminal alkene. 
Since that time, the Stille (coupling organopseudohalides with organotin reagents),4– 6 
Suzuki-Miyaura (coupling organopseudohalides with organoboronic acids),7 
Sonogashira (coupling organopseudohalides with terminal alkynes),8– 10 Kumada-Corriu 
(coupling organopseudohalides with Grignard reagents) and Hiyama (coupling 
organopseudohalides with organosilanes) reactions have been developed (Figure 1), 
which take advantage of the unique reactivity of organometallic species. 
 
 
 
Figure 1: Examples of traditional Pd-catalysed cross-coupling chemistry.  
 
These reactions offer high selectivity and relatively mild conditions which were 
previously unavailable to synthetic chemists. Indeed, they often become alternatives to 
alkyl lithium bases (with the exception of the Kumada-Corriu reaction), which can be 
incompatible with high molecular complexity. Thus they have become an essential part 
of the organic chemistry tool-kit, and consequently simple cross-coupling partners and 
catalysts have become commercially available.  
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The utility of these methodologies can be seen in their application to the synthesis of 
complex natural products. For example, Nicolaou’s 123 step synthesis of Brevetoxin A 
3, a marine algae natural product consisting of ten consecutive fused rings, makes use 
of a novel ketene acetal phosphate Stille cross-coupling to install a vinyl moiety under 
relatively mild conditions (Scheme 1).11   
 
 
 
Scheme 1: Nicolaou’s use of cross-coupling chemistry in the synthesis of Brevetoxin A, 3.
11
 
 
Similarly, the Sonagashira reaction has been employed in the syntheses of large 
macrocyclic natural products, where more conventional organic techniques may have 
proved less successful. For example, Wipf and Graham’s synthesis of disorazole C1 8 
makes use of two Sonagashira reactions (Scheme 2).12 Using sub-stoichiometric 
amounts of copper, it was possible to install two internal alkynes in excellent (94%) 
yield, which could be later reduced to macrocyclic alkenes.  
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Scheme 2: Wipf’s use of cross-coupling chemistry in the synthesis of Disorazole C1, 8.
12
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1.1.2 Pd-Mediated C-H Bond Functionalisation  
Despite their versatility, traditional cross-coupling methodologies have disadvantages. 
They require pre-functionalisation of substrates. For example, with an organoboronic 
acid in the Suzuki-Miyaura reaction or an alkyl tin reagent in a Stille reaction. In cases 
where these reagents are not commercially available, or prohibitively expensive, this 
adds an extra reaction step to the pathway and may be a limiting factor. However, such 
pre-functionalisation is not required in direct C-H bond functionalisation (Figure 2). 
Broadly, C-H bond functionalisations can be split into those that involve the 
combination of C-H/C-X (where X is a halide or pseudohalide) or C-H/C-H bond (that 
is, oxidative couplings). Such transition metal-mediated transformations have 
employed palladium, rhodium, iron, ruthenium and other metal catalysts.13 This results 
in an enhanced efficiency in synthesis time, atom efficiency and reagent costs over 
traditional methodologies. 
 
 
 
Figure 2: Comparison of direct C-H bond functionalisation and traditional cross-coupling 
methodologies (X = halide or pseudohalide or boronic acid, M = organometallic reagent). 
 
C-H bond functionalisation remains relatively new, but there are an increasing number 
of examples of how it might be applied in the literature. For example, Sames and co-
workers have published a synthesis of Teleocidin B4 13 using C-H bond 
functionalisation in a key step (Scheme 3).14 Although the yield for the C-H bond 
functionalisation was moderate, previous methodology would have required pre-
functionalisation of the arene ring, increasing the number of steps in the total synthesis. 
This demonstrates the efficiency of C-H bond functionalisation methodologies as 
previously discussed.  
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Scheme 3: Sames and co-workers synthesis of Telocidin B4, 13.
14
 
 
Trauner and co-workers have demonstrated the credibility of C-H bond 
functionalisations in complex molecules incorporating N-containing heterocycles. For 
example, in their total synthesis of rhazinal 16, a Pd(OAc)2/DavePhos-catalyst system 
is used in a 9-membered macrocyclisation (Scheme 4).15 The use of C-H bond 
functionalisation in the synthesis of natural products has recently been extensively 
reviewed by Chen and Youn.16 
 
 
 
Scheme 4: Trauner and co-workers synthesis of Rhazinal.
15
 
 
There has also been early work in the use of C-H bond functionalisation as a 
methodology for the introduction of labels for biological experiments. The labeling of 
complicated natural products is often used to deduce mechanistic information in 
biological processes. For example, the fluorescence of the amino acid tryptophan is 
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used to determine the surrounding protein environment of the tryptophan, and hence 
can be used to infer changes in protein conformation.17,18 In addition to fluorescence 
labeling, radio-,19 spin-,20 electrochemical21 and biotin22 labels are also common.  
Previously labels might have been introduced by, for example, amide formation, or Cu-
mediated ‘click’ cyclisation with azides.23– 25 These methods, in general, do not result in 
the formation of C-C bonds. Although traditional Pd-mediated cross-coupling has also 
been utilized (vide infra), a significant improvement would be to take previously 
unmodified complex biomolecules and use a C-H bond functionalisation to introduce 
the label. Fairlamb, Baumann and co-workers have developed a C-H bond 
functionalisation of purine-based nucleosides which introduces a fluorescent group 
directly.26– 28 However, the extension of this and other similar methodologies to more 
complex systems is limited by the need for exceptionally mild conditions.  
 
This thesis will focus on the direct C-H bond functionalisation of the N-containing 
heterocycles to form C-Ar bonds. Specifically, the arylation of 1,3-azoles (and their 
benzo-fused analogues, Chapter 2) and indoles (in particular, the amino acid 
tryptophan, Chapter 3) by Pd, Cu and mixed Pd/Cu catalyst systems will be 
considered. An in-depth introduction to each area will be given at the start of each 
relevant chapter.  
 
 
 
 
Figure 3: Representation of C-H bond functionalisation of heterocycles in this thesis.  
 
1.1.3 A Definition for Reactions of C-H Bonds 
In the chemical literature, reactions in which C-H bonds are modified, either by the 
formation of C-C or C-X (where X = N, O, S etc) bonds, by transition metal-mediated 
catalysis are known interchangeably as C-H bond ‘functionalisation’ or C-H bond 
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‘activation’ reactions depending on the author’s preference. To further complicate 
matters, it is also acceptable to refer to metallation processes as ‘activation’ and the 
overall process as ‘functionalisation’.  
 
Before such reactions became more wide-spread in organic chemistry, the term C-H 
bond activation was generally used by organometallic chemists to refer to processes in 
which a metal inserts into a C-H bond, usually in an oxidative process. For example, 
this term might have been applied to an oxidative addition,29 σ-bond metathesis30 or σ-
CAM mechanism.31 It would have not been applied to electrophilic or 
deprotonation/metallation processes, which are the common mechanistic basis for 
many organic direct C-H bond functionalisations/activations.  
 
For the purposes of this thesis, ‘activation’ will be avoided. C-H bond functionalisation 
will refer to the overall process for the modification of a C-H bond in the formation of 
(unless otherwise stated) C-C bonds.  
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1.2 Aim of the Project and Objectives 
1.1 Aims 
i. To develop new synthetic methods for the direct C-H functionalisation of N-
containing heterocycles, and related complex biomolecules. 
 
ii. To increase our mechanistic understanding of catalytic C-H functionalistion 
processes.  
 
1.2 Objectives 
i. To understand the mechanism of Pd/Cu-mediated direct C-H functionalisation 
processes for benzoxazoles, benzothiazoles and benzimidazoles, in particular 
the role of Pd0 nanoparticles and Cu-NHC complexes.  
 
ii. To develop a mild, low-temperature and selective method for the direct C-H 
functionalisation of the amino acid tryptophan, and to gain a mechanistic 
understanding of these complicated processes using a variety of techniques, 
including NMR and ReactIR™ , and to isolate possible PdII and PdIV 
intermediates in these reactions. 
 
iii. To synthesise a library of C2-aryl labeled tryptophan derivatives 
 
iv. To apply the methodology developed in (iii) to complex biomolecules, such as 
short peptides.  
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CHAPTER 2: 
C-H BOND FUNCTIONALISATION OF BENZAZOLES 
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2.1 –  Introduction 
2.1.1 –  Direct Arylation of Benzazoles 
Nitrogen-containing heterocycles (azoles) and their benzo-fused analogues are found 
throughout nature and synthetic chemistry. Imidazole 21 for example, can be found in 
the proteinogenic amino acid histidine 22, as well as in synthetic pharmaceuticals such 
as the the antifungal mediciation clotrimazole 23. Related heterocyles include 
oxazoles, thiazoles, xanthines (including caffeine 24), purines (for example, adenosine) 
and benzimidazoles 25 (Figure 4).  
 
 
 
Figure 4: Examples of imidazole-based compounds. (a) NH-Imidazole, (b) histidine, (c) 
clotrimazole, (d) caffeine, and () benzimidazole.  
 
The prevalence of these heterocyclic systems has resulted in high levels of interest in
the synthesis of functionalised analogues. For many years, organic chemists relied on 
traditional annulation reactions.32 The advent of Pd-catalysed cross-coupling reactions 
allowed quick access to scaffolds previously time-consuming to make or entirely 
unavailable. This methodology also allowed for divergent functionality to be introduced 
later in synthetic pathways. However, as previously discussed (Chapter 1, Section 
1.1.2, page 12), cross-coupling reactions bring their own disadvantages. This, and the 
relatively high reactivity of N-heterocyclic C-H bonds, has led to this class of 
compounds being fertile ground in the development of transition metal catalysed direct 
C-H bond functionalisation.   
 
One key area addressed by direct C-H bond functionalisation methodology has been 
the formation of N-heterocycle-arene C-C bonds. Whilst many metals have been used 
for these transformations, systems mediated by Pd and Cu have proved to be of 
particular interest.33 Miura and co-workers pioneered this field in the late nineties with a 
study of the direct arylation of 1-methylimidazole, 26, with Pd(OAc)2 and carbonate 
bases (Scheme 5).34 By varying the nature of the metal catalyst system, it was found 
that the regioselectivity of the reaction could be influenced (Figure 5). When catalysed 
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by Pd alone, the reaction was preferentially selective for the C5 position 27 (although 
substantial quantities of C2/C5 diarylated product 28 were formed, decreasing the 
preparative utility of this reaction). However, the addition of stoichiometric quantities of 
CuI resulted in a switch of selectivity for the C2 position 29. When the reaction was 
performed with CuI in the absence of Pd, the reaction was entirely regioselective for 
the C2 position 29. However, under these conditions the overall yield was substantially 
reduced from 77% to 37%.  
  
 
 
Scheme 5: Direct C-H bond functionalisation of 1-methylimidazole with Pd, Cu and Pd/Cu 
catalyst systems, as proposed by Miura and co-workers.
34
 Results shown in Figure 5. 
 
 
Figure 5: Regioselectivity outcome in the direct C-H bond functionalisation of 1-methylimidazole 
with Pd, Cu and Pd/Cu catalyst systems displayed graphically, as reported by Miura and co-
workers.
34
 
 
Miura extended this study to other N-heterocycles and, whilst this reactivity was 
mirrored in thiazole analogues, the outcome of the addition of stoichiometric CuI salts 
was found to be substrate dependent. Benzo-fused substrates gave mixed results: the 
C2 arylation of benzo[d]oxazole was optimal in the absence of CuI (95% yield), whilst 
that of 1-methylbenzo[d]imidazole could be performed with CuI in the absence of Pd 
N
N
N
NPd(OAc)2 (10 mol%), PPh3 (20 mol%), 
[and/or CuI (2.0 eq.)],
PhI (2.0 eq.), Cs2CO3 (2.0 eq.),
 DMF, 140 oC, 20 h
N
N
N
N
54 
24 
0 
0 
37 
40 
0 
37 
0 
0 20 40 60 80 100 
C5 
C2 
C5/C2 
Yield % 
P
o
s
it
io
n
 o
f 
A
ry
la
ti
o
n
 
Pd(OAc)2 (cat.) Pd(OAc)2 (cat)/CuI (stoich.) Cu(stoich.) 
26 27 28 29 
2 
5 
Pd(OAc)2 ( t). Pd(OAc)2 (cat). / CuI (stoich.) CuI (stoich.) 
&7!;$*%+'+A+&=7+"()2+B6)&$9()!19#!$9()+(B+"*)C!C(1*#+++++ '@ 
 
(89% yield). Uniquely, diarylation of benzo[d]thiazole was most efficient with a 
substoichiometric quantity of CuI (2 eq.).   
 
In an in-depth study by Bellina, Rossi and co-workers in 2005, the regioselectivity 
observed by Miura in the C-H bond functionalisation of imidazoles was corroborated.35 
Optimised, ‘ligandless’* conditions for this chemistry were later developed, with CsF 
emerging as a more suitable base than Cs2CO3 (Scheme 6).
36 It is hypothesised by 
Bellina that the greater efficacy of CsF results from greater solubility in DMF, 
increasing the homogeneity of the reaction mixture. However, CsF is a significantly 
harder base than its carbonate analogue (driven by the formation of the HF2
- anion), 
and this may account for the difference in reactivity. A range of 2-arylated imidazoles 
were synthesised by this route in reasonable yields (38 –  79%), and little diarylated 
product was observed (<20%).  
 
 
 
Scheme 6: Direct C-H bond functionalisation of 1-arylimidazoles using Pd/Cu catalyst systems 
and CsF base, as proposed by Bellina, Rossi and co-workers.
36
 
Bellina proposed that different catalytic manifolds are operative which gives rise to the 
different regioselectivity (Scheme 7). C5 arylation was proposed to result from 
oxidative addition of the aryl iodide to Pd0, followed by electrophilic aromatic 
substitution of the C5-H. The product is then reductively eliminated. Conversely, C2 
arylation results from what can be described as a more traditional cross-coupling 
reaction mechanism. CuI was proposed to coordinate with the substrate, with this 
complex existing in equilibrium with an organocuprate III. This can be thought of as 
analogous to the Sonagashira reaction.10 Transmetallation with PdII can then occur with 
loss of CuX. The C2-arylated product is reductively eliminated. This mechanism was 
well supported by experimental evidence. Electron-donating substituents, such as 
phenylmethylsulfinate, were found to be rate enhancing. Bellina proposed that the 
substituents altered the acidity of the C2-H and, therefore, the rate of cupration. 
                                                
* ‘Ligandless’ refers, in this context, to the absence of deliberately added 2-electron 
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Further, decreased selectivity with increased Pd-loading supported the existence of a 
rate-limiting cupration.  
 
 
Scheme 7: Mechanism for the direct C-H bond functionalisation of imidazoles using Pd/Cu 
catalyst systems, demonstrating the reason for the effect of Cu
I
 stoichiometry on reaction 
regiochemistry.
36
  
 
However, this mechanism is not a complete description. Indeed, it suggests that the 
reaction should be catalytic in CuI, but when the stoichiometry of CuI was reduced the 
selectivity switched back to C5. To explain this, Bellina proposed that the equilibrium 
between the organocuprate and CuI lies towards the imidazole starting material. By 
using excess CuI, this equilibrium can be pushed towards the organocuprate.  
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Scheme 8: ‘Base-free’ conditions using Pd/Cu catalyst systems for the C-H bond 
funcitonalisation of (benz)azole heterocycles, proposed by Bellina and Rossi.
37,38
 
 
Bellina and Rossi later published ‘base-free’ conditions for the same reaction (Scheme 
8).37,38 These reactions are performed at high temperatures in DMF. At these 
temperatures, DMF has been demonstrated to degrade to the dimethylamine.39 As 
such, these reactions are free of carbonate base, but not strictly ‘base-free’ as 
described. These conditions were found to be applicable to a wide variety of 1,3-N,X-
heterocycles including 1-substituted imidazoles (66 –  99% yield), thiazole (84% yield), 
oxazole (23% yield), and imidazole (47 –  89% yield with various aryl iodides). NH-
indole was also successfully functionalised (35% yield).†   Piguel and co-workers 
applied these conditions to the C2-arylation of oxazoles using aryl bromides with 
microwave irradiation.40  
 
 
 
Scheme 9: The direct C-H bond functionalisation of benzyl-protected purines, as proposed by 
Hocek and co-workers.
41
 
 
Hocek and co-workers demonstrated that similar conditions could be applied to benzyl 
protected purine heterocycles 38, functionalising at the C8 position 39 (Scheme 9).41 In 
this case, Cs2CO3 was found to be the optimal base. Depending on reaction conditions, 
                                                
†  The direct C-H functionalisation of indoles will be discussed further in Chapter 4.  
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dipurinyl homocoupling and other by-products were also observed. The use of aryl 
iodides gave good yields (85-95%), whilst aryl bromides were less efficacious (62% 
yield for 1-bromo-2-methylbenzene, compared with 95% yield for the iodide analogue). 
The scope of these conditions with different substituents was explored in-depth.42 The 
use of 9-aryladenines was, although moderately successful, plagued by poor selectivity 
(with functionalisation proceeding at the N6 position resulting from a competing Cu-
catalysed Ullman-type reaction). This remained a problem even at lower temperatures 
and decreased reaction times (120 °C, 48 h). 
 
 
 
Scheme 10: An improved direct C-H bond functionalisation of benzyl-protected purine using 
microwave irradiation, as proposed by Alami and co-workers.
43
 
 
Alami and co-workers significantly improved upon Hocek’s functionalisation of free-NH2 
adenines, using Pd(OH)2/C, NMP solvent and microwave irradiation (Scheme 10).
43 A 
variety of aryl halides (iodides, bromides and chlorides) were found to give good yields 
(42-95% yield). Interestingly, 8-vinylation was also demonstrated to be possible with β-
E-bromostyrene (55% yield).  
 
 
 
Scheme 11: Direct C-H bond functionalisation of adenosine using Pd/Cu catalyst systems, at 
high temperature, as proposed by Hocek and co-workers.
44
 
 
The high temperatures employed for these reactions made them unsuitable for 
application to natural purines, including nucleosides (Scheme 11). Hocek was able to 
functionalise adenosine 42, using 4-iodotoluene at 150 °C using piperidine as a base 
(68% yield, with 18% of 8,N6-diarylated product 44). A reduced yield was observed at 
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125 °C, with an increased proportion of diarylation. 2′-Deoxyadenosine was found to be 
too sensitive for these conditions. 
 
 
 
 
Scheme 12: An improved direct C-H bond functionalisation of adenosine using Pd/Cu catalyst 
systems,  as proposed by Fairlamb and co-workers.
26
 
Fairlamb and co-workers simultaneously developed similar conditions with significantly 
better yields for the arylation of nucleosides (Scheme 12).26 Reaction temperature and 
time were both reduced (120 °C, 13 h), and Cs2CO3 used as base. Application of these 
conditions to adenosine 45, proved successful (34-99% yields). In general, electron-
withdrawing ortho-substituted aryl iodides proved to be problematic, as is precedented 
in the literature for other Pd-catalysed reactions. For 2′-deoxyadenosine 47, the 
temperature was lowered to 80 °C (84% yield was recorded using PhI). However, 
yields for the deoxyadenosine were not repeatable and found to be dependent on the 
solvent batch. The presence of trace dimethylamine, from the degradation of DMF, was 
found to reduce the Pd(OAc)2 precatalyst to the active Pd
0 species.39 The addition of 
piperidine (0.4 eq.) was shown to give reliably high yields (Scheme 13).27
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Scheme 13: The direct C-H bond functionalisation of adenosine and deoxyadenosine at much 
reduced temperature, and reaction mechanism, as proposed by Fairlamb and co-workers.
27
 
 
Fairlamb proposed a reaction mechanism similar to that of Bellina and Rossi (Scheme 
13).36 A recurring theme of these reactions is the necessity for stoichiometric quantities 
of CuI despite the proposed mechanisms suggesting a catalytic amount should 
function just as well.  
 
 
 
Scheme 14: The direct C-H bond functionalisation of benzothiazole, using a Pd/Cu catalyst 
system, as proposed by Mori and co-workers.
45,46
 Note the stoichiometry of the Cu.  
 
Mori and co-workers have developed a mild process for the C2-arylation of 
benzothiazole 49,  using Pd and Cu in sub-stoichiometric quantities, with TBAF used 
as an ‘activator’ (its exact role is not commented on, however it is possible that 
degradation to tributylamine occurs via a Hoffmann elimination)47 at 60 °C in DMSO 
(Scheme 14).45,46 This methodology was applied, with a sequential Pd-catalysed C5-
arylation, to the synthesis of diarylthiazoles for liquid crystal applications. Mori later 
adapted these conditions for benzo[d]thiazole by substituting expensive TBAF with 
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solid NaOH and tri-tert-butylphosphine!HBF4.
48 Although these adapted conditions 
could be used for thiazoles, some diarylation was observed.  
 
 
 
Scheme 15: The direct C-H bond functionalisation of benzazoles, using Pd and a 
Cu(Xantphos)I catalyst.
49
 
 
 
 
Scheme 16: Mechanism proposed by Huang and co-workers.
49
 
 
Interestingly, Huang and co-workers have proposed similar conditions to Miura, Bellina, 
Hocek and Fairlamb that are catalytic in CuI (Schemes 15 and 16).49 A catalytic system 
comprising of Cu(Xantphos)I (1 mol% loading) III and PXPd (0.25 mol%) gave high 
yields with benzo[d]oxazole 53 and benzo[d]thiazole 49 but more moderate yields with 
benzo[d]imidazoles (benzimidazoles are generally more resistant to functionalisation 
than their sulfur or oxygen analogues due to increased pKa).  
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Miura’s pioneering results demonstrated that it was possible to arylate with a CuI-only 
system. In 2007, Daugulis and co-workers reported conditions for the arylation of 
benzo[d]oxazole 53 using a substoichiometric quantity of copper with butoxide bases 
(Scheme 17).50 Daugulis’ conditions benefited from both short reaction times and high 
yields: after a reaction time of only 10 minutes, 91% yield was obtained with PhI. All 
aryl iodides assessed achieved yields of greater than 85% except 2-iodomesitylene 
(55% yield). However, high temperatures were required. Other fused heterocycles, 
including benzo[d]thiazole 49, benzo[d]imidazoles and caffeine also gave high yields. 
However, under these conditions non-fused systems lacked the selectivity 
demonstrated by Miura.34  
 
 
 
Scheme 17: Cu-only mediated direct C-H bond functionalisation of benzoxazole, as proposed 
by Daugulis and co-workers.
50
 
 
Mechanistic investigations on these reactions indicated that base played a key role. 
KOtBu, when used with iodobenzene-d5 resulted in 
1H-incorporation at the ortho 
position of the arene. The authors explain that this suggests a benzyne mechanism. No 
such incorporation is observed when LiOtBu is used. This suggests a deprotonation/Li-
Cu transmetallation followed by the reaction of the organocuprate species with the aryl 
iodide.  
 
Do and Daugulis later developed these conditions into a ‘general method’ for the 
arylation of arenes and heteroarenes.51 1,10-Phenanthroline had been employed by 
Daugulis in the C-H funtionalisation of fluoroarenes with CuI,52 and previously by 
Buchwald53,54 and Venkataraman55 in the formation of C-N and C-O bonds. When 
applied to the C-H arylation of heterocycles, it allowed substrates previously requiring 
KOtBu  {which proceeds via a benzyne mechanism, making it incompatible with 
substituted aryl iodides (vide supra)} to be functionalised with weaker bases.  For most 
acidic heterocyles (such as thiazole), K3PO4 was found to be effective. For others, 
including caffeine, LiOtBu was used.56  
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&7!;$*%+'+A+&=7+"()2+B6)&$9()!19#!$9()+(B+"*)C!C(1*#+++++ '> 
 
 
 
Scheme 18: Direct C-H bond functionalisation of benzoxazole using a stoichiometric quantity of 
Cu, and a substoichiometric quantity of PPh3, as proposed by Miura and co-workers.
57
 This 
methodology allows for a reduced stoichiometry of ArI.  
 
The work of Daugulis and co-workers required a significant excess of aryl iodide (3 
equivalents). Miura has demonstrated that by using a stoichiometric quantity of CuI and 
phosphine (20 mol%), a reduction in the stoichiometry of aryl iodide could be achieved 
in the C-H arylation of benzo[d]oxazole 53.57 This system also allowed for the use of 
weaker bases. These conditions were extended to 1-methylbenzo[d]imidazole, 
oxazole,58 oxadiazoles, and triazoles.59 When a sub-stoichiometric quantity of CuI was 
used, ring-opening (to ortho-(diphenyl)aminophenol) was observed. This side product 
was suppressed by increasing the stoichiometry of the aryl iodide, supporting Daugulis’ 
findings.     
2.1.2 –  Pd Nanoparticles in Catalysis 
Heterogeneous catalysis is defined as a process in which the catalyst is in a different 
phase from the reagents. Often, it involves metal species held on a support (e.g. silica, 
alumina or carbon). This allows for the easy separation of catalyst from reaction 
mixture during work-up and purification, which represents a significant advantage over 
homogeneous catalysis (that is, when the catalyst is in the same phase as the 
reagents).60  
 
Transition metal (including Pt, Pd and Re supported on alumina, silica and zeolites) 
nanoparticles have been used in catalysis since ca. 1950.61 Generally, this has been in 
large-scale gaseous processes, particularly in the petrochemical industry, and 
hydrogenation.62 Pt nanoparticles have also been utilised in catalytic converters.63 
Lewis and co-workers first identified the use of Pt nanoparticles in a solution system for 
hydrosilylation reactions.64 Over this period there has been an increase in research 
interest, as can be shown by Figure 6.  
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Figure 6: The number of papers matching the Web of Science® search phrase ‘nanoparticles 
AND catalysis’ on 17
th
April 2013.
 
The first use in a Pd-mediated cross-coupling reaction was in a Mizoroki-Heck reaction, 
reported by Beller, Herrmann and co-workers.65 Pd colloid was derived from PdCl2, 
N(n-oct)4Br and sodium triethyl boronate (using the method of Bonnemann and co-
workers).66 Blackmond and co-workers have developed Pd nanoparticles supported on 
polymer (specifically polyvinylpyrrolidone, PVP 55 and applied these as catalysts in the 
Mizoroki-Heck reaction.67 The nanoparticles were easily accessible from the 
hydrogenation of Pd2(dba)3.dba in the presence of the polymer. By varying the 
pressure of H2, the size (as measured by transmission electron microscopy) of the 
nanoparticles could be controlled: higher pressures result in smaller nanoparticles, 
possibly due to forcing conditions resulting in rapid nucleation. From the micrographs, it 
could be seen that these nanoparticles were equidimensional polyhedra, allowing the 
authors to characterize them by applying statistics relevant to face-centred cubic 
cuboctahedra, also called truncated polyhedra (Figure 8).68  
 
 
Figure 7: Structure of polyvinylpyrrolidone (PVP).  
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Figure 8: (a) A truncated icosohedral nanoparticle, showing terrace (blue) and defect (yellow) 
sites, and (b) graph showing the ratio of defect to terrace sites with the increase in particle size 
(nm).
69
 (Nanoparticle image prepared by Prof. I. J. S. Fairlamb and Prof. A. F. Lee) 
Adapted with permission from Langmuir 1999, 15, 7621. 
Copyright 1999 American Chemical Society 
 
On the surface of these polyhedral nanoparticles are two different Pd sites: terrace 
(high valent) and defect (low valent). Blackmond calculated how the ratio of terrace to 
defect sites varies with particle size (Figure 8). Nanoparticles of various sizes were 
then applied to a cross-coupling reaction. Exceptionally high yields (99%), TON 
(100,000 h-1) and TOF (80,000 h-1) could be obtained. Initial rates were measured for 
nanoparticles of each size, and normalized per surface Pd atom. If all nanoparticles 
were equally reactive, there should be no variation in initial rate with particle size. 
However, it was shown that smaller nanoparticles (i.e. those with a greater proportion 
of defect sites) had a higher initial rate. When the initial rate was normalized per defect 
Pd atom, there is no variation in the initial rate with particle size. This confirms that the 
defect site is the active site (whether active to surface chemistry or to leaching, vide 
infra). Further work on the Mizoroki-Heck reaction has been reported by Antonietti and 
co-workers (catalyzing with Pd colloids stabilized by block co-polymer micelles), and 
Ding and co-workers (liquid crystal polymer templates).70,71 
 
Reetz and co-workers reported a Suzuki-Miyaura reaction catalysed by Pd/Ni 
nanoparticles (prepared electrochemically, and redispersed in DMA).72 El-Sayeed and 
co-workers developed a Suzuki-Miyaura cross-coupling reaction catalysed by 
nanoparticles (diameter ca. 3.6 nm) similar to those of Blackmond and co-workers, 
stabilized by PVP.73 However, El-Sayeed’s nanoparticles were generated in aqueous 
EtOH solution from H2PdCl4, using the methodology of Miyake and co-workers.
74 Using 
this methodology, nanoparticle size can be varied by changing the concentration of 
PVP, and type/concentration of alcohol in solution. El-Sayeed used these 
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nanoparticles, in 40% EtOH at reflux, to synthesise a variety of biaryl products. Pd 
nanoparticles stabilised by PVP can also be generated by the reduction of Na2PdCl4 by 
H2 in sodium polyphosphate, or from Pd(PPh3)4.
75 
 
Despite these findings, the activation of C-X or C-H bonds in Pd-mediated catalysis 
had generally been considered to be an exclusively homogeneous process. Indeed, 
significant progress has been made in the elucidation of mechanisms for 
homogeneous cross-coupling reactions.76– 78 However, some processes have displayed 
heterogeneous characteristics, including the observation of Pd0 nanoparticles following 
the degradation of pre-catalysts (including palladacycles),79 as well as kinetic profiles 
that cannot be explained by exclusively homogeneous mechanisms.80 Some workers 
have attempted to explain such findings with Pd0 nanoparticles acting as a ‘reservoir’ of 
molecular Pd0 which is the active catalytic species in the homogeneous phase.81,82 
 
The catalytic activity of nanoparticle surfaces have been assessed in several ways. 
Single Pd crystals have been used as model systems in a clean environment using 
ultra high vacuum techniques. However, although evidence is available in the literature 
for the binding of sulphate anions and acetic acid,69 little is known with regard to the 
activity of the organoboronic acids. 
 
Rothanberg and co-workers have shown that Mizoroki-Heck and Sonagashira 
couplings can be catalysed by Pd clusters of < 5 nm in diameter. That is, using a 
nanoporous alumina membrane to separate other reagents from Pd nanoparticles of 
15 nm in diameter (stabilized by N(n-oct)4Br, and too large to pass through the 
membrane) reaction would still occur. Rothanberg described this as being indicative of 
molecular Pd leaching. However, since Blackmond and co-workers’ most active PVP 
stabilized Pd nanoparticles are <5 nm, this is inconclusive. Davis and co-workers have 
reported studies in which an atomic force microscopy (AFM) probe was coated with Pd 
nanoparticles.83 This probe was then used to initiate spatially-controlled coupling of 
surface-tethered aryl halides with phenylboronic acid. Such a reaction would be 
unlikely to occur if the reaction was mediated by Pd species in solution.  
 
Fairlamb, Lee and co-workers have used in operando (i.e. under working conditions) X-
ray absorbance spectroscopy (XAS) to study PVP stabilized Pd nanoparticles in 
Suzuki-Miyaura cross-coupling reactions.84,85 The XAS studies yielded TOF, which can 
be expressed with respect to nanoparticle size. When the TOF was normalized per 
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surface Pd atom, an inverse relationship with nanoparticle size was observed. When 
normalized per defect site, no variation with nanoparticle was observed. This supports 
the findings of Blackmond and co-workers. However, it has been suggested that this 
correlation may result from the greater propensity of lower coordinate Pd to solubilize 
(i.e. leach). XAS was further used to study leaching from the nanoparticle leaching 
sites –  the co-ordination number of the defect sites did not change throughout the 
reaction (Figure 9). This data was confirmed by monitoring of EXAFS fine structure 
(Figure 9 inset), which remained constant throughout the reaction.  
 
Fairlamb and co-workers also conducted leaching/spiking experiments on this system. 
The reaction was run under normal working conditions, and conversion monitored. At t 
= 18 min, the theoretical amount of leached Pd was added in the form of Pd(OAc)2. No 
change in conversion was observed as compared to normal working conditions. The 
Hg drop-test has been shown to inhibit surface reactions.86,87 When Hg was added to 
the reaction at t = 8 min, there was a significant reduction in conversion (note: the Hg-
coated Pd nanoparticles were characterised by XPS, which revealed the formation of 
Pd core, Hg-shell nanoparticles). Conversion did not recover on the addition of 
Pd(OAc)2 at t = 18 min (the amount added mirrored the theoretical amount of Pd that 
would be leached from a nanoparticle surface).  
 
 
 
Figure 9: XAS study demontrating lack of leaching from Pd-PVP nanoparticles.
85,88
 
Adapted with permission from Angew. Chem, Int. Ed. 2010, 49, 1820. 
Copyright 2010 Wiley® 
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Evidence for nanoparticles being involved in direct C-H bond functionalisation reactions 
remains scarce. Fairlamb and co-workers have demonstrated that Pd nanoparticles do 
form in the C-H bond functionalisation nucleosides (vide supra), and these 
nanoparticles have been characterized by TEM.26,27  
2.1.3 –  The Role of N-Heterocyclic Carbenes in Cu-Catalysis 
The existence of N-heterocyclic carbene (NHC) species was first hypothesised by 
Wanzlick and co-workers (Figure 19).89 Although only a dimer (the Wanzlick dimer 58) 
was isolated from this reaction, it was conjectured that an intermediate carbene was 
generated from the elimination of chloroform. 
 
 
 
Scheme 19: Synthesis of the Wanzlick dimer.
89
 
 
Wanzlick dedicated much of his career to the isolation of a stable N-heterocyclic 
carbene but never succeeded. It was not until the 1990s that Arduengo and co-workers 
published their isolation of 1,3-diadamantylimidazol-2-ylidene 60. This carbene (IAd) –
accessed from the deprotonation of the parent imidazolium salt 59 (Scheme 20) –  has 
been shown to be kinetically and thermodynamically stable. Indeed, Arduengo has 
retained a solution of IAd in THF-d8 (under an atmosphere of CO) for over seven years 
without observing decomposition or other reaction. The lack of reactivity when stored in 
this manner is unexpected, as other carbenes have been shown to generate ketenes 
under CO atmospheres.90
 
 
Scheme 20: Synthesis of IAd, as proposed by Arduengo.
89
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A crystal structure of IAd 60 obtained by Arduengo demonstrated that the valence 
angle (102°) was consistent with calculated angles for singlet carbenes. Arduengo later 
isolated a variety of analogues, including p-tolyl 62 (ITol), mesityl 63 (IMes), and methyl 
66 (IMe) (Figure 10).  
 
The isolation of IAd resulted in significant interest in the synthesis of similar stable 
nucleophilic carbenes, including other imidazole heterocycles and structures based on 
triazole backbones. Germanylenes91 and silylenes92 have also been isolated and 
characterised 
 
 
 
Figure 10: Examples of unsaturated N-heterocyclic carbenes.  
 
Arduengo and co-workers turned to the isolation of saturated variants of these 
compounds. Calculations and electron density studies indicated that, although, 
delocalization of electrons did play a part in the stability of unsaturated NHC species, 
there was little evidence of a highly delocalized π-system. In fact, compared to their 
parent imidazolium salts they appeared to show a substantial decrease in 
delocalization. 1,3-Dimesitylimidazolin-2-ylidene (SIMes) was the first of these 
carbenes to be isolated, again from the deprotonation of parent imidazolinium salts. 
This discovery led to, as with their unsaturated counterparts, the synthesis of a 
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significant library of analogues. Shortly after, Alder and co-workers published the 
isolation of an acyclic diaminocarbene (bis(diisopropylamino)carbene).93  
 
In the literature, there has been some discussion as to the electronic nature of N-
heterocyclic carbenes. A true carbene is defined as a compound containing a two-
coordinate carbon, in oxidation state II, which has two non-bonding electrons and no 
formal charge. In N-heterocyclic carbenes –  a subset of the Fischer carbene class –  
the divalent carbon centre is stabilized by a ‘push-pull’ effect: electron density is 
withdrawn by the nitrogen atoms through the σ-bond network, whereas the nitrogen 
lone pairs donate electron density into the empty p-orbital. As such, these species can 
be seen as either truly carbenoid 57 in character or as diamino ylides 57a (Scheme 
21).  
 
 
 
Scheme 21: Resonances structures of N-heterocyclic carbenes. There is debate as to whether 
these are most appropriately described as N-heterocyclic carbenes or amino ylides.  
 
   
 
Figure 11: Diagrammatic representation of calculations showing the electron density of a model 
N-heterocyclic carbene (a) in the molecular plane, and (b)  70 pm above the molecular plane.
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Adapted with permission from Acc. Chem. Res., 1999, 32, 913. 
Copyright 1999 American Chemical Society. 
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Neutron diffraction, X-ray diffraction, DFT calculations and solid-state 13C NMR 
spectroscopic data published by Arduengo have pointed to a true carbene 
character.94,95 In the molecular plane, electron density is highest at the C2 position, i.e. 
a σ lone-pair as would be expected in a singlet carbene. At 70 pm above the molecular 
plane, the π-bond of the C4-C5 bond is clearly visible, as are the nitrogen lone-pairs 
(Figure 11). However, little delocalization of these lone pairs into the empty p-orbital at 
C2 can be seen. This hypothesis has been supported by various ab initio studies.  
 
In-depth work by Schwarz and co-workers has indicated that there is a role for 
aromatic stabilization in unsaturated N-heterocyclic carbenes (that is, an ylide model), 
but noted that different theoretical approaches lead to different conclusions. Schwarz 
provides, in this paper, a comparison of different work on the subject and the 
conclusions reached. Studies by Sauers indicate that the extent of aromatic 
stabilisation is dependent on the carbene studied, and that in some there is 
theoretically some build-up of negative charge on the C2 position, as one might expect 
in an ylide model.  
 
NHC species have shown to be of interest to the organocatalytic community, but have 
found a key role in organo-transition metal chemistry, in particular transition-metal 
mediated catalysis. The first NHC-metal complex was reported by Ofele in the mid-
‘sixties, long before the isolation of stable free carbenes.96 Simultaneously, Wanzlick 
published a synthesis of NHC-Hg compounds (Scheme 22).  
 
 
 
Scheme 22: Early organometallic complexes containing N-heterocyclic carbenes.
96,97
  
Note: the use of perchlorate salts (ClO4
–
) should be carried out with extreme caution, as they 
are potentially explosive.  
 
N
N R
R
N
N R
R
[HCr(CO)5] Cr(CO)5
120 oC
H2
Ofele:
Wanzlick:
N
N R
R
N
N R
R
[ClO4]
Hg
N
NR
R
2
2 [ClO4]
Hg(OAc)2
72 73 
74 75 
&7!;$*%+'+A+&=7+"()2+B6)&$9()!19#!$9()+(B+"*)C!C(1*#+++++ ,: 
 
NHC-CuI complexes have been shown to have important roles in catalysis,98– 101 and 
demonstrated cytotoxic activity.102 The first NHC-CuI complex was isolated by 
Arduengo and co-workers from CuIOTf (Scheme 22). Nolan and co-workers have used 
similar homoleptic complexes, with PF6 or BF4 counter anions, as efficient pre-catalysts 
for the hydrosilylation of carbonyl compounds.103 These catalysts mediated these 
reactions with good yields and selectivity with short reaction times.  
 
 
 
Scheme 23: Synthesis of the first Cu-NHC complex, as proposed by Arduengo and co-
workers.
104
 
 
However, the first monocarbene complex was characterised by Raubenheimer and co-
workers (Scheme 24). These complexes –  using thiazole-derived carbenes –  existed 
as chloride dimers in the solid-state. This methodology was extended to a greater 
variety of thiazolylidene and N-methylimidazolylidene scaffolds.105  
 
 
 
Scheme 24: Initial monocarbene Cu-NHC complex, as proposed by Raubenheimer and co-
workers.
105
 
 
NHC-Cu complexes remained relatively rare in comparison to other group 11 transition 
metals. This was despite calculations by Boehme and Frenking reporting that the C-Cu 
dissociation energy would be 61 kcal mol-1 higher than their Ag congeners. 
Danopoulous and co-workers synthesised pyridine-N-functionalised CuI complexes 
from imidazolium bromides and Cu2O (Scheme 25).
106 Dependent on substituents and 
recrystallisation conditions, these complexes existed as monomers, dimers and 
polymers.  
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Scheme 25: Synthesis of Cu-NHC complexes with Cu2O, as proposed by Danopoulous and co-
workers.
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Douthwaite and co-workers used this method in the synthesis of carbene-phenoximine 
complexes.107 Cazin and co-workers demonstrated that this ‘green’ approach (the only 
by-product being water) to Cu(NHC)X 85 formation could be applied to a variety of well 
used NHC.HX 84 salts, including (S)IMes, (S)IPr, and (S)ICy in different solvents 
(Scheme 26, Figure 12).108  
 
 
 
Scheme 26: Synthesis of Cu(NHC)X complexes using the Danopoulous method, in different 
solvents, as proposed by Cazin and co-workers.
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Figure 12: Results for the synthesis of Cu(NHC)X complexes using the Danopoulous method, 
in different solvents, as proposed by Cazin and co-workers.
108
 
 
In water, when ICy or SICy are used, formation of imidazolid-2-one is observed, 
confirming findings by Albrecht (vide infra).110  
 
Arnold and co-workers reported the first use of a NHC-chelate ligand in CuI complexes 
Scheme 27).111 The proligand (i.e. the imidazolium salt) is synthesised in one step with 
epichlorohydrin and 1-tert-butylimidazole. The ligand is then treated with AgI2O, 
followed by CuII, to yield 90 (85% yield).  
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Scheme 27: First synthesis of a NHC-chelate ligand, proposed by Arnold and co-workers.
111
 
 
Other bidentate NHC-CuI complexes have been synthesised by Bellemin-Laponnaz 
and Gade.112    
 
Buchwald and co-workers synthesised the first NHC-Cu complex of the form 
(NHC)CuX, where X is a halide, via the simple reaction of free carbene with CuICl 
(Scheme 28).53 The resulting complex was found to be air and moisture stable, and 
demonstrated to be useful as a catalyst in the conjugative reduction of α,β-unsaturated 
carbonyl compounds.  
 
 
 
Scheme 28: Synthesis of monocarbene Cu-NHC complexes, as proposed by Buchwald and co-
workers.
53
 
 
In similar work by Nolan and co-workers, the reduction of carbonyls was performed by 
(NHC)CuCl complexes formed in situ from the parent imidazolium salt.113 The reaction 
was found to be as efficacious when a pre-synthesised (using a method identical to 
that used by Buchwald), well-defined (NHC)CuCl complex was used. Lebel has utilized 
Nolan’s catalysts in the synthesis of styrenes and aliphatic alkenes from carbonyls.114 
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Nolan later demonstrated the utility of Cu(NHC)X complexes in the hydrosilylation of 
ketones and ‘click’ chemistry,115 and to the direct C-H bond carboxylation of arenes.109  
 
Sadighi and co-workers have successfully synthesised a (NHC)CuMe complex 94, via 
a novel (NHC)CuOAc complex 93 (Scheme 29).116 This complex reacts cleanly with 
CO2 to reform the acetate complex in near-quantitative yield, which suggests these 
species could be utilised in CuI-catalysed carboxylation reactions. Sadighi later 
published syntheses of (NHC)CuOtBu, (NHC)CuH and (NHC)Cu(alkenyl) complexes. 
Wang and co-workers have successfully synthesised (NHC)CuICp complexes.117  
 
 
 
Scheme 29: Synthesis of a (NHC)CuMe complex, proposed by Sadighi and co-workers.
116
 
 
Tsubomura and co-workers have synthesised a bi-metallic NHC-CuI complex 97 
(Scheme 30).118 In doing so, they also demonstrated these complexes could be 
produced via transmetallation from AgI. These complexes were considered for 
applications as luminescent materials in light emitting diodes. Similar bi-metallic 
complexes –  with only one carbene per metal –  were reported by Hoffman and co-
workers.119  
 
Albrecht and co-workers, after a study of a comprehensive library of bis-NHC-CuI 
complexes, demonstrated that substituents play an important role in stability.110 Their 
complexes, synthesised either by the Buchwald/Nolan method or from the reaction of 
free carbene with [Cu(NCMe)4]PF6, demonstrated that aryl (e.g. IMes or IDipp) 
produced the most stable CuI complexes, whilst alkyl substituents (including seemingly 
more hindered NHCs such as IPr) induced rapid demetallation in the presence of 
water. Albrecht used these complexes in a novel ligand transfer to Ru (Scheme 31). 
Furst and Cazin demonstrated that Cu(NHC)X complexes could also be used as 
carbene transfer reagents to AuI and PdII.120  
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Scheme 30: Synthesis of bimetallic Cu(NHC) complexes, proposed by Tsubomura and co-
workers.
118
 
 
 
 
Scheme 31: Cu(NHC) complexes as a carbene transfer agent to S and to other transition 
metals, as proposed by Albrect and co-workers. 
 
Metal-carbene complexes as intermediates in catalysis are well known, and have been 
particularly well studied in cross-metathesis reactions. CuI carbene complexes have 
been implicated in the Cu-catalysed cyclopropanation of alkenes.121– 123 However, in 
general these intermediates have been traditional Fischer or Schrock carbenes, rather 
than NHCs.  
 
Bergman and Ellman have shown the intermediacy of NHCs in the C-H bond 
functionalisation of benzimidazoles with Rh (Scheme 32).124 Using calculations and 
stoichiometric studies, it was demonstrated that this intermediate is a catalytic resting 
state, and the insertion into the Rh-carbene bond is the rate-limiting step of this 
reaction. 
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Scheme 32: Bergman and Ellman’s synthesis of proposed Rh(NHC) intermediates for C-H 
bond functionalisation reactions.
124
  
 
NHCs have most usually been synthesised via the deprotonation of their onium salts, 
as demonstrated by Arduengo’s initial synthesis of IAd.125 However, the generation of 
carbene by this method can prove problematic, especially in the presence of other 
acidic protons (benzylic positions, for example). A relatively underused method, 
developed by Hedrick and Waymouth, uses pentafluorophenyl in place of a chloroform 
adduct.126 These have been shown, on heating, to release free carbene and C6F5H, 
and have been used as organocatalysts in polymerisation chemistry. They are also 
useful synthons for generating the free carbene for use in organometallic chemistry.  
2.1.4 Summary  
As detailed above, direct C-H bond functionalisation with Pd, Cu and Pd/Cu systems 
has become an important and highly productive area of research. However, the 
mechanism of these reactions – in particular the role of CuI salts – is poorly 
understood. Further, although the catalytic phase of traditional Pd-mediated cross-
coupling reactions has been probed in depth, the possibility of heterogeneous or 
hybrid-phase catalysis in direct C-H bond functionalisation chemistry remains relatively 
underexplored.  
 
In this chapter are detailed studies into the role played by Pd0 nanoparticles in the C-H 
bond functionalisation of benzoxazoles and benzothiazoles using pre-synthesised Pd0 
nanoparticles, trapping of nanoparticles formed in situ, and their analysis by 
transmission electron microscopy. The role of CuI in direct C-H bond functionalisation 
chemistry (specifically that developed by Miura, Bellina and Rossi) is probed using 
model (1,3-dibenzylbenzimidazoliydene)copper(I) halide complexes in stoichiometric 
reactions.  
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2.2 C-H bond Functionalisation of Benzazoles with Pd0 
Nanoparticles 
2.2.1 Synthesis of Pd-PVP Nanoparticles 
Pd0 nanoparticles supported on PVP (molecular weight ca. 29,000) were synthesised 
by reduction in the presence of polymer, using the method of Fairlamb and co-
workers.60,84 The particles produced were a black, glass-like solid which were ground to 
a black powder for use in reaction mixtures using a pestle and mortar. 
 
The particles were suspended in EtOH, applied to transmission electron microscopy 
slides, and micrographs of the sample recorded (Figure 13). These experiments were 
performed with the assistance of Thomas Herbert MChem (project student).  
 
 
 
Figure 13: Example electron micrograph of sample of pre-synthesised PVP (MW = 29,000) 
stabilised Pd nanoparticles. Inset shows histogram of particle diameter (nm) across a sample of 
nanoparticles (n = 98). 
 
A random sample of nanoparticles was chosen (n = 98) and their diameter measured 
manually. Statistical data is shown in Table 1. This data can also be represented as a 
histogram (inset, Figure 13).  
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Table 1: Table showing simple statistical measurement for Pd-PVP particles (MW = 29000). 
SD  = Standard Deviation, IQR = Interquartile Range, IQM = Interquartile Mean 
 
 Mean SD Median Mode IQR IQM 
Pd-PVP 3.20 1.01 3.09 3.34 1.17 3.04 
 
This data shows that the particles are within the 2-5 nm size regime and, within error, 
are consistent with previously reported data.84  
 
X-ray photoelectron spectroscopy (XPS) on this sample provided information on 
particle surface oxidation state, and was performed by Dr K. Wilson (Cardiff Catalysis 
Institute, University of Cardiff). The Pd 3d XP spectrum for the sample is shown in 
Figure 14. It indicates the presence of Pd0 and a small amount of PdII. The higher 
oxidation state is probably the result of minor oxidation of surface Pd. This is consistent 
with previously recorded data.85  
 
The nanoparticles also exhibit a strong NR3 bonding mode in the N 1s XP spectrum 
(Figure 15). This is consistent with the structure of the tertiary amide present in the 
polymer subunit. Further, this is evidence that polymeric degradation has not occurred 
under the reaction conditions.  
 
 
 
Figure 14: Pd 3d XP spectral data showing the presence of Pd
0
, and a small quantity of Pd
II
. 
Analysis performed by Dr K. Wilson, University of Cardiff.  
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Figure 15: N 1s XP spectral data showing the NR3 bonding mode. 
Analysis performed by Dr. K. Wilson, University of Cardiff.  
 
2.2.2 Role of Pd0 Nanoparticles in Bellina-Rossi Functionalisations
Bellina and Rossi have published base- and ligand-free C-H bond functionalisation of 
1H-imidazole 21 (vide supra) which have previously been studied within the Fairlamb 
group by Dr Jonathan P. Reed (Scheme 33).37,38,127 It was noted that in different 
vessels (Radley’s® carousel tube and Schlenk tube, Figure 16), using otherwise 
identical conditions starkly different results were obtained (Table 2, Entries 1-2). When 
the reaction was performed using Pd(OAc)2 as a pre-catalyst in the Radley’s® carousel 
tube, 57% yield was obtained. However only trace product was observed in the 
Schlenk tube. It is proposed in this, and similar systems, that the Pd(OAc)2 is reduced 
in situ to Pd0. Nanoparticles (Pd black) are clearly present in the reaction mixture. It 
was thought that the presence of these nanoparticles could explain the difference in 
reactivity.  
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The Radley’s® carousel system is generally thought to exclude air and water less 
vigorously than traditional Schlenk techniques. This suggests that trace quantities of air 
and water could be necessary for the reaction to proceed. However, intentional 
addition of air and water to the reaction mixture in the Schlenk tube had no effect 
(entries 4-6).  
 
 
 
Figure 16: Radley’s® Carousel Tube (left) and traditional Schlenk tube. 
 
 
 
Scheme 33: Direct C-H bond functionalisation of 1H-imidazole using Pd/Cu system, and no 
base.
127
 
 
Similarly, when the reaction was performed in an open system (that is, with a constant 
flow of N2 exiting through a bubbler) or with a balloon, no increase in yield was 
observed (entries 9, 10). Other PdII and Pd0 palladium sources (entries 3, 11) gave only 
trace yields. Unsurprisingly, the use of Pd2(OMe-dba)3.(OMe-dba) as a catalyst in a 
Radley’s® carousel tube resulted in some conversion to product (35% yield). However, 
this did confirm that Pd0 could be the active catalyst. The successful reactions with 
both PdII and Pd0 precatalysts could be visibly observed to form Pd0 nanoparticles 
during the course of the reaction. In light of the group’s experience with Pd0 
nanoparticles in the Suzuki-Miyaura reaction,84,85 it was decided to test some pre-
synthesised nanoparticles to assess their efficacy as catalysts for this process. 
Excitingly, the use of Pd-PVP nanoparticles in the reaction gave a higher yield than 
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Pd(OAc)2 in the Radley’s® tube. We were keen to examine whether nanoparticles 
could catalyse C-H bond functionalisation in other reactions and on other heterocycles.  
 
Table 2: Results for the direct C-H bond functionalisation of 1H-imidazole using Pd/Cu system, 
and no base.
127
These reactions were peformed in a traditional Schlenk tube unless otherwise 
stated 
Entry Pd Source Conditions Yield % 
1 Pd(OAc)2 Radley’s® Carousel 57 
2 Pd(OAc)2  Trace 
3 [Pd(mal)2(MeCN)2]  Trace 
4 Pd(OAc)2 30 mL air 0 
5 Pd(OAc)2 Trace Air Trace 
6 Pd(OAc)2 H2O Trace 
7 Pd(OAc)2 NMP solvent Trace 
8 Pd(OAc)2 Cu(OAc)2 0 
9 Pd(OAc)2 Balloon Trace 
10 Pd(OAc)2 Bubbler 7 
11 [Pd2(OMe-dba)3.(OMe-dba)]  Trace 
12 [Pd2(OMe-dba)3.(OMe-dba)] Radley’s® Carousel 35 
13 Pd-PVP Radley’s® Carousel 67 
 
 
 
Scheme 34: Direct C-H bond functionalisation of benzo(azoles) using Pd/Cu catalyst systems. 
 
 
 
Scheme 35: Direct C-H bond functionalisation of benzimidazole using Pd/Cu catalyst systems, 
demonstrating that CsF is a more effective base for these transformations than Cs2CO3. 
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The direct C-H bond functionalisation reactions published by Bellina and Rossi128 that 
are not ‘base-free’ (specifically, utilising Cs2CO3 or CsF, Scheme 34) were investigated 
in a similar fashion to above. First, the efficacy of each base was assessed on 1-
methylbenzimidazole 105 (Scheme 35). CsF was found to be a more effective base in 
line with the findings of Bellina and Rossi. As such, this was selected as a base for this 
study. Benzoxazole 53 and benzothiazole 49 were used as substrates. The reaction 
time in Bellina and Rossi’s published work varies on substrate between 19 and 40 h. It 
was considered that for comparison of catalyst efficiency, a uniform reaction time was 
required. A time of 16 h was chosen because it was felt it would give conversion 
reflective of reaction efficacy within a reasonable (i.e. preparatively useful) timeframe. 
Therefore, the yields presented below cannot be compared directly with those in 
Bellina and Rossi’s papers. Indeed, they all represent a significant reduction in reaction 
time. 
 
When Pd(OAc)2 was used as a pre-catalyst, yields were found in both substrates to be 
lower in the carousel tube than the Schlenk tube (Table 3). This is the opposite effect 
to that observed by J. P. Reeds above, where the reaction performed in a carousel 
tube was found to be more effective.  
 
For benzothiazole 49, the use of Pd-PVP nanoparticles increased yields in both 
reaction vessels (an increase of 8% in the Schlenk tube, 36% in the carousel tube). 
This is consistent with the previous results. Indeed, it makes the yields in both vessels 
almost identical. It is therefore proposed, for benzothiazole 49, the exact nature of the 
Pd0 nanoparticles is key to ensuring catalytic efficacy. The nanoparticles formed in situ 
in the Schlenk tube are more effective catalysts than those formed in the carousel tube. 
When the nature of the particles is fixed by using pre-synthesised Pd-PVP catalyst, 
there is less difference in reactivity between the two systems.  
 
The situation with benzoxazole 53 does differ. For Pd(OAc)2, again we see reduced 
yield in the carousel tube as compared to the Schlenk tube. However, whilst the 
reaction in the carousel tube experiences a significantly increased yield (difference 
52%) with Pd-PVP nanoparticles, in the Schlenk tube the opposite is true (the yield is 
reduced by 31%). The reason for this is unclear. However, on both substrates it would 
seem that the Pd-PVP in a carousel tube is an effective reaction system.  
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Table 3: Table showing the results for the direct C-H bond functionalisation of benzoxazole and 
benzothiazole in different reaction vessels with molecular and nanoparticle catalsyts. 
Entry Heterocycle Schlenk Tube Carousel Tube 
  Pd(OAc)2 Pd-PVP Pd(OAc)2 Pd-PVP 
1 Benzothiazole 49 53 61 23 59 
2 Benzoxazole 53 71 40 27 79 
 
It was thought that the reactivity difference with Pd(OAc)2 pre-catalyst could result from 
the nature of the Pd0 nanoparticles formed. It is possible that the difference in H2O/O2 
concentration, or the reaction stirring (the dynamics of which would differ based on 
reaction vessel), could result in nanoparticles of different size, shape or composition. It 
was hypothesised that the particles generated in situ with the Schlenk tube might 
mimic the pre-synthesised Pd-PVP nanoparticles, hence explaining the increase in 
reactivity when the pre-synthesised particles are used.  
 
It is worth noting that for the C-H bond functionalisation of benzoxazole 53, Miura and 
co-workers had previously recorded a yield of 88% over a period of 9 h using Pd(OAc)2 
for a similar reaction (PPh3 was also added). However, this reaction was run at 140 °C. 
The work presented here demonstrates that similarly high yields can be obtained at 
lower temperatures with Pd-PVP nanoparticles.  
 
Previously, the Fairlamb group has developed a method for the trapping of Pd0 
nanoparticles that have been generated in situ.27 This involves the addition of an 
extragenous polymer, which acts as a stabiliser. PVP is usually employed for this 
purpose. This polymer encapsulates the nanoparticles, and improves the reliability of 
size distribution analysis without changes in solvent concentration in vacuo promoting 
metal aggregation.  
 
Two samples were taken from the direct C-H bond functionalisation reaction of 
benzothiazole 49 with Pd(OAc)2 in the Schlenk and carousel tube. To a reaction 
sample was added PVP (10 eq. per theoretical quantity of Pd, assuming a fully 
homogenous mixture in the reaction, thus in reality a large excess). The solvent was 
removed from the samples under reduced pressure, heating at ca. 50 °C. Transmission 
electron micrographs were recorded for each of these samples (Figure 17, 18). In the 
samples containing polymer, Pd0 nanoparticles were clearly observed. The samples 
without polymers were unclear, and could not be analysed (indeed one, shown in 
Figure 19, showed large needle-shaped crystals believed to be CsF).  
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Figure 17: Example electron micrograph of sample taken from the direct C-H bond 
functionalisation of benzothiazole 49 performed in a Carousel tube after 2 h, with PVP (10 eq. 
per Pd) added before solvent removal. Inset shows histogram of particle diameter (nm) across a 
sample of nanoparticles (n = 100). 
 
  
 
Figure 18: Example electron micrograph of sample taken from the direct C-H bond 
functionalisation of benzothiazole 49 performed in a Schlenk tube after 2 h, with PVP (10 eq. 
per Pd) added before solvent removal. Inset shows histogram of particle diameter (nm) across a 
sample of nanoparticles (n = 100). 
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Figure 19: Example electron micrograph of sample taken from the direct C-H bond 
functionalisation of benzothiazole 49 performed in a Schlenk tube after 2 h followed by solvent 
removal. There is a significant quantitity of large needle-shaped crystals, hypothesized to be 
CsF. Note the scale is significantly larger than Figures 17-18. 
 
A random sample of nanoparticles was chosen (n = 100) from each sample and 
measured manually. Statistical data is shown in Table 4. This data can also be 
represented in a histogram (insets, Figures 17, 18). 
 
Table 4: Table showing simple statistical measures for nanoparticles isolated from the direct C-
H bond functionalisation of benzothiazole 49 with Pd(OAc)2/CuI catalyst systems.  
SD  = Standard Deviation, IQR = Interquartile Range, IQM = Interquartile Mean 
 
 Mean SD Median Mode IQR IQM 
Carousel 4.64 1.62 3.39 3.39 2.54 4.52 
Schlenk 6.07 2.25 6.68 6.03 1.72 5.98 
 
The average size of the nanoparticles generated in both the Carousel and Schlenk 
vessels are slightly larger than the pre-synthesised nanoparticles and, indeed, other in 
situ generated nanoparticles found elsewhere in this thesis (vide infra). The 
nanoparticles generated in the reaction in the Schlenk tube are larger than those taken 
from the Carousel tube (difference in mean size 1.43 nm). This size difference is not 
within the estimated error. The Schlenk tube sample exhibits a larger range of particle 
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sizes, as shown by the greater standard deviation and interquartile range. Further, 
visual inspection of the histograms (Figures 18-18, insets) reveals a greater number of 
outlying sizes (at sizes > 10 nm).  
 
This result was unexpected. The more active (Schlenk) in situ generated nanoparticles 
were larger than both those generated in the carousel and the Pd-PVP nanoparticles. 
As previously stated, it is generally assumed that the carousel tube excludes O2 and 
H2O less vigorously than the Schlenk. Generally, their presence results in the growth of 
larger nanoparticles.129 Therefore, the slight difference in particle size is surprising. It 
cannot be said that mimicking the Pd-PVP particle size can explain their reactivity.  
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2.2.3 Direct C-H bond Functionalisation of Benzoxazole with PhI(OAc)2 
This section resulted in the following publication: Williams, T. J.; Fairlamb, I. J. S. A key 
role for iodobenzene in the direct C-H bond functionalisation of benzoxazoles using 
PhI(OAc)2 mediated by a Pd(OAc)2/1,10-phenanthroline catalyst system: in situ 
formation of well-defined Pd nanoparticles. Tetrahedron Letters (in press). 
 
In 2012, Chen, Cheng and co-workers published a methodology for the direct C-H 
functionalistion of benzoxazole 53 mediated by Pd(OAc)2 to give 2-phenylbenzoxazole 
14.130 This work differed from conditions for this transformation previously published, in 
that PhI(OAc)2 107 was utilized as an aryl source (Scheme 36). Although hypervalent 
iodine compounds are found as aryl sources in the direct C-H bond functionalisation of 
indoles (vide supra), PhI(OAc)2 107 had not previously been used for this 
purpose.131,132 By comparison with other functionalisations using hypervalent iodine 
salts, and considering the strong oxidizing nature of the reagent, the authors proposed 
that this reaction proceeded via a PdII/IV manifold (the intermediacy of PdIV complexes is 
discussed in more detail in Chapter 3).133  
 
 
 
Scheme 36: Direct C-H bond functionalisation of benzoxazoles with PhI(OAc)2.
 
This reaction is performed at high temperature (150 °C) in polar solvent (DMSO), with 
carbonate base (Cs2CO3). These conditions are similar to those previously reported for 
the functionalisation of benzazoles with aryl iodide. For example, studies by Murai and 
co-workers use near-identical conditions with PhI, and DMA as opposed to DMSO.134 
Chen and Cheng, however, report that the reaction with PhI does not proceed.  
 
When this work was repeated using PhI(OAc)2  107, a 69% yield was obtained (84% 
reported). Almost immediately on addition of solvent to the reaction mixture, a colour 
change from orange to dark brown was observed, which indicates the presence of Pd0 
colloidal nanoparticles (Figure 20). The reaction appeared similar to the Bellina-Rossi 
arylations previously discussed. Consequently, two separate aliquots of the reaction 
mixture were taken (after 2 h heating). To one of these samples, PVP (10 eq. per 
O
N
O
N
PhI(OAc)2 (1.25 eq.)
Cs2CO3 (1 eq.)
Pd(OAc)2 (5 mol%), Phen (10 mol%) Ph
N2, DMSO, 150 
oC, 20 h
84%
54 108 
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theoretical amount of Pd, assuming the reaction was a homogenous mixture) was 
added. Solvent was removed from both samples under reduced pressure, heating at 
50 °C. Transmission electron micrographs were recorded for each of these samples 
(Figure 21). In both samples, Pd0 nanoparticles were clearly observable.  
 
 
 
Figure 20: Reaction using ‘Chen-Cheng’ conditions for the direct C-H bond functionalisation of 
benzazole – taken immediately after the addition of dry solvent, under N2.
130
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Figure 21: Example electron micrograph of sample taken from ‘Chen-Cheng’ reaction after 2 h, 
with PVP (10 eq. per Pd) added before solvent removal. Inset shows histogram of particle 
diameter (nm) across a sample of nanoparticles (n = 100).  
 
A random sample of nanoparticles was chosen (n = 100) from each sample and 
measured manually. Statistical data is shown in Table 5. This data can also be 
represented in a histogram (inset, Figure 21). 
 
Table 5: Statistical analyses for nanoparticles produced in Chen-Cheng reaction.  
 
 Mean SD Median Mode IQR IQM 
With PVP 2.44 0.58 2.13 2.55 0.638 2.43 
Without PVP 2.11 0.46 1.69 1.69 0.636 2.07 
 
 
Nanoparticles in both samples are generally < 5 nm, similar to pre-synthesised 
nanoparticles supported on PVP. There is a small difference between the two samples, 
which is within error (mean difference 0.3 nm).  
  
The stability of PhI(OAc)2 107, under the reaction conditions was assessed. The 
reagent was purchased from Sigma-Aldrich®, and purity established by comparison to 
literature 1H NMR spectra in CDCl3. It has previously been reported that 
(dicarboxy)iodoarenes are susceptible to degradation via thermal and radical 
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mechanisms.135,136 PhI(OAc)2  107 was fully dissolved in DMSO-d6 at ambient 
temperature (Figure 22). A 1H NMR spectrum recorded ca. 5 min after dissolution 
indicated the presence of one major species. After ca. 30 min, several species are 
observable in solution, including PhI (identified by comparison with an authentic 
sample). These species continue to grow over time. The presence of AcOH in solution 
can also be observed.  
 
Figure 22: 
1
H NMR spectra for the degradation of PhI(OAc)2 107 at ambient temperature (500 
MHz, DMSO-d6); (a) t = 5 min, (a) t = 30 min, (c) t = 40 min, (d) t = 50 min, (e) PhI (commercial 
sample, Sigma-Aldrich®).  Note: the stacked spectra on the left hand side show the appearance 
of an acetic acid proton. 
 
 
The progress of this reaction has been monitored by 1H NMR spectroscopy over 16 h, 
integrating a resonance for each species with respect to residual deutrated solvent 
(Figure 23). Rapid formation of intermediate was observed over the initial 30 min. After 
this time, loss of intermediate was observed concomitant with the increased formation 
of PhI. An apparent slight recovery of PhI(OAc)2 107 concentration is also observed, 
however 1H-13C HSQC has indicated that this is the result of a fourth uncharacterised 
species which is co-incident with the proton resonances of PhI(OAc)2 107. This 
experiment indicates that this reaction does not proceed to completion at ambient 
temperature.  
 
(a) 
(b) 
(c) 
(d) 
(e) 
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Figure 23: Kinetic curves (
1
H NMR spectroscopy, 500 MHz, DMSO-d6) showing relative 
integrations of PhI(OAc)2, intermediate and PhI with respect to residual undeutrated solvent. 
 
This reaction was repeated in the presence of Cs2CO3 (0.8 eq., as per the reaction 
stoichiometry). Cs2CO3 does not fully dissolve in DMSO-d6. A 
1H NMR spectrum was 
recorded at t = 5 min, and shows an identical but accelerated reaction.  Further spectra 
were recorded at t = 10, 30 and 60 min intervals (Figure 24). The AcOH resonance is 
not observed, and is presumably being sequestered by the base. 
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Figure 24: 
1
H NMR spectra for the degradation of PhI(OAc)2 and Cs2CO3 at ambient 
temperature (500 MHz, DMSO-d6); (a) PhI(OAc)2 without Cs2CO3 (t = 5 min after dissolution) (b) 
PhI(OAc)2 and Cs2CO3, t = 5 min,  (c) PhI(OAc)2 and Cs2CO3, t = 10 min, (d) PhI(OAc)2 and 
Cs2CO3, t = 30 min, (e) PhI(OAc)2 and Cs2CO3, t = 60 min, (f) PhI (commercial sample, Sigma-
Aldrich®).  Note: the stacked spectra on the left hand side show the acetic acid proton does not 
appear. 
 
A freshly prepared sample of PhI(OAc)2 in DMSO-d6 was heated to 150 °C for 10 min 
(Figure 25). A 1H NMR spectrum was then recorded, which indicated complete 
conversion to PhI. Therefore, under the reaction conditions, PhI(OAc)2 rapidly 
degrades to PhI. The intermediate species observed at room temperature is most likely 
the product of solvolysis, consistent with the formation of AcOH. This reaction was 
repeated with Cs2CO3 (0.8 eq., reaction stoichiometry), and an identical result 
recorded. It can be assumed that, as at room temperature, the reaction is accelerated 
but this cannot be observed due to the rapid nature of the reaction.  
 
(a) 
(b) 
(c) 
(d) 
(e) 
(f) 
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Figure 25: 
1
H NMR spectra for the degradation of PhI(OAc)2 at 150 °C in a sealed Young’s Tap 
tube (500 MHz, DMSO-d6); (a) before heating, ca. 5 min after dissolution (b) t = 10 min (c) PhI 
(commercial sample, Sigma-Aldrich®).  Note: the stacked spectra on the left hand side show 
the appearance of acetic acid proton [in (b)]. 
 
When the reaction was performed using PhI, an 84% yield was obtained. Chen, Cheng 
and co-workers had previously reported that PhI as an aryl source gave only trace 
product. To understand this, it was found that when the reaction was conducted in the 
presence of air, a lower yield (45%) was recorded.  
 
 
 
Scheme 37: Competition experiment between PhI(OAc)2 and 1-iodo-4-methylbenzene. 
 
A competition experiment was run between PhI(OAc)2 107 and 1-iodo-4-
methylbenzene with benzoxazole (Scheme 37). Two products, 108 and 109, were 
formed in this reaction, in a ratio of 1.5:1 (as determined by 1H NMR spectroscopy, 
O
N O
NPhI(OAc)2 (1.25 eq.), 4-MeC6H4I (1.25 eq.) 
Cs2CO3 (1 eq.)
Pd(OAc)2 (5 mol%)
1,10-Phenanthroline (10 mol%)
N2, DMSO, 150 
oC, 20 h
O
N
Ratio of 108:109 by 1H NMR spectroscopy: 1:1.5
(a) 
(b) 
(c) 
108 
109 53 
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Figure 26). The observation demonstrates that both aryl sources are viable cross-
coupling partners. The reactivity difference between iodobenzene generated in situ and 
1-iodo-4-methylbenzene is as expected for a Pd0/PdII type catalytic process, as 
demonstrated by Jutand and co-workers.137–139 
 
 
Figure 26: 
1
H NMR spectrum (selected region) of the crude mixture from the competition 
experiment using PhI(OAc)2 and 4-MeC6H4I. Resonances shown have been identified as 2-(4-
methylphenyl)benzoxazole (8.18 ppm – 2H, d) and 2-phenylbenzoxazole (8.26 ppm – 2H, m) by 
comparison with literature data. 
 
Therefore, it seems most likely that PhI(OAc)2 107 is not the aryl source in this 
reaction. Rather, it is proposed that PhI is formed in situ. In light of the presence of Pd0 
nanoparticles, which have now been characterized, the PhI will functionalise 
benzoxazole in an electrophilic aromatic substitution mechanism consistent with that 
proposed in Scheme 7. That is, one mediated by a Pd0/II manifold as opposed to the 
PdII/IV process postulated by Chen, Chang and co-workers (with little evidence).140  
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2.3 Role for Cu-NHC Complexes in Pd/Cu-Mediated Systems 
2.3.1 Cu(NHC)X Complexes as Model Intermediates 
Elements of this section resulted in the following publications: Lake, B. R. M.; Bullough, 
E. K.; Williams, T. J.; Whitwood, A. C.; Little, M. A.; Willans, C. E. Simple and versatile 
selective synthesis of neutral and cationic copper(I) N-heterocyclic carbene complexes 
using an electrochemical procedure. Chem Commun. 2012, 48, 4887-4889; Williams, 
T. J.; Lake, B. R. M.; Whitwood, A. C.; Willans, C. E.; Fairlamb, I. J. S. Arylation and 
decomposition of copper(I) N-heterocyclic carbenes of relevance in C-H bond 
functionalisation (submitted). 
 
Bellina, Rossi and co-workers and Fairlamb and co-workers have proposed similar 
mechanisms for the C-H bond functionalisation of N-heterocycles using Pd and Cu 
catalysts.26–28,35–37 A combined mechanism is shown in Figure 27. Complex I is 
proposed as an intermediate formed from the cupration of imidazole. They propose 
that the equilibrium for the deprotonation/cupration lies significantly towards the starting 
material. Therefore, they propose that an excess of CuI is required to push the 
equilibrium towards the intermediate. Complex I is a tautomer of intermediate II, an N-
heterocyclic carbene copper(I) complex. Daugulis has proposed similar intermediates 
for sub-stoichiometric Cu-only C-H bond functionalisations.141  
 
As discussed, Cu(NHC)X complexes are well known in the literature. Cu(NHC) 
complexes with sterically unhindered N-substituents are unstable and susceptible to 
oxidation. Therefore, the proposed intermediate II would be highly sensitive and it 
would be impractical to detect in situ or isolate from a stoichiometric study. 
 
It was thought that 1,3-disubstituted imidazolyidene complexes could be used as model 
systems to test whether these complexes could be intermediates in C-H bond 
functionalisation reactions. It was decided that (1,3-
dibenzylbenzimidazolydene)copper(I) bromide 110 might be an effective model. 1-
benzylimidazole is a common substrate in direct C-H bond functionalisation, and the 
second benzyl group could mimic the proton in intermediate II. The use of a benzo-
fused system avoids complications with activation at the C4 and C5 positions, which 
might occur with the imidazolium analogues.  
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Figure 27: Mechanism for the direct C-H bond functionalisation of imidazoles and related purines, as proposed by Bellina, Rossi and Fairlamb.
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2.2.2 Synthesis of Cu-NHC Complexes 
As discussed, Cu-NHC complexes can be synthesised by a variety of different 
methods. 1,3-Dibenzylbenzoimidazolium bromide 113 (Figure 28 shows single crystal 
X-ray diffraction structure) is a sensitive substrate due to the relatively high acidity of 
the benzylic position. Of particular interest was the method of Cazin and co-workers,108 
which allows access to a variety of different NHC complexes whilst avoiding tert-
butoxide or lithium amide/alkyl bases.  
 
 
 
Figure 28: Single crystal X-ray diffraction structure of 1,3-dibenzylbenzoimidazolium bromide 
113 (the bromide anion and H2O not bonded to the benzimidazolium). Hydrogen atoms have 
been removed for clarity. Thermal ellipsoids shown at 50%. Selected bond lengths (Å), bond 
angles and torsion angles (°): N(2)-C(8) = 1.476(2), C15, N(1)-C(15) = 1.481(2), N(2)-C(8)-C(9) 
= 112.20(16), C(7)-N(2)-C(8)-C(9) = 76.2(2). 
 
When 1,3-dibenzylimidazolium bromide was subjected to these reaction conditions, 
Cu(NHC)X product was not observed. Instead, brown needle crystals were isolated 
from recrystallization of the reaction mixture from CDCl3.  
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Single crystal X-ray diffraction studies were initially inconclusive. The 1,3-
dibenzylimidoloylidene was present, and an intriguing ‘CuBr2’ cluster. However, initial 
structural solutions also indicated the presence of Li (a Q peak with ca. 3 electrons) 
interacting with the carbene. This seemed an unlikely solution, given that no Li was 
present in the reaction mixture. It was possible that Li could be a contaminant in the 
Cu2O from the manufacturing process (although Sigma-Aldrich® consider their process 
to be commercially sensitive), XPS analysis of a sample by Dr. K. Wilson at the 
University of Cardiff showed no Li present (although it did contain ca. 0.6% Pb). A 
sample of the Cu2O was also analyzed by solid-state 
7Li NMR (Solid-State NMR 
Service, Durham University), but again no Li was detected.  
 
The brown crystals were dissolved in DMSO-d6 and the 
1H NMR spectrum compared to 
that of (1,3-dibenzyl)benzimidazolium bromide 113 starting material (Figure 29). A 
small change in resonance chemical shifts can be observed. Crucially, a resonance 
characteristic of an imidazolium C2-H is present. This has shifted upfield in comparison 
with the starting material, becoming more shielded and less acidic.  
 
Figure 29: 
1H NMR (300 MHz) spectra of (a) product of the reaction of (1,3-
dibenzyl)benzimidazolium bromide and Cu2O, recrystallized from CDCl3, in DMSO-d6 and (b) 
(1,3-dibenzyl)benzimidazolium bromide in DMSO-d6. 
 
A 1H NMR spectrum was recorded in various solvents (DMSO-d6, CD2Cl2 and MeCN-
d3, Figure 30). The complex was stable in both DMSO-d6 and MeCN-d3, but degraded 
(a) 
(b) 
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in CD2Cl2. A similar degradation occurred over time in MeCN-d3 (four weeks, Figure 
31).  
 
 
Figure 30: 
1H NMR spectrum of unknown complex in various solvents, showing aromatic and 
benzylic 1H environments; (a) DMSO-d6, (b) CD2Cl2, (c) MeCN-d3. 
 
 
 
Figure 31: 
1H NMR of unknown complex in MeCN-d3, showing degradation of the sample after 
4 weeks (upper). 
(a) 
(b) 
(c) 
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The presence of C2-H in the 1H NMR spectra suggests that a carbene had not been 
formed. Rather, it is proposed that the imidazolium C2-H is in place, and interacting 
with a [Cu2Br4] counterionic cluster 114 (Figure 32). Complexes where imidazolium 
cations can act as hydrogen bond donors (or carbenes as hydrogen bond acceptors, 
depending on C-H and H-X distances involved) in the form NHC-H-X are well 
known.143,144 Generally, X is a halide or oxygen. Indeed, in 1,3-(2,4,6-
trimethylphenyl)imidazolium chloride  there is an identified hydrogen bond interaction 
between the C2-H and the chloride anion. The distance between C2-H and the chloride 
anion is 3.3 Å.145 It is worth noting that the comparable distance in 1,3-
dibenzylbenzoimidazolium bromide is 4.604(2) Å, and therefore out of the range 
normally associated with hydrogen bonding. ‘Exotic’ examples of NHC-H-X interactions 
with arene π-systems are known. Typically, such complexes have donor-acceptor 
distances of ca. 3 Å. Complexes containing hydrogen bonds of the form Y-H-M  (where 
Y = N, O, C and M = transition metal) are known, but those where Y = C are rare. 
Indeed, to our knowledge, this complex would be the only example of such an 
interaction with a (benz)imidazolium C2-H participating.  
 
 
 
Figure 32: The chemical structure of 114a.  
Calculations (by Dr. A. C. Whitwood, Small Molecule X-Ray Crystallographic Service, 
University of York) showed that these complexes had co-crystallised with 10% and 8% 
of the initially desired Cu(NHC)Br 110. This results in the unusual electron density 
observed experimentally. The single X-ray diffraction structure is shown in Figure 33 –  
it should be noted that the C2-H cannot be located definitively by this technique (in that 
case neutron diffraction would be required), but is shown here to give structural clarity.   
H Cu
Cu H
Br
Br
N
NH
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Figure 33: Single crystal X-ray diffraction structure of 1,3-dibenzylbenzoimidazolium copper dibromide complex 114a. Hydrogen atoms have been removed, with the 
exception of C2-H, for clarity. Thermal ellipsoids shown at 50%. Selected bond lengths (Å), bond angles (°): C(1)-Cu(1) = 3.8293(1), Cu(1)-Cu(1) = 2.8093(4), Cu(1)-
Br(1) = 2.3201(3), Cu(1)-Br(2) = 2.4164(3), Br(1)-Cu(1)-Br(2) = 125.812(11), Cu(1)-Br(2)-Cu(1) = 71.099(10). Two molecules of CHCl3 omitted. 
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In separate reactions, a polymorph of this complex has been isolated where, as 
opposed to being a stoichiometrically defined cluster, ‘CuxBry’ exists as an infinite 
anionic polymer 114b (Figure 34) 
 
 
 
Figure 34: Single crystal X-ray diffraction structure of 1,3-dibenzylbenzoimidazolium copper 
dibromide complex 114b, where the cluster exists as an infinite anion polymer. Benzyl groups 
are shown in stick-form.  
 
The distance between C(1) and Cu(1) is 3.83 Å. As previously discussed, typical 
donor-acceptor distances for similar complexes are ca. 3 Å. As such, this interaction is 
considerably weaker. Jeffrey has described hydrogen bonds with a distance of 2.2-2.5 
Å as to be considered to mostly covalent, 2.5-2.3 Å as mostly electrostatic, and 3.2-4.0 
Å is considered to be entirely electrostatic.146,147 As such, the interaction is here entirely 
electrostatic, and the bond energy to be <4 kcal mol-1. Given the marginal nature of this 
length, there is some ambiguity as to whether this really constitutes a weak hydrogen 
bond or a van der Waals-type interaction. However, hydrogen bonds express a 
preference of linearity that is generally not observed in van der Waals interactions. 
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Bond angle C(1)-H(1)-Cu(1) is 177°, and such linearity would suggest a hydrogen bond 
interaction. However, linearity could be considered to be induced by packing.  
 
CuI complexes are known to form close Cu-Cu interactions. This phenomenon is 
known as cuprophilicity, and is usually defined as twice the van der Waals of Cu (ca. 
2.8 Å).148–151 The nature of these interactions is controversial, and they may or not be 
considered bonds. CuI is d10, and therefore repulsion should be generally expected 
between metal centres. However, it has been shown theoretically that van der Waals-
type forces (attractive dispersion) can overcome this repulsion, resulting in interactions 
of approximately the same strength as a hydrogen bond. 152 Further, often it is unclear 
whether or not the Cu atoms are ‘fixed’ in position by the ligands. A similar observation 
has been made in binuclear Au complexes (aurophilicity), and this interaction is better 
characterized and stronger due to relativistic effects.153,154 In this complex, the Cu(1)-
Cu(1) distance is 2.8093(4) Å – this is on the outer limit of the a accepted cuprophilic 
distance. Generally Cu-Cu distances for the [Cu2Br4]
2- counter-anion fall in the range of 
2.6-2.9 Å,155–159 although there are outliers > 3 Å.160 The only example of an 
imidazolium salt (in this case, 3-allyl-1-(4-cyanobenzyl)-2-methylbenzimidazolium), has 
a Cu-Cu distance of 2.8874(15) Å.161 The literature has not discussed whether or not 
this cluster exhibits a Cu-Cu interaction, and the experimental data here is 
fundamentally inconclusive.  
 
It was found that Cu(NHC)Br 110 could be prepared using this method when both the 
reaction and the work-up were performed under anaerobic conditions. Decreasing 
reaction concentration and increased reaction time increased yield of 110. However, an 
amount of 114 was always present.   
 
Willans and co-workers have developed an electrochemical method for the synthesis of 
Cu(NHC)X 117 and Cu(NHC)2X  116 (Scheme 38). Cu metal plates are used as 
sacrificial electrodes. The electrolyte is imidazolium salt dissolved in MeCN (Cl/Br salts 
resulted in monocarbene complexes, whereas PF6 salts gave the homoleptic cationic 
complex). At the anode, Cu0 is oxidized to CuI, whilst at the cathode imidazolium is 
reduced to imidazolyidene. As can be seen, this methodology is effective for both 
hindered and unhindered NHCs.  
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Scheme 38: Electrochemical synthesis of Cu(NHC) complexes from benzimidazolium salts and 
Cu0, as proposed by Willans and co-workers.162 
 
Using this method, Mr B. R. M. Lake and Dr C. E. Willans at the University of Leeds 
were able to provide (1,3-dibenzylbenzimidazoliydene)copper(I) bromide 110 in 68% 
yield. This was recrystallized by vapour diffusion of pentane into a solution of CH2Cl2 
containing the complex. Single crystal X-ray diffraction (Figure 35) shows that the 
complex exists in the solid-state as a bromide-bridged dimer. The geometry at Cu is 
distorted trigonal planar. The C-Cu bond is 1.914(3) Å, which is average for complexes 
of this type. The Cu-Cu distance is 3.1589(5) Å, and therefore we can assume that
there is no cuprophilic interaction in this complex.  
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Figure 35: Single crystal X-ray diffraction structure of (1,3-
dibenzylbenzoimidazolylidene)copper(I) bromide complex 110, which exists as a bromide-
bridged dimer in the solid-state. Hydrogen atoms have been removed for clarity. Thermal 
ellipsoids shown at 50%. Selected bond lengths (Å), bond angles (°): C(1)-Cu(1) = 1.914(3), 
Cu(1)-Br(1) = 2.5073(5), Cu(1)-Cu(1) = 3.1589(5), N(2)-C(1) = 1.365(3), N(1)-C(1) = 1.369(3), 
C(1)-Cu(1)-Br(1) = 134.16(8), N(1)-C(1)-N(2) = 104.9(2).  
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When complex 110 was dissolved in H2O, and heated at 100 °C for 16 h under N2, 
recrystallization of the reaction mixture from CDCl3 results in the formation of complex 
113. It is therefore proposed that in the reaction of 1,3-dibenzylbenzimidazolium 
bromide 113 and Cu2O, the NHC complex is formed. However, the relative lack of fixed 
steric bulk (compared to the substituents on IMes, IPr, or ItBu, the benzyl groups are 
highly flexible) the NHC exposes the carbene to electrophilic attack by water. This 
results in the formation of 113. Gunnoe and co-workers have shown that when ((1,3-
bis(2,6-diisopropylphenyl)imidazol-2-ylidene)copper(I) chloride complex (IPrCuCl) is 
exposed to water, no reaction occurs. However, addition of strong acid decomposes 
this complex to [IPrH][CuCl2] in a similar fashion. IPr is considerably more hindered 
than the benzylic ligand presented in this thesis.163 
 
 
Scheme 39: Synthesis of complex 114 from the (1,3-dibenzyl)benzimidazolium bromide from 
Cu2O. 
 
The stability of 110 was assessed. A sample was dissolved in dry, degassed MeCN-d3. 
Under these anhydrous conditions, the complex was found to be stable. On the 
addition of 40 µl of degassed H2O, a shift in the benzylic 
1H chemical shift was 
observed from δ 5.69 to δ 5.63 ppm (Figure 36, spectrum c). After 31 h, a minor new 
species evolves on the right shoulder of this signal. This new signal can be identified 
as 114, by comparison to an authentic sample. Simultaneously, multiplet 1H signals are 
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observed at δ 7.74 – 7.59 ppm. When this sample is exposed to air,‡ the formation of 
complex 17 accelerates. At 69 h, a 1:1 ratio of 110:114 is observed.  
 
Figure 36:
 
 Stability of complex 110 (in anhydrous CD3CN, under N2 and in a Young’s NMR 
tube) monitored by 1H NMR spectroscopic analysis and its decomposition on exposure to H2O 
and air. (a) authentic sample of 113 (b) authentic sample of 110, (c) addition of degassed H2O 
(40 mL) to (b) under N2, (d) after 3.5 h, (e) after 31 h, (f) at 45 h, the Young’s tube was exposed 
to air for 1 min, then sealed and shaken (x3), (g) after 55 h, (h) authentic sample complex 114. 
The expanded section on the left shows the benzo-protons which are observed on formation 
complex 114.  
Note: experiment carried out with the assistance of Dr C. E. Willans and Prof. I. J. S. Fairlamb.  
                                                
‡ Although Cu(NHC)Br complex 110 has low solubility in in CD3CN, the degradation 
products are soluble. 
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After 9 days (Figure 37), a ratio of 5:1 was observed for 114:110. A minor species is 
observed resonating at δ 5.09 and δ 6.97 ppm. A sample was taken of the reaction 
mixture and analysed by HPLC-MS (Figure 38), and this species has been identified 
1,3-dibenzyl-2-benzimidazolone 126. This was confirmed by removing solvent from the 
HPLC-MS, dissolving the residue in CDCl3 and comparing to literature values.
164  
 
 
 
 
 
 
Figure 37: 
1H NMR spectrum (400 MHz, MeCN-d3) of the decomposition of 110 after 9 d – 
products 114 and 126 are observed (labelled).  
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Figure 38: HPLC-MS data indicating the presence of (a) 11 (derived fragment [NHC.H]+, m/z 
299), (b) 110 (derived fragment [Cu(NHC)2]
+ m/z 659), (c) 1,3-dibenzyl-2-benzimidazolone 129
(molecular ion [C21H19N2O]
+, m/z 215, Na dimer [C42H36N4NaO2]
+, m/z 651. 
 
In C-H bond functionalisations with Pd and Cu, both O2 and H2O have been found to 
negatively affect reaction efficacy. These findings reflect this.  
2.3.3 Application to C-H Bond Functionalisation 
A reliable method for the synthesis of 110 had been established. To test the viability of 
such intermediates in C-H bond functionalisation reactions, a set of model reaction 
conditions had to be developed. C6D6 was selected as a reaction solvent. In addition to 
ease of availability, aromatic hydrocarbon solvents (e.g. xylene and mesitylene) are 
used in the arylations developed by Daugulis and co-workers.141 
 
 
 
Scheme 40: Proposed reaction of 110 with PhI.  
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Several products might be expected from this process: the direct C-H bond arylation 
product (1,3-dibenzyl-2-phenylbenzimidazolium bromide 127), an 
arylation/debenzylation product (1-benzyl-2-phenybenzimidazole 128 – loss of H+ from 
arylated cuprate was hypothesised by Bellina and Rossi,142 which is being modelled by 
a benzyl group in this system), and a protodecuprated product (1,3-
dibenzylimidazolium bromide 113). Authentic samples of these compounds were 
synthesised. 
 
An initial reaction of complex 110 and PhI (2 eq.) was performed (Scheme 40, Figure 
39) – this reaction was performed on a small scale (ca. 10 mg) in a NMR tube 
equipped with a Youngs’ Tap. The reaction was monitored by observing the resonance 
associated with the benzylic position (4H, δ 4.93 ppm, s). Complex 110 is partially 
soluble in C6D6 (spectrum A). After the addition of PhI, no reaction was observed 
(spectrum B). The reaction mixture was then heated to 90 oC. After 2 h, the starting 
material had been entirely consumed.  Two singlets could be observed at 5.10 (broad) 
and 4.81 ppm. After 24 h heating, the singlet at 4.80 had grown. The second singlet 
had shifted slightly to 5.14 ppm, and had significantly broadened.  
 
 
 
Figure 39: 
1H NMR spectra for the reaction of PhI and complex 110 in C6D6 (a) complex 110 
immediately after addition, (b) complex 110 and PhI, (c) complex 110 and PhI, after heating at 
90 oC for 2 h, (d) complex 110 and PhI, after heating at 90 oC for 24 h.  
 
(a) 
(b) 
(c) 
(d) 
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The solubility of authentic samples of possible products in C6D6 was low (the 
counterion may have an effect on solubility). As such it was not possible to identify 
these resonances as products. The solvent was thus removed under reduced 
pressure, and redissolved in MeCN-d3 (Figure 40). 
 
 
 
  
 
 
Figure 40: 
1H NMR spectra for the work up of reaction of complex 110 and PhI in MeCN-d3  
(a) authentic sample of 1,3-dibenzyl-2-phenylbenzimidazolium bromide 127,  
(b) authentic sample of 1-benzyl-2-phenylbenzimidazole 128, (c) authentic sample of 1,3-
dibenzylimidazolium bromide 113 (d) work-up of reaction mixture.  
 
In MeCN-d3, three major benzyl species are observed in the 
1H NMR spectrum:  δ 5.71 
ppm (s), δ 5.53 ppm (s), δ 5.09 ppm (s). This was compared to spectra of authentic 
samples of possible products (spectra a-c). The resonance at 5.53 ppm was 
ambiguous – both arylated and arylated/debenzylated products were possible. ESI-MS 
(Figure 41) revealed the presence of arylated product (m/z 375) and not 
arylated/bebenzylated product. Therefore, it is proposed that the peak at 5.53 ppm is 
127.  
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Figure 41: ESI-MS of the reaction of complex 18 and PhI at 24 h. 
 
The resonance at δ 5.81 ppm has been identified as 110 complex by comparison to the 
starting material. The resonance at δ 5.09 ppm has previously been identified as (1,3-
dibenzyl-2-benzimidazolone 126. Therefore, the complex 110 has been arylated under 
these reaction conditions, but the reaction has not proceeded to full conversion. 
 
 
 
Scheme 41: Reaction of 110 with PhI in the presence of Pd(OAc)2. 
 
The reaction was then performed in the presence of Pd(OAc)2 (1 eq. with respect to 
complex 110, Scheme 41). Again, this reaction was performed on a small scale (ca. 10 
mg) in a NMR tube equipped with a Youngs’ Tap (under N2). On the addition of 
Pd(OAc)2 (Figure 42, spectrum c), the resonance at 4.98 ppm was no longer present. A 
new resonance at δ 6.07 ppm appears. HPLC-MS (Figure 43) has indicated that this 
compound is [PdBr(Bn2-bimy)2]
+ (m/z 783). Cu(NHC)X complexes have been 
demonstrated to act as carbene transfer reagents to Pd by Cazin and co-workers.120 
The reaction mixture was heated at 90 °C. Reduction to Pd0 was observed 
immediately. After 2 h, no benzylic resonances are visible in the 1H NMR spectrum 
(spectrum d). No further change occurred after 24 h heating.120 
N
N
Cu Br
N
N
N
N
PhI (5 eq.)
Pd(OAc)2 (1 eq.)
C6D6
 
110 127 128 
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Figure 42: 
1H NMR spectra for the reaction of complex 110 and PhI in the presence of 
Pd(OAc)2 in C6D6 (a) complex 110 immediately after addition, (b) complex 110 and PhI, (c) 
complex 110, PhI and Pd(OAc)2 (identified as [PdBr(Bn2-bimy)2]
+ ),  (d) complex 110, PhI and 
Pd(OAc)2, after heating at 90 
oC for 2 h, (d) complex 110, PhI and Pd(OAc)2, after heating at 90 
oC for 24 h.  
 
 
 
 
 
 
Figure 43: HPLC-MS data identifying the resonance at δ 6.07 ppm as Pd transmetallation 
product [PdBr(Bn2-bimy)2]
+ (m/z 783). 
 
Identical reactions were stopped at 2 h and 24 h, respectively. Solvent was removed 
under reduced pressure, and MeCN-d3 added. In both cases, only one major benzylic 
resonance was observed (Figure 44, spectra d and e). By comparison to an authentic 
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sample, this was identified as 1,3-dibenzyl-2-phenylbenzimidazolium salt 113. In ESI-
MS, only this product was observed (Figure 45). No Cu(NHC)Br complex 110 was 
observed.  
 
 
 
 
 
 
Figure 44: 
1H NMR spectra for the work up of reaction of complex 110 and PhI in the presence 
of Pd(OAc)2 in MeCN-d3. (a) authentic sample of 1-benzyl-2-phenylbenzimidazole 128, (b) 
authentic sample of 1,3-dibenzyl-2-phenylbenzimidazolium bromide 127, (c) authentic sample of 
1,3-dibenzylimidazolium bromide 113, 
(d) work-up of reaction mixture at 2h, (e) work-up of reaction mixture at 24 h. 
 
Minor resonances can be observed at δ 5.09 ppm (1,3-dibenzyl-2-benzimidazolone) 
and an AB quartet centred at 5.9 ppm (2JHH ca. 17 Hz). This AB quartet is identified as 
cis-[PdBr2(Bn2-bimy)2] 129.
165 The diastereotopy is determined by the molecular 
symmetry.165 A trace amount of 1,3-dibenzylbenzimidazolone 129 is also observed. 
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Figure 45: ESI-MS of the reaction of complex 110, Pd(OAc)2 and PhI at 24 h. 
 
In the presence of Pd, arylation is cleaner and considerably faster – rather than 
multiple products, only one (the desired product) is observed. Transmetallation 
appears to be rapid.  It is proposed, therefore, that the subsequent reductive 
elimination from Pd is faster than the electrophilic aromatic substitution proposed to 
occur in the Cu-only systems.  
 
The mechanism for these processes requires further study. However, it seems possible 
that a carbene insertion mechanism (as reported by Perez and co-workers)166 could be 
in operation (Scheme 42). Alternatively, a CuI/III manifold could be operative.  
 
 
 
 
Scheme 42: Possible mechanism of arylation. 
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2.4 Experimental  
2.4.1 General Experimental Details 
Reagents were purchased from Sigma-Aldrich®, Alfa Aesar® or Fluorochem® and 
used as received unless otherwise stated. Dry THF, CH2Cl2, hexane, toluene and 
acetonitrile were obtained from a Pure Solv MD-7 solvent system and stored under 
nitrogen. Dry methanol was obtained by drying over 3 Å molecular sieves. Dry DMF 
was obtained from Acros® and degassed by N2 bubbling with sonication. Dry deutrated 
solvents were distilled (under static vacuum) from Na. Petroleum ether refers to the 
fraction of petroleum that is collected at 40 – 60 °C. Air sensitive procedures were 
performed using standard Schlenk techniques. Nitrogen gas was oxygen free and dried 
immediately prior to use by passing through a column of sodium hydroxide pellets and 
silica. Where indicated, a Braun® Unilab glove (dry) box used (<0.5 ppm O2).. Filtration 
was performed under gravity through fluted filter paper unless otherwise stated.  
 
TLC analysis was carried out using Merck 5554 aluminium backed silica plates, and 
visualised using UV light (254 nm) or an iodine tank. All column chromatography was 
performed using silica gel 60 and a solvent system as stated in the text.  
 
1H, 13C, 19F and 31P NMR spectra were recorded on a Jeol ECS/ECX400 (400, 100, 
376 and 162 MHz respectively). Alternatively and where specified, 1H, 13C and 31P 
NMR spectra were recorded on a Bruker AV500 (500, 126 and 202 MHz respectively) 
spectrometer. Chemical shifts are reported in parts per million and were referenced to 
residual undeuterated solvent. Coupling constants have been quoted to ±0.2 Hz. 1H 
NMR chemical shift are given to 2 decimal places; 13C NMR chemical shift are given to 
1 decimal place. Spectra were typically recorded at 298 K. 13C, 31P, and 19F spectra 
were obtained with 1H decoupling. 19F and 31P spectra were externally referenced to 
CFCl3 and H3PO4 respectively. Spectra were processed using MestreNova®. Some 
images were produced as .png, .bmp or .jpeg files and copied into ChemDraw, then 
structures added. Finally, the file was saved as an appropriate image file.  
 
IR spectroscopy was performed using a Perkin Elemer Spectrum 2 or a Unicam 
Research Series FTIR, both using an ATR attachment. Where indicated, reactions 
were monitored in situ using a Mettler Toledo ReactIR™  ic10 with K6 conduit SiComp 
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(silicon) probe and MCT detector. Resolution 4 cm-1, range 4000-650 cm-1 and gain 
adjustment at 1x.  
 
UV-Visible spectroscopy was performed on a Jasco® V-560 spectrometer. A baseline 
in the appropriate solvent was obtained prior to recording spectra.  
 
Mass spectrometry was performed using a Bruker daltronics micrOTOF spectrometer, 
an Agilent series 1200 LC, or a Thermo LCQ using electrospray ionization (ESI), with 
less than 5 ppm error for all HRMS. Liquid induction field desorption ionization (LIFDI) 
mass spectrometry was performed using a Wasters GCT Premier mass spectrometer. 
 
Chiral stationary phase HPLC was performed with a multiple wavelength, UV-vis diode 
array detector; integration was performed at 210, 230, and 250 nm. Optical rotations 
were recorded at 20 °C (using the sodium D line; 259 nm), and [α]D values are given in 
units of 10-1 deg cm3 g-1. Melting points were recorded using a Stuart digital SMP3 
machine.  
 
Transmission electron microscopy was performed at the University of York Department 
of Biology Technology Facility using a Technai 12 BioTWIN microscope, operated at 
120 kV. The images were enlarged, and particle sizes measured manually. Statistical 
analyses were performed and histograms drawn using Microsoft Excel:mac 2010 with 
AnalystSoft StatPlus:mac LE.2009  (build 5.8.0.0). 
 
Diffraction data were collected at 110 K on an Oxford Diffraction SuperNova 
diffractometer with Mo-Kα radiation (λ = 0.71073 Å) using a EOS CCD camera.  The 
crystal was cooled with an Oxford Instruments Cryojet. Diffractometer control, data 
collection, initial unit cell determination, frame integration and unit-cell refinement was 
carried out with “Crysalis”.167  Face-indexed absorption corrections were applied using 
spherical harmonics, implemented in SCALE3 ABSPACK scaling algorithm.  OLEX2 168 
was used for overall structure solution, refinement and preparation of computer 
graphics and publication data.  Within OLEX2, the algorithms used for structure 
solution were direct methods.169 Refinement by full-matrix least-squares used the 
SHELXL-97170 algorithm within OLEX2. All non-hydrogen atoms were refined 
anisotropically.  Hydrogen atoms were placed using a “riding model” and included in 
the refinement at calculated positions.  
!"#$%&'()(*(!+"(,-./(01.!%2-.#324#%2-.(-0(,&.5#5-3&4((((( >= 
 
 
Pd-PVP Nanoparticles 
 
To a three-necked round-bottomed flask fitted with a mechanical stirrer and reflux 
condenser was added PdCl2 (255 mg, 1.44 mmol), HCl (aq., 0.2 M, 14.4 mL), and 
water (706 mL). The reaction mixture was stirred for 1 h, after which time PdCl2 had 
dissolved to give an orange solution. PVP (3.2 g), water (672 mL) and EtOH (1000 mL) 
were added and the reaction heated to reflux with stirring for 4.5 h. The mixture was 
cooled to room temperature, and the solvent removed under reduced pressure to give 
3.367 g of black solid.  
 
Ca. 1 mg of material was suspended in EtOH (with vigorous shaking), applied to a 
TEM slide, and the solvent evaporated. They were then analyzed by transmission 
electron microscopy. This data is shown on page 45. 
 
General Procedure for the Bellina-Rossi Direct Arylation Reaction 
 
To an oven-dried Schlenk or carousel tube was added CsF (2.5 eq.), Pd catalyst, and 
CuI (2 eq.). The reaction vessel was evacuated under high vacuum with stirring and 
refilled with N2. This process was repeated twice. To this was added heterocycle (1 
eq.), iodobenzene (2 eq.) and DMF (5 mL). The reaction mixture was then heated to 
120 °C with stirring for 24 h. To the reaction mixture was added sat. aq. NH4Cl (20 mL) 
and the mixture stirred in air for 1 h to give a homogeneous blue solution. If the mixture 
remained heterogeneous, pyridine (100 µl) was added. The mixture was then extracted 
into EtOAc (3 x 40mL). The organic layers were combined, dried over MgSO4, filtered 
and the solvent removed under reduced pressure. The resulting brown residue was 
dry-loaded onto silica gel, and purified by flash chromatography eluting with EtOAc in 
petroleum ether solvent systems to give product.  
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2-Phenylbenzo[d]thiazole, 131 
 
 
 
Eluted from silica gel column using 4% EtOAc in petroleum ether. 
 
RF 0.88 (20% EtOAc/PE); MP 114 – 116 °C (lit. 111 – 112 °C)
49; 1H NMR (400 MHz, 
CDCl3) δ 8.11 – 8.05 (m, 3H), 7.92 – 7.89 (m, 1H), 7.53 – 7.45 (m, 4H), 7.38 (ddd, J = 
8.2, 7.4, 1.1 Hz, 1H); 13C NMR (101 MHz, CDCl3) δ 168.2, 154.2, 135.2, 133.7, 131.1, 
129.1, 127.7, 126.4, 125.3, 123.3, 121.7; ESI-MS m/z 212 [M+H]; ESI-HRMS m/z 
212.0532 [M+H] (calc. for C13H10NS 212.0528); IR (solid-state ATR, cm
-1) 1509, 1477, 
1454, 1432, 1313, 1257, 1225, 1159, 1088, 1070, 1012, 962, 797, 758, 729, 684.   
 
2-Phenylbenzo[d]oxazole, 108 
 
 
 
Eluted from silica gel column using 4% EtOAc in petroleum ether.  
 
RF 0.79 (20% EtOAc/PE); MP 103 – 106 (lit. 102.8 °C)
49; 1H NMR (400 MHz, CDCl3) δ 
8.31 – 8.20 (m, 2H), 7.83 – 7.72 (m, 1H), 7.63 – 7.55 (m, 1H), 7.55 – 7.48 (m, 3H), 
7.37 – 7.31 (m, 2H); 13C NMR (101 MHz, CDCl3) δ 163.2, 150.9, 142.2, 131.7, 129.1, 
127.8, 127.3, 125.3, 124.7, 120.2, 110.8; ESI-MS m/z 196 [M+H]; ESI-HRMS m/z 
196.0855 [M+H] (calc. for C13H10NO 196.0757); IR (solid-state ATR, cm
-1) 1617, 1552, 
1446, 1258, 1241, 1021, 923, 806, 780, 758.  
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1-Methyl-2-phenylbenzo[d]imidazole, 106171 
 
 
 
Eluted from silica gel column using 20-26% EtOAc in petroleum ether.  
 
RF 0.23 (20% EtOAc/PE); 
1H NMR (400 MHz, CDCl3) δ 7.86 – 7.79 (m, 3H), 7.57 – 
7.46 (m, 3H), 7.36 – 7.27 (m, 3H), 3.85 (s, 3H); 13C NMR (101 MHz, CDCl3) 153.9, 
143.0, 136.4, 130.3, 129.9, 129.5, 128.8, 122.9, 122.6, 119.9, 109.7, 31.8; ESI-MS m/z 
209 [M+H]; ESI-HRMS m/z 209.1076 [M+H] (calc. for C14H13N2 209.1073, error 1.7 
ppm); IR (solid-state ATR, cm-1) 1468, 1440, 1377, 1328, 1277, 1243, 1197, 1177, 
1151, 1128, 1099, 1075, 1052, 1020, 1006, 925, 849, 819, 774, 764. 
 
Analysis of Nanoparticles from the Bellina-Rossi Direct Arylation Reaction  
 
Two reactions were prepared, using the general procedure with benzothiazole: one in a 
Schlenk tube and the second in a Radley’s® carousel tube. The reactions were heated 
to 120 °C for 2 h.  
 
Each sample was suspended in EtOH, applied to a TEM slide, and the solvent 
evaporated. They were then analyzed by transmission electron microscopy. 
Representative images are shown in Figures 17 and 18 (page 51). Two aliquots (1 mL) 
were removed from each reaction mixture via syringe. To one aliquot per reaction, PVP 
(22 mg, 10 eq. per theoretical amount of Pd) was added. The solvent of all aliquots 
was removed under reduced pressure. 
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2.4.3 Direct C-H Bond Functionalisation of Benzoxazole with PhI(OAc)2 
General Procedure for the ‘Chen-Cheng’ Direct Arylation of Benzoxazole, 108130 
 
 
 
To a Schlenk tube was added benzoxazole (119 mg, 1 mmol, 1 eq.), PhI(OAc)2 (415 
mg, 1.25 mmol, 1.25 eq.), Cs2CO3 (326 mg, 1 mmol, 1 eq.), 1,10-phenanthroline (18.0 
mg, 0.1 mmol, 0.1 eq.) and Pd(OAc)2 (11.1 mg, 0.05 mmol, 0.05 eq.). The reaction 
vessel was then placed under vacuum and refilled with N2. This process was repeated 
twice. DMSO (5 mL) was added via syringe, and the reaction heated to 150 °C for 20 
h.  The reaction mixture was then exposed to air, diluted with EtOAc (15 mL) and 
washed with water (3 x 20 mL). The organic layer was dried over MgSO4, filtered, and 
the solvent removed under reduced pressure to give a residue. This residue was dry 
loaded onto silica gel, and purified by flash chromatography (4% EtOAc in petroleum 
ether 40-60 °C) to give product as a white solid (135 mg, 69% yield). 
 
Analytical data identical to that reported above.  
 
Degradation of PhI(OAc)2 at Room Temperature 
 
To a NMR tube was added PhI(OAc)2 (15 mg) which was then dissolved in DMSO-d6 
(0.7 mL). 1H NMR spectra were recorded at ca. t = 5, 30, 40 and 50 min intervals.  
 
Spectra shown in Figure 22 (page 57). 
 
Degradation of PhI(OAc)2 at 150 °C 
 
To a Young’s Tap NMR tube was added PhI(OAc)2 (15 mg) which was then dissolved 
in DMSO-d6 (0.7 mL). A
 1H NMR spectrum was recorded. The reaction mixture was 
heated to 150 °C for 10 min, and a 1H NMR spectrum recorded.  
 
Spectra shown in Figure 25 (page 60). 
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Analysis of Nanoparticles from the Direct C-H Bond Functionalisation with PhI(OAc)2 
 
To a Schlenk tube was added benzoxazole (119 mg, 1 mmol, 1 eq.), PhI(OAc)2 (415 
mg, 1.25 mmol, 1.25 eq.), Cs2CO3 (326 mg, 1 mmol, 1 eq.), 1,10-phenanthroline (18 
mg, 0.1 mmol, 0.1 eq.) and Pd(OAc)2 (11.1 mg, 0.05 mmol, 0.05 eq.). The reaction 
vessel was then placed under vacuum and refilled with N2. This process was repeated 
twice. DMSO (5 mL) was added via syringe, and the reaction heated to 150 °C for 2 h.  
Two aliquots (1 mL) were removed via syringe from the reaction mixture. To one 
aliquot, PVP (22 mg, 10 eq. per theoretical amount of Pd) was added. The solvent of 
both aliquots was removed under reduced pressure.  
 
Each sample was suspended in EtOH, applied to a TEM slide, and the solvent 
evaporated. They were then analyzed by transmission electron microscopy. 
Representative images are shown in Figure 21 (page 56).  
 
Particle size was measured according to the method outlined in general experimental 
procedure.  
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2.4.4 Role for Cu-NHC Complexes in Pd/Cu-Mediated Systems 
Dibenzylbenzo[d]imidazolium bromide, 113172 
 
 
 
To a round-bottom flask was added benzimidazole (10 g, 84.7 mmol, 1 eq.), benzyl 
bromide (29 g, 169.5 mmol, 20 mL, 2 eq.), K2CO3 (17.527 g, 127 mmol, 1.6 eq.) and 
acetonitrile (200 mL). This mixture was stirred for 3 d at ambient temperature. Solvent 
was removed under reduced pressure. Water (200 mL) was added, and the mixture 
stirred. The reaction mixture was filtered to give product as a white solid (31.873 g, 
99% yield).  
 
MP 228 – 229 oC  (lit. 210-212 oC ); 1H NMR (400 MHz, (CD3)2SO) δ 9.98 (s, 1H), 7.96 – 
7.90 (m, 2H), 7.64 – 7.57 (m, 2H), 7.50 – 7.46 (m, 4H), 7.43 – 7.33 (m, 6H), 5.75 (s, 
4H); 13C NMR (101 MHz, (CD3)2SO) 134.0, 131.1, 129.0, 128.8, 128.3, 126.8, 114.0, 
50.0 (note: C2 not observed); ESI-MS m/z 299 [M-Br]; ESI-HRMS m/z 299.1539 [M-Br] 
(calc. for C21H19N2 229.1543). 
 
Crystals suitable for X-ray diffraction were grown from CHCl3 solution in air at ambient 
temperature. . 
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Summary of X-ray data for 113 
Chemical formula Br•C21H19N2•H2O 
Formula Mass 397.31 
Crystal system Triclinic 
a/Å 9.3864(4) 
b/Å 9.9323(4) 
c/Å 11.3331(6) 
α/° 69.308(4) 
β/° 80.860(4) 
γ/° 69.207(4) 
Unit cell volume/Å3 923.36(7) 
Temperature/K 110(2) 
Space group P1‾  
No. of formula units per unit cell, Z 2 
No. of reflections measured 8860 
No. of independent reflections 5751 
Rint 0.0204 
Final R1 values (I > 2σ(I)) 0.0392 
Final wR(F2) values (I > 2σ(I)) 0.0929 
Final R1 values (all data) 0.0482 
Final wR(F2) values (all data) 0.0978 
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Bis{1,3-dibenzylbenzo[d]imidazolium} dicopper(I)tetrabromide, 114a 
 
 
 
To a Schlenk tube was added 1,3-dibenzylbenzo[d]imidazolium bromide (500 mg, 
1.318 mmol, 1 eq.) and Cu2O (71 mg, 0.657 mmol). The reaction vessel was placed 
under vacuum and back-filled with N2 (3 cycles). Water (5 mL, degassed) was added, 
and the reaction heated at 100 oC for 16 h. The solvent was removed in vacuo, and the 
resulting solid dissolved in laboratory grade (i.e. wet) CH2Cl2 (20 mL). This was filtered, 
and the solvent removed under reduced pressure. The resulting solid was 
recrystallised from laboratory grade CHCl3 to give product as brown crystals (60.4 mg, 
8.3% yield).  
 
From separate reactions were obtained different polymorphs in which CuxBry exists as 
an infinite anionic polymer, as opposed to a stoichiometrically defined cluster.  
 
X-Ray crystallographic data for each observed structure shown on the following page.  
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Compound reference ijsf1222 (CuBr2) ijsf1221 (CuxBry) ijsf1103 (CuxBry) 
 Chemical formula 0.5(Br4Cu2)•C21H19N2•CHCl3 C21H18.91Br3Cu2.09N2 0.5(C42H37.84Br6Cu4.1N4) 
Formula Mass 642.11 672.10 671.29 
Crystal system Triclinic Orthorhombic Orthorhombic 
a/Å 9.5428(3) 20.7826(7) 20.6640(18) 
b/Å 11.1470(4) 14.9253(4) 14.8519(12) 
c/Å 11.8115(4) 6.9568(2) 6.9524(7) 
α/° 74.193(3) 90.00 90.00 
β/° 89.234(3) 90.00 90.00 
γ/° 83.652(3) 90.00 90.00 
Unit cell volume/Å3 1201.32(7) 2157.90(12) 2133.7(3) 
Temperature/K 110.00(10) 110.00(10) 110.0 
Space group P1‾  Pbcn Pbcn 
No. of formula units per unit cell, Z 2 4 4 
No. of reflections measured 19512 6663 5150 
No. of independent reflections 7072 2979 2208 
Rint 0.0246 0.0240 0.0283 
Final R1 values (I > 2σ(I)) 0.0250 0.0457 0.0509 
Final wR(F2) values (I > 2σ(I)) 0.0529 0.0854 0.0888 
Final R1 values (all data) 0.0314 0.0624 0.0645 
Final wR(F2) values (all data) 0.0553 0.0927 0.0938 
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(1,3-dibenzylbenzo[d]imidazolin-2-ylidene) copper(I) bromide, 110162 
 
 
To a three-necked round-bottom flask was added 1,3-dibenzylbenzo[d]imidazolium 
bromide (389 mg, 1 mmol, 1 eq.) and MeCN (15 mL, dry) to form a suspension. Cu 
electrodes (1 x 3 cm3) were inserted into the reaction mixture, and 50 mA current 
passed through solution for 45 min. The reaction mixture was then filtered, and the 
solvent removed under reduced pressure to give an off-white solid. This was washed 
with MeOH, dissolved in CH2Cl2 and filtered. The solvent was removed under reduced 
pressure to give an off-white solid. This was dissolved in CH2Cl2, and layered with 
Et2O. This resulted in the formation of crystals, which were collected by filtration to give 
product as a white solid (300 mg, 68% yield).  
 
MP 211 – 213 oC; 1H NMR (500 MHz, CD2Cl2) δ 7.40 – 7.32 (m, 12H), 7.30 – 7.27 (m, 
2H), 5.69 (s, 4H); 13C NMR (126 MHz, CD2Cl2) δ 135.9, 129.6, 129.0, 128.0, 124.7, 
112.5, 53.4 (only 7 of 9 resonances observed); LIFDI-MS m/z (%) 440 (67)  
[63Cu79BrM], 441 (12)  [63Cu79Br13CM], 442 (100)  [63Cu81BrM and 65Cu79BrM], 442 (22) 
[63Cu81Br13CM or 65Cu79Br13CM], 443 (28) [65Cu81BrM] (observed as monomer only); 
Anal. calc. for C21H18BrCuN2 C 57.09, H 4.11, N 6.34, observed C 56.90, H 4.05, N 
6.15. 
 
Crystals suitable for X-ray diffraction were grown by vapour diffusion of pentane into a 
CH2Cl2 solution under N2.  
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Summary of X-ray data for 110 
Chemical formula C42H36Br2Cu2N4 
Formula Mass 883.65 
Crystal system Orthorhombic 
B a/Å 9.4581(6) 
b/Å 9.5482(7) 
c/Å 11.2949(10) 
α/° 69.206(7) 
β/° 82.837(6) 
γ/° 69.262(6) 
Unit cell volume/Å3 891.80(12) 
Temperature/K 110.00(10) 
Space group P1‾  
No. of formula units per unit cell, Z 1 
No. of reflections measured 8485 
No. of independent reflections 5176 
Rint 0.0285 
Final R1 values (I > 2σ(I)) 0.0406 
Final wR(F2) values (I > 2σ(I)) 0.0877 
Final R1 values (all data) 0.0539 
Final wR(F2) values (all data) 0.0953 
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1-Benzylbenzo[d]imidazole, 132173 
 
 
 
To a round-bottomed flask was added ground KOH (950 mg, 16.94 mmol) and DMSO 
(13.5 mL). The reaction mixture was stirred vigorously for 5 min at ambient 
temperature. Benzo[d]imidazole (1 g, 8.47 mmol) was added to give a pale yellow 
solution which was stirred for 45 min. Benzylbromide (1.21 mL, 1.740 g, 10.2 mmol) 
was added drop-wise and the reaction mixture stirred for 2 h. The reaction mixture was 
then added to water (50 mL) and extracted into Et2O (3 x 50 mL). The organic layers 
were combined, dried over MgSO4, filtered and the solvent removed under reduced 
pressure to give a yellow solid. This was dry-loaded onto silica gel and purified by 
column chromatography, eluting with 50-100% EtOAc in petroleum ether to give 
product as a white solid (778 mg, 3.7 mmol, 44%). 
 
MP 119.8 – 121.1 oC  (lit. 119 – 120 oC); 1H NMR (400 MHz, (CD3)2SO) δ 8.37 (s, 1H), 
7.66 – 7.58 (m, 1H), 7.51 – 7.43 (m, 1H), 7.33 – 7.21 (m, 5H), 7.20 – 7.11 (m, 2H), 
5.46 (s, 2H); 13C NMR (101 MHz, (CD3)2SO) δ 144.3, 143.6, 133.7, 137.5, 129.2, 
128.3, 128.0, 122.9, 122.1, 120.0, 111.2, 48.14; ESI-MS m/z 209 [M+H].  
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1-Benzyl-2-phenylbenzo[d]imidazole, 128174 
 
 
 
To a sealed tube was added 1-benzylbenzimidazole (60 mg, 0.288 mmol, 1 eq.), CuI 
(26 mg, 0.136 mmol, 0.47 eq.), LiOtBu (216 mg, 2.04 mmol, 7 eq.) and p-xylene (3.4 
mL). PhI (278 mg, 1.364 mmol, 152 µl, 4.7 eq.) was added via syringe. The reaction 
mixture was heated to 160 oC for 16 h. The reaction mixture was added to water (10 
mL), and extracted into CH2Cl2 (3 x 20 mL). The organic layers were combined, dried 
over MgSO4, filtered and the solvent removed under reduced pressure to give a yellow 
solid. This was dry-loaded onto silica gel and purified by flash chromatography eluting 
with 20% EtOAc in petroleum ether to give product as a white solid (22 mg, 23% yield). 
 
MP 142 – 144 oC; 1H NMR (400 MHz, CD3CN) δ 7.76 – 7.79 (m, 3H), 7.56 – 7.46 (m, 
3H), 7.35 – 7.21 (m, 6H), 7.05 – 7.00 (m, 2H), 5.54 (s, 2H); 13C NMR (101 MHz, 
CD3CN) δ 154.0, 143.3, 137.1, 136.2, 130.7, 129.9, 129.3, 128.9, 128.8, 127.6, 126.2, 
110.9, 48.0 (only 13 of 16 resonances observed); ESI-MS m/z 285 [M+H]; ESI-HRMS 
m/z 285.1382 (calc. for C20H17N2 285.1385); IR (solid-state ATR, cm
-1) 3060, 1924, 
1495, 1460, 1452, 1443, 1377, 1354, 1330, 1250, 1074, 1028, 777, 764, 743, 729, 
696.  
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(1,3-Dibenzyl)-2-phenylbenzo[d]imidazolium bromide, 127 
 
 
 
To a sealed tube was added 1,3-dibenzylbenzimidazole 113 (100 mg, 0.263 mmol, 1 
eq.), CuI (13 mg, 0.067 mmol, 0.25 eq.), LiOtBu (106 mg, 1.00 mmol, 4 eq.) and p-
xylene (3.4 mL). PhI (278 mg, 0.668 mmol, 75 µl, 4.7 eq.) was added via syringe. The 
reaction mixture was heated to 160 oC for 16 h. The reaction mixture was added to 
water (10 mL), and extracted into CH2Cl2 (3 x 20 mL). The organic layers were 
combined, dried over MgSO4, filtered and the solvent removed under reduced pressure 
to give a yellow solid. This was dry-loaded onto silica gel and purified by flash 
chromatography eluting with MeOH:CH2Cl2 (4:96) to give product as a white solid (25 
mg, 19% yield). 
 
MP 101 – 103 oC (decomp.); 1H NMR (400 MHz, CD3CN) δ 7.85 – 7.74 (m, 3H), 7.71 – 
7.61 (m, 6H), 7.38 – 7.29 (m, 6H), 7.18 – 7.09 (m, 4H), 5.54 (s, 4H); 13C NMR (101 
MHz, CD3CN) 134.5, 134.40, 132.6, 131.2, 130.9, 130.0, 129.6, 128.4, 128.1, 121.7, 
115.0, 50.9 (note: C2 not observed); ESI-MS m/z 374 [M+H]; ESI-HRMS m/z 375.1854 
(calc. for C27H23N2 375.1856); IR (solid-state ATR, cm
-1) 3036, 2190, 1501, 1478, 1466, 
1453, 1432, 1018, 917, 727, 697. 
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NMR Study into the Decomposition of (1,3-dibenzylbenzo[d]imidazolin-2-ylidene) 
copper(I) bromide 
 
To a Young’s Tap NMR tube in the glovebox a saturated anhydrous CD3CN solution of 
(1,3-dibenzylbenzo[d]imidazolin-2-ylidene) copper(I) bromide (ca. 1.5 mg) was made, 
and 1H NMR spectrum recorded. No change was observed over a period of 24 h by 1H 
NMR spectroscopy.  Degassed water (40 µl) was added to the sample under N2 and 
Young’s NMR tube resealed.  1H NMR spectra were recorded at regular intervals to 
(see page 74).  After 31 h, the tube was exposed to air for 1 min and shaken (3 times). 
Regular 1H NMR spectra were then taken up to 9 days.  The last sample indicated that 
the ratio of 7:9 was 1:5 at this time. LC-MS analysis of this mixture revealed three 
major components (characterised). The acetonitrile was removed from the LC-MS 
analysis sample, dissolved in CDCl3 and a 
1H NMR spectrum recorded.  
 
Spectra shown in Figure 36, page 74. 
 
NMR Study of the Arylation of (1,3-dibenzylbenzo[d]imidazolin-2-ylidene)copper(I) 
bromide 
 
To a Young’s Tap NMR tube in the glovebox was added (1,3-
dibenzylbenzo[d]imidazolin-2-ylidene) copper(I) bromide (6 mg, 0.0145 mmol, 1 eq.) 
and dissolved in C6D6. A 
1H NMR spectrum (400 MHz) was recorded. In the glovebox, 
PhI (14.7 mg, 0.0724 mmol, 8 µl, 5 eq.) was added. A 1H NMR spectrum was recorded. 
The sample was then heated to 90 oC, and 1H NMR spectra recorded at regular 
intervals to monitor any change (over 24 h). Spectra shown in Figure 39, page 77. 
  
The solvent was removed under reduced pressure, to give a brown solid (no mass was 
lost). A sample of this solid was analysed by ESI-MS. Under air, MeCN-d3 was added 
to the mixture. A 1H NMR spectrum was recorded. Spectra shown in Figure 40, page 
78. 
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NMR Study of the Arylation of (1,3-dibenzylbenzo[d]imidazolin-2-ylidene) copper(I) 
bromide with Pd(OAc)2 
 
To a Young’s Tap NMR tube in the glovebox was added (1,3-
dibenzylbenzo[d]imidazolin-2-ylidene) copper(I) bromide (6 mg, 0.0145 mmol, 1 eq.) 
and Pd(OAc)2 (3 mg, 0.0146 mmol, 1 eq.) and dissolved in C6D6. A 
1H NMR spectrum 
(400 MHz) was recorded. In the glovebox, PhI (14.7 mg, 0.0724 mmol, 8 ul, 5 eq.) was 
added. A 1H NMR spectrum was recorded. In a glovebox, Pd(OAc)2 was added. A 
1H 
NMR spectrum was recorded. The sample was then heated to 90 oC, and 1H NMR 
spectra recorded at regular intervals to monitor any change (over 24 h). Immediately 
on heating, Pd black was observed to form. Spectra shown in Figure 42, page 80. 
 
The solvent was removed under reduced pressure, to give a brown solid (no mass was 
lost). A sample of this solid was analysed by ESI-MS. Under air, MeCN-d3 was added 
to the mixture. A 1H NMR spectrum was recorded. Spectra shown in Figure 44, page 
81. 
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CHAPTER 3: 
C-H BOND FUNCTIONALISATION OF INDOLE BIOMOLECULES 
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3.1 Introduction 
3.1.1 Arylation of Indoles 
Indoles are a key sub-class of benzo-fused N-heterocycles. The indole moiety is found 
embedded in important biomolecules, including the proteinogenic amino acid 
tryptophan 132 and the metabolite serotonin, other natural products (for example, 
meridianins A-E 134)175 and synthetic pharmaceuticals (for example, the migraine drug 
sumatripitan 133).176  
 
 
 
Figure 46: Examples of natural products and pharmaceuticals containing indole functionality. 
 
Arylated indoles can be difficult to access via traditional methods (for example, the 
Fisher indole synthesis)177 and have typically required the use of Pd-catalysed cross-
coupling methodologies such as the Suzuki-Miyaura reaction.178 There are limited 
examples of Pd-catalysed cross-couplings performed at the C2 and C3 position of 
indole. As such, the ability to selectively functionalise indole C-H bonds under mild 
conditions is of considerable interest. This would not only be useful in the synthesis of 
new natural products and pharmaceutical candidates, but also in fluorescence labelling 
similar to work on purines reported by Fairlamb and co-workers.26–28,179,180  
 
As with the direct C-H bond functionalisation of imidazoles, Pd is commonly used as 
the metal catalyst, although Rh,181 Ir,182 and Ni183 have also been applied. The use of 
catalytic Pd for arylation at the C2 of indole 135 with aryl iodides was developed by 
Sames and co-workers, utilising catalytic amounts of Pd(OAc)2 and PPh3, with a 
stoichiometric quantity of MgO (acting as the base) (Scheme 43). The reaction 
proceeds via a N-MgIIOH intermediate 137, which consequently makes it highly 
sensitive to air and moisture.  
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Scheme 43: Pd-mediated direct C-H bond functionalisation of NH-indole with PhI, as proposed 
by Sames, proceeding via a N-Mg intermediate.
184
   
 
When indole was substituted with 1-methylindole, it was found that these conditions 
were no longer effective. However, CsOAc was found to be an effective alternative 
base. This supported the hypothesis that MgO played a key role in the arylation of the 
NH-indole. Larger N-alkyl substituents were tolerated, as were N-aryl substituents. 
Electron-withdrawing groups, such as Ac, were not.  
 
 
 
Scheme 44: Possible mechanisms for the direct C-H of indole, as proposed by Sames.
33,184
  
  
Kinetic studies indicated that this reaction was zero order with respect to iodobenzene, 
suggesting that the rate-determining step occurred after oxidative addition (it would 
normally be first order). Sames proposed three possible reaction pathways (Scheme 
44): electrophilic metallation migration (a 1,2-migration of Pd must be included in this 
pathway, as electrophilic substitution on indoles is known to occur preferentially at the 
C3-position), non-electrophilic metallation (σ-bond metathesis) and carbometallation 
(i.e. a “Heck-type” reaction).185 Kinetic isotope effect (KIE) studies suggested that 
electrophilic metallation-migration was most likely.  
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Using this mechanistic interpretation, it was possible for the investigators to develop a 
C3-selective methodology. Increased steric bulk on both the indole and Pd-catalyst 
disfavoured the 1,2-migration.  When MgCl/TMEDA or Mg(HMDS)2 were used, a 
C3:C2 selectivity of 14:1 and 26:1 were obtained, respectively. Furthermore, by 
employing IMes in place of PPh3, a selectivity of 98.5:1.5 was recorded. 
 
The functionalisation of indoles with alkenes in a Fujiwara-Moritani oxidative Heck-type 
fashion has been pioneered by Gaunt and co-workers (Scheme 45).186,187 By variation 
of solvent and additives, it has proved possible to control the regioselectivity of the 
process. Utilising Cu(OAc)2 in DMF/DMSO (10:1, v/v), it was possible to achieve an 
impressive C3:C2 ratio of >95:5, with a 79% combined yield. These results are 
particularly interesting as they occur under milder conditions (70 °C). 
 
 
 
Scheme 45: Pd-mediated direct C-H bond functionalisationvia an oxidative Fujiwara-Moritani 
oxidative Heck-type process, showing that careful selection of reagents can influence 
regiochemistry.
186
  
 
Gaunt proposes a mechanism (Scheme 46) which bears some similarities to that 
offered by Sames, with both suggesting an electrophilic substitution occurring at the 
C3-position. Solvent-controlled palladation results either in the retention of C3 
regiochemistry, or a 1,2-migration into the C2 position.  
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Scheme 46: Mechanistic basis of regioselectivity in oxidative Fujiwara-Moritani oxidative Heck-
type direct C-H bond functionalisationprocess, as proposed by Gaunt and co-workers.
186
 
 
An active area of research in modern organometallic chemistry has been the use of 
proposed PdII/IV manifolds in catalysis.133 Although the first organopalladium(IV) 
complex was identified in 1975 by Uson and co-workers (Nyholm had previously 
claimed such a synthesis by the reaction of BrTl(C6F5)2 and Cl2Pd(PPh3)2,
188 but it was 
later shown that this in fact led to a mixture of bi- and mononuclear PdII complexes189), 
it has been in the past five-to-ten years that such intermediates have been significantly 
implicated to have a role in various reactions catalysed by Pd.188–190 Molecules 
accessible from these new methods include the synthesis of conjugated dienes.191,192 
Cross-coupling and C-H bond functionalisation processes were also possible. 193,194  
 
In 2006, Sanford and co-workers published a method using such chemistry to 
selectively arylate the C2-position of N-methylated 143 and free 1H-indole 135 (and 
analogues, Scheme 47) using aryl iodonium salts.131 Initial work on this methodology 
utilised Pd(OAc)2, giving moderate yields; after five minutes’ reaction time, only 49% 
yield was obtained. However, leaving the reaction for a greater period of time did not 
increase the yield, suggesting catalyst deactivation was occurring.  Following a catalyst 
screen, IMesPd(OAc)2 145 was found to be the most suitable for this system. This 
reaction has a high selectivity for the C2 position, with a C3:C2 ratio of 1:20. High 
yields were obtained at ambient temperature on a variety of substituted indoles and 
pyrroles (Scheme), both with N-H and N-Me derivatives. Where the C2 position was 
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blocked, a low yield of C3 functionalised product was obtained. Substituted 
symmetrical diaryliodonium salts were found to be well tolerated.  
 
 
 
Scheme 47: Pd-mediated direct C-H bond functionalisation of N-Me indole with diaryliodonium 
salts, as proposed by Sanford and co-workers.
131
  
 
The proposed mechanism (Scheme 48) for this reaction involves palladation at the 
indole C2 position, followed by oxidative addition of the aryl iodonium salt to give a PdIV 
octahedral intermediate. The product is then reductively eliminated. 
 
 
 
Scheme 48: Pd
II/IV
-mediated mechanism for the direct C-H bond functionalisation of indole 
using diaryliodonium salts, as proposed by Sanford and co-workers.
131
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This work was further developed to allow for the in situ formation of aryl iodonium salts 
from diacetoxyiodobenzene and phenylboronic acid. With these conditions, it was 
found that Pd(OAc)2 performed better than the IMesPd(OAc)2 catalyst.  
 
 
 
Scheme 49: Pd-mediated direct C-H bond functionalisation of N-Me indole with diaryliodonium 
salts formed in situ, as proposed by Sanford and co-workers.  
 
It should be noted that, through the work of Ritter and co-workers, some processes 
previously proposed to proceed via PdIV intermediates are thought by some (including 
Sanford) to be PdIII-mediated.195–198 
 
Larossa has developed a room temperature C2 arylation of indole utilising 
substoichiometric amounts of Ag2O (Scheme 50).
199 Since it is believed that the rate-
limiting step of indole C-H bond functionalisation is electrophilic palladation, Larossa 
reasoned that the use of AgI salts would increase rate by abstraction of a halide anion 
from the PdII oxidative addition product (Scheme 51).  
 
 
 
Scheme 50: Pd-mediated direct C-H bond functionalisation of indole using Ag2O, as proposed 
by Larossa and co-workers.
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Scheme 51: Mechanism for the direct C-H bond functionalisation of indole with Ag2O, as 
proposed by Larossa and co-workers.
199
  
 
These conditions were found to be tolerant of functional groups on both the aryl iodide 
and the indole. Changing the N-protecting group from Me to Bn was also tolerated. 
However, free NH-indoles gave only moderate yields, despite an increase in catalyst 
loading to 10 mol% and temperature to 50 °C. 
 
Other room temperature conditions in acidic media have recently been developed, 
including arylation with arylsiloxanes.200 
 
Bellina and Rossi have developed an azole C-H bond functionalisation methodology for 
azoles (Scheme 52) using what they describe as ligand- and base-free conditions (vide 
supra).37,38 These conditions were applied to free NH-indole 135 and gave moderate 
results (29 – 53% yield), and negligible yields for substituted analogues.  
 
 
 
Scheme 52: Pd-mediated direct C-H bond functionalisation of indole using stoichiometric 
quantities of CuI, as propopsed by Bellina, Rossi and co-workers.
35
 
 
Bellina and Rossi have since developed a further ‘ligandless’ set of conditions 
specifically for the arylation of indoles with aryl bromides.35 An extensive screen of 
bases, ligands, aryl bromides and solvents indicated that there was no beneficial role 
for the ligand in this reaction. However, the addition of substoichiometric amounts of a 
lipophilic quaternary ammonium salt, such as BnEt3NCl or BnBu3NCl, substantially 
increased yield. It is known that these lipophilic salts stabilise Pd clusters, slowing their 
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deactivation by conversion to Pd black.201 Similar to previous conditions, N-substituted 
indoles proved unsuitable for arylation.  
 
Although most indole C-H arylations are performed using aryl halides, other reagents 
have been used in their place. Zhang and co-workers have published conditions 
(Scheme 53) utilising potassium aryl trifluoroborates (reagents which have become 
popular as alternatives to aryl boronic acids in the Suzuki-Miyaura reaction for their 
supposed resistance to homocoupling)202,203 with a Pd(OAc)2/Cu(OAc)2 co-catalyst 
system.204 These conditions are air and moisture stable, where O2 acts as a terminal 
oxidant.  
 
 
Scheme 53: Pd-mediated direct C-H bond functionalisation of indole using potassium 
aryltrifluoroborates.  
 
Fagnou and co-workers published an oxidative cross-coupling (Scheme 54), described 
as ‘double C-H activation’ between N-acetate protected indole and benzene.205 
Pd(TFA)2 was used as catalyst, with substoichiometric amounts of Cu(OAc)2. The 
arene was required to be in large excess (30 eq.).  
 
Fagnou expanded this work to allow for regiocontrol based on oxidant and protecting 
group. By substituting AgOAc for Cu(OAc)2, and pivaloate for acetate (pivaloate has a 
greater degree of steric bulk than acetate), it was possible to switch preferential 
regioselectivity from C3 to C2 (C3:C2 ratio of 1:25).  
 
 
 
 
Scheme 54: Pd-mediated oxidative direct C-H bond functionalisation of indole using benzene, 
showing that careful choice of reagents can affect the regiochemistry.  
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3.1.2 Pd-Mediated Functionalisation of C-X Bonds in Amino Acids, Peptides and 
Proteins  
The modification of amino acids by the metal-catalysed formation of C-C bonds was 
pioneered by Casalnuovo and co-workers in their paper on cross-coupling in aqueous 
media.206 In the paper’s single example of an amino acid, it was demonstrated that the 
Sonogashira reaction [mediated by Pd(tppms)3] could functionalise 4-iodotyrosine 161 
(Scheme 55). The cross-coupled product cyclised in situ to form a benzofuran, a 
process common in ortho-OH phenylalkynes.207 Crisp and co-workers also developed a 
set of conditions for low temperature Sonogashira reactions for the labelling of amino 
acids with a variety of commercially available fluorescent tags. However, these 
conditions required highly undesirable solvents (DMF, DMSO and piperidine).208  
 
 
 
Scheme 55: The functionalisation of iodotyrosine using the Sonogashira reaction, as proposed 
by Casalnuovo and co-workers.
206
 
 
Tilley and co-workers first developed the use of Mizoroki-Heck and Stille cross-
coupling reactions on amino acids (Scheme 56): tyrosine p-triflate 164 (triflates had 
been demonstrated as suitable cross-coupling partners in the literature, and were 
found in this case to be more accessible than organohalides)209 was cross-coupled with 
stannyl (65% yield after 1.5 h) and tert-butyl acrylates (54% after 24 h).210 Sengupta 
and co-workers have published a one-pot Heck-Matsuda reaction.211  
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Scheme 56: Functionalisation of tryosine p-triflate using Stille, Mizoroki-Heck and Heck-
Matsuda reactions.
210
  
 
Although these are important proofs-of-concept, the use of Sn and diazo- reagents 
remains undesirable. The Suzuki-Miyaura reaction was applied to similar substrates by 
Shieh and co-workers (Scheme 57).212 Initial conditions (Pd(PPh3)4, K2CO3 in DMF at 
90 °C) afforded high yields, but suffered from erosion of enantiomeric purity. Extensive 
optimisation (which considered, amongst other bases, TlOH)213 led to a solvent switch 
to toluene, which resulted in both high yield and high retention of enantiomeric purity 
(93% yield, >99% ee by chiral HPLC).  
 
 
 
Scheme 57: Functionalisation of tryosine p-triflate using the Suzuki-Miyaura reaction.
212
 
 
The first amino acid Suzuki-Miyaura reaction on a halide substrate was developed by 
Burk and co-workers (Scheme 58).214 Using DuPHOS-Rh catalyst, they successfully 
synthesised 2-, 3- and 4-bromophenylalanine. Cross-coupling was performed using 
Pd(OAc)2, 2 M Na2CO3 and P(p-tol)3 in DME at 80 °C, and excellent yields (75-99%) 
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were observed without loss of enantiomeric purity and with good tolerance to 
substitution on the boronic acid. The conditions were applied to a tri-peptide substrate, 
and product was isolated in excellent yield (71%).  
 
 
Scheme 58: Synthesis of Ar-functionalised tryosine from vinyl substrates, using Ru- and Pd-
mediated catalysis. 
 
Satoh and co-workers have developed Suzuki-Miyaura methodology where the 
organoboron cross-coupling partner rather than the pseudo(halide) is incorporated 
within the amino acid.215,216 It was found that (4-pinacolylborono)phenylalanine ethyl 
ester was successfully coupled with aryl halides using Pd and Ni catalysts in 
NMP/dioxane. 
 
These methodologies have generally moved away from the aqueous conditions first 
developed by Casalnuovo.206 The use of non-polar organic solvents (e.g. benzene and 
toluene) makes conditions unsuitable for the modification of unprotected amino acids, 
or peptides and proteins. DMF can result in mechanistic complications, toxicity and 
occasional irreproducibility.39 Goss, Wagner and co-workers have developed conditions 
(Scheme 59) for aqueous media Suzuki-Miyaura reactions on halotryptophans 
(available via an enzymatic route).217,218 Utilising Na2PdCl4 with TPPTS, 5-bromo- and 
5-chlorotryptophan were both functionalised with organoboronic acids in reasonable 
yield. 7-Bromotryptophan was also functionalised, but in poor yield. By substituting 
TPPTS with TXPTS, a reduction in temperature to 40 from 80 °C proved possible. 
Application to a dipeptide gave good yield (62% by HPLC), although some methyl ester 
deprotection was also observed.  
 
 
Scheme 59: Functionalisation of halotryptophan using the Suzuki-Miyaura reaction, as 
proposed by Wagner, Goss and co-workers.
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Cross-coupling on peptides was pioneered by Schmittchen and co-workers.219 
Schmittchen suggested that, as under the basic conditions of cross-coupling reactions 
peptides would carry an overall negative charge, the sulfonate-containing water soluble 
phosphines developed by Casalnuovo would have an electrostatic barrier compared to 
cross-coupling on uncharged substrates (although, this had not been found to be a 
problem on nucleotides).206 Peptides were encoded with haloaryl and propagyl 
modified amino acids. To solve this supposed problem, positively charged analogues 
were developed, e.g. guanadinophosphines.220,221 The catalyst was prepared by mixing 
Pd(OAc)2, guanadinophosphine ligand and CuI (1:5:10) in acetonitrile, and allowing the 
solution to ‘condition’ over five days under an N2 atmosphere at 4 °C. Initially, the 
Sonogashira reaction was performed on 4-iodobenzoate 174 and propagyl glycine 175 
in water/acetonitrile (7:3), from which a good yield (71%) was obtained (Scheme 60), 
with no evidence of homocoupled products.222 When these conditions were applied to 
the cross-coupling of 3-iodotyrosine 178 with propiolic acid 179 (Scheme 61), 86% 
yield was obtained after a 25 h reaction time (longer reaction times, or exposure to 
acidic conditions, resulted in rearrangements). The reaction was found to be as 
effective in buffered solution (3-[tri(hydroxymethyl)methylamino[-1-propanesulfonic 
acid, TAPS, pH 8).  Application to multi-functional peptide 181 (Scheme 62) resulted in 
an excellent 75% yield, and it was demonstrated to be possible to functionalise using a 
alkynylated biotin derivative (commonly used in biological chemistry, Scheme 63).223  
 
 
 
 
Scheme 60: The functionalisation of 4-iodobenzoic acid using the Sonogashira reaction. 
[Pd] is a a solution of Pd(OAc)2, guanodinophosphate and CuI (1:5:10) in MeCN which has 
been ‘conditioned’ for 5 d at 4 °C under N2. No stereochemistry given.
220
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Scheme 61: The functionalisation of 3-iodotyrosine using the Sonogashira reaction. 
[Pd] is a a solution of Pd(OAc)2, guanodinophosphine and CuI (1:5:10) in MeCN which has 
been ‘conditioned’ for 5 d at 4 °C under N2. No stereochemistry given. 
 
 
 
Scheme 62: The functionalisation of a peptide using the Sonogashira reaction. 
[Pd] is a a solution of Pd(OAc)2, guanodinophosphine and CuI (1:5:10) in MeCN which has 
been ‘conditioned’ for 5 d at 4 °C under N2. No stereochemistry given. 
 
 
 
Scheme 63: The functionalisation of a peptide using the Sonogashira reaction. 
[Pd] is a a solution of Pd(OAc)2, guanodinophosphine and CuI (1:5:10) in MeCN which has 
been ‘conditioned’ for 5 d at 4 °C under N2. No stereochemistry given. 
 
Ghadiri and co-workers, contrary to Schmittenchen’s hypothesis that negatively 
charged phosphine ligands would be inappropriate for the functionalisation of peptides, 
have shown that quantitative yields can be achieved in such Sonogashira reactions.224 
This work also indicated that the presence of thiol, thioether or bipyridyl functionality in 
the peptide was not tolerated by the reaction, presumably due to competitive ligation to 
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Pd and Cu. This is surprising, as Schmittchen had demonstrated that when biotin, a 
cyclic thioether, was included in the alkynyl coupling partner, a reaction could occur. In 
addition, biotin is generally tolerated in cross-coupling on small molecules.225 
 
The use of the Suzuki-Miyaura cross-coupling reaction on peptides was first developed 
by Kotha and co-workers.226 In a biphasic (THF/toluene/water) system, good yields 
were generally obtained. Hamachi and co-workers have shown that a 33-residue 
peptide (WW domain, Pin1 protein) could be functionalised by the Suzuki-Miyaura 
reaction.227 Using Na2PdCl4 (10 mol% with respect to boronic acid) as catalyst, 
moderate yields were obtained (40%). Higher temperatures increased yield, and the 
addition of substoichiometric quantities of glycerol (10-50 mol%) resulted in significant 
improvements (54-90% yield, depending on substrate). Glycerol likely increased 
peptide solubility, but it does have a demonstrated role in the stabilisation of Pd-
nanoparticles.228  
 
Fournier and co-workers have shown that it is possible to use the Suzuki-Miyaura 
reaction to functionalise peptides whilst they are tethered to solid-phase resin as used 
in peptide synthesis.229 Higher temperatures in DMF, with Pd(PPh3)4, were found to be 
optimal.  
 
Work by Valencia, Barluenga and co-workers (Scheme 64) has combined, in a one-pot 
process, aqueous iodination of tyrosine and phenylalanine residues in peptides with a 
Suzuki-Miyaura reaction.230 The cross-coupling conditions differ from Casalnuovo’s 
conditions only by the use of potassium aryltrifluoroborates (which are only partially 
soluble in water),202 and Barluenga had previously reported the iodination of 
biomolecules.231 However, this paper represents the first entirely post-synthetic 
modification of peptides by Pd-catalysed cross-coupling chemistry. 
 
 
 
Scheme 64: Post-synthetic modification of a peptide using iodonidation and Suzuki-Miyaura 
cross-coupling chemistry.
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Scheme 65: Mizoroki-Heck reaction performed on a peptide, as proposed by Tachibana and 
co-workers.
232
 
The first cross-coupling reaction performed on a protein was developed by Tachibana 
and co-workers (Scheme 65).232 iF32-Ras-His 188 was functionalised using a Mizoroki-
Heck reaction with vinylated biotin 189, Pd(OAc)2, TPPTS, 12% DMSO and MgCl2 (to 
suppress biotinylation at cysteine by S-coordination) in TAPS buffer (pH 8.3). The 
reaction occurred at 5 °C, although a 50 h reaction time was needed. An estimated 2% 
yield was observed, with significant amounts of dehalogenation of the protein (28%). 
Mg and Pd were removed by the addition of sodium stearate in reaction work-up, and 
the authors performed experiments that indicated that the use of transition metals did 
not affect the biological assays.  
 
 
Scheme 66: Sonogashira reaction performed on a peptide, as proposed by Tachibana and co-
workers.
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Tachibana and co-workers performed further investigations into these conditions using 
a model peptide substrate.233 Optimisation gave conditions which resulted in 
quantitative conversion to product by HPLC. This optimisation screen considered 
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concentration, reaction time, temperature, and the presence of additives. The optimal 
conditions were peptide, vinylated biotin, decyl-β-D-glucopyranoside and Pd-TPPTS 
(1:7.14:1.45:1:43) at 22 °C, giving 26% isolated yield.  
 
This methodology was extended to the Sonogashira (Scheme 66) and Suzuki-Miayura 
cross-coupling. The Sonogashira reaction was significantly faster than the Suzuki-
Miyaura, and finished typically after 4 h. The conditions were applied to Ras protein 
containing a 4-iodophenylalanine residue, and a 25% yield was obtained (yields were 
calculated by HPLC, SDS-PAGE or Western Blot).  
 
Conversely, Schultz and co-workers have developed a method for encoding boronate-
containing amino acid residues into proteins.234 The Suzuki-Miyaura reaction was 
applied to these modified proteins, coupling with an iodinated bodipy ‘reporter’ 
molecule. The solvent for these reactions was EPPS aqueous buffer (3-[4-(2-
hydroxyethyl)-1-peperazinyl]propanesulfonic acid, pH 8.5), using Pd2(dba)3.dba as the 
Pd source.235 This is unusual for aqueous cross-coupling methodologies, although a 
substituted water-soluble dba has been reported, but not used for this type of 
chemistry.236 
 
Davis and co-workers have developed ground-breaking conditions which begin to 
address some of the problems associated with preceding methodologies (Scheme 
67).237 They considered phosphines to be too sensitive to oxidation for the everyday 
functionalisation of proteins. Hence, the sodium salt of 2-amino-4,6-dihydroxypyridine 
was used as an alternative . These ligands had previously been used in Mizoroki-Heck 
alkynylation reactions in organic solvents.238 Near quantitative yields were obtained for 
cross-coupling reactions on model amino acids and short-chain peptides. The 
conditions were effective for aryl bromides and iodides, but not for aryl chlorides. 
Terminal cysteine and cysteine-derived residues inhibited catalysis, but internal S-
containing p-iodobenzyl cysteine (Pic) residues gave cross-coupled products in 
excellent yield.  
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Scheme 67: Functionalisation of p-iodobenzyl cysteine using the Suzuki-Miyaura reaction, as 
proposed by Davis and co-workers.
237
 
 
Pic was chemically incorporated into the serine protease subtilisin Bacillus lentus (SBL) 
mutant S156C. Davis applied these conditions to this protein, using phenylboronic acid 
as a cross-coupling partner. After 30 min, conversions to product exceeded 95% (by 
HPLC-MS). Similar excellent yields were obtained with a variety of aryl and 
vinylboronic acids. This work was later extended to cross-coupling on genetically 
encoded phenylalanine-derived aryl iodides.239 Maltose binding protein (MBP) was 
chosen for stability and solubility.240,241 Problems with non-specific metal binding initially 
resulted in signal suppression in mass spectral measurements.23 EDTA, DTT, and 
cysteine were tested as Pd scavengers.242 However, 3-mercaptopropionic acid was 
found to be effective in low concentrations (4.4 µmol mL−1, or 3 eq. with respect to Pd).  
 
 
 
Scheme 68: Functionalisation of p-iodobenzyl cysteine residues in peptides using the Suzuki-
Miyaura reaction, as proposed by Davis and co-workers.
237
 
 
With the reaction-monitoring problem solved, the cross-coupling reaction was found to 
be effective with ca. 680 eq. of furan-3-boronic acid. Full conversion was observed 
after 37 °C. The catalyst was loaded at 50 eq. with respect to protein. Control reactions 
without Pd or organoboronic acid were performed, confirming that this reaction is Pd-
mediated.  
 
Davis later demonstrated that it was possible to perform cross-coupling reactions on 
proteins residing within cell membranes (Scheme 69).243 Escherichia coli strains were 
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grown containing outer member OmpC proteins modified with p-iodophenylalanine 
residues incorporated at different positions.244 These cells (OD600 = 0.2) were treated 
with a fluorescein-derived organoboronic acid and Pd(OAc)2(ADHP)2 in phosphate 
buffer at 37 °C. The labelling was visible (exciting at 488 nm, emitting at 500-640 nm) 
after 1 h. At lower temperatures, labelling was decreased even with high Pd loadings. 
Control experiments were performed, again demonstrating a need for both Pd and 
organoboronic acid. The reaction remained effective even in the presence of reducing 
sugars.  
 
 
Scheme 69: Functionalisation of p-iodobenzyl cysteine residues in proteins in the cell wall of 
cells using the Suzuki-Miyaura reaction, as proposed by Davis and co-workers. Reprinted and 
adapted with permission from C. D. Spicer, T. Triemer, and B. G. Davies, J. Am. Chem. Soc. 
2012, 800-803. © American Chemical Society.  
 
It is difficult to compare ‘cell surface’ reactions with the stoichiometry of traditional small 
molecule cross-coupling reactions. Optimal organoboronic acid concentration is 
achieved at ca. 7.5 eq. relative to Pd. No cross-coupling is observed at Pd 
concentrations lower than 330 µM, at which a critical point is reached. No further 
benefit to increased Pd loading is observed after 450 µM. Many metal-catalysed 
synthetic modifications in biology, for example Cu-catalysed ‘click’ chemistry, suffer 
from toxicity problems.245 Davis and co-workers demonstrated that at optimal Pd 
concentration, cell death was identical to control (<3%).  
3.1.3 Pd-Mediated Functionalisation of C-H Bonds in Amino Acids and Peptides 
Over the years Grignard, Mannich or enolate chemistries have been used for the C-C 
bond formation by functionalisation of C-H bonds in amino acids. For example, the 
Mannich reaction was used by Li and co-workers to form a C-C bond at the α-position 
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of protected glycine.246 Other examples include the reaction of Li-enolates quenched 
with alkylstannanes,107 or low-temperature Grignard chemistry.247 
 
Examples of Pd-catalysed direct C-H bond functionalisation reactions on amino acids, 
however, are limited. In the literature, there are a number of examples of the synthesis 
of ortho-palladacycle complexes of amino acids, including phenylglycine and 
phenylalanine.248–253 PdII metallocycles are of interest as pre-catalysts for cross-
coupling reactions,79 as well as for their cytotoxicity.254–256 Vincente and Urriolabeitia 
have demonstrated how ortho-palladacycle amino acid complexes can be used in 
organic synthesis.  
Vincente and co-workers synthesised a phenylalanine palladacycle complex by 
reacting methyl protected phenylalanine with Pd(OAc)2 in MeCN (Scheme 70).
248 Using 
this compound it was possible to carbonylate to form tetrahydroisoquinoline 
heterocycles 201, and react with isocyanide to form isoquinolinium salts 200. Swapping 
to a bromide bridged complex facilitated halogenation to 203 via a proposed PdIV 
intermediate 202. However, no evidence for this high valence Pd species was 
proposed in the paper.133 1,10-Phenanthroline was then used to promote de-
coordination of the organic product from the complex.  
 
 
 
Scheme 70: Stoichiometric Pd-mediated direct C-H bond functionalisation of phenylalanine.
248
 
 
Urriolabeitia and co-workers, in similar studies, have shown that a cyclopalladated 
phenylglycine can be functionalised in a similar way (Scheme 71).250,253 Halogenation 
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proceeds from the chloride dimer (as opposed to the bromide dimer, as required in the 
work of Vicente). An alternate mechanism is also proposed, although still via a PdIV 
pathway. Measurement of enantiomeric purity by the Mosher amide approach257,258 
showed there to be some racemisation (ee 82% and 87% for bromo- and iodo- 
products respectively). Carboxylation results in an isoindole, although complete 
racemisation was noted. Isocyanides are unreactive, forming only co-ordination 
complexes.  
 
Scheme 71: Stoichiometric Pd-mediated direct C-H bond functionalisation of phenyglycine.
253
  
 
Iodine(III) reagents259,260 are often used to access PdIV/PtIV species. In the presence of 
PhI(OAc)2 and a large excess of alcohol, the palladacycle can be etherified. Significant 
amounts of racemisation do occur in this process (ee 20% for MeOH and 50% for 
EtOH), but could be a useful method for accessing these modified amino acids which 
has previously been unavailable. When the cyclopalladated phenylglycine reacts with 
dimethyl acetylenedicarboxylate (DMAD), C-C bond formation occurs simultaneously 
with the generation of spiro-palladacycles. Reductive elimination of the isolated 
intermediate resulted in C-N bond formation. Cyclopalladated complexes of N-
dimethylphenylglycine are also accessible.261 When this complex is carbonylated in the 
presence of a nucleophile such as an alcohol or an amine, esters and amides are 
obtained respectively.
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Scheme 72: Stoichiometric Pd-mediated direct C-H bond functionalisation of tryptophan with 
I2.
262
  
 
A tryptophan palladacycle complex 211 has been synthesised by Vicente and co-
workers (Scheme 72).262 With I2, this complex reacts to give iodination at the C2-
position of the indole (to give 212). 
 
Lavilla and co-workers have demonstrated C2-position selective arylation of tryptophan 
using a Pd-mediated system similar to that initially developed by Larrosa (Scheme 
73).199,263 Very good yields were obtained with a protected amino acid, with retention of 
enantiomeric purity. However, a significantly higher temperature was required as 
compared to Larrosa’s methodology for indoles, which would make it incompatible with 
protein functionalisation. 
 
 
 
 
Scheme 73: Arylation of tryptophan as propopsed by Lavilla and co-workers.
263
 
 
Lavilla adapted this methodology to the C-H bond functionalisation of peptides 
(Scheme 74) in phosphate buffer, lowering the temperature to 80 °C. Peptides with S-
containing residues were not tolerated by these conditions, due to selective hydrolysis 
of the peptide bond. These conditions still suffer from high temperatures, so application 
to proteins remains limited. The stereochemical intregrity of the peptides was 
preserved, and assessed by chiral HPLC.  
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Scheme 74: Arylation of tryptophan residues in peptides as propopsed by Lavilla and co-
workers.
263
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3.2 Direct C-H bond Functionalisation of Tryptophan 
3.2.1 Initial Method Development  
It was initially decided to consider the C-H bond functionalisation of tryptophan 
protected at both the N and O positions. Whilst this would simplify method 
development and mechanistic interpretation, selection of appropriate protecting groups 
could provide an accurate model for internal tryptophan residues in peptides. As such, 
N-acetyl-O-methyl tryptophan 213 was synthesised in excellent yield over two well-
precedented steps using the method of Taylor and co-workers.264 The resulting product 
was demonstrated to have high enantiomeric purity by chiral HPLC (Figure 47).  
 
 
 
 
Scheme 75: Synthesis of N-Ac, O-Me protected tryptophan, 213, over two steps (overall yield  
94%) using the method established by Taylor and co-workers.
264
  
 
 
Figure 47: Chromatogram showing enantiomeric purity of protected tryptophan 213, recorded 
on chiral stationary phase HPLC
§
 monitoring at multiple wavelengths. 
 
                                                
§ Chiracel OD column, eluting with 99.5:0.5 hexane:i-propanol at 1 mL min-1.
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Although there is an extensive variety of possible conditions available in the literature 
for the direct C-H bond functionalisation of indoles (vide supra) only a few are 
appropriate for this type of transformation. Mild and selective reactions were required, 
especially if the methodology was to be extended to more complicated and sensitive 
substrates at a later stage. As such, the work of Shi, Larossa and Sanford was 
carefully considered. Sanford’s direct C-H bond functionalisation of indole131 with 
hypervalent iodine reagents (formed in situ from organoboronic acid and 
diacetoxyiodobenzene, or pre-prepared) seemed especially favourable, due to low 
reaction temperature and high efficacy. The wide availability and stability of 
organoboronic acids (as of 18/03/13, Sigma-Aldrich listed 1165 products in the 
category ‘boronic acids’) could allow for significant freedom in the synthesis of 
analogues. Additional to this, it was felt that the unique properties of tryptophan might 
allow the proposed PdII/IV-mediated mechanism to be probed in more detail.  
 
As discussed, the Sanford indole functionalisation can be conducted using either 
phenylboronic acid and diacetoxyiodobenzene (Method A, Scheme 76) or using a pre-
prepared diaryl iodonium salt (Method B, Scheme 77). Initial results for both methods 
were encouraging (Table 6) with 22% and 35% yields obtained, respectively. Raising 
the temperature to 40 °C increased yields to 57% and 51% respectively. 
 
 
 
Scheme 76: Direct C-H bond functionalisation of tryptophan with PhI(OAc)2/PhB(OH)2 (Method 
A) .  
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Scheme 77: Direct C-H bond functionalisation of tryptophan with [Ar2I][OTf] (Method B). 
 
 
Table 6: Initial results for the direct C-H bond functionalisation of tryptophan. 
 
Entry Method Temperature / °C Yield / % 
1 A Ambient
**
 22 
2 B Ambient**  35 
3 A 40 57 
4 B 40 51 
 
It was thought that glacial AcOH could possibly be an unsuitable solvent for highly 
sensitive substrates. However, an attempt to develop a non-acidic or diluted AcOH 
medium for Method A proved fruitless. Acetic acid/sodium acetate buffer solution (pH 
5.6) gave no conversion to product, either with Pd(OAc)2 or with water-soluble 
Na2PdCl4. The use of THF/AcOH solvent mixtures in varying ratios resulted in dramatic 
drops in yields. Addition of sodium dodecyl sulphate (SDS) to the increase mixture 
resulted in slightly depressed yield (40%). It had been previously shown that this 
additive could increase the stability of proteins in acidic solution.  
 
Table 7: Variation of solvent and additives for the C-H bond functionalisation of tryptophan.  
a 
Na2PdCl4 catalyst used. 
 
Entry Solvent Yield / % 
1 AcOH/NaOAc Buffer 0 
2 AcOH/NaOAc Buffer
a
 0 
3 4:1 AcOH/THF 28
4 3:2 AcOH/THF 21 
5 AcOH (with SDS) 40 
 
                                                
** Ambient temperature ranged from 6 – 15 °C.
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This mirrored similar observations in 1-methylindole, although in a more pronounced 
fashion (Table 8). A variety of solvents (including THF and toluene) and additives 
(including the well-precedented oxidant p-benzoquinone) were used, but none gave the 
same efficacy as glacial AcOH. Use of stoichiometric and substoichiometric quantities 
of AcOH also failed. TFA and pivalic acid additives were similarly unsuccessful – 
Fagnou and co-workers had previously used these in CMD/AMLA-6-mediated C-H 
functionalisations.265 
 
 
Scheme 78: The C-H bond functionalisation of N-methylindole. 
 
Table 8: Variation of solvent and additives for the C-H bond functionalisation of N-methylindole. 
 
Entry Solvent Additive Yield† / % 
1 AcOH - 84 
3 THF - 0 
4 THF NaOAc (3 eq.) 0 
5 THF p-Benzoquinone (2 eq.) 0 
6 THF p-Benzoquinone (2 eq.) Trace 
7 THF / AcOH (1:1) NaOAc (3 eq.) 72 
8 THF AcOH (2 eq.) / NaOAc (2 eq.) 14 
9 THF AcOH (10 mol%) Trace 
10 THF TFA (2 eq.) Trace 
11 THF PivOH (2 eq.) Trace 
12* AcOH - 58 
13 Tol. - 0 
14 Tol. / AcOH (1:1) - 64 
15 AcOH - 0 
* using Pd2(dba)3 instead of Pd(OAc)2, † Yield after flash chromatography. 
 
Pd(OAc)2(pip)2 (TomCat 216), has been found to be an excellent pre-catalyst for the 
direct C-H bond functionalisation of nucleosides with Pd/Cu-mediate systems.27 The 
complex is synthesised from Pd(OAc)2 (Scheme 79). However, the reaction mixture 
N
PhB(OH)2 (2 eq.)
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25 oC, 15 h
N
Ph
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contained a 2.1:1 mixture of Pd(OAc)2(pip)2 and, unexpectedly, Pd(OAc)(NO2)(pip)2.
266 
The source of nitrate contamination was traced to commercial Pd(OAc)2.  
 
 
 
Scheme 79: Synthesis of TomCat 216 and the discovery of impurities in Pd(OAc)2. 
 
Cotton had noted non-trivial behaviour of Pd(OAc)2, which exists as a trinuclear 
complex Pd3(OAc)6 with D3h symmetry.
267 With trace water, an acetate bridge is 
disrupted to form Pd3(OAc)6(OH2) – this results in desymmetrisation of the 
1H NMR 
spectrum. Pd3(OAc)6 is synthesised from metallic Pd
0 by oxidation with HNO3/AcOH 
mixture. A strong flow of N2 should remove the NO2(g) evolved by this process. 
However, a poor flow will result in the formation of the nitrate complex Pd3(OAc)5(NO2). 
Recrystallisation of Pd(OAc)2, followed by manual separation and characterisation (by 
elemental analysis, 1H NMR and IR spectroscopy) confirmed complex was the 
contaminant. In a study of commercial Pd(OAc)2 sources from various research groups 
at the University of York showed that 80% of the samples tested were contaminated 
with nitrate (Figure 48).  
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Figure 48: 
1
H NMR spectra showing ‘pure’ Pd(OAc)2 (>99%, orange) compared to a variety of 
commercial samples collected at the Department of Chemistry, University of York. All these 
samples show the presence of Pd3(OAc)5NO2 impurity (purple). Green indicates 
Pd3(OAc)6(OH2). (Figure prepared by Prof. I. J. S. Fairlamb). 
 
The presence of nitrate impurity can have a profound effect in Pd co-ordination 
chemistry, and should be a significant cause for concern for those working in that field. 
In addition to 216, Fairlamb and co-workers have shown that nitrate has a non-
innocent role in the synthesis of papavarine palladacycles.268,269 Nonoyama and co-
workers had suggested the unexpected synthesis of nitrate complexes arises from 
oxidation of acetonitrile. This was shown not to be the case, with the nitrate thought 
most likely to have been from a significantly contaminated batch of Pd(OAc)2. 
 
Pd(OAc)2 is often found as a pre-catalyst in Pd-mediated cross-coupling reactions. 
Given the lack of literature comment, and the apparent ubiquity of the contaminant, it 
seems reasonable to conclude that in such processes there is no difference in catalytic 
activity between Pd3(OAc)6 and Pd3(OAc)5(NO2) complexes in orthodox Pd
0/II systems. 
However, in the PdII/IV manifold proposed for Sanford’s indole C-H functionalisation, it 
was hypothesised that the nitrate complex could help to stabilise PdIV intermediates. 
The direct C-H bond functionalisation of N-methylindole was performed using pure 
samples of Pd3(OAc)6 and Pd3(OAc)5(NO2). Both catalysts gave identical yields (84%). 
This does not preclude differences in other catalytic systems.  
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Scheme 80: Direct C-H bond functionalisation of 1-methylindole using pure Pd3(OAc)6 and that 
contaminated with Pd3(OAc)5(NO2).  
3.2.2 Unsymmetrical Diaryliodonium Salts  
Work by Gaunt and co-workers on the selective functionalisation of aryl meta C-H 
bonds had indicated that the use of asymmetric diaryl iodonium salts in which one aryl 
ring is highly substituted results only in the transfer of the less sterically hindered 
aryl.132 Rather than synthesising a number of such diaryliodonium salts, it was thought 
that it might be possible to introduce different substituents to the tryptophan using a 
constant, sterically hindered hypervalent iodine compound and varying aryl boronic 
acid, forming the diaryl iodonium salt in situ. Attempts to synthesise 
bis(acetyloxy)(2,4,6-trimethylphenyl)-λ3-iodane, however, proved to be unsuccessful. 
(3-Oxo-1-λ3-2-benziodoxol-1(3H)-yl)methyl acetate 220 is a by-product of Dess-Martin 
periodinane (DMP) oxidation.270 The IIII in this compound is in a similar environment to 
diacetoxyiodobenzene, and it was proposed that this hypervalent iodine compound 
could be used as a non-transferring half of a diaryl iodonium salt. It can be easily 
synthesised in two steps in excellent overall yield (Scheme 81): 2-iodobenzoic acid is 
oxidised to I-III using NaIO4, followed by a rapid (10 min) acylation with neat Ac2O.   
 
 
 
Scheme 81: Synthesis of iodine(III) compound 220. 
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Scheme 82: Direct C-H functionaliastion of tryptophan using iodine(-III) compound 220. 
When applied to the direct C-H functionalisation no reaction was observed. The 
employment of unsymmetrical arylmesityliodonium salts have been previously used by 
Gaunt and Greaney.132,271,272 These reagents are available from aryl iodide and 
mesitylene, oxidised to iodine(III) by m-CPBA. Triflate is commonly used as the 
counter-ion. Generally, the yields of these salts range from moderate to poor. 
Application of these reagents proved to be disappointing. Although yields were 
maintained with the 4-tolylmesitiyliodonium triflate (Table 9, entry 1), CF3-substituents 
resulted in poor yield (entries 2-3).  
 
Table 9: The direct C-H bond functionalisation of tryptophan using [(Mes)I(Ar)][OTf]. 
 
 
 
 
 
 
 
 
 
† Yield after flash chromatography.  
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1 221 52 
2 222 28 
3 223 21 
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3.2.3 Mechanism: Pd0/II or PdII/IV?  
 
 
Figure 49: Direct C-H bond functionalisation reaction of indole. (a) Solution of 
PhI(OAc)2/PhB(OH)2  and Pd(OAc)2 in AcOH (b) Immediately (ca. 15 s) after the addition of 1-
methylindole. 
 
These reactions were notable for their rapid (sometimes immediate) formation of Pd0 
(Figure 49), which appear as nanoparticulate species (most likely colloidal in nature) 
To analyse these Pd nanoparticles, two samples of reaction mixture after heating for 1 
h were collected. To one of these samples, PVP (10 eq. per theoretical amount of Pd, 
assuming the reaction was a homogenous mixture) was added. Solvent was removed 
from both samples under reduced pressure, heating at 40 °C. Transmission electron 
micrographs were recorded for each of these samples (Figures 50 and 51). As with the 
direct C-H bond functionalisation of benz(azoles) discussed in Chapter 2, Pd0 
nanoparticles were clearly visible.  
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Figure 50: TEM image of Pd
0
nanoparticles isolated from the direct C-H bond functionalisation 
of tryptophan using PhI(OAc)2/PhB(OH)2, trapped with PVP. Inset: histogram showing the 
distribution of particles by size, n = 100. 
 
 
 
 
Figure 51: TEM image of Pd
0
 nanoparticles isolated from the direct C-H bond functionalisation 
of tryptophan using PhI(OAc)2/PhB(OH)2, without PVP. Inset: histogram showing the distribution 
of particles by size, n = 100. 
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Table 10: Simple statistical analyses of the Pd nanoparticles isolated from the direct C-H bond 
functionalisation of tryptophan using PhI(OAc)2/PhB(OH)2 (see Figures 50 and 51) 
 
 Mean SD Median Mode IQR IQM 
With PVP 2.52 0.52 2.20 2.40 0.680 2.46 
Without PVP 2.22 0.32 3.05 2.17 0.435 2.20 
 
These nanoparticles are small (in the 2-5 nm size regime) and well defined (as 
demonstrated by small standard deviation). No significant difference was noted 
between the samples (the mean difference, 0.3 nm, is within the estimated error).  
 
 
 
Scheme 83: See Table 11.  
 
Table 11: Variation of catalyst loading for the direct C-H bond functionalisation of tryptophan. 
a
 Reaction time 69 h.  
 
 
 
Sanford, in the original publication, noted the formation of nanoparticles and suggested 
it was the result of catalyst poisoning (i.e. that active PdII is reduced to Pd0, effectively 
removing it from the catalytic cycle). If this hypothesis was correct, then avoiding 
colloid formation could increase reaction yield. Reduction in catalyst loading did 
prevent visible Pd colloid formation, and there was a significant increase in turnover 
number. This could suggest the active phase of the reaction is in solution. However, 
low yields were observed (Table 11). At lower loadings, the catalyst remained active for 
N
H
N
H
O
O
O PhB(OH)2 (2 eq.)
PhI(OAc)2 (2 eq.)
Pd(OAc)2
AcOH, 16 h
N
H
N
H
O
O
O
Ph
Entry Catalyst Loading Yield / % TON 
1 100 79 0.79 
2 10 66 6.60 
3 5 57 11.4 
5 2.5 44 17.6 
6 1 15 15.0 
7
a
 1 44 44.0 
213 215 
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longer periods: when the reaction with 1 mol% Pd(OAc)2 was left for 69 h, an increased 
yield was observed over that reacted for 16 h. This observation was not repeated at 
higher loadings.  Negligible change in yield was observed when the reaction was 
performed under inert conditions. This would suggest that Ostwald ripening (that is, 
aggregation resulting from interaction of the Pd nanoparticles with O2, potentially 
seeding growth) was not an issue in aggregation.129 
 
 
 
 
Scheme 84: Direct C-H bond functionalisation of tryptophan using Pd-PVP nanoparticles.  
 
It was found that intentionally synthesised Pd-PVP nanoparticles (ca. 3 nm) gave a 
comparable yield to the Pd(OAc)2-catalysed reactions (Scheme 84). Since this reaction 
– both on simple indole and tryptophan substrates – had been proposed to proceed via 
a PdII/IV-mediated manifold, this result was surprising. This suggests that either this 
reaction proceeds via a traditional Pd0/II manifold or that atoms of Pd are labilised from 
the polymer support and oxidised to PdII by solvent, reagents or air. Although by no 
means conclusive, infrared spectroscopic analysis under working conditions did not 
show the appearance of Pd(OAc)2 (by ReactIR®) when Pd-PVP nanoparticles were 
suspended in acetic acid. 
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Scheme 85: Synthesis of complex Pd(SIMes)(OAc)2(H2O), via Pd-allyl complexes x to y. 
The amino acid tryptophan had been C-H bond functionalised in moderate yield, and 
Pd0 nanoparticles had been identified in the reaction mixture. Further, pre-synthesised 
nanoparticles had been shown to be catalytically active. In Sanford’s direct C-H bond 
functionalisation of indoles, it was noted that N-heterocyclic carbene PdII complexes 
were highly efficacious for this reaction, particularly when used with pre-synthesised 
diaryliodonium salts. It is thought that such complexes are particularly stable at PdII. 
Novel SIMes complex 228 was synthesised in three steps (Scheme 85) with excellent 
overall yield (93%). 2-Methylallyl complex 224 was heated under reflux in air with 1,3-
di(2,4,6-trimethylphenyl)-2-(pentafluorophenyl)-2,4,5-trihydroimidazole, allowing novel 
complex 228 to be collected in quantitative yield.126 When treated with ethereal HCl, 
226 dimerises with loss of 2-methylpropene to give known 227. Treatment with AgOAc 
yields the desired catalyst [1,3-di(2,4,6-trimethylphenyl)-4,5-
dihydroimidazolylidene]diacetateaquopalladium(II) 228. Novel complexes 226 and 228 
have been thoroughly characterised by NMR spectroscopy.  
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Figure 52: 
1
H NMR assignments for complex 226. 
 
For 226 (Figure 52), 1H NMR spectroscopy (Figure 53) revealed a simple aromatic 
region consisting of two equally integrating singlets (δ 6.97, 6.93 ppm). These were 
integrated as 2H each, and correspond to the ArH in the mesityl groups. Three singlets 
(δ 2.49, 2.41, 2.29 ppm), each integrating to 6H, were observed and assigned as the 
mesityl CH3 groups. 
1H-1H NOESY experiments (Figure 55) indicated interaction 
between the singlet at δ 2.29 ppm and both ArH environments – this indicated that this 
methyl group is situated in the para position. nOe interactions for δ 2.49/6.97 and δ 
2.41/6.93 were both observed, suggesting they are adjacent to each other.  
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Figure 53: 
1
H NMR (400 MHz, CDCl3) spectrum of complex 226. 
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Figure 54: 
1
H-
1
H COSY NMR (500 MHz, CDCl3) spectrum of 226. Coloured lines connect 
resonances for which cross-peaks are observed.  
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Figure 55: 
1
H-
1
H NOESY NMR of 226 (500 MHz, CDCl3) spectrum. 
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The singlets at δ 2.49 and δ 2.41 ppm also exhibit nOe interactions with a 4H multiplet 
at 4.01. This signal is assigned as the C3-H2 and C4-H2 of the dihydroimidazolyl moiety.  
 
The 2-methyl allyl ligand is represented by two 1H doublets, two 1H singlets, and a 3H 
singlet (assigned as the methyl group). A significant difference in chemical shifts 
between the signals suggests an asymmetric or ‘slipped’ allyl complex – the highest 
field signals are the ‘end’ of the allyl with the most double-bonded character. The 
doublets have a coupling constant of δ 3.01 Hz – this indicates an allyl W-coupling.273 
Each doublet exhibits an nOe interaction with one singlet, suggesting they are on the 
same C atom. This is confirmed by HSQC (Figure 58). The doublet proton signals also 
exhibit nOe interactions with the methyl group, suggesting they are on the same side of 
the allyl.  
 
nOe interactions are observed between the singlet at δ 2.49 ppm and the double bond 
character end of the allyl, suggesting that this end is closer in space to the mesityl 
moiety, and that both the allyl and mesityls are locked in space.  
 
 
 
 
 
Figure 56: 
13
C NMR assignments for complex 226. 
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Figure 57: 
13
C and 
13
C DEPT 135 NMR spectra for 226 (101 MHz, CDCl3).  
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Figure 58: 
1
H-
13
C HSQC NMR (400, 101 MHz, CDCl3) spectrum of 226.
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Figure 59: 
1
H-
13
C HMBC NMR (400, 101 MHz, CDCl3) spectrum of 226.
 
 
13C resonances were assigned by comparison with HSQC (Figure 58) and HMBC 
(Figure 59). Allyl C2 carbon and the dihydroimidazolyl C1 have not been observed.  
 
Complex 228 was similarly characterised, and the 1H and 13C resonances are shown in 
Figures 60 and 61. Similarly, the dihydroimidazolyl C1 have not been observed. 
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Figure 60: 
1
H NMR assignments for 228. 
 
 
 
Figure 61: 
13
C NMR assignments for complex 228. 
 
Nolan and co-workers have synthesised similar complexes (of 1,3-di(2,4,6-
trimethylphenyl)-4,5-imidazolylidene) from free carbene and recrystallized Pd(OAc)2, in 
which one acetate adopts a κ2O,O configuration (Figure 62).274 However, in complex 
228 only one acetate environment is observed by 1H NMR spectroscopic analysis. 
Furthermore, a broad ligated H2O signal is also present.  
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Figure 62: Possible κ
2
O,O configuration of 228. 
 
In the C-H bond functionalisation of tryptophan 213 using a pre-synthesised 
diphenyliodonium triflate salt (Method B), a slight increase in yield is obtained for 228 
over Pd(OAc)2 (Scheme 86).  
 
 
 
Scheme 86: The direct C-H bond functionalisation of trytophan using  Method B, catalysed by 
228 and Pd(OAc)2.  
 
However, a significant difference in reactivity is observed for C-H bond functionalisation 
with phenylboronic acid and diacetoxyiodobenzene (Scheme 87). The reaction with 
SIMes(OAc)2(H2O) does not proceed at all. This gives the first indication that there 
could be a different mechanism operating under the two reaction conditions (i.e. the 
different methods). 
 
 
 
Scheme 87: The direct C-H bond functionalisation of trytophan using  Method A, catalysed by 
228 and Pd(OAc)2. 
 
The roles of reagents in Method A were scrutinised. Reagent elimination studies on 
Method A (Scheme 88, Table 12) indicated that, as expected, the reaction did not 
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proceed in the absence of Pd. Also, in the absence of PhB(OH)2, the reaction did not 
proceed. This was consistent with the proposed in situ formation of diaryliodonium salt. 
However, when PhI(OAc)2 was omitted, the yield increased to 93%. Without PhI(OAc)2, 
the diaryliodonium salt cannot be forming.  
 
 
 
Scheme 88: Component elimination studies in the direct C-H bond functionalisation of 
trytophan using  Method B, catalysed by 228 and Pd(OAc)2.  
 
Table 12: Component elimination studies for the direct C-H bond functionalisation of 
tryptophan, 213.  
Entry Reagents Omitted Component Yield / % 
1 
PhI(OAc)2 (2 eq.) 
PhB(OH)2 (2 eq.) 
None 56 
2 
PhI(OAc)2 (2 eq.) 
PhB(OH)2 (2 eq.) 
Pd(OAc)2 0 
3 
PhI(OAc)2 (5 mol%) 
 
PhB(OH)2 0 
4 
PhB(OH)2 (2 eq.) 
 
PhI(OAc)2 93 
 
This reactivity was further probed using PhI(OAc)2 and 4-MeC6H4B(OH)2 in the 
reaction. If the diaryliodonium salt was formed, as proposed, then we should expect an 
equal mixture of tryptophan functionalised with Ph- and 4-MeC6H4- groups. However, 
by ESI-MS only trace quantities of 4-MeC6H4-modified tryptophan were observed by 
ESI-MS and 1H NMR spectroscopy and no Ph-modified tryptophan.  
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Scheme 89: The direct C-H bond functionalisation of tryptophan using PhI(OAc)2 and 4-
MeC6H4B(OH)2, catalysed by Pd(OAc)2.  
 
These results suggest that the diaryliodonium salt is not being formed in situ in the C-H 
bond functionalisation of tryptophan using ArB(OH)2 and PhI(OAc)2. As a 
consequence, it seems unlikely that this reaction is proceeding via the same PdII/IV 
mediated mechanism as Method B.  The presence and catalytic activity of Pd0 
nanoparticles suggest that a Pd0/II catalytic manifold is operative.  
 
The proposed mechanisms for both methods are shown in Scheme 90. Both 
mechanisms involve coordination of tryptophan via the amide nitrogen (intermediate 
II). Cyclopalladation can then occur (intermediate III). Presumably, this occurs initially 
at the C3-position, followed by a rapid 3,2-migration as proposed by Sames. After this 
point, the two mechanisms diverge. For Method B, diaryliodonium oxidatively adds, 
resulting in PdIV intermediate IVa. Reductive elimination of product can then occur, 
feeding PdII back into the catalytic cycle.  
 
For Method A, transmetallation occurs with aryl boronic acid to give PdII intermediate 
IVb. Reductive elimination of the product regenerates Pd0. It is proposed that this is in 
equilibrium with Pd0 nanoparticles – that is, that the nanoparticles are acting as a 
resting state or reservoir. The Pd0 Vb can be returned by PdII using a sacrificial oxidant 
(possibly due to oxidation from the surface of the particle). PhI(OAc)2 was acting in this 
fashion. It has been shown this can also act as an oxidant in the boronic acid 
homocoupling process – a process that can outcompete with C-H bond 
functionalisation, consuming the boronic acid (dependent on the structure of the 
boronic acid) and reducing the reaction yield. With PhI(OAc)2  removed, O2 in the air 
can act as the oxidant. Homocoupling can still occur, but at a reduced rat
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Scheme 90: Proposed catalytic cycles for Pd
0/II
 and Pd
II/IV
 mediated direct C-H bond functionalisation of tryptophan 213. It is thought that Pd
0
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The formation of intermediate II was also observed by in situ monitoring by ReactIR®. 
Tryptophan 213 was dissolved in THF, and Pd(OAc)2 added. The reaction was 
monitored at 1616 cm-1 (Figures 63-64) This is a carbonyl stretching band associated 
with Pd(OAc)2 {e.g. Pd3(OAc)6).
267 Within 45 minutes of addition, the starting material 
had been entirely consumed. A new band at 1586 cm-1 concurrently increased in 
intensity. It is proposed that this infrared band is associated with intermediate II.  
 
 
 
Figure 63: 3D plots on data acquired on ReactIR® for the formation of intermediate II (Scheme 
90).  
 
 
Figure 64: Kinetic curves for the reaction of tryptophan and Pd(OAc)2, monitored by ReactIR® 
 
Intermediate II proved to be unstable in solution for extended periods. Attempts to 
recrystallise the proposed intermediate, or obtain LIFDI-MS evidence, resulted in 
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formation of insoluble Pd0 precipitate. It is thought that this arises from the rapid 
reductive elimination of AcOH. It was considered that the trifluoroacetate analogue 
might exhibit increased stability. The complexation of Pd(F3CCOO)2 and tryptophan 
213 was monitored by 19F NMR spectroscopy. Immediate formation of a single new 
species was observed. However, this complex suffered from the same stability issues 
as II, and no further evidence was obtained. Complex 213 did not react with Pd(acac)2. 
 
Attempts to isolate intermediate III proved inconclusive. 213 was dissolved in AcOH-
d4, and a 
1H NMR spectrum recorded. C2-1H is observed as a singlet at ! 7.08 ppm, 
coincident with an indole aromatic multiplet (2H). Overall, this multiplet was integrated 
as 3H with respect to an indole 1H resonating at δ 7.34 ppm. It was thought that, on the 
addition of Pd(OAc)2, the cyclopalladated intermediate could be observed. However, a 
1H NMR spectrum recorded immediately after addition showed no change (Figure 65).  
 
 
Figure 65:  1H NMR (400 MHz, CD3COOD) spectrum of tryptophan 213, following the addition 
of Pd(OAc)2. Integration indicates no metallation has occurred at C2.  
 
Since intermediate III could not be observed directly, it was proposed that it may be 
accessible using the methodology developed by Vicente and co-workers (vide supra) in 
stoichiometric cyclopalladations.262 It was proposed that tryptophan 213 could be 
exposed to these conditions and, in the absence of a chloride anions, would form the 
acetate bridge complex. Unfortunately, only insoluble Pd0 precipitate was obtained 
from this reaction.  
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Scheme 91: Synthesis of chloride-bridge complex 211.  
 
It was found that Vicente’s cyclopalladated complex could be successfully synthesised 
in good yield (Scheme 91). It was anticipated that treatment of 211 with AgOAc would 
exchange the bridging chloride ligands for acetate groups, giving intermediate III. With 
this in hand, the reaction of this complex with PhB(OH)2 could then be studied.  
 
 
 
Scheme 92: Proposed stoichiometric studies for the direct C-H bond functionalisation of 
tryptophan from chloride- and acetate-bridged complexes. 
 
However, the ligand exchange did not proceed to give the desired product. Instead, a 
significant amount of Pd0 precipitate was observed both under air and in an inert 
atmosphere. Therefore, as a model system complex 211 was subjected to PhB(OH)2 
(10 eq.) for 16 h. After approximately 20 minutes, Pd0 precipitate was observed in the 
reaction mixture. Crude ESI-MS indicated the starting material had been consumed 
and arylated product had been formed.  
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The reaction was found to be unreliable when performed under air – different rates of 
stirring and changing the reaction vessel were found to have an effect on reaction 
efficacy. This was not observed when the reaction was performed under O2 (1 atm). 
However, the addition of a substoichiometric quantity (10 mol%) of Cu(OAc)2 increased 
the reliability of this reaction (with a 94% yield obtained of product 215). CuII simply 
catalyses the oxidation process – O2 remains the terminal oxidant. Indeed, when the 
reaction is performed under an inert atmosphere (Ar), only 11% yield is obtained, which 
is equal to one turnover of CuII.  
3.2.4 Organoboron Reagents 
Mechanistic studies have, therefore, demonstrated that Method A for the direct C-H 
bond functionalisation of tryptophan may be mediated by a Pd0/II manifold rather than 
by PdII/IV. With this enhanced mechanistic knowledge, hypervalent iodide reagents 
could be removed from the method, and a 94% yield obtained for the reaction with 
PhB(OH)2.  Method development was then extended to variation of substituents on the 
phenyl group of the organoboronic acid. With the exception of 230 (entry 2), yields 
were poor (Table 13), and it appeared that substitution on the arylboronic acid was not 
tolerated by the current conditions. Performing the reaction under O2 (1 atm) had no 
effect.  
 
Table 13: Direct C-H bond functionalisation of tryptophan using ArB(OH)2 (2 eq.) under air. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Entry Compound Ar Yield / % 
1 215 
 
94 
2 230 
 
66 
3 222 
 
7 a 
4 231 
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It was thought that C-H bond functionalisation could be competing with homocoupling 
of the aryl boronic acid. This process, oxidised by O2, is a common side reaction in the 
Suzuki-Miyaura cross-coupling reaction, and has been extensively studied.275–280 This 
oxidation has been shown to be catalysed by CuII complexes, similar to the conditions 
proposed here.281 Molander and co-workers have proposed aryltrifluoroborate 
potassium salts can be used as substitutes for traditional arylboronic acids in the 
Suzuki-Miyaura reaction, and do not suffer from many of the problems supposedly 
associated with arylboronic acids, including homocoupling.202,282–284 However, this is 
disputed by Lloyd-Jones and co-workers, who showed after significant mechanistic 
investigation that these compounds hydrolyse to give the boronic acid.203 The rate of 
this hydrolysis determines the amount of homocoupling that occurs. Nonetheless, 
these reagents have become popular and it was thought that they may be useful 
reagents for this direct C-H bond functionalisation.  
 
A variety of aryltrifluoroborate potassium salts were synthesised using the method 
developed by Vedejs and co-workers (Scheme 93) in excellent yields (Table 14).285 It 
should be noted that since these compounds were prepared, Lloyd-Jones and co-
workers have developed a much improved and milder methodology for the synthesis of 
these salts which does not involve the generation of HF.286 PhBF3K was obtained 
commercially.  
 
 
Scheme 93: Synthesis of potassium aryltrifluoroborate salts. 
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Table 14: Synthesis of potassium aryltrifluorborates using the method of Vedejs. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 15: Direct C-H bond functionalisation of tryptophan using potassium aryltrifluoroborates. 
Trace is < 5% conversion observed by 1H NMR spectroscopy.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Boronic neo-pentyl esters have been used in the Suzuki-Miyaura reaction, either as a 
protecting group (for selective functionalisation) or to inhibit homocoupling reactions. 
Boronic ester 237 was synthesised in excellent yield (94%). When applied to the C-H 
bond functionalisation reaction only 20% conversion was observed by 1H NMR 
Entry Compound Ar Yield / % 
1 233 
 
97 
2 234 
 
>99 
3 235 
 
93 
4 236 
 
75 
Entry Compound Ar Yield / % 
1 215 
 
60 
2 221 
 
56 
3 230 
 
21 
4 222 
 
Trace 
5 231 
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O
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spectroscopic analysis. Although low, this was better than the trace yield obtained 
using the analogous aryltrifluoroborate.  
 
 
 
Figure 66: 4-Methoxyphenylboronic neo-pentyl ester and 4-methoxyphenylboronic boronic 
MIDA ester.  
 
MIDA boronic esters, such as commercially available compound 238, are used in a 
similar way. These organoboron reagents are highly resistant to homocoupling. 
However, this has a consequential impact on their reactivity. When applied to the C-H 
bond functionalisation reaction, no conversion to product was observed.  
 
Varying the nature of the organoboron reagent had not increased product yield. Using 
reagents that inhibited homocoupling generally led to inhibited transmetallation with 
intermediate II (Scheme 90). Since it was hypothesised that non-productive 
consumption of boronic acid was depressing yield, increasing the stoichiometry of the 
boronic acid could lead to increased yields. With five equivalents of ArB(OH)2, 
generally good yields were obtained (Table 16).   
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Table 16: Direct C-H bond functionalisation of tryptophan using ArB(OH)2 (5 eq.).  
 
Entry Compound Ar Yield % 
1 215 
 
93 
2 221 
 
88 
3 230 
 
79 
4 222 
 
58 
5 231 
 
28 
6 239 
 
0 
 
 
Table 17: Direct C-H bond functionalisation of tryptophan using ArB(OH)2 (5 eq.).  
 
The reduced yields of the electron rich aryl boronic acid could be due to their increased 
propensity to form homocoupled products, which have been observed by HPLC (vide 
infra). The lack of reactivity of the 4-bromophenylboronic acid is likely due to poor 
solubility in AcOH.  
3.2.5 Stereochemistry and X-Ray Crystallography 
The stereochemistry of amino acids is important, particularly as residues in larger 
systems such as peptides (where molecular shape can affect biological functionality, 
with respect to enzymes and proteins) or, more fundamentally, proteins (where 
stereochemistry helps define secondary, tertiary and quaternary structure). Therefore, 
it is essential that any modification strategy must result not in racemisation.  
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To assess this for the C-H bond functionalisation reaction, [ ]D measurements were 
recorded for the synthesised analogues. They were found to be non-zero, and in 
agreement with the literature values (Table 18).  
 
Table 18: [ ]D values for tryptophan analogues, as compared to literature values.  
 
Entry Ar Found [α]D ° (conc) Lit. [α]D ° (conc) 
1 
 
47.3 (0.11) 48.3 (0.13)263 
2 
 
54.4 (0.10) 47.6 (0.15)263 
3 
 
59.1 (0.10) 38.2 (0.65)287 
4 
 
62.0 (0.13) 
 
47.2 (0.13)263 
 
5 
 
34.9 (0.10) 37.5 (0.16)263 
 
 
Racemic protected starting material was synthesised from DL-tryptophan in excellent 
overall yield. Using chiral HPLC, it was determined that the racemate had an 
enatiomeric ratio of 52.1:47.9 (the error in the measurement is therefore ca. 5%). Both 
the racemate and an enantiopure sample (er 99.9:0.1 by HPLC) were functionalised, 
and the products analysed by chiral HPLC (Figure 67). No racemisation was found to 
occur – the product obtained from enantiopure starting material had an enantiomeric 
ratio of 99.9:0.1. 
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Figure 67: Chiral HPLC traces of product as compared to known racemate. 
 
X-ray crystal structures have been obtained for 4-CF3C6H4- and 4-FC6H4- analogues 
(Figures 68-69). However, absolute configuration of stereochemistry could not be 
obtained from these two structures as they lack a ‘heavy’ atom, such as Br. Attempts to 
introduce a Br proved unsuccessful. Functionalisation with 4-BrC6H4B(OH)2 had failed 
due to lack of solubility in AcOH. Increasing to ten equivalents of the aryl boronic acid 
had no effect. 5-Bromotryptophan was obtained from Dr. Rebecca Goss (University of 
East Anglia, now St. Andrews), and protected (Scheme 94) in excellent overall yield 
(98%). However, only trace product was obtained when the C-H bond functionalisation 
conditions applied. Running the reaction under O2 (1 atm) had no effect.  
 
 
 
Scheme 94: Protection of 5-bromotryptophan.  
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Figure 68:  4-FC6H4-functionalised analogue of tryptophan, 230. Hydrogen atoms have been 
removed for clarity. Thermal ellipsoids shown at 50%. Selected bond lengths (Å) and torsion 
angles (°): (F(1)-C(1) = 1.3600(18), N(2)-C(7)-C(4)-C(3) = 135.53(15). 
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Figure 69: 4-F3CC6H4-functionalised analogue of tryptophan, 222. Hydrogen atoms have been 
removed for clarity. Thermal ellipsoids shown at 50%. Selected bond lengths (Å) and torsion 
angles (°): F(1)-C(21) 1.340(3), N(2)-C(11)-C(12)-C(17) 142.1(2).. 
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3.2.5 UV-Visible and Fluorescence of 2-Aryltryptophan Analogues 
UV-Vis spectra were recorded for the unsubstituted tryptophan starting material and 
each of the synthesised analogues. Overlaid examples of spectra are shown in Figure 
70 (complete spectra available in Appendix B). The λmax of the analogues are shifted 
with respect to the unsubstituted starting material. All of the analogues have points at 
which they absorb where the unsubstituted tryptophan does not – this is encouraging 
for the intended use, as it is important to be able to selectively excite the analogues 
without exciting unlabelled tryptophan residues.  
 
Figure 70: Comparative UV-Visible λmax, normalised with respect to C6H4F- analogue. 
 
The absorbance of a compound is related to its concentration by the Beer-Lambert 
Law.288 Using this law, the molar absorption coefficients can be calculated for each 
analogue (Table 19). All the analogues have molar absorption coefficients of similar 
magnitude. All are higher than that recorded for the unsubstituted tryptophan, and the 
C6H4F analogue has the highest. This suggests it absorbs mostly strongly of these 
analogues. 
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Table 19: Molar absorption coefficients for tryptophan analogues, as compared to unsubstituted 
tryptophan starting material. ε given at λmax. 
 
 
The λmax of the analogues were plotted against their σP Hammett parameters (Figure 
71).  The analogues were bathochromically (red) shifted with respect to the 
unsubstituted tryptophan (as indicated by the red dashed line). The most electronically 
extreme analogues (both electron-withdrawing and electron-donating) have the most 
shifted absorptions, generating a characteristic V-shape. This pattern has been 
observed by Marder and co-workers in 1,4-bis(p-R-phenylethynyl)benzenes and 2,5-
bis(phenylethynyl) thiophenes.289,290 It was proposed by Marder that electron-donating 
substituents increase HOMO energy further with respect to LUMO. Conversely, 
electron-withdrawing substitutes decrease LUMO energy further with respect to the 
HOMO. Both these processes result in a lower HOMO-LUMO energy gap, and a 
bathchromically shifted absorption. 
Entry Compound Ar λmax / nm ε / cm
-1
 mol
-1
 dm
-3
 
1 215 
 
308 9120 
2 230 
 
306 14684 
3 222 
 
318 10297 
4 231 
 
320 11644 
5 221 
 
310 8893 
6 213 
 
282 5804 
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Figure 71: Absorption maxima (nm) of tryptophan analogues plotted against Hammett 
parameters (σ+), and compared to the unsubstituted tryptophan.  
 
Fluorescence spectra were similarly recorded (Figure 72) Fluorescence typically 
occurs when an excited state (S1) returns to the ground state (S0) by the emission of a 
photon. In DMSO solution, the substituted tryptophan compounds were excited by 
irradiation with light at the UV-Visible maximum. The emission maxima are 
bathchromically shifted from the parent tryptophan, unsubstituted compound. This was 
typically a shift of ca. 30 nm. However, unexpectedly the C6H4F substituted tryptophan 
recorded an emission maximum of 416 nm. 
 
The Stokes’ Shift is defined as the difference in wavelength between the excitation 
maximum (i.e. the aborption maximum) and the emission maximum. This can be 
plotted against the Hammett parameters (Figure 73). C6H4F is clearly shown to be a 
furthest shifted with respect to the other analogues.  
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Figure 72: Comparative fluorescence λmax, normalised with respect to C6H5- analogue. 
  
 
Figure 73: Stokes’ shift of tryptophan analogues plotted against Hammett parameters (σ+), and 
compared to the unsubstituted tryptophan.  
 
0 
0.2 
0.4 
0.6 
0.8 
1 
320 370 420 470 520 
N
o
rm
a
li
s
e
d
 E
m
is
s
io
n
 I
n
te
n
s
it
y
 
Wavelength / nm 
C6H4OMe Norm. 
C6H5 Norm. 
C6H4CF3 Norm. 
C6H4F Norm. 
C6H4Me Norm. 
40 
50 
60 
70 
80 
90 
100 
110 
120 
-0.8 -0.3 0.2 0.7 
S
to
k
e
s
 S
h
if
t 
σ+ 
C6H5 C6H4CF3 
C6H4Me C6H4F 
C6H4OMe C6H4  
C6H5 C6H4 3 
C6H4  C6H4
 C6H4 e 
C6H5 
C6H4 F  
C6H4  
C6H4 e 
!"#$%&'()(*(!+"(,-./(01.!%2-.#324#%2-.(-0(2./-3&(,2-5-3&!13&4(((((6;; 
 
 
The relative intensity of emission maxima were recorded on the same instrument at 
different concentrations for each compound. Since this instrument was not 
appropriately calibrated, this can be not be used as a general method to quantify 
emissivity (which would be most accurate done by recording quantum yields – see 
Future Work section, Chapter 4, Section 4.2.2), however it allows us to directly 
compare these analogues. Linear regression was used to calculate a gradient 
coefficient, which was used to normalise the emission maxima with respect to the most 
emissive compound (set at 1 arbitrary unit). This is shown in Figure 72. The substituted 
compounds are greater than 10 times more emissive than tryptophan itself.  
 
 When these normalised intensities are plotted against σP Hammett parameters (Figure 
74), The Ph analogue is considerably more emissive than the 4-substituted aromatic 
analogues.  
 
 
Figure 74: Relative intensity of emission maxima (nm) of tryptophan analogues plotted against 
Hammett parameters (σ+). 
 
3.2.6 Peptides  
Designed as a simple extension of the protected tryptophan used above, compound 
240 was synthesised by a traditional carbodiimide-mediated solution-phase peptide 
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coupling methodology (Scheme 95). Glycine 243 was chosen as a second amino acid 
as, although it would increase the molecular weight of the system (and hence the 
possibility of ‘non-specific’ peptide binding to the metal catalysts), it did not introduce 
significantly different, and complicating, chemical functionality.  
 
 
 
 
 
Scheme 95: Synthesis of 244 using EDC.HCl (WSC).  
 
 
            
 
 
Scheme 96: Direct C-H bond functionalisation of 244. Inset: ESI-MS signals of product.  
 
The dipeptide was subjected to the C-H bond functionalisation conditions. ESI-MS 
indicated the presence of product (Scheme 96, inset). Analysis of the reaction mixture 
by HPLC showed complete conversion of starting material to product (Figure 75). Also 
present in the reaction mixture (as identified by comparison to an authentic sample) 
was biphenyl.  
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Figure 75: Stacked HPLC data for the C-H bond functionalisation of dipeptide 244; (a) dipeptide 
244, (b) biphenyl (Sigma-Aldrich ®), (c) reaction mixture of C-H bond functionalisation reaction. 
 
(a) 
(b) 
(c) 
!"#$%&'()(*(!+"(,-./(01.!%2-.#324#%2-.(-0(2./-3&(,2-5-3&!13&4(((((6;> 
 
 
 
 
Scheme 97: Direct C-H bond functionalisation of peptide 246.  
 
Longer chained peptides were obtained commercially from GeneCust Europe 
(Laboratoire de Biotechnologie du Luxembourg S.A.). Peptide 246 was subjected to 
the C-H bond functionalisation condition (Scheme 97). Higher loadings of Pd(OAc)2 
and Cu(OAc)2 (to 30 mol% and 60 mol%, respectively) were required to obtain 
functionalisation. It was proposed that this resulted from the non-specific binding of Pd 
and Cu by the peptide. The reaction mixture was analysed by HPLC-MS (Figure 76). A 
conversion to product of 86% was observed (starting material, 14%).  
 
 
 
Figure 76: HPLC-MS BPC of the direct C-H bond functionalisation of peptide 246. 
 
ESI-MS-MS was used to demonstrate that functionalisation had occurred on the 
tryptophan (spectrum shown in Figure 78). The molecular ion (m/z 791.8) was 
selected. Ions from fragmentations at amide bonds were identified, the structural 
providence for which are shown in Figure 77. Fragment m/z 305 was identified as the 
phenylated tryptophan residue.  
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Figure 77: Direct C-H bond functionalisation of peptide 246.  
 
 
 
Figure 78: ESI-MS-MS spectrum of the reaction mixture of the C-H bond functionalisation of 
peptide 246, selected for m/z 791 ([M+H] ion). Ion arising from phenyltryptophan residue is 
highlighted.  
 
 
 
Scheme 98: Direct C-H bond functionalisation of peptide 248. 
 
When tripeptide 248 was subjected to the same conditions (Scheme 98), complete 
consumption of starting material was observed. By HPLC-MS (Figure 80), there was a 
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54% conversion to arylated product. Also observed was a peak with m/z corresponding 
to a diarylation product (this is the first time such a product has been observed). Two 
other products with identical masses were also identified as dihydroxylation products – 
the position of the hydroxyls in each product is currently unknown, although purification 
and high field NMR studies are being carried out by another member of the Fairlamb 
research group. It is most likely that the phenyl group has been oxidised, and 3- and 4-
hydroxylated products are tentatively proposed. CuI and CuII complexes play an 
important role in many oxidation processes, including as enzymatic co-factors.291,292   
Extensive work by Karlin and co-workers has shown that CuII-O-O-CuII species can 
oxidise C-H bonds.292 Furthermore, it is clear that CuII can bond via the terminal oxygen 
of a carboxylic acid terminated peptide sequence. For example, Costa-Filho and co-
workers have demonstrated that TrpGly CuII complexes can be synthesised and 
isolated. X-ray diffraction studies indicate that the CuII centre can be brought in close 
proximity to an adjacent tryptophan residue (Figure 79).293 It is notable that peptides 
which exhibit the dihydroxylation products in this thesis (vide infra) contain a tryptophan 
adjacent to the terminal residue whilst these products are not observed in other 
positions. 
   
Figure 79: TryGlyOH CuII complex (coordination polymer), isolated by Costa-Filho and co-
workers.293 
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Figure 80: HPLC-MS BPC of the direct C-H bond functionalisation of peptide 248. 
 
 
 
Scheme 99: Direct C-H bond functionalisation of peptide 250. 
 
Similar results were observed with peptide 250 (Scheme 99). The starting material was 
completely consumed. Arylated product was observed in 42% conversion (Figure 81). 
No diarylation product was observed, although large quantities of dioxidation products 
were observed.  
 
 
 
 
Figure 81: HPLC-MS BPC of the direct C-H bond functionalisation of peptide 250. 
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3.3 Experimental 
3.3.1 General Information 
General information as detailed in Chapter 2, page 83. 
 
Where indicated, reactions were monitored in situ using a Mettler Toledo ReactIR™  
ic10 with K6 conduit SiComp (silicon) probe and MCT detector. Resolution 4 cm-1, 
range 4000-650 cm-1 and gain adjustment at 1x.  
 
Peptide HPLC-MS was performed on a Bruker® HCTultra at the University of Leeds. 
 
Chiral stationary phase HPLC was performed with a multiple wavelength, UV-vis diode 
array detector; integration was performed at 210, 230, and 250 nm. Optical rotations 
were recorded at 20 °C (using the sodium D line; 259 nm), and [α]D values are given in 
units of 10-1 deg cm3 g-1.  
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3.3.2 Synthesis of Protected Amino Acid Residues 
Methyl (2R)-2-amino-3-(1H-indol-3-yl)propionate, 210 
 
 
 
To a Schlenk tube under N2 was added dry MeOH (50 mL). Thionyl chloride (7.04g, 59 
mmol, 4.3 mL, 2.4 eq.) was added dropwise at -15 °C. Tryptophan (5 g, 24.5 mmol, 1 
eq.) was then added in three portions, resulting in a white suspension. The reaction 
mixture was warmed to ambient temperature and stirred for 24 h. During this time, an 
orange solution was formed. Water (5 mL) was added to the reaction mixture, and the 
solvent removed under reduced pressure to give product as an off-white solid (2.027 g, 
97%).  
 
MP 211 – 213 °C (lit. 214 °C, decomp.)294; 1H NMR (400 MHz, (CD3)2SO) δ 11.11 (s, 
1H), 8.55 (s, 3H), 7.50 (d, J = 8.0 Hz, 1H), 7.37 (dt, J = 8.0, 1.0 Hz, 1H), 7.24 (d, J = 
2.5 Hz, 1H), 7.09 (ddd, J = 8.0, 7.0, 1.0 Hz, 1H), 7.01 (ddd, J = 8.0, 7.0, 1.0 Hz, 1H), 
4.28 – 4.17(m, 1H), 3.66 (s, 3H), 3.33 – 3.26 (m, 2H); 13C NMR (101 MHz, (CD3)2SO) δ 
170.0, 136.2, 126.9, 125.0, 121.2, 118.6, 118.0, 111.6, 106.5, 52.8, 52.6, 26.3; ESI-MS 
m/z 219 [M+H], 241 [M+K]; ESI-HRMS m/z 219.1136 [M+H] (calc. for C12H14N2O2 
219.1128); IR (solid-state ATR, cm-1) 1747, 1549, 1501, 1437, 1284, 1229, 1210, 1108, 
1074, 1007, 730.0.  
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Methyl (2RS)-2-amino-3-(1H-indol-3-yl)propionate, 210-rac 
 
 
 
The racemate was prepared from DL-tryptophan using the method outlined for 210. 
Product was obtained as a white solid (5.72 g, 92%). 
 
The analytical data was identical to that reported for 210.  
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Methyl (2R)-2-acetylamino-3-(1H-indol-3-yl)propioniate, 213 
 
 
 
To a three-necked round-bottomed flask fitted with a reflux condenser and purged with 
N2, was added methyl (2R)-2-amino-3-(1H-indol-3-yl)propanoate (300 mg, 1.38 mmol, 
1 eq.). To this was added dry THF (15 mL) and triethylamine (0.2 mL). The mixture 
was stirred to give a white suspension. The mixture was cooled to 0 °C, and acetic 
anhydride (143 µl, 154 mg, 1.51 mmol, 1.1 eq.) added in one portion. The reaction was 
then stirred for 2 h at 80 °C to give a white suspension. This was added to water (40 
mL) and extracted into EtOAc (3 x 50 mL). The organic layers were combined and 
washed sequentially with 1 M aq. HCl (1 x 40 mL), sat. aq. NaHCO3 (40 mL) and brine 
(1 x 40 mL). The organic layer was collected and dried over MgSO4, filtered and the 
solvent removed under reduced pressure to give colourless oil. Trituration with Et2O 
resulted in product as an off-white solid (327 mg, 91%, er 99.9:1 by HPLC). 
 
[α]D = +52.5  (c 0.11, CHCl3); MP 156 – 157 °C (lit. 155 – 156 °C)
264; 1H NMR (400 
MHz, CDCl3) δ 8.07 (s, 1H), 7.52 (dq, J = 8.0, 1.0 Hz, 1H), 7.36 (dt, J = 8.0, 1.0 Hz, 
1H), 7.19 (ddd, 8.2, 7.0, 1.0 Hz, 1H), 7.11 (ddd, J = 8.2, 7.0, 1.0 Hz, 1H), 6.97 (d, J = 
2.4 Hz, 1H), 5.96 (d, J = 8.0 Hz, 1H), 4.95 (dt, J = 8.0, 5.2 Hz, 1H), 3.69 (s, 3H), 3.35 
(ddd, J = 15.0, 5.2 Hz, 0.8, 1H), 3.29 (ddd, J = 15.0, 5.2, 0.8 Hz, 1H), 1.95 (s, 3H); 13C 
NMR (101 MHz, CDCl3) δ 172.5, 169.8, 136.3, 127.8, 122.7, 122.4, 119.7, 118.7, 
111.4, 110.2, 53.1, 52.5, 27.7, 23.4; ESI-MS m/z 261 [M+H], 283 [M+K]; ESI-HRMS 
m/z 261.1234 [M+H] (calc. for C14H17N2O3 261.1234); IR (solid-state ATR, cm
-1) 3404, 
3317, 1732, 1660, 1521, 1434, 1434, 1221, 848, 747; UV-Vis (DMSO, nm) λmax 282 (ε 
= 5804 mol dm-3 cm-1).  
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Methyl (2RS)-2-acetylamino-3-(1H-indol-3-yl)propioniate, 213-rac 
 
 
 
The racemate was prepared from methyl (2RS)-2-amino-3-(1H-indol-3-yl)propionate 
using the method outlined for 213. Product was obtained as a white solid (6.3 g, 83%, 
er 52.1:47.9 by HPLC). 
 
[α]D = +0.353 (c 0.11, CHCl3). The remaining data analytical data was identical to that 
reported for 213.  
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Methyl (2R)-2-amino-3-(1H-5-bromoindol-3-yl)propionate, 241 
 
 
 
To a Schlenk tube under N2 was added dry MeOH (2 mL). Thionyl chloride (93 mg, 
0.785 mmol, 57 µl) was added dropwise at -15 °C. 5-Bromotryptophan (52 mg, 0.166 
mmol) was then added in three equal portions, resulting in a white suspension. The 
reaction mixture was warmed to ambient temperature and stirred for 24 h. During this 
time, a red solution was formed. Water (5 mL) was added to the reaction mixture, and 
the solvent removed under reduced pressure to give product as a pink solid (55 mg, 
99%). 
   
1H NMR (400 MHz, CD3OD) δ 10.85 (s, 1H), 7.66 (d, J = 1.8 Hz, 1H), 7.30 (d, J = 8.6 
Hz, 1H), 7.23 – 7.18 (m, 2H), 4.30 (t, J = 6.4 Hz, 1H), 3.78 (s, 3H), 3.38 (dd, J = 18.0, 
6.4 Hz, 2H); 13C NMR (101 MHz, CD3OD) δ 169.4, 135.7, 128.7, 126.0, 124.3, 120.3, 
113.1, 112.2, 106.0, 53.2, 52.4, 25.9; ESI-MS m/z (%) 297 (99) [79BrM-Cl], 399 (100) 
[81BrM-Cl]; ESI-HRMS m/z 297.0243 [79BrM-Cl] (calc. for C12H14BrN2O2 297.0243). 
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Methyl (2R)-2-acetylamino-3-(1H-5-bromoindol-3-yl)propionate, 242 
 
 
 
To a three-necked round-bottomed flask fitted with a reflux condenser, purged with N2, 
was added methyl (2R)-2-amino-3-(1H-5-bromoindol-3-yl)propanoate (55 mg, 0.166 
mmol). To this was added dry THF (10 mL) and triethylamine (0.125 mL). The mixture 
was stirred to give a pink suspension. The mixture was cooled to 0 °C, and acetic 
anhydride (19 mg, 0.183 mmol, 17.2 µl) added in one portion. The reaction was then 
stirred for 2 h at 80 °C to give a yellow solution. This was added to water (20 mL) and 
extracted into EtOAc (3 x 20 mL). The organic layers were combined and washed 
sequentially with 1 M aq. HCl (10 mL), sat. aq. NaHCO3 (10 mL) and brine (10 mL). 
The organic layer was collected and dried over MgSO4, filtered and the solvent 
removed under reduced pressure to give product as brown oil (52.9 mg, 94%). 
 
1H NMR (400 MHz, CDCl3) δ 8.63 (s, 1H), 7.62 (d, J = 1.8 Hz, 1H), 7.24 (dd, J = 8.6, 
1.8 Hz, 1H), 7.20 (d, J = 8.6 Hz, 1H), 6.95 (d, J = 2.2 Hz, 1H), 6.15 (d, J = 7.8 Hz, 1H), 
4.91 (dt, J = 7.8, 5.2 Hz, 1H), 3.70 (s, 3H), 3.29 (dd, J = 14.8, 5.2 Hz, 1H), 3.22 (dd, J = 
14.8, 5.2 Hz, 1H), 1.98 (s, 3H); 13C NMR (101 MHz, CDCl3) δ 170.0, 134.9, 129.5, 
125.1, 125.0, 124.2, 121.3, 113.0, 109.7, 53.1, 52.6, 27.6, 23.3, 23.3; ESI-MS m/z (%) 
339 (13) [79BrM+H], 361 (100) [81BrM+H], [79BrM+Na], 363 (88) [81BrM+Na]; ESI-HRMS 
m/z 339.0356 [79BrM+H] (calc. for C14H16BrN2O3 339.0339). 
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N-Acetylglycine, 243 
 
 
 
To a round-bottomed flask was added glycine (5 g, 66.6 mmol, 1 eq.) and water (150 
mL). To this, acetic anhydride (20.4 g, 200 mmol, 18.9 mL, 3 eq.) was added dropwise 
and the reaction mixture was stirred at ambient temperature for 1 h. The mixture was 
then cooled to 4 °C for 16 h, and the resulting precipitate collected by filtration through 
a sintered funnel to give product as a white solid (4.46 g, 57%). 
 
MP 207 – 208 °C (decomp., lit. 206 – 208 °C)295; 1H NMR (400 MHz, (CD3)2SO) δ 
12.51 (s, 1H), 8.18 (s, 1H), 3.71 (d, J = 6.0 Hz, 2H), 1.84 (s, 3H); 13C NMR (101 MHz, 
(CD3)2SO) δ 171.5, 169.6, 40.6, 22.3; ESI-MS m/z 118 [M+H], 140 [M+Na]; ESI-HRMS 
m/z 118.0501 [M+H] (calc. for C4H8NO3 118.0499); IR (solid-state ATR, cm
-1) 3350, 
1944, 1897, 1717, 1580, 1547, 1439, 1379, 1351, 1276, 1227, 1137, 993, 902. 682.  
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AcNGlyTrpOMe, 240 
 
 
 
To a Schlenk tube was added methyl (2R)-2-amino-3-(1H-indol-3-yl)propionate (190 
mg, 0.872 mmol, 1 eq.), N-acetylglycine (102 mg, 0.872 mmol, 1 eq.) and 1-ethyl-3-(3-
dimethylaminopropyl)carbodiimide hydrochloride (167 mg, 0.872 mmol, 1 eq.). The 
reaction mixture was placed under vacuum and refilled with N2, and this process 
repeated twice. Dry CH2Cl2 (5 mL) was added, and the mixture stirred for 16 h at 
ambient temperature. The solvent was removed under reduced pressure. The resulting 
residue was dissolved in EtOAc (15 mL) and washed with 1 M aq. HCl (20 mL), sat. aq. 
NaHCO3 (40 mL) and brine (1 x 40 mL). The organic layer was collected and dried over 
MgSO4, filtered and the solvent removed under reduced pressure to give product as a 
white solid (96 mg, 35%).  
 
MP 98 – 102 °C; 1H NMR (400 MHz, CD3OD) δ 7.48 (dt, J = 8.0, 1.0 Hz, 1H), 7.31 (dt, 
J = 8.0, 1.0 Hz, 1H), 7.10 – 7.04 (m, 3H), 7.00 (ddd, J = 8.0, 7.0, 1.0 Hz, 1H), 4.73 (dd, 
J = 7.0, 5.8 Hz, 1H), 3.83 (d, J = 16.6, 1H), 3.78 (d, J = 16.6 Hz, 1H), 3.64 (s, 3H), 3.27 
(ddd, J = 14.6, 7.2, 0.6 Hz, 1H), 3.19 (ddd, J = 14.6, 7.2, 0.6 Hz, 1H), 1.92 (s, 3H); 13C 
NMR (101 MHz, CD3OD) δ 173.9, 173.7, 171.4, 138.0, 128.7, 124.6, 122.5, 119.9, 
119.1, 112.3, 110.3, 54.8, 52.7, 49.0, 43.4, 28.4; ESI-MS m/z 318 [M+H], 340 [M+Na]; 
ESI-HRMS m/z 318.1433 [M+H] (calc. for C16H20N3O4 318.1448); IR (solid-state ATR, 
cm-1) 3286, 2947, 1737, 1655, 1610, 1508, 1460, 1439, 1372, 1285, 1248, 1215, 1177, 
1030.  
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3.3.3 Synthesis of Hypervalent Iodine Compounds 
Bis(acetyloxy)phenyl-λ3-iodane (Diacetoxyiodobenzene/DIB), 107259,296 
 
 
 
To a three-necked round-bottomed flask fitted with a reflux condenser was added 
acetic anhydride (6 mL) and hydrogen peroxide (30% in water, 2 mL). The reaction 
mixture was heated to 40 °C with stirring for 4 h. Iodobenzene (1 g, 4.9 mmol, 546 µl) 
was added, and heating continued for 1.5 h. The mixture was left to stir at ambient 
temperature for 15 h.  Water (50 mL) was added. The resulting white precipitate was 
collected by filtration through a sintered funnel and washed with cold water (2 x 10 mL) 
to give product as a white solid (1.275 g, 80%).  
 
MP 163 – 167 °C (lit. 164 °C)140; 1H NMR (400 MHz, CDCl3) δ 8.07 (ddd, J = 4.5, 2.2, 
1.1 Hz, 2H), 7.61 – 7.56 (m, 1H), 7.48 (m, 2H), 1.99 (s, 6H); 13C NMR (101 MHz, 
CDCl3) δ 176.4, 135.0, 131.8, 131.0, 121.7, 20.4; LIFDI-MS m/z 321.97 [M+H]; IR 
(solid-state ATR, cm-1) 1737, 1642, 1626, 1365, 1290, 1270, 1012, 924.  
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1-Hydroxy-1H-1λ3-benzo[d][1,2]iodoxol-3-one, 219 
 
 
 
To a round-bottomed flask fitted with a reflux condenser was added NaIO4 (950 mg, 
4.43 mmol, 1.1. eq.) and 4-iodobenzoic acid (1 g, 4.03 mmol, 1 eq.) The apparatus was 
purged with N2. AcOH (10 mL, 30% v/v in water) was added to give a white 
suspension. The reaction mixture was heated to reflux with stirring for 4 h. The reaction 
mixture was then diluted with cold water, and left to cool to ambient temperature. The 
resulting precipitate was collected by filtration and washed with cold water and 
acetone. This was dried under reduced pressure to give product as a white solid (9.7 
mg, 85%).   
 
MP 225 – 227 °C (lit. 223 – 225 °C, decomp.)297; 1H NMR (400 MHz, (CD3)2SO) δ 8.00 
(s, 1H), 7.97 (dd, J = 7.6, 1.4 Hz, 1H), 7.92 (ddd, J = 8.6, 7.2, 1.6 Hz, 1H), 7.80 (d, J = 
8.0, 1.0 Hz, 1H), 7.67 (app. td, J = 7.4, 1.0 Hz, 1H); 13C NMR (101 MHz, (CD3)2SO) δ 
167.7, 134.4, 131.5, 131.1, 130.4, 126.3, 120.4; ESI-MS m/z 264 [M+H]; ESI-HRMS 
m/z 264.9430 [M+H] (calc. for C7H6IO3 264.9356, error 31.1 ppm); IR (solid-state ATR, 
cm-1) 2390, 1598, 1553, 1441, 1338, 1301, 1148, 1018, 835, 809.  
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1-Acetyl-1H-1λ3-benzo[d][1,2]iodoxol-3-one, 220 
 
 
 
To a round-bottomed flask fitted with a reflux condenser was added 1-hydroxy-1H-1λ3-
benzo[d][1,2]iodoxol-3-one (850 mg, 3.22 mmol) and acetic anhydride (5 mL). The 
reaction mixture was heated to reflux with stirring for 10 min, and then left to cool to 
ambient temperature to give a white precipitation. The resulting precipitate was 
collected by filtration and dried under reduced pressure to give product as a white solid 
(765 mg, 78%). 
 
MP 175 – 177 °C (lit. 165 – 167 °C, decomp.)298; 1H NMR (400 MHz, CDCl3) δ 8.25 
(dd, J = 7.5, 1.6 Hz, 1H), 7.99 (d, J = 7.7 Hz, 1H), 7.91 (ddd, J = 8.4, 7.3, 1.5 Hz, 1H), 
7.74 – 7.68 (m, 1H), 2.24 (s, 3H); 13C NMR (101 MHz, CDCl3) δ 176.4, 168.2, 136.2, 
133.2, 131.3, 129.4, 129.1, 118.4, 20.4; ESI-MS m/z 279 [M-Ac+MeOH], 301 [M-
Ac+MeOH+Na]; ESI-HRMS m/z 278.9519 [M-Ac+MeOH] (calc. for C8H8IO3 279.9518); 
IR (solid-state ATR, cm-1) 3071, 1652, 1586, 1568, 1447, 1366, 1249, 1260, 1240, 
1126, 1025, 1013, 921, 807, 824, 754, 674.  
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3.3.4 Synthesis of Potassium Aryltrifluoroborates 
General Procedure 
 
In a round-bottomed flask, boronic acid (1 eq.) was dissolved in THF (40 mL). To this 
was slowly added a suspension of potassium hydrogen bifluoride (6 eq.) in water (12.5 
mL). The reaction mixture was stirred at ambient temperature for 24 h. The solvent was 
removed under reduced pressure. The resulting white solid was suspended in acetone 
and filtered through a glass sinter. The precipitate was washed with hot acetone, and 
the combined filtrate collected. The solvent was removed under reduced pressure to 
give potassium aryltrifluoroborate as a white solid.  
 
Potassium 4-fluorophenylborontrifluoride, 234 
 
 
 
Obtained according to the general procedure as a white solid (1.046 g, 100%).  
 
MP 290 °C (lit. 297 °C, decomp.)202; 1H NMR (400 MHz, (CD3)2CO) δ 7.45 (app. t, J = 
7.3 Hz, 2H), 6.81 (br t, 2H); 13C NMR (101 MHz, (CD3)2CO) δ 162.6 (d, JCF = 242.4 Hz), 
134.0 (dq, JCB = 6.9, 1.9 Hz), 113.4 (d, J = 18.7 Hz) (three of four resonances observed 
– 13C ipso to B substituent not observed)284; 11B NMR (128 MHz, (CD3)2CO) δ 2.63 (q, J 
= 48.2 Hz); 19F NMR (376 MHz, (CD3)2CO) δ -120.58 (m), -142.42 (dd, J = 99.6, 46.5 
Hz); ESI-MS m/z (%) 185 (12) [11BM-H], 184 (3) [10BM-H], 163 (100) [11BM-K], 162 (26) 
[10BM-K]; ESI-HRMS m/z 163.0352 [11BM-K] (calc. for C7H4BF4 163.0349); IR (solid-
state ATR, cm-1) 1607, 1512, 1224, 1209, 986, 969, 952, 917, 831. 
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Potassium 4-methoxyphenylborontrifluoride, 236 
 
 
 
Obtained according to the general procedure as a white solid (1.046 g, 74%).  
 
MP 259 – 261 °C (lit. 250 °C, decomp.)202; 1H NMR (400 MHz, (CD3)2CO) δ 7.38 (d, J = 
8.5 Hz, 2H), 6.67 (br d, J  = 8.5 Hz, 2H), 3.70 (s, 3H); 13C NMR (101 MHz, (CD3)2CO) δ 
158.7, 133.4 (q, J = 1.9 Hz), 112.6, 55.0 (four of five resonances observed)284; 19F 
NMR (376 MHz, (CD3)2CO) δ -62.26; 
11B NMR (128 MHz, (CD3)2CO) δ 3.74 – 0.99 (m); 
ESI-MS m/z (%) 197 (100) [11BM-H], 196 (21) [10BM-H], 175 (65) [11BM-K], 174 (14) 
[10BM-K]; ESI-HRMS m/z 175.0554 [11BM-K] (calc. for C7H7BF3O 175.0549); IR (solid-
state ATR, cm-1) 1604, 1568, 1513, 1463, 1443, 1404, 1281, 1213, 1175, 1032, 985, 
968, 910, 828, 730. 644. 
 
Potassium 4-(trifluoromethyl)phenylborontrifluoride, 235 
 
 
 
Obtained according to the general procedure as a white solid (1.236 g, 93%).  
 
MP 298 °C (lit. >300 °C, decomp.)202; 1H NMR (400 MHz, (CD3)2CO) δ 7.65 (d, J = 7.6 
Hz, 2H), 7.40 (d, J = 7.6 Hz, 2H); 13C NMR (126 MHz, (CD3)2CO) δ 156.2 (br), 132.8, 
127.5 (q, J = 34.0 Hz), 126.5 (q, J = 270 Hz), 123.5; 11B NMR (128 MHz, (CD3)2CO) δ 
2.10 (q, J = 52.1, 50.9 Hz); 19F NMR (376 MHz, (CD3)2CO) δ -138.59, -143.64 (m); ESI-
MS m/z (%) 235 (100) [11BM-H], 234 (21) [10BM-H], 213 (30) [11BM-K], 212 (6) [10BM-K]; 
ESI-HRMS m/z 213.0320 [11BM-K] (calc. for C7H4BF6 213.0320); IR (solid-state ATR, 
cm-1) 1397, 1328, 1206, 11521108, 1061, 1020, 957, 941, 853, 825, 773, 744, 701. 
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Potassium 4-methylphenylborontrifluoride, 233 
 
 
 
Obtained according to the general procedure as a white solid (1.452 g, 97%).  
 
MP 294 – 295 °C (lit. 293 – 294 °C, decomp.)202; 1H NMR (400 MHz, (CD3)2CO) δ 7.36 
(d, J = 7.6 Hz, 2H), 6.92 (d, J = 7.6 Hz, 2H), 2.22 (s, 3H); 13C NMR (101 MHz, 
(CD3)2CO) δ 134.3, 132.6 (q, J = 1.9 Hz), 127.8, 21.5 (four of five resonances 
observed)284; 11B NMR (128 MHz, (CD3)2CO) δ 2.67 (q, J = 55.8 Hz); 
19F NMR (376 
MHz, (CD3)2CO) δ -142.26 (m); ESI-MS m/z (%) 181 (100) [
11BM-H], 180 (23) [10BM-H], 
159 (88) [11BM-K], 158 (16) [10BM-K]; ESI-HRMS m/z 159.0608 [11BM-K] (calc. for 
C7H7BF3 159.0600); IR (solid-state ATR, cm
-1) 1242, 1231, 1198, 1023, 968, 918, 807. 
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3.3.5 Synthesis of Palladium Catalysts 
1,3-[di(2,4,6-trimethylphenyl)-4,5-dihydroimidazolylidene](η3-2-
methylpropenyl)chloropalladium(II), 226299 
 
 
 
To a round-bottomed flask containing 1,3-di(2,4,6-trimethylphenyl)-2-
(pentafluorophenyl)-2,4,5-trihydroimidazole (200 mg, 0.421 mmol, 2 eq.) and di-µ-
chlorobis(η3-2-methylpropenyl)dipalladium(II) (82.7 mg, 0.211 mmol) was added 
toluene (5 mL). The reaction mixture was stirred at 80 °C for 3 h. Solvent was removed 
under reduced pressure to give product as a white solid (211 mg, 100%). 
 
MP 135 – 136 °C; 1H NMR (400 MHz, CDCl3) δ 6.92 (d, J = 10.0 Hz, 4H), 4.02 – 3.91 
(m, 4H), 3.60 (d, J = 3.1 Hz, 1H), 2.98 (d, J = 2.4 Hz, 1H), 2.62 (s, 1H), 2.46 (s, 6H), 
2.39 (s, 6H), 2.27 (s, 6H), 1.79 (s, 1H), 1.25 (s, 3H); 13C (101 MHz, CDCl3) δ 138.2, 
136.2, 129.5, 129.4, 71.8, 51.1, 49.7, 22.1, 21.0, 18.7, 18.6 (allyl C2 carbon has not 
observed); IR (solid-state ATR, cm-1) 3651, 3238, 2912, 1734, 1656, 1607, 1488, 1434, 
1403, 1376, 1298, 1265, 1232, 1184, 1098, 1061, 860, 850, 837, 738, 696.  
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Trans-di-µ-chlorobis{[1,3-di(2,4,6-trimethylphenyl)-4,5-
dihydroimidazolylidene]chloropalladium(II)}, 227  
 
 
 
To a round-bottomed flask containing 1,3-[di(2,4,6-trimethylphenyl)-4,5-
dihydroimiazolylidene](η3-2-methylpropenyl)chloropalladium(II) (150 mg, 0.297 mmol) 
was added hydrogen chloride (6 mL, 1 M in diethyl ether). The reaction was stirred at 
ambient temperature for 24 h. The solvent was removed under reduced pressure to 
give product as an orange solid (146 mg, 98%). 
 
MP >260 °C (lit. >239 °C)120; 1H NMR (400 MHz, CDCl3) δ 6.99 (s, 4H), 3.85 (s, 4H), 
2.49 – 2.18 (m, 18H); 13C (101 MHz, CDCl3) δ 177.8, 138.4, 134.4, 129.7, 122.8, 51.3, 
21.3, 19.1; IR (solid-state ATR, cm-1) 3650, 2967, 1607, 1489, 1452, 1404, 1377, 1265, 
11847, 1099, 1029.  
 
This compound was not observed by ESI-MS or LIFDI-MS.  
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[1,3-Di(2,4,6-trimethylphenyl)-4,5-dihydroimidazolylidene]diacetateaquopalladium(II), 
228300 
 
 
  
To a round-bottomed flask containing trans-di-µ-chlorobis{[1,3-di(2,4,6-
trimethylphenyl)-4,5-dihydroimidazolylidene]chloropalladium(II)} (120 mg, 0.124 mmol, 
1 eq.) and CH2Cl2 (6 mL) was added silver acetate (167 mg, 0.510 mmol, 4.1 eq.). The 
reaction mixture was stirred at ambient temperature for 2 h. The reaction mixture was 
filtered though Celite® to give a yellow solution. Solvent was removed under reduced 
pressure to give product as a yellow solid (112 mg, 82%). 
 
MP 259 – 261 °C (decomp.); 1H NMR (400 MHz, CDCl3) δ 7.04 (s, 4H), 4.00 (d, J = 5.6 
Hz, 4H), 2.37 (s, 18H), 1.75 (s, 6H); 13C NMR (101 MHz, CDCl3) δ 181.5, 181.3, 139.1, 
136.6, 134.4, 129.8, 50.6, 23.7, 21.3, 17.9; ESI-MS m/z 307 [M-Pd-2OAc-H2O]; IR 
(solid-state ATR, cm-1) 3438, 3415, 3229, 3310, 3229, 1723, 1444, 1406, 1331, 1276, 
1237, 1119, 1104, 1068, 1008, 918, 738, 651, 638, 506. 
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3.3.6 Direct C-H bond functionalisation of Tryptophan with Boronic Acids/DIB 
Methyl (2S)-2-acetyl-3-(2-phenyl-1H-indol-3-yl)propanoate, 215 
 
 
 
To a microwave tube was added phenylboronic acid (47 mg, 0.384 mmol, 2 eq.), 
bis(acetyloxy)phenyl-λ3-iodane (123 mg, 0.384 mmol, 2 eq.), Pd(OAc)2 (2 mg, 9.6 
µmol, 5 mol%) and acetic acid (5 mL). The reaction mixture was stirred at 40 °C for 10 
min. To the resulting orange-brown solution was added methyl (2R)-2-acetylamino-3-
(1H-indol-3-yl)propioniate (50 mg, 0.192 mmol, 1 eq.). The reaction was stirred at 40 
°C for 16 h. The resulting black reaction mixture was filtered though Celite®, and the 
solvent removed under reduced pressure to give a brown solid. This was dissolved in 
EtOAc (10 mL) and washed with sat. aq. NaHCO3. The organic layer was collected and 
dried over MgSO4, filtered and the solvent removed under reduced pressure to give a 
brown solid. This was dry-loaded onto silica gel and purified by flash chromatography 
eluting with ethyl acetate:petroleum ether (1:1) to give product as a white solid (36 mg, 
56%). 
 
MP 83 – 84 °C; 1H NMR (400 MHz, CDCl3) δ 8.20 (s, 1H), 7.63 – 7.54 (m, 3H), 7.51 – 
7.45 (m, 2H), 7.44 – 7.33 (m, 2H), 7.21 (ddd, J = 8.0, 7.0, 8.0 Hz, 1H), 7.15 (ddd, J = 
8.0, 7.0, 8.0 Hz, 1H), 5.77 (d, J = 8.0 Hz, 1H), 4.84 (dt, J = 8.0, 5.5 Hz, 1H), 3.56 (dd, J 
= 15.0, 5.5 Hz, 1H), 3.53 (dd, J = 15.0, 5.5 Hz, 1H), 3.30 (s, 3H), 1.67 (s, 3H); 13C NMR 
(101 MHz, CDCl3) δ 172.6, 170.0 136.4, 136.1, 133.6, 129.9, 129.6, 128.7, 128.6, 
123.0, 120.5, 119.4, 111.4, 107.2, 53.2, 52.5 27.0, 23.4.; ESI-MS m/z 337 [M+H], 359 
[M+Na], 395 [M+K]; ESI-HRMS m/z 337.1539 [M+H] (calc. for C20H20N2O3 337.1547); 
IR (solid-state ATR, cm-1) 3284, 2961, 1735, 1654, 1525, 1434, 1259, 1094, 1013, 795, 
741, 697. 
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1-Methyl-2-phenylindole, 144131 
 
 
 
To a microwave tube was added phenylboronic acid (93 mg, 0.763 mmol, 2 eq.), 
bis(acetyloxy)phenyl-λ3-iodane (246 mg, 0.763 mmol, 2 eq.) and Pd(OAc)2 (4 mg, 19.1 
µmol, 5 mol%) and acetic acid (5 mL). The reaction mixture was stirred at 40 °C for 10 
min. To the resulting orange-brown solution was added 1-methylindole (50 mg, 0.381 
mmol, 48 µl, 1 eq.). The reaction was stirred at 40 °C for 16 h. The resulting black 
reaction mixture was filtered through Celite®, and the solvent removed under reduced 
pressure to give a brown solid. This was dissolved in EtOAc (10 mL) and washed with 
sat. aq. NaHCO3. The organic layer was collected and dried over MgSO4, filtered and 
the solvent removed under reduced pressure to give a solid. This was dry-loaded onto 
silica gel and purified by flash chromatography eluting with ethyl acetate:petroleum 
ether (1:24) to give product as a white solid (66 mg, 84%). 
 
MP 101.1 – 102.9 °C (lit. 99 – 102 °C); 1H NMR (500 MHz, CDCl3) δ 7.65 (dt, J = 8.1, 
1.0 Hz, 1H), 7.55 – 7.51 (m, 2H), 7.48 (t, J = 7.5 Hz, 2H), 7.43 – 7.39 (m, 1H), 7.38 (dd, 
J = 8.1, 1.0 Hz, 1H), 7.26 (ddd, J = 8.1, 7.0, 1.0 Hz, 1H), 7.16 (ddd, J = 8.1, 7.0, 1.0 Hz, 
1H), 6.58 (s, 1H), 3.76 (s, 3H); 13C NMR (126 MHz, CDCl3) δ 141.68, 138.47, 132.97, 
129.49, 128.59, 128.09, 127.95, 121.77, 120.58, 119.96, 109.70, 101.77, 31.26; ESI-
MS m/z 208 ([M+H]+); ESI-HRMS m/z 208.1120 [M+H] (calc. for C15H14N 208.1121); IR 
(CDCl3 solution, cm
-1) ν 3061, 2948, 2365, 2338, 2245, 1470; UV-Vis301 (cyclohexane, 
nm) λmaxima 206 (26304), 222 (ε = 27028 mol dm
-3 cm-1), 298 (ε = 15334 mol dm-3 cm-1). 
 
Using the same procedure, the reaction was performed using Pd(OAc)2 contaminated 
with palladium nitro complex266 (4 mg) to give the title compound as a white solid (67 
mg, 84%). 
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3.3.7 Direct C-H bond functionalisation of Tryptophan with Diaryliodonium 
Trifluoromethanesulfonates 
Methyl (2S)-2-amino-3-(2-phenyl-1H-indol-3-yl)propanoate 
 
 
 
To a microwave tube was added methyl (2R)-2-acetylamino-3-(1H-indol-3-
yl)propioniate (50 mg, 0.192 mmol, 1 eq.), Pd(OAc)2 (2 mg, 9.6 µmol, 5 mol%) and 
acetic acid (5 mL). The reaction mixture was stirred at 40 °C for 10 min. To the 
resulting orange-brown solution was added diphenyliodonium 
trifluoromethanesulfonate (159 mg, 0.384 mmol, 2 eq.). The reaction was stirred at 40 
°C for 16 h. The resulting black reaction mixture was filtered through Celite®, and the 
solvent removed under reduced pressure to give a brown solid. This was dissolved in 
EtOAc (10 mL) and washed with sat. aq. NaHCO3. The organic layer was collected and 
dried over MgSO4, filtered and the solvent removed under reduced pressure to give a 
brown solid. This was dry-loaded onto silica gel and purified by flash chromatography 
eluting with ethyl acetate:petroleum ether (1:1) to give product as a white solid (34 mg, 
51%). 
 
Analytical data identical to that reported above, on page 191.  
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Methyl (2S)-2-amino-3-[2-(4-methylphenyl)-1H-indol-3-yl]propanoatei, 221 
 
 
 
To a conical flask was added methyl (2R)-2-acetylamino-3-(1H-indol-3-yl)propioniate 
(50 mg, 0.192 mmol, 1 eq.), Pd(OAc)2 (0.0096 mmol, 2 mg, 5 mol%) and acetic acid (5 
mL). The reaction mixture was stirred for 10 min at 40 °C. 4-
methylphenyl(mesityl)iodonium trifluoromethanesulfonate (187 mg, 0.384 mmol, 2 eq.) 
was added in one portion, and the reaction mixture stirred 16 h at 40 °C. The resulting 
black suspension was filtered through Celite®, and the filter cake and reaction vessel 
were washed with toluene and acetic acid. The solvent was removed under reduced 
pressure. The resulting brown solid was dissolved in EtOAc (20 mL) and washed with 
sat. aq. NaHCO3 (20 mL). The organic layer was dried over MgSO4, filtered and the 
solvent removed under reduced pressure to give a yellow oil.  This was dry-loaded 
onto silica gel and purified by flash chromatography eluting with 50% EtOAc in 
petroleum ether to give product yellow solid (36 mg, 53 %).  
 
RF 0.32 (50% EtOAc/PE); MP 97 – 99 °C; 
1H NMR (400 MHz, CDCl3) δ 8.09 (s, 1H), 
7.56 (d, J = 7.8 Hz, 1H), 7.48 – 7.44 (m, 2H), 7.36 (d, J = 7.8 Hz, 1H), 7.30 (d, J = 7.8 
Hz, 2H), 7.19 (ddd, J= 8.0, 7.0, 1.0 Hz, 1H), 7.13 (ddd, J = 8.0, 7.0, 1.0 Hz, 1H), 5.77 
(d, J = 8.0 Hz, 1H), 4.82 (dt, J = 7.8, 5.4 Hz, 1H), 3.53 (d, J = 5.4 Hz, 1H), 3.52 (d, J = 
5.5Hz, 1H), 3.33 (s, 3H), 2.41 (s, 3H), 1.66 (s, 3H); 13C NMR (126 MHz, CDCl3): δ 
172.3, 169.9, 136.1, 134.4, 134.2, 131.8, 129.9, 129.5, 123.3, 120.5, 119.4, 111.3, 
108.2, 52.9, 52.2, 31.8, 29.8, 26.9, 23.0; ESI-HRMS m/z 391.0166 [M+H] (calc. for 
C16H15F3I 391.1065); IR (solid-state ATR, cm
-1) 3331, 2951, 1731, 1657, 1506,1372, 
1305, 1215, 1010, 822, 742.   
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Methyl (2S)-2-amino-3-{2-[4-(trifluoromethyl)phenyl]-1H-indol-3-yl}propanoate, 222 
 
 
 
Obtained according to the procedure for 221 as an off-white solid (22 mg, 28%). 
 
RF 0.34 (50% EtOAc/PE); MP 202 – 206 °C; 
1H NMR (400 MHz, CDCl3) δ 8.41 (s, 1H), 
7.72 – 7.63 (m, 4H), 7.58 (d, J = 8.0 Hz, 1H), 7.35 (d, J = 8.0 Hz, 1H), 7.22 (ddd, J = 
8.2, 7.0, 1.2 Hz, 1H), 7.15 (ddd, J = 8.2, 7.0, 1.2 Hz, 1H), 5.87 (d, J = 8.0 Hz, 1H), 4.84 
(dt, J = 8.0, 5.2 Hz, 1H), 3.59 – 3.48 (m, 2H), 3.29 (s, 3H), 1.67 (s, 3H); 13C NMR (101 
MHz, CDCl3) δ 172.2, 169.9, 136.9, 136.1, 134.3, 129.9 (q, J = 31.8 Hz), 129.5, 128.5, 
126.1 (q, J = 3.8 Hz), 124.1 (q, J = 247 Hz), 123.3, 120.4, 119.2, 111.4, 108.2, 53.0, 
52.2, 27.0, 23.0; ESI-MS m/z 405 [M+H], 427 [M+Na]; ESI-HRMS m/z 405.1410 [M+H] 
(calc. for C21H20F3N2O3 405.1421); IR (solid-state ATR, cm
-1) 3288, 2925, 2860, 1730, 
1651, 1505, 1438, 1285, 1245, 1215, 1027, 835, 743.  
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Methyl (2S)-2-amino-3-{2-[3-(trifluoromethyl)phenyl]-1H-indol-3-yl}propanoate, 223 
 
 
 
Obtained according to the procedure for 221 as an orange solid (16 mg, 21%). 
 
1H NMR (400 MHz, CDCl3) δ 8.15 (s, 1H), 7.80 (m, 2H), 7.65 (s, 1H), 7.62 (s, 1H) 7.61 
(m, 1H), 7.39 (dd, J = 8.0, 1.0 Hz, 1H), 7.24 (dd, J =8.0, 1.0 Hz, 1H), 7.17 (dd, J = 8.0, 
1.0 Hz, 1H), 5.81 (s, 1H), 4.86 (dt, J = 8.0, 5.4 Hz, 1H), 3.54 (t, J = 5.4 Hz, 2H), 3.30 (s, 
3H), 1.71 (s, 3H); 13C NMR (126 MHz, CDCl3): δ 231.5, 172.4, 169.9, 151.0, 138.1, 
136.3, 135.7, 130.3, 129.9, 129.6, 128.3, 122.5, 120.1, 118.9, 111.0, 106.5, 53.0, 52.2, 
38.6, 31.1, 29.8; ESI–HRMS m/z 405.1422 [M+H] (calc. for C21H19F3N2O3 405.1421).  
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3.3.8 Direct C-H bond Functionalisation of Tryptophan with Boronic Acids 
Methyl (2S)-2-amino-3-(2-phenyl-1H-indol-3-yl)propanoate 215 
 
 
 
To a microwave tube was added phenylboronic acid (47 mg, 0.384 mmol, 2 eq.), 
methyl (2R)-2-acetylamino-3-(1H-indol-3-yl)propioniate (50 mg, 0.192 mmol, 1 eq.) and 
Pd(OAc)2 (2 mg, 9.6 µmol, 5 mol%) and acetic acid (5 mL). The reaction mixture was 
stirred at 40 °C for 16 h. The resulting black reaction mixture was filtered through 
Celite®, and the solvent removed under reduced pressure to give a brown solid. This 
was dissolved in EtOAc (10 mL) and washed with sat. aq. NaHCO3. The organic layer 
was collected and dried over MgSO4, filtered and the solvent removed under reduced 
pressure to give a brown solid. This was dry-loaded onto silica gel and purified by flash 
chromatography eluting with ethyl acetate:petroleum ether (1:1) to give product as a 
white solid (60 mg, 93%, er 99.9:1). 
 
[α]D = +47.3 (c 0.11, CHCl3); UV-Vis (DMSO, nm) λmaxima 308 (ε = 9120 mol dm
-3 cm-1).  
 
Other analytical data identical to that reported above.  
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Methyl (2RS)-2-amino-3-(2-phenyl-1H-indol-3-yl)propanoate, 215-rac 
 
 
 
Obtained according to the method outlined above to give product as a white solid (59 
mg, 91%, er 50.9:49.1). 
  
[α]D = +0.0353 (c 0.11, CHCl3).  
 
Other analytical data identical to that reported above.  
 
Methyl (2S)-2-amino-3-[2-(4-methylphenyl)-1H-indol-3-yl]propanoate 
 
 
[α]D = +51.9 (c 0.10, CHCl3); UV-Vis (DMSO, nm) λmaxima 310 (ε = 8893 mol dm
-3 cm-1).  
 
Other analytical data identical to that reported above.  
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Methyl (2S)-2-amino-3-[2-(4-fluorophenyl)-1H-indol-3-yl]propanoate, 230 
 
 
 
RF 0.57 (50% EtOAc/PE); [α]D = +54.4 (c 0.10, CHCl3); MP 213 – 216 °C (decomp.); 
1H 
NMR (400 MHz, CDCl3) δ 8.26 (s, 1H), 7.55 (d, J = 8.0 Hz, 1H), 7.53 – 7.46 (m, 2H), 
7.34 (d, J = 8.0 Hz, 1H), 7.23 – 7.10 (m, 4H), 5.83 (d, J = 8.1 Hz, 1H), 4.82 (dt, J = 8.0, 
5.4 Hz, 1H), 3.50 (dd, J = 15.0, 5.5 Hz, 1H), 3.46 (dd, J = 15.0, 5.5 Hz, 1H), 3.32 (s, 
3H), 1.70 (s, 3H); 13C (101  MHz, CDCl3) 172.3, 169.7, 163.6, 160.9, 135.8, 135.1, 
130.2 (d, JCF = 8.1), 129.4, 129.3 (d, JCF = 3.5 Hz), 121.6 (d, JCF = 253.0 Hz), 119.5, 
116.1, 116.2, 111.1, 106.9, 52.9, 52.2, 26.8, 23.0; 19F NMR (376 MHz, CDCl3) δ -
112.83 (m); ESI-MS m/z 355 [M+H], 377 [M+Na]; ESI-HRMS m/z 355.1443 [M+H] 
(calc. for C20H20FN2O3 355.1452); IR (solid-state ATR, cm
-1) 3332, 2960, 1729, 1659, 
1541, 1505, 1444, 1219, 848, 749;  UV-Vis λmaxima 306 (ε = 14684 mol dm
-3 cm-1). 
 
Crystals suitable for X-ray diffraction were grown from CDCl3.  
 
Summary of X-ray data 
Compound reference ijsf1202 
Chemical formula C20H19F1N2O3 
Formula mass 345.37 
Crystal system Trigonal 
a/Å 21.0404(11) 
b/Å 21.0404(11) 
c/Å 10.4652(7) 
α/Å 90.00 
β/Å 90.00 
γ/Å 120.00 
Unit cell volume/Å3 4012.2(6) 
Temperature/K 110.00(10) 
Space group R3 
No. of formula units per unit cell, Z 9 
No. of reflections measured 9531 
No. of independent reflections 5613 
Rint 0.0271 
Final R1 values (I >2σ(I)) 0.0424 
Final wR(F2) values (I >2σ(I)) 0.0946 
Final R1 values (all data) 0.0479 
Final wR(F2) values (all data) 0.0995 
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Methyl (2S)-2-amino-3-{2-[4-(trifluoromethyl)phenyl]-1H-indol-3-yl}propanoate, 222 
 
 
 
 [α]D = +62.0 (c 0.13, CHCl3); UV-Vis (DMSO, nm) λmax 318 (ε = 10297 mol dm
-3 cm-1). 
 
Other analytical data identical to that reported above.  
 
Crystals suitable for X-ray diffraction were grown from CDCl3.  
 
Summary of X-ray data 
Compound reference ijsf1201 
Chemical formula C21H19F3N2O3 
Formula mass 404.38 
Crystal system Monoclinic 
a/Å 8.7492(3) 
b/Å 9.0043(3) 
c/Å 24.1842(7) 
α/Å 90.00 
β/Å 98.900(3) 
γ/Å 90.00 
Unit cell volume/Å3 1882.30(10) 
Temperature/K 110.00(10) 
Space group P21 
No. of formula units per unit cell, Z 4 
No. of reflections measured 14377 
No. of independent reflections 8188 
Rint 0.0306 
Final R1 values (I >2σ(I)) 0.0480 
Final wR(F2) values (I >2σ(I)) 0.1077 
Final R1 values (all data) 0.0572 
Final wR(F2) values (all data) 0.1135 
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Methyl (2S)-2-amino-3-[2-(4-methoxyphenyl)-1H-indol-3-yl]propanoate, 213 
 
 
 
RF 0.12 (50% EtOAc/PE); [α]D = +34.9 (c 0.10, CHCl3); MP 202 – 205 °C; 
1H NMR (400 
MHz, CDCl3) δ 8.07 (s, 1H), 7.56 (d, J = 7.5 Hz, 1H), 7.53 – 7.45 (m, 2H), 7.35 (d, J = 
7.5 Hz, 1H), 7.19 (ddd, J = 8.0, 7.0, 1.5 Hz, 1H), 7.13 (ddd, J = 8.0, 7.0, 1.5 Hz, 1H), 
7.02 (d, J = 9.0 Hz, 2H), 5.78 (d, J = 8.0 Hz, 1H), 4.83 (dt, J = 8.0, 5.5 Hz, 1H), 3.87 (s, 
3H), 3.48 (m, 2H), 3.35 (s, 3H), 1.70 (s, 3H); 13C NMR (101 MHz, CDCl3) δ 172.4, 
169.7 159.6, 136.1, 135.6, 129.7, 129.6, 125.6, 122.4, 120.1, 118.8, 114.7, 111.0, 
106.3, 55.6, 53.0, 52.2, 26.8, 23.1; ESI-MS m/z 367 [M+H], 389 [M+Na]; ESI-HRMS 
m/z 367.1644 [M+H] (calc. for C21H23N2O4 367.1652); IR (solid-state ATR, cm
-1) 3333, 
2954, 1728, 1656, 1505, 1458, 1439, 1246, 1216, 1177, 1027, 836, 747; UV-Vis 
(DMSO, nm) λmax 320 (ε = 11644 mol dm
-3 cm-1). 
3.3.9 Peptide Arylations 
All peptides were functionalised using a general experimental procedure: 
 
Peptide (10 mg), PhB(OH)2 (5 eq.), Pd(OAc)2 (30 mol%) and Cu(OAc)2 (60 mol%) were 
dissolved in AcOH (0.5 mL) at 40 °C. The reaction mixture was stirred for 16 h. The 
solvent was removed under reduced pressure (at a temperature that did not exceed 40 
°C) to give a brown residue. This was analysed by HPLC-ESI-MS.  
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3.3.10 Mechanistic Experiments 
Detection of Mechanistic Intermediate II (Scheme) by ReactIR® 
 
 
 
To a three-necked round-bottomed flask fitted with a nitrogen inlet and ReactIR® probe 
was added THF (3 mL). The reaction was monitored by IR at 1616 and 1606 cm-1. To 
this was added methyl (2R)-2-acetylamino-3-(1H-indol-3-yl)propioniate (45 mg, 0.173 
mmol, 1 eq.). Once this was observed to be fully dissolved, Pd(OAc)2 (39 mg, 0.173 
mmol, 1 eq.) was added. The reaction was monitored for ca. 1.5 h (page 150).  
 
Detection of Mechanitic Intermediate III (Scheme) by NMR Spectroscopy 
 
 
 
To a NMR tube in air was added methyl (2R)-2-acetylamino-3-(1H-indol-3-
yl)propioniate (10 mg, 38.4 µmol, 1 eq.), Pd(OAc)2 (8.6 mg, 38.4 µmol, 1 eq.) and 
CD3COOD (0.7 mL). 
1H NMR spectrum was immediately recorded (page 151). 
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CHAPTER 4: 
CONCLUSIONS AND FUTURE WORK 
  
!"#$%&'(:(*(!-.!3142-.4(#./(01%1'&(?-'@(((((98: 
 
 
4.1 – Direct C-H Bond Functionalisation of Benzoxazole 
4.1.1 – Conclusions  
Pd0 nanoparticles have previously been implicated in traditional Pd cross-coupling 
reactions, and extensive studies have demonstrated the viability of heterogeneous and 
hybrid-phase reactions in these systems (vide supra).60,84,85 However, their activity has 
remained underexplored in the field of direct C-H bond functionalisation reactions, 
beyond acknowledgement of their presence.26 In this thesis has been presented 
compelling evidence for the presence and activity of such nanoparticles in these 
reactions.  Nanoparticles have been shown to play a role in both ‘redox-neutral’ C-H 
bond functionalisations (formal loss of HX) and oxidative coupling processes, at both 
high and ambient temperatures, and across a variety of electronically diverse 
heterocycles.  
 
The difficult reproducibility of C-H bond functionalisations catalysed by Pd (cat.) and Cu 
(stoich.) ‘base-free’ systems, as developed by Bellina, Rossi and co-workers had 
previously been noted by J. P. Reeds, who also noted that PVP stabilised Pd0 
nanoparticles could act as efficient catalysts.127 Here, Bellina and Rossi’s C-H bond 
functionalisations of benzoxazole and benzothiazole in the presence of base 
(specifically, CsF) was studied in a similar way. Varying results were observed in 
different vessels. With Pd(OAc)2 precatalysts (observed to reduce under the reaction 
conditions), isolated yields were higher in the Schlenk tube than the Radley’s® 
carousel tube. With Pd-PVP nanoparticles, the yields with benzothiazole increased in 
both the Schlenk tube and (considerably) in the carousel. For benzoxazole 53, the yield 
increased in the carousel, but decreased in the Schlenk tube.  
 
It was proposed that, with Pd(OAc)2, different sizes of nanoparticles were being formed 
in in the different vessels. This could result from differences in stirring, in water/air 
infiltration, or from Pd-PVP. Using benzothiazole 49, nanoparticles (which were trapped 
using the method of Fairlamb and co-workers using PVP) were isolated and 
characterized by TEM. There was a difference in particle size, with larger particles (by 
1.43 nm) being observed in the Schlenk tube. This was unexpected, as in previous 
work it has been suggested that smaller particles have increased activity (due to a 
greater proportion of active defect sites). It was proposed initially that by pre-
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synthesising Pd-PVP, and controlling the size and composition of the nanoparticles, 
greater reproducibility across reaction vessels could be obtained. However, this 
increase was not observed in the benzoxazole C-H bond functionalisations. These are 
complicated, multicomponent systems, and it seems likely that other factors may play a 
role. Importantly, it suggests that the benz(azole) heterocycles display reactivity 
differences. 
 
Chen and Cheng have published a direct C-H functionalisation of benzoxazole using 
PhI(OAc)2 107 catalysed by Pd(OAc)2.
130 They have proposed this to proceed via a 
PdII/IV manifold. PhI(OAc)2 is a commonly used oxidant in organic chemistry. It has been 
demonstrated here that this species, in DMSO solution, will degrade via multiple 
uncharacterised intermediates to PhI. This process is observable on the NMR 
spectroscopic timescale at room temperature. At elevated temperatures, this process is 
rapid. Full conversion is observed after only 10 minutes heating at 150 °C. When the 
Chen-Cheng arylation was attempted, it was found that PhI was an efficacious aryl 
source. Therefore, it is proposed that PhI(OAc)2 is degrading rapidly under reaction 
conditions to give PhI.  
 
Aryl iodides are rarely implicated in PdII to PdIV oxidative addition processes. Whilst 
performing these reactions, Pd0 nanoparticles were observed. These were isolated and 
characterised by TEM. This evidence suggests that this process does not proceed via 
PdIV intermediates. Rather, a traditional Pd0/II cycle is proposed, with the nanoparticles 
acting as a reservoir for Pd0. Further evidence was obtained with a competition 
experiment between PhI(OAc)2 and 1-iodo-4-methylbenzene, which gave results 
consistent with oxidative addition to Pd0.  
 
Cu(NHC)X (X = halide) complexes have been proposed as intermediates in the direct 
C-H bond functionalisation of imidazoles catalysed by Pd/Cu and Cu-only systems. A 
model complex (1,3-dibenzylbenzimdazolilydenecopper(I) bromide) 110 has been 
synthesised, and it has been have demonstrated that this complex undergoes a direct 
reaction with PhI, in the presence and absence of Pd(OAc)2. The reaction is less 
effective in the absence of Pd(OAc)2. This is consistent with previous methodological 
studies which have shown that Cu only C-H functionalisations require higher 
temperatures. 
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The decomposition of 1,3-dibenzylbenzimdazolilydenecopper(I) bromide is observed in 
the presence of H2O and air (accelerated by the latter). The novel bis(1,3-
dibenzylbenzimidazolium) dicoppertetrabromide 114a is observed as a decomposition 
product, and has been characterized by NMR spectroscopy and single crystal X-ray 
diffraction. This can exist as different polymorphs, including where dicopper 
tetrabromide is not a definitive stoichiometric cluster, but rather an infinite anionic 
polymer in the form CuxBr2y 114b. This decomposition provides the first clear 
explanation for the requirement for stoichiometric CuI in several C-H bond 
functionalization reactions. 
4.1.2 – Future Work 
Although the presence and catalytic relevance of Pd0 nanoparticles has been 
established in various systems for the C-H bond functionalisation of benz(azoles), the 
exact nature of their role remains undetermined. For example, it remains unclear 
whether catalysis occurs on the surface of the observed particles or whether they are 
merely acting as a reservoir for Pd0, leaching molecular Pd (i.e. complexes of Pd0 or 
PdII that contain only one metal centre) or smaller clusters of Pd0.  
 
A kinetic study of the C-H bond functionalisation of benz(azoles) with Pd(OAc)2 and Pd-
PVP (monitoring, for example, by GC) is key to understanding the role of nanoparticles 
further. If the formation of nanoparticles is required before catalysis can occur, we 
should expect an induction period with Pd(OAc)2 and not in the Pd-PVP nanoparticles. 
An induction period observed with Pd-PVP nanoparticles might suggest leaching, 
aggregation or disaggregation to smaller particles. The use of extended X-ray 
absorption fine structure (EXAFS) to study the particles in operando would provide 
complementary information.  
 
The Hg drop test has previously been used to assess the catalytic relevance of Pd 
nanoparticles. However, on its own it can lack reliability. Using a methodology 
developed to study nanoparticles in the Suzuki-Miyaura reaction,84 a more adequate 
picture might be obtained. Conversion as a function of time is monitored in the 
presence and absence of Hg. For catalytically active nanoparticles (both as 
heterogeneous catalysts or a reservoir for homogeneous Pd), we should observe 
reaction cessation. Molecular Pd (in the form of Pd(OAc)2), equal to the amount that 
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can theoretically be leached from particles of that size, is added to the reaction. If the 
reaction resumes, then it is likely that leaching is important in that process. This study 
would not only provide information on the role of nanoparticles in the C-H 
functionalisation of benz(azoles), but also in arylation of tryptophan discussed 
elsewhere in this thesis.  
 
Further studies are required on the degradation of PhI(OAc)2 to PhI in DMSO solution. 
The intermediate has not been identified. An in-depth kinetic study may provide more 
information. If such a study could identify a period where the populations of different 
species in solution are stable, detailed NMR spectroscopic experiments (for example, 
1H DOSY experiments) might give more insight into the nature of the observed species. 
Synthesis of possible hypervalent iodine intermediates (such as iodosylbenzene, PhIO) 
could also provide useful information.  
 
A role for N-heterocyclic carbene complexes in C-H bond functionalisation has been 
established, although some factors are still unknown. The mode of transmetallation to 
Pd has not been explored. This could happen at both PdII (post-oxidative addition of 
ArI) and Pd0 (before oxidative addition of ArI). This could be tested by the synthesis of 
Pd0 and PdII N-heterocyclic carbenes analogous to the Cu complexes described in this 
thesis. DFT calculations would also provide valuable information into these processes.  
 
The requirement for stoichiometric quantities of CuI in Bellina-Rossi and Fairlamb C-H 
bond functionalisations is still not completely understood. Although the stability of the 
Cu(NHC) complexes could play a decisive role, this has not been established. There is 
further evidence that Cs2CO3 reactions with CuI to give Cu2CO3, and eventually Cu2O 
and CO2.
302  A kinetic study of these reactions to ascertain the reaction order with 
respect to Cu, Pd and substrates is required.  
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4.2 – Direct C-H Bond Functionalisation of Indole Biomolecules 
4.2.1 – Conclusions  
A key objective of this work was the development of a mild and selective C-H bond 
functionalisation for the amino acid tryptophan 213. In initial experiments, PhI(OAc)2 (2 
eq.), ArB(OH)2 (2 eq.) and Pd(OAc)2 (5 mol%) were used in AcOH. This methodology 
was adapted from that developed by Sanford and co-workers.131 Moderate yields were 
obtained (maximum 56%). It had previously been proposed that this system resulted in 
the in situ formation of diaryliodonium salts, which acted as the aryl source. However, 
reagent elimination studies indicated that the process performed better in the absence 
of PhI(OAc)2 with trace air acting as the oxidant. When p-TolB(OH)2 and PhI(OAc)2 
were used in conjunction, only the incorporation of p-TolB(OH)2 into the tryptophan was 
observed. If an unsymmetrical driaryliodonium ([Ar′IAr′′][OAc]) salt had been formed, a 
mixture of products would be expected. Therefore, it is proposed that the 
diaryliodonium salts are not forming in situ, under the reaction conditions tested. 
 
Similarly, this methodology had previously been proposed to proceed via a PdII/IV 
manifold. However, Pd0 nanoparticles were observed to form in the reaction mixture. 
These well-defined particles have been characterized by TEM, and were found to have 
a mean diameter of 2.5 nm. When pre-synthesised Pd nanoparticles supported on 
polymer (PVP) were used instead of Pd(OAc)2, similar yields were obtained (57%).  
 
Therefore, it is proposed this reaction proceeds via a traditional Pd0/II mechanism. 
ArB(OH)2 acts as an aryl source, transmetallating to Pd
II. Product is reductively 
eliminated to leave Pd0. It is proposed that this exists in equilibrium with Pd0 
nanoparticles, which acts as a ‘reservoir’. The Pd0 is then oxidized to PdII. This occurs 
in the initial methodology with PhI(OAc)2. Without the PhI(OAc)2 present, O2 acts as a 
terminal oxidant. It was found that this reaction was more reliable in the presence of a 
substoichiometric quantity of Cu(OAc)2 (10 mol%). This is a known catalyst for 
oxidation processes. In the absence of air, only one turnover of Cu(OAc)2 is observed.  
 
Therefore, a mild, low-temperature and selective method for the direct C-H bond 
functionalisation of the amino acid tryptophan 213 has been developed. A small library 
of analogues was synthesised. With substituted organoboronic acids, an increase in 
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stoichiometry was required to give good yields. It is proposed organoboronic acid is 
consumed competitively by Pd0 catalyst homocoupling. These were screened for their 
fluorescence properties (UV-Vis absorption maxima and emission spectra). It was 
important that these properties were sufficiently removed from those of unsubstituted 
tryptophan. It was found that those with the most extreme electronic properties (-
C6H4OMe, -C6H4CF3) were most effective for absorption (with the most shift absorption 
maxima of the analogues). The -C6H5 and -C6H4F had favourable fluorescence data, 
showing a significant shift from starting material was observed for the latter, whereas 
the -C6H5 analogue was especially emissive.  
 
The optimized methodology was then applied to simple peptides. The dipeptide 
AcGlyTrpOMe showed full conversion to arylated product. Also observed in this 
reaction mixture was biphenyl, confirming the operation of an organoboronic acid Pd0-
catalysed homocoupling pathway.  
 
These conditions were applied to more complicated peptides, including tri-, tetra and 
hexapeptides. Arylated product was detected in all systems, in 46-86% yields. Small 
quantities of dioxidised product were observed in some peptides (specifically, where 
Trp is adjacent to a terminal Ala residue possessing a carboxylic acid end group), 
although the position of oxidation has not been determined.  
4.2.2 – Future Work 
The fluorescent analogues of tryptophan described in this thesis must be assessed for 
their use in biological experiments. It is proposed they might be of particular use when 
probing protein-peptide interactions. In order to be effective, they would have to be 
shown to be distinct from background fluorescence (for example, from unlabeled 
tryptophan-containing compounds, protein backbone, and DNA/RNA). It has already 
been demonstrated they are distinct from native tryptophan absorption and 
fluorescence. This work would have to be undertaken with the assistance of 
collaborators in biology. If these labels prove unsuitable, work should be undertaken to 
attempt to incorporate more traditional fluorescent labels such as fluorescein 250 or N-
hydroxysuccimidide esters 251 (Figure 83).303 
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Figure 82: Fluorescein and Atto 465 NHS Ester. 
 
There is an overwhelming number of peptides known, and an almost infinite number of 
possible permutations (e.g. for di- to decapeptides alone, there are 44,352,143 
possible permutations using the 21 eukaryotic proteinogenic amino acids). Although 
only a small percentage of these are known natural peptides, a significant amount of 
work is required to assess the application of the C-H bond functionalisation conditions 
in different peptidic environments. Of particular interest will be peptides that contain 
cysteine residues (which has an S-functionalised side chain). Sulfur ligands have been 
implicated in the poisoning of Pd catalysts in cross-coupling reactions, and Davies and 
co-workers used a sulfur-ligand (3-mercaptopropionic acid) as a scavenger for Pd in 
their cross-coupling on the surface of proteins.239,304 These conditions may require 
further optimization to overcome these possible problems. The functionalized peptides 
are to be purified by preparative HPLC-MS, and the products analysed by NMR 
spectroscopy (using a 700 MHz instrument). Their UV-visible and fluorescent 
spectroscopic data will also be analysed.  
 
The fluorescent properties of the analogues must be characterized further. Quantum 
yields and fluorescent lifetimes will give further details on the effectiveness of these 
compounds as photochemical probes. This work is to be done in collaboration with 
Prof. Andy Beeby at the University of Durham.  
 
Pd0 nanoparticles have been characterised in this reaction. Studies similar to those 
outlined in 4.2.1 (kinetics, XPS, Hg drop tests and EXAFS) would provide more 
information on their exact nature and role.  
 
The ultimate goal in the development of this methodology is the C-H bond 
functionalisation of tryptophan residues in proteins. The challenges associated with 
long chain peptides (multiple sites of functionalisation, non-specific binding of metal 
catalysts etc.) are relevant to proteins, but interruption of tertiary and quaternary 
O OHO
CO2H
NHN
O
O
NH2
N
O
O
250 251 
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structure (‘unfolding’) and loss of co-factors (e.g. heme) are also key problems to be 
solved. An initial way forward would be to select a ‘simple’, well-characterized protein 
for early method development. It is proposed that equine apomyoglobin might be a 
suitable substrate, as it contains only one tryptophan residue. Further, it does not 
incorporate any co-factors or have a quaternary structure. An important and 
challenging area of study would be the detection of products, and possible methods 
include ESI-MS or MALDI-MS, fluorescence spectroscopy, and circular dichroism (CD). 
 
 
Figure 83: CO-RM JW-3. 
 
The Fairlamb group has developed a ‘light-activated’ CO releasing molecule (CO-
RM)305–313 based on tryptophan. In the future, the tryptophan analogues described in 
this thesis could be used to modify the UV-Visible and fluorescence properties of these 
compounds.  
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ABBREVIATIONS 
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Ac Acetyl 
OAc Acetate 
AFM Atomic force microscopy 
aq. Aqueous 
Ar Aryl 
Bn Benzyl 
tBu tert-Butyl 
cat. Catalytic 
Coord. Coordination 
m-CPBA 2-Chloroperoxybenzoic acid 
δ Chemical shift downfield from tetramethylsilane 
d (NMR) Doublet 
Deprot. Deprotonation 
DMA N,N’-Dimethylacetamide 
DMF N,N’-Dimethylformamide  
DMSO Dimethylsulfoxide 
EAS Electrophillic aromatic substitution 
Et Ethyl 
eq. Equivalents 
ESI Electrospray ionisation 
g gram(s) 
h hour(s) 
Het Heteroarene 
HRMS High-resolution mass spectrometry 
Hz Hertz 
IR Infrared 
J Spin-spin coupling constant 
L Ligand 
LIFDI Liquid introduction field desorption ionisation 
lit.  Literature value 
µ Micro 
M (concentration) mol dm-3 
m Milli 
m (NMR) Multiplet 
Me Methyl 
Mes Mesityl 
MP Melting point 
MW Microwave 
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m/z Mass-to-charge ratio 
NHC N-Heterocyclic carbene 
NMP 1-Methyl-2-pyrrolidinone 
NMR Nuclear magnetic resonance 
nOct n-Octyl 
OMe-dba 4,4’-dimethoxydibenzylideneacetone  
Ox. Add. Oxidative addition 
Ph Phenyl 
Phen 1,10-Phenanthroline 
Pic p-Iodobenzyl cysteine 
ppm Part(s) per million 
iPr iso-Propyl 
PXPd Dichlorobis(chlorodi-tert butylphosphine)palladium(II) 
PVP Polyvinylpyrrolidone 
Pd-PVP PVP stabilised Pd0 nanoparticles 
Py Pyridine 
q (NMR) Quarter 
R Substituent 
Red. Reduction 
Red. Elim. Reductive elimination 
Rf Retention factor 
s Second(s) 
s (NMR) Singlet 
Stoich. Stoichiometric 
t (NMR) Triplet 
t  Time 
TEM Transmission electron microscopy 
Tf Trifluoromethylsulfonyl (trifyl) 
TLC Thin layer chromatography 
THF Tetrahydrofuran 
TMS Trimethylsilane 
TOF Time-of-flight 
Tol Toluene 
p-Tol 4-Methylphenyl 
Trans. Met. Transmetallation 
UV Ultra-violet 
Vis Visible 
X (Pseudo)halide 
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Xantphos 4,5-Bis(diphenylphosphino)-9,9-dimethylxanthene 
EXAFS Extended X-ray fine structure spectroscopy 
XAS X-Ray absorption spectroscopy 
XPS X-ray photoelectron spectroscopy 
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(1,3-Dibenzyl)-2-phenylbenzo[d]imidazolium bromide A11 
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N-Acetylglycine A18 
AcNGlyTrpOMe A19 
Bis(acetyloxy)phenyl-λ
3
-iodane A20 
1-Hydroxy-1H-1 λ
3
-benzo[d][1,2]iodoxol-3-one A21 
1-Acetyl-1H-1 λ
3
-benzo[d][1,2]iodoxol-3-one A22 
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Potassium 4-(trifluoromethyl)phenylborontrifluoride A27 
1,3-[di(2,4,6-trimethylphenyl)-4,5-dihydroimidazolylidene](η
3
-2-
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A29 
Trans-di-µ-chlorobis{[1,3-di(2,4,6-trimethylphenyl)-4,5-
dihydroimidazolylidene]chloropalladium(II)} 
A32 
[1,3-di(2,4,6-trimethylphenyl)-4,5-dihydroimidazolylidene]diacetateaquopalladium(II) A33 
1-Methyl-2-phenylindole A36 
Methyl (2S)-2-acetyl-3-[2-phenyl-1H-indol-3-yl]propanoate A37 
Methyl (2S)-2-acetyl-3-[2-(4-methylphenyl)-1H-indol-3-yl]propanoate A40 
Methyl (2S)-2-amino-3-{2-[3-(trifluoromethyl)phenyl]-1H-indol-3-yl}propanoate A41 
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2-Phenylbenzo[d]thiazole 
 
 
 
Figure 1: 
1
H NMR spectrum (400 MHz, CDCl3). 
 
 
 
 
Figure 2: 
13
C NMR spectrum (101 MHz, CDCl3). 
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2-phenylbenzo[d]oxazole 
 
 
 
Figure 3: 
1
H NMR spectrum (400 MHz, CDCl3).  
 
 
 
 
Figure 4:
 13
C NMR spectrum (101 MHz, CDCl3). 
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1-Methyl-2-phenylbenzo[d]imidazole 
 
 
 
Figure 5:
 1
H NMR spectrum (400 MHz, CDCl3). 
 
 
 
Figure 6: 
13
C NMR spectrum (101 MHz, CDCl3). 
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1,3-Dibenzylbenzo[d]imidazolium bromide 
 
 
 
Figure 7: 
1
H NMR spectrum (400 MHz, (CD3)2SO). 
 
 
 
Figure 8: 
13
C NMR spectrum (101 MHz, (CD3)2SO). 
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(1,3-Dibenzylbenzo[d]imidazolin-2-ylidene)copper(I) bromide 
 
 
Figure 9: 
1
H NMR spectrum (400 MHz, CD2Cl2). 
 
 
Figure 10: 
13
C NMR spectrum (101 MHz, CD2Cl2). 
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1-Benzylbenzo[d]imidazole 
 
 
 
Figure 11: 
1
H NMR spectrum (400 MHz, (CD3)2SO). 
 
 
 
Figure 12: 
13
C NMR spectrum (101 MHz, (CD3)2SO). 
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1-Benzyl-2-phenylbenzo[d]imidazole 
 
 
Figure 13: 
1
H NMR spectrum (400 MHz, CD3CN). 
 
Figure 14: 
13
C NMR spectrum (101 MHz, CD3CN).  
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(1,3-Dibenzyl)-2-phenylbenzo[d]imidazolium bromide 
 
Figure 15: 
1
H NMR spectrum (400 MHz, CD3CN). 
 
 
Figure 16:
 13
C NMR spectrum (101 MHz, CD3CN). 
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Methyl (2R)-2-amino-3-(1H-indol-3-yl)propionate hydrochloride 
 
 
 
Figure 17: 
1
H NMR spectrum (400 MHz, CD3OD). 
 
 
 
Figure 18: 
13
C NMR spectrum (101 MHz, CD3OD). 
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Methyl (2R)-2-acetylamino-3-(1H-indol-3-yl)propionate 
 
 
 
Figure 19: 
1
H NMR spectrum (400 MHz, CDCl3). 
 
 
Figure 20: 
13
C NMR spectrum (101 MHz, CDCl3) 
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Methyl (2R)-2-benzylamino-3-(1H-indol-3-yl)propionate 
 
 
Figure 21: 
1
H NMR spectrum (400 MHz, CDCl3). 
 
 
 
Figure 22:
 13
C NMR spectrum (101 MHz, CDCl3). 
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Methyl (2R)-2-(trifluoroacetyl)-3-(1H-indol-3-yl)propionate 
 
Figure 23: 
1
H NMR spectrum (400 MHz, CDCl3). 
 
Figure 24: 
13
C NMR spectrum (101 MHz, CDCl3). 
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Methyl (2R)-2-amino-3-(1H-5-bromoindol-3-yl)propionate 
 
 
 
Figure 25: 
1
H NMR spectrum (400 MHz, MeOD). 
 
 
 
Figure 26:
 13
C NMR spectrum (101 MHz, MeOD). 
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Methyl (2R)-2-acetyl-3-(1H-5-bromoindol-3-yl)propionate 
 
 
Figure 27: 
1
H NMR spectrum (400 MHz, CDCl3). 
 
 
Figure 28: 
13
C NMR spectrum (101 MHz, CDCl3). 
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N-Acetylglycine 
 
Figure 29: 
1
H NMR spectrum (400 MHz, MeOD). 
 
 
Figure 30: 
13
C NMR spectrum (101 MHz, MeOD).   
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AcNGlyTrpOMe 
 
 
 
Figure 31: 
1
H NMR spectrum (400 MHz, CD3OD). 
 
 
 
Figure 32: 
13
C NMR spectrum (101 MHz, CD3OD). 
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Bis(acetyloxy)phenyl-λ3-iodane 
 
 
 
Figure 33: 
1
H NMR spectrum (400 MHz, CDCl3). 
 
 
 
Figure 34: 
13
C NMR spectrum (101 MHz, CDCl3). 
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1-Hydroxy-1H-1 λ3-benzo[d][1,2]iodoxol-3-one 
 
 
Figure 35:
 1
H NMR spectrum (400 MHz, (CD3)2SO). 
 
Figure 36: 
13
C NMR spectrum (101 MHz, (CD3)2SO).  
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1-Acetyl-1H-1 λ3-benzo[d][1,2]iodoxol-3-one 
 
 
 
Figure 37: 
1
H NMR spectrum (400 MHz, CDCl3). 
 
 
 
Figure 38: 
13
C NMR spectrum (101 MHz, CDCl3) 
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Potassium 4-fluorophenylborontrifluoride 
 
 
 
Figure 39: 
1
H NMR spectrum (400 MHz, (CD3)2CO). 
 
Figure 40: 
13
C NMR spectrum (101 MHz, (CD3)2CO). 
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Figure 41:
 11
B NMR spectrum (218 MHz, (CD3)2CO). 
 
 
Figure 42: 
19
F NMR spectrum (376 MHz, (CD3)2CO). 
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Potassium 4-methoxyphenylborontrifluoride 
 
 
 
Figure 43: 
1
H NMR spectrum (400 MHz, (CD3)2CO). 
 
 
 
Figure 44: 
13
C NMR spectrum (101 MHz, (CD3)2CO). 
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Figure 45: 
11
B NMR spectrum (218 MHz, (CD3)2CO). 
 
 
Figure 46: 
19
F NMR spectrum (376 MHz, (CD3)2CO). 
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Potassium 4-(trifluoromethyl)phenylborontrifluoride 
 
 
 
Figure 47: 
1
H NMR spectrum (400 MHz, (CD3)2CO). 
 
 
 
Figure 48: 
13
C NMR spectrum (101 MHz, (CD3)2CO). 
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Figure 49: 
11
B NMR spectrum (218 MHz, (CD3)2CO). 
 
 
Figure 50: 
19
F NMR spectrum (376 MHz, (CD3)2CO). 
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1,3-[di(2,4,6-trimethylphenyl)-4,5-dihydroimidazolylidene](η3-2-
methylpropenyl)chloropalladium(II) 
 
Figure 51: 
1
H NMR spectrum (400 MHz, CDCl3). 
 
 
 
Figure 52:
 13
C NMR spectrum (101 MHz, CDCl3). 
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Figure 53: 
1
H-
1
H COSY NMR spectrum (400 MHz, CDCl3). 
 
 
Figure 54:
 13
C DEPT 135 NMR spectrum (101 MHz, CDCl3).  
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Figure 55: 
1
H-
13
C HSQC NMR spectrum (400, 101 MHz, CDCl3). 
 
Figure 56: 
1
H-
13
C HMBC NMR spectrum (400, 101 MHz, CDCl3). 
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Trans-di-µ-chlorobis{[1,3-di(2,4,6-trimethylphenyl)-4,5-
dihydroimidazolylidene]chloropalladium(II)} 
 
Figure 57:
 1
H NMR spectrum (400 MHz, CDCl3). 
 
 
Figure 58: 
13
C NMR spectrum (101 MHz, CDCl3).  
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[1,3-di(2,4,6-trimethylphenyl)-4,5-dihydroimidazolylidene]diacetateaquopalladium(II) 
 
Figure 59: 
1
H NMR spectrum (400 MHz, CDCl3). 
 
 
Figure 60: 
13
C NMR spectrum (101 MHz, CDCl3). 
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Figure 61:
 1
H-
1
H COSY NMR spectrum (400 MHz, CDCl3). 
 
Figure 62: 
13
C DEPT 135 NMR spectrum (101 MHz, CDCl3). 
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Figure 63:
 1
H-
13
C HSQC NMR spectrum (400, 101 MHz, CDCl3). 
 
Figure 64: 
1
H-
13
C HMBC NMR spectrum (400, 101 MHz, CDCl3). 
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1-Methyl-2-phenylindole 
 
 
 
Figure 65:
 1
H NMR spectrum (400 MHz, CDCl3). 
 
 
 
Figure 66:
 13
C NMR spectrum (101 MHz, CDCl3). 
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Methyl (2S)-2-acetyl-3-[2-phenyl-1H-indol-3-yl]propanoate 
 
 
 
Figure 67:
 1
H NMR spectrum (400 MHz, CDCl3). 
 
 
APPENDIX A     A38 
 
 
 
 
Figure 68: 
13
C NMR spectrum (101 MHz, CDCl3). 
 
Figure 69: 
13
C NMR DEPT 135 spectrum (101 MHz, CDCl3). 
 
 
Figure 70: 
1
H-
1
H COSY NMR spectrum (400 MHz, CDCl3). 
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Figure 71: 
1
H-
13
C HSQC NMR spectrum (400, 101 MHz, CDCl3). 
 
Figure 72:
 1
H-
13
C HMBC NMR spectrum (400, 101 MHz, CDCl3). 
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Methyl (2S)-2-acetyl-3-[2-(4-methylphenyl)-1H-indol-3-yl]propanoate 
 
 
 
Figure 73: 
1
H NMR spectrum (400 MHz, CDCl3). 
 
 
Figure 74: 
13
C NMR spectrum (101 MHz, CDCl3). 
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Methyl (2S)-2-acetyl-3-{2-[4-(trifluoromethyl)phenyl]-1H-indol-3-yl}propanoate 
 
 
Figure 75: 
1
H NMR spectrum (400 MHz, CDCl3). 
 
Figure 76: 13C NMR spectrum (101 MHz, CDCl3). 
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Methyl (2S)-2-amino-3-[2-(4-fluorophenyl)-1H-indol-3-yl]propanoate 
 
 
Figure 77: 
1
H NMR spectrum (400 MHz, CDCl3). 
 
Figure 78: 
13
C NMR spectrum (101 MHz, CDCl3).  
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Methyl (2S)-2-amino-3-[2-(4-methoxyphenyl)-1H-indol-3-yl]propanoate 
 
 
 
Figure 79: 
1
H NMR spectrum (400 MHz, CDCl3). 
 
 
Figure 80: 
13
C NMR spectrum (101 MHz, CDCl3). 
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2-Phenyltryptophan  
 
UV-Visible Spectroscopy  
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APPENDIX C - Compopund 110
data_ijsf1115
_audit_creation_date              2011-09-13
_audit_creation_method
;
  Olex2 1.1
  (compiled 2011.09.07 svn.r1971, GUI svn.r3853)
;
_publ_contact_author_address      ?
_publ_contact_author_email        ?
_publ_contact_author_name         ''
_publ_contact_author_phone        ?
_chemical_name_common             ?
_chemical_name_systematic
;
 ? 
;
_chemical_formula_moiety          'C42 H36 Br2 Cu2 N4'
_chemical_formula_sum             'C42 H36 Br2 Cu2 N4'
_chemical_formula_weight          883.65
_chemical_melting_point           ?
_chemical_oxdiff_formula          'C21 H18 Br1 Cu1 N2'
_chemical_oxdiff_usercomment      'Tom's BRML58'
loop_
  _atom_type_symbol
  _atom_type_description
  _atom_type_scat_dispersion_real
  _atom_type_scat_dispersion_imag
  _atom_type_scat_source
 'C' 'C' 0.0033 0.0016 'International Tables Vol C Tables 4.2.6.8 and 6.1.1.4'
 'H' 'H' 0.0000 0.0000 'International Tables Vol C Tables 4.2.6.8 and 6.1.1.4'
 'N' 'N' 0.0061 0.0033 'International Tables Vol C Tables 4.2.6.8 and 6.1.1.4'
 'Cu' 'Cu' 0.3201 1.2651 'International Tables Vol C Tables 4.2.6.8 and 6.1.1.4'
 'Br' 'Br' -0.2901 2.4595
 'International Tables Vol C Tables 4.2.6.8 and 6.1.1.4'
_space_group_crystal_system       'triclinic'
_space_group_IT_number            2
_space_group_name_H-M_alt         'P -1'
_space_group_name_Hall            '-P 1'
loop_
  _space_group_symop_id
  _space_group_symop_operation_xyz
 1 'x, y, z'
 2 '-x, -y, -z'
_cell_length_a                    9.4581(6)
_cell_length_b                    9.5482(7)
_cell_length_c                    11.2949(10)
_cell_angle_alpha                 69.206(7)
_cell_angle_beta                  82.837(6)
_cell_angle_gamma                 69.262(6)
_cell_volume                      891.80(12)
_cell_formula_units_Z             1
_cell_measurement_reflns_used     3571
_cell_measurement_temperature     110.00(10)
_cell_measurement_theta_max       31.2520
_cell_measurement_theta_min       2.9964
_exptl_absorpt_coefficient_mu     3.470
_exptl_absorpt_correction_T_max   0.827
_exptl_absorpt_correction_T_min   0.579
_exptl_absorpt_correction_type    analytical
_exptl_absorpt_process_details
;
CrysAlisPro, Agilent Technologies,
Version 1.171.35.15 (release 03-08-2011 CrysAlis171 .NET)
(compiled Aug  3 2011,13:03:54)
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Analytical numeric absorption correction using a multifaceted crystal
   model based on expressions derived by R.C. Clark & J.S. 
Reid.
(Clark, R. C. & Reid, J. S. (1995). Acta Cryst. A51, 887-897)
;
_exptl_crystal_colour             'dull ? colourless'
_exptl_crystal_colour_lustre      dull
_exptl_crystal_colour_modifier    ?
_exptl_crystal_colour_primary     colourless
_exptl_crystal_density_diffrn     1.645
_exptl_crystal_density_meas       ?
_exptl_crystal_density_method     'not measured'
_exptl_crystal_description        needle
_exptl_crystal_F_000              444
_exptl_crystal_size_max           0.217
_exptl_crystal_size_mid           0.1108
_exptl_crystal_size_min           0.0626
_exptl_special_details
;
 ? 
;
_diffrn_reflns_av_R_equivalents   0.0285
_diffrn_reflns_av_unetI/netI      0.0541
_diffrn_reflns_limit_h_max        13
_diffrn_reflns_limit_h_min        -11
_diffrn_reflns_limit_k_max        13
_diffrn_reflns_limit_k_min        -13
_diffrn_reflns_limit_l_max        15
_diffrn_reflns_limit_l_min        -15
_diffrn_reflns_number             8485
_diffrn_reflns_theta_full         29.07
_diffrn_reflns_theta_max          31.32
_diffrn_reflns_theta_min          3.00
_diffrn_ambient_temperature       110.00(10)
_diffrn_detector_area_resol_mean  16.1450
_diffrn_measured_fraction_theta_full 0.9956
_diffrn_measured_fraction_theta_max 0.887
_diffrn_measurement_details
;
#__ type_ start__ end____ width___ exp.time_
  1 omega  -35.00    9.00   1.0000   20.0000
omega____ theta____ kappa____ phi______ frames
    -      -23.1156  -84.0000 -133.0000 44
#__ type_ start__ end____ width___ exp.time_
  2 omega  -20.00   67.00   1.0000   20.0000
omega____ theta____ kappa____ phi______ frames
    -       24.6781  -99.0000    0.0000 87
#__ type_ start__ end____ width___ exp.time_
  3 omega   60.00  101.00   1.0000   20.0000
omega____ theta____ kappa____ phi______ frames
    -       24.6781 -178.0000 -180.0000 41
#__ type_ start__ end____ width___ exp.time_
  4 omega    4.00   89.00   1.0000   20.0000
omega____ theta____ kappa____ phi______ frames
    -       24.6781   57.0000 -150.0000 85
#__ type_ start__ end____ width___ exp.time_
  5 omega  -46.00   97.00   1.0000   20.0000
omega____ theta____ kappa____ phi______ frames
    -       24.6781    0.0000    0.0000 143
;
_diffrn_measurement_device_type   'SuperNova, Single source at offset), Eos'
_diffrn_measurement_method        '\w scans'
_diffrn_orient_matrix_UB_11       0.0773826000
_diffrn_orient_matrix_UB_12       -0.0281660000
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_diffrn_orient_matrix_UB_13       0.0168238000
_diffrn_orient_matrix_UB_21       0.0207234000
_diffrn_orient_matrix_UB_22       -0.0171925000
_diffrn_orient_matrix_UB_23       -0.0571610000
_diffrn_orient_matrix_UB_31       0.0035803000
_diffrn_orient_matrix_UB_32       0.0775774000
_diffrn_orient_matrix_UB_33       -0.0310147000
_diffrn_radiation_monochromator   mirror
_diffrn_radiation_type            'Mo K\a'
_diffrn_radiation_wavelength      0.7107
_diffrn_source                    'SuperNova (Mo) X-ray Source'
_diffrn_standards_decay_%         ?
_diffrn_standards_interval_count  ?
_diffrn_standards_interval_time   ?
_diffrn_standards_number          ?
_reflns_number_gt                 4252
_reflns_number_total              5176
_reflns_odcompleteness_completeness 99.56
_reflns_odcompleteness_iscentric  1
_reflns_odcompleteness_theta      29.07
_reflns_threshold_expression      >2sigma(I)
_computing_cell_refinement
;
CrysAlisPro, Agilent Technologies,
Version 1.171.35.15 (release 03-08-2011 CrysAlis171 .NET)
(compiled Aug  3 2011,13:03:54)
;
_computing_data_collection
;
CrysAlisPro, Agilent Technologies,
Version 1.171.35.15 (release 03-08-2011 CrysAlis171 .NET)
(compiled Aug  3 2011,13:03:54)
;
_computing_data_reduction
;
CrysAlisPro, Agilent Technologies,
Version 1.171.35.15 (release 03-08-2011 CrysAlis171 .NET)
(compiled Aug  3 2011,13:03:54)
;
_computing_molecular_graphics
;
O. V. Dolomanov, L. J. Bourhis, R. J. Gildea, J. A. K. Howard and H. Puschmann,
OLEX2: a complete structure solution, refinement and analysis program.
J. Appl. Cryst. (2009). 42, 339-341.
;
_computing_publication_material
;
O. V. Dolomanov, L. J. Bourhis, R. J. Gildea, J. A. K. Howard and H. Puschmann,
OLEX2: a complete structure solution, refinement and analysis program.
J. Appl. Cryst. (2009). 42, 339-341.
;
_computing_structure_refinement
;
XL, G.M. Sheldrick, Acta Cryst.
(2008). A64, 112-122
;
_computing_structure_solution
;
XS, G.M. Sheldrick, Acta Cryst.
(2008). A64, 112-122
;
_refine_diff_density_max          1.177
_refine_diff_density_min          -0.757
_refine_diff_density_rms          0.110
_refine_ls_extinction_coef        ?
_refine_ls_extinction_method      none
_refine_ls_goodness_of_fit_ref    1.045
_refine_ls_hydrogen_treatment     constr
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_refine_ls_matrix_type            full
_refine_ls_number_parameters      226
_refine_ls_number_reflns          5176
_refine_ls_number_restraints      0
_refine_ls_R_factor_all           0.0539
_refine_ls_R_factor_gt            0.0406
_refine_ls_restrained_S_all       1.045
_refine_ls_shift/su_max           0.001
_refine_ls_shift/su_mean          0.000
_refine_ls_structure_factor_coef  Fsqd
_refine_ls_weighting_details
'calc w=1/[\s^2^(Fo^2^)+(0.0335P)^2^+0.6919P] where P=(Fo^2^+2Fc^2^)/3'
_refine_ls_weighting_scheme       calc
_refine_ls_wR_factor_gt           0.0877
_refine_ls_wR_factor_ref          0.0953
_refine_special_details
;
 Refinement of F^2^ against ALL reflections.  The weighted R-factor wR and 
 goodness of fit S are based on F^2^, conventional R-factors R are based 
 on F, with F set to zero for negative F^2^. The threshold expression of 
 F^2^ > 2sigma(F^2^) is used only for calculating R-factors(gt) etc. and is 
 not relevant to the choice of reflections for refinement.  R-factors based 
 on F^2^ are statistically about twice as large as those based on F, and R- 
 factors based on ALL data will be even larger. 
;
_atom_sites_solution_hydrogens    geom
_atom_sites_solution_primary      direct
_atom_sites_solution_secondary    difmap
loop_
  _atom_site_label
  _atom_site_type_symbol
  _atom_site_fract_x
  _atom_site_fract_y
  _atom_site_fract_z
  _atom_site_U_iso_or_equiv
  _atom_site_adp_type
  _atom_site_occupancy
  _atom_site_symmetry_multiplicity
  _atom_site_calc_flag
  _atom_site_refinement_flags
  _atom_site_disorder_assembly
  _atom_site_disorder_group
 Br1 Br 0.88769(3) 0.86509(3) 0.01639(3) 0.02247(8) Uani 1 1 d . . .
 C1 C 0.6870(3) 1.2503(3) 0.1094(3) 0.0140(5) Uani 1 1 d . . .
 C2 C 0.4412(3) 1.3572(3) 0.1612(2) 0.0133(5) Uani 1 1 d . . .
 C3 C 0.2877(3) 1.3886(3) 0.1890(3) 0.0161(5) Uani 1 1 d . . .
 H3 H 0.2377 1.3207 0.1884 0.019 Uiso 1 1 calc R . .
 C4 C 0.2135(3) 1.5265(3) 0.2176(3) 0.0192(5) Uani 1 1 d . . .
 H4 H 0.1109 1.5521 0.2365 0.023 Uiso 1 1 calc R . .
 C5 C 0.2898(3) 1.6282(3) 0.2186(3) 0.0197(5) Uani 1 1 d . . .
 H5 H 0.2360 1.7201 0.2376 0.024 Uiso 1 1 calc R . .
 C6 C 0.4429(3) 1.5958(3) 0.1921(3) 0.0169(5) Uani 1 1 d . . .
 H6 H 0.4934 1.6628 0.1936 0.020 Uiso 1 1 calc R . .
 C7 C 0.5172(3) 1.4573(3) 0.1629(2) 0.0134(5) Uani 1 1 d . . .
 C8 C 0.5152(3) 1.0960(3) 0.1240(3) 0.0158(5) Uani 1 1 d . . .
 H8A H 0.5947 1.0403 0.0775 0.019 Uiso 1 1 calc R . .
 H8B H 0.4207 1.1325 0.0793 0.019 Uiso 1 1 calc R . .
 C9 C 0.5040(3) 0.9826(3) 0.2558(2) 0.0133(5) Uani 1 1 d . . .
 C10 C 0.6192(3) 0.9276(3) 0.3441(3) 0.0197(5) Uani 1 1 d . . .
 H10 H 0.7031 0.9608 0.3221 0.024 Uiso 1 1 calc R . .
 C12 C 0.4855(4) 0.7714(3) 0.4976(3) 0.0233(6) Uani 1 1 d . . .
 H12 H 0.4800 0.6999 0.5779 0.028 Uiso 1 1 calc R . .
 C13 C 0.6086(3) 0.8234(3) 0.4646(3) 0.0227(6) Uani 1 1 d . . .
 H13 H 0.6848 0.7884 0.5235 0.027 Uiso 1 1 calc R . .
 C14 C 0.3712(3) 0.8257(3) 0.4114(3) 0.0240(6) Uani 1 1 d . . .
 H14 H 0.2883 0.7909 0.4335 0.029 Uiso 1 1 calc R . .
 C15 C 0.3794(3) 0.9328(3) 0.2908(3) 0.0188(5) Uani 1 1 d . . .
 H15 H 0.3007 0.9710 0.2336 0.023 Uiso 1 1 calc R . .
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 C16 C 0.7913(3) 1.4465(3) 0.1303(3) 0.0160(5) Uani 1 1 d . . .
 H16A H 0.7545 1.5617 0.0968 0.019 Uiso 1 1 calc R . .
 H16B H 0.8706 1.4086 0.0746 0.019 Uiso 1 1 calc R . .
 C17 C 0.8564(3) 1.3922(3) 0.2618(3) 0.0159(5) Uani 1 1 d . . .
 C18 C 0.9635(3) 1.2420(3) 0.3103(3) 0.0196(5) Uani 1 1 d . . .
 H18 H 0.9950 1.1750 0.2622 0.023 Uiso 1 1 calc R . .
 C19 C 1.0236(3) 1.1918(3) 0.4304(3) 0.0217(6) Uani 1 1 d . . .
 H19 H 1.0965 1.0919 0.4617 0.026 Uiso 1 1 calc R . .
 C20 C 0.9757(3) 1.2895(4) 0.5039(3) 0.0218(6) Uani 1 1 d . . .
 H20 H 1.0151 1.2552 0.5846 0.026 Uiso 1 1 calc R . .
 C21 C 0.8684(3) 1.4388(3) 0.4559(3) 0.0212(6) Uani 1 1 d . . .
 H21 H 0.8357 1.5048 0.5048 0.025 Uiso 1 1 calc R . .
 C22 C 0.8094(3) 1.4905(3) 0.3354(3) 0.0186(5) Uani 1 1 d . . .
 H22 H 0.7381 1.5913 0.3037 0.022 Uiso 1 1 calc R . .
 Cu1 Cu 0.86386(4) 1.11836(4) 0.04996(3) 0.01957(9) Uani 1 1 d . . .
 N1 N 0.5474(2) 1.2331(2) 0.1279(2) 0.0135(4) Uani 1 1 d . . .
 N2 N 0.6671(2) 1.3875(2) 0.1316(2) 0.0132(4) Uani 1 1 d . . .
loop_
  _atom_site_aniso_label
  _atom_site_aniso_U_11
  _atom_site_aniso_U_22
  _atom_site_aniso_U_33
  _atom_site_aniso_U_23
  _atom_site_aniso_U_13
  _atom_site_aniso_U_12
 Br1 0.01446(13) 0.02129(14) 0.03516(18) -0.01419(12) 0.00375(11) -0.00652(10)
 C1 0.0136(11) 0.0148(11) 0.0148(12) -0.0048(10) 0.0003(9) -0.0063(9)
 C2 0.0139(11) 0.0149(11) 0.0097(11) -0.0018(9) -0.0004(9) -0.0055(9)
 C3 0.0137(12) 0.0193(12) 0.0145(13) -0.0033(10) 0.0021(9) -0.0076(10)
 C4 0.0142(12) 0.0237(13) 0.0161(13) -0.0051(11) 0.0019(10) -0.0042(10)
 C5 0.0214(13) 0.0180(12) 0.0161(14) -0.0053(10) 0.0012(11) -0.0031(11)
 C6 0.0206(13) 0.0152(12) 0.0148(13) -0.0044(10) 0.0010(10) -0.0071(10)
 C7 0.0125(11) 0.0151(11) 0.0113(12) -0.0024(9) 0.0004(9) -0.0049(9)
 C8 0.0163(12) 0.0184(12) 0.0156(13) -0.0066(10) -0.0001(10) -0.0081(10)
 C9 0.0142(11) 0.0113(11) 0.0154(13) -0.0060(9) 0.0013(9) -0.0044(9)
 C10 0.0164(12) 0.0191(12) 0.0226(15) -0.0038(11) -0.0025(11) -0.0071(10)
 C12 0.0341(16) 0.0171(13) 0.0174(14) -0.0020(11) 0.0034(12) -0.0119(12)
 C13 0.0237(14) 0.0200(13) 0.0205(15) -0.0023(11) -0.0051(11) -0.0053(11)
 C14 0.0249(14) 0.0263(14) 0.0255(16) -0.0069(12) 0.0064(12) -0.0179(12)
 C15 0.0176(12) 0.0191(13) 0.0216(14) -0.0054(11) -0.0002(10) -0.0098(11)
 C16 0.0151(12) 0.0187(12) 0.0164(13) -0.0048(10) 0.0021(10) -0.0099(10)
 C17 0.0150(12) 0.0180(12) 0.0179(13) -0.0058(10) 0.0018(10) -0.0101(10)
 C18 0.0156(12) 0.0197(13) 0.0259(15) -0.0096(11) 0.0023(11) -0.0076(10)
 C19 0.0159(12) 0.0201(13) 0.0274(16) -0.0048(11) -0.0029(11) -0.0063(11)
 C20 0.0195(13) 0.0304(15) 0.0187(14) -0.0049(12) -0.0009(11) -0.0152(12)
 C21 0.0208(13) 0.0271(14) 0.0224(15) -0.0120(12) 0.0015(11) -0.0125(12)
 C22 0.0171(12) 0.0190(12) 0.0228(14) -0.0073(11) 0.0001(10) -0.0096(10)
 Cu1 0.01534(16) 0.02226(18) 0.02025(19) -0.00870(14) 0.00149(13) -0.00418(13)
 N1 0.0152(10) 0.0129(9) 0.0131(11) -0.0026(8) 0.0008(8) -0.0076(8)
 N2 0.0131(10) 0.0134(10) 0.0135(11) -0.0032(8) 0.0009(8) -0.0064(8)
_geom_special_details
;
 All esds (except the esd in the dihedral angle between two l.s. planes) 
 are estimated using the full covariance matrix.  The cell esds are taken 
 into account individually in the estimation of esds in distances, angles 
 and torsion angles; correlations between esds in cell parameters are only 
 used when they are defined by crystal symmetry.  An approximate (isotropic) 
 treatment of cell esds is used for estimating esds involving l.s. planes. 
;
loop_
  _geom_bond_atom_site_label_1
  _geom_bond_atom_site_label_2
  _geom_bond_distance
  _geom_bond_site_symmetry_2
  _geom_bond_publ_flag
 Br1 Cu1 2.5073(5) . ?
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 Br1 Cu1 2.4183(5) 2_775 ?
 C1 Cu1 1.914(3) . ?
 C1 N1 1.369(3) . ?
 C1 N2 1.365(3) . ?
 C2 C3 1.393(3) . ?
 C2 C7 1.390(3) . ?
 C2 N1 1.391(3) . ?
 C3 H3 0.9300 . ?
 C3 C4 1.385(4) . ?
 C4 H4 0.9300 . ?
 C4 C5 1.404(4) . ?
 C5 H5 0.9300 . ?
 C5 C6 1.387(4) . ?
 C6 H6 0.9300 . ?
 C6 C7 1.394(4) . ?
 C7 N2 1.398(3) . ?
 C8 H8A 0.9700 . ?
 C8 H8B 0.9700 . ?
 C8 C9 1.516(4) . ?
 C8 N1 1.461(3) . ?
 C9 C10 1.396(4) . ?
 C9 C15 1.386(4) . ?
 C10 H10 0.9300 . ?
 C10 C13 1.389(4) . ?
 C12 H12 0.9300 . ?
 C12 C13 1.382(4) . ?
 C12 C14 1.376(4) . ?
 C13 H13 0.9300 . ?
 C14 H14 0.9300 . ?
 C14 C15 1.396(4) . ?
 C15 H15 0.9300 . ?
 C16 H16A 0.9700 . ?
 C16 H16B 0.9700 . ?
 C16 C17 1.520(4) . ?
 C16 N2 1.467(3) . ?
 C17 C18 1.392(4) . ?
 C17 C22 1.391(4) . ?
 C18 H18 0.9300 . ?
 C18 C19 1.389(4) . ?
 C19 H19 0.9300 . ?
 C19 C20 1.386(4) . ?
 C20 H20 0.9300 . ?
 C20 C21 1.385(4) . ?
 C21 H21 0.9300 . ?
 C21 C22 1.387(4) . ?
 C22 H22 0.9300 . ?
 Cu1 Br1 2.4183(5) 2_775 ?
loop_
  _geom_angle_atom_site_label_1
  _geom_angle_atom_site_label_2
  _geom_angle_atom_site_label_3
  _geom_angle
  _geom_angle_site_symmetry_1
  _geom_angle_site_symmetry_3
  _geom_angle_publ_flag
 Cu1 Br1 Cu1 79.757(15) 2_775 . ?
 N1 C1 Cu1 126.29(18) . . ?
 N2 C1 Cu1 128.60(19) . . ?
 N2 C1 N1 104.9(2) . . ?
 C7 C2 C3 122.2(2) . . ?
 C7 C2 N1 106.4(2) . . ?
 N1 C2 C3 131.4(2) . . ?
 C2 C3 H3 121.8 . . ?
 C4 C3 C2 116.4(2) . . ?
 C4 C3 H3 121.8 . . ?
 C3 C4 H4 119.3 . . ?
 C3 C4 C5 121.5(3) . . ?
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 C5 C4 H4 119.3 . . ?
 C4 C5 H5 119.0 . . ?
 C6 C5 C4 121.9(3) . . ?
 C6 C5 H5 119.0 . . ?
 C5 C6 H6 121.8 . . ?
 C5 C6 C7 116.5(2) . . ?
 C7 C6 H6 121.8 . . ?
 C2 C7 C6 121.5(2) . . ?
 C2 C7 N2 105.9(2) . . ?
 C6 C7 N2 132.6(2) . . ?
 H8A C8 H8B 107.9 . . ?
 C9 C8 H8A 109.3 . . ?
 C9 C8 H8B 109.3 . . ?
 N1 C8 H8A 109.3 . . ?
 N1 C8 H8B 109.3 . . ?
 N1 C8 C9 111.7(2) . . ?
 C10 C9 C8 120.3(2) . . ?
 C15 C9 C8 120.6(2) . . ?
 C15 C9 C10 119.0(2) . . ?
 C9 C10 H10 120.0 . . ?
 C13 C10 C9 120.1(3) . . ?
 C13 C10 H10 120.0 . . ?
 C13 C12 H12 120.1 . . ?
 C14 C12 H12 120.1 . . ?
 C14 C12 C13 119.8(3) . . ?
 C10 C13 H13 119.8 . . ?
 C12 C13 C10 120.5(3) . . ?
 C12 C13 H13 119.8 . . ?
 C12 C14 H14 119.9 . . ?
 C12 C14 C15 120.2(3) . . ?
 C15 C14 H14 119.9 . . ?
 C9 C15 C14 120.4(3) . . ?
 C9 C15 H15 119.8 . . ?
 C14 C15 H15 119.8 . . ?
 H16A C16 H16B 107.9 . . ?
 C17 C16 H16A 109.2 . . ?
 C17 C16 H16B 109.2 . . ?
 N2 C16 H16A 109.2 . . ?
 N2 C16 H16B 109.2 . . ?
 N2 C16 C17 111.9(2) . . ?
 C18 C17 C16 119.9(2) . . ?
 C22 C17 C16 120.9(2) . . ?
 C22 C17 C18 119.2(3) . . ?
 C17 C18 H18 119.9 . . ?
 C19 C18 C17 120.2(3) . . ?
 C19 C18 H18 119.9 . . ?
 C18 C19 H19 119.8 . . ?
 C20 C19 C18 120.4(3) . . ?
 C20 C19 H19 119.8 . . ?
 C19 C20 H20 120.3 . . ?
 C21 C20 C19 119.4(3) . . ?
 C21 C20 H20 120.3 . . ?
 C20 C21 H21 119.8 . . ?
 C20 C21 C22 120.5(3) . . ?
 C22 C21 H21 119.8 . . ?
 C17 C22 H22 119.8 . . ?
 C21 C22 C17 120.3(3) . . ?
 C21 C22 H22 119.8 . . ?
 Br1 Cu1 Br1 100.242(15) 2_775 . ?
 C1 Cu1 Br1 134.16(8) . 2_775 ?
 C1 Cu1 Br1 125.58(8) . . ?
 C1 N1 C2 111.3(2) . . ?
 C1 N1 C8 124.8(2) . . ?
 C2 N1 C8 123.7(2) . . ?
 C1 N2 C7 111.4(2) . . ?
 C1 N2 C16 123.3(2) . . ?
 C7 N2 C16 125.1(2) . . ?
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loop_
  _geom_torsion_atom_site_label_1
  _geom_torsion_atom_site_label_2
  _geom_torsion_atom_site_label_3
  _geom_torsion_atom_site_label_4
  _geom_torsion
  _geom_torsion_site_symmetry_1
  _geom_torsion_site_symmetry_2
  _geom_torsion_site_symmetry_3
  _geom_torsion_site_symmetry_4
  _geom_torsion_publ_flag
 C2 C3 C4 C5 -0.2(4) . . . . ?
 C2 C7 N2 C1 0.7(3) . . . . ?
 C2 C7 N2 C16 -175.6(2) . . . . ?
 C3 C2 C7 C6 -0.3(4) . . . . ?
 C3 C2 C7 N2 179.5(2) . . . . ?
 C3 C2 N1 C1 -179.8(3) . . . . ?
 C3 C2 N1 C8 -4.6(4) . . . . ?
 C3 C4 C5 C6 -0.5(4) . . . . ?
 C4 C5 C6 C7 0.7(4) . . . . ?
 C5 C6 C7 C2 -0.3(4) . . . . ?
 C5 C6 C7 N2 179.9(3) . . . . ?
 C6 C7 N2 C1 -179.5(3) . . . . ?
 C6 C7 N2 C16 4.3(4) . . . . ?
 C7 C2 C3 C4 0.6(4) . . . . ?
 C7 C2 N1 C1 0.4(3) . . . . ?
 C7 C2 N1 C8 175.6(2) . . . . ?
 C8 C9 C10 C13 -179.8(3) . . . . ?
 C8 C9 C15 C14 178.6(3) . . . . ?
 C9 C8 N1 C1 100.5(3) . . . . ?
 C9 C8 N1 C2 -74.1(3) . . . . ?
 C9 C10 C13 C12 1.0(4) . . . . ?
 C10 C9 C15 C14 -1.8(4) . . . . ?
 C12 C14 C15 C9 1.5(4) . . . . ?
 C13 C12 C14 C15 0.1(5) . . . . ?
 C14 C12 C13 C10 -1.3(5) . . . . ?
 C15 C9 C10 C13 0.6(4) . . . . ?
 C16 C17 C18 C19 179.9(2) . . . . ?
 C16 C17 C22 C21 179.2(2) . . . . ?
 C17 C16 N2 C1 -93.7(3) . . . . ?
 C17 C16 N2 C7 82.2(3) . . . . ?
 C17 C18 C19 C20 1.1(4) . . . . ?
 C18 C17 C22 C21 -0.3(4) . . . . ?
 C18 C19 C20 C21 -0.8(4) . . . . ?
 C19 C20 C21 C22 -0.1(4) . . . . ?
 C20 C21 C22 C17 0.6(4) . . . . ?
 C22 C17 C18 C19 -0.6(4) . . . . ?
 Cu1 Br1 Cu1 Br1 -0.001(1) 2_775 . . 2_775 ?
 Cu1 Br1 Cu1 C1 178.90(10) 2_775 . . . ?
 Cu1 C1 N1 C2 -174.84(18) . . . . ?
 Cu1 C1 N1 C8 10.0(4) . . . . ?
 Cu1 C1 N2 C7 174.26(19) . . . . ?
 Cu1 C1 N2 C16 -9.4(4) . . . . ?
 N1 C1 Cu1 Br1 170.94(17) . . . 2_775 ?
 N1 C1 Cu1 Br1 -7.6(3) . . . . ?
 N1 C1 N2 C7 -0.4(3) . . . . ?
 N1 C1 N2 C16 175.9(2) . . . . ?
 N1 C2 C3 C4 -179.2(3) . . . . ?
 N1 C2 C7 C6 179.5(2) . . . . ?
 N1 C2 C7 N2 -0.6(3) . . . . ?
 N1 C8 C9 C10 -51.6(3) . . . . ?
 N1 C8 C9 C15 128.0(3) . . . . ?
 N2 C1 Cu1 Br1 178.86(19) . . . . ?
 N2 C1 Cu1 Br1 -2.6(3) . . . 2_775 ?
 N2 C1 N1 C2 0.0(3) . . . . ?
 N2 C1 N1 C8 -175.2(2) . . . . ?
 N2 C16 C17 C18 82.8(3) . . . . ?
 N2 C16 C17 C22 -96.6(3) . . . . ?
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loop_
  _exptl_crystal_face_index_h
  _exptl_crystal_face_index_k
  _exptl_crystal_face_index_l
  _exptl_crystal_face_perp_dist
  _exptl_oxdiff_crystal_face_indexfrac_h
  _exptl_oxdiff_crystal_face_indexfrac_k
  _exptl_oxdiff_crystal_face_indexfrac_l
  _exptl_oxdiff_crystal_face_x
  _exptl_oxdiff_crystal_face_y
  _exptl_oxdiff_crystal_face_z
 0 0 1 0.0378 0.0000 0.0000 1.0000 0.0168 -0.0572 -0.0310
 0 0 -1 0.0378 -0.0000 -0.0000 -1.0000 -0.0168 0.0572 0.0310
 1 1 1 0.0955 1.0000 1.0000 1.0000 0.0660 -0.0536 0.0501
 -1 -1 -1 0.0955 -1.0000 -1.0000 -1.0000 -0.0660 0.0536 -0.0501
 0 -1 0 0.0535 -0.0000 -1.0000 -0.0000 0.0282 0.0172 -0.0776
 0 1 0 0.0535 0.0000 1.0000 0.0000 -0.0282 -0.0172 0.0776
 -2 -1 1 0.0942 -2.0000 -1.0000 1.0000 -0.1098 -0.0814 -0.1158
 2 1 -1 0.0942 2.0000 1.0000 -1.0000 0.1098 0.0814 0.1158
 0 -1 -2 0.0313 -0.0000 -1.0000 -2.0000 -0.0055 0.1315 -0.0155
 0 1 2 0.0313 0.0000 1.0000 2.0000 0.0055 -0.1315 0.0155
 1 -1 0 0.0582 1.0000 -1.0000 -0.0000 0.1055 0.0379 -0.0740
 -2 2 -1 0.0452 -2.0000 2.0000 -1.0000 -0.2279 -0.0187 0.1790
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data_ijsf1118
_audit_creation_date              2011-10-06
_audit_creation_method
;
  Olex2 1.1
  (compiled 2011.09.07 svn.r1971, GUI svn.r3853)
;
_publ_contact_author_address      ?
_publ_contact_author_email        ?
_publ_contact_author_name         ''
_publ_contact_author_phone        ?
_chemical_name_common             ?
_chemical_name_systematic
;
 ? 
;
_chemical_formula_moiety          'Br, C21 H19 N2, H2 O'
_chemical_formula_sum             'C21 H21 Br N2 O'
_chemical_formula_weight          397.31
_chemical_melting_point           ?
_chemical_oxdiff_formula          'C21 H19 Br3 N2'
_chemical_oxdiff_usercomment      'Toms pale pink block'
loop_
  _atom_type_symbol
  _atom_type_description
  _atom_type_scat_dispersion_real
  _atom_type_scat_dispersion_imag
  _atom_type_scat_source
 'C' 'C' 0.0033 0.0016 'International Tables Vol C Tables 
4.2.6.8 and 6.1.1.4'
 'H' 'H' 0.0000 0.0000 'International Tables Vol C Tables 
4.2.6.8 and 6.1.1.4'
 'Br' 'Br' -0.2901 2.4595
 'International Tables Vol C Tables 4.2.6.8 and 6.1.1.4'
 'N' 'N' 0.0061 0.0033 'International Tables Vol C Tables 
4.2.6.8 and 6.1.1.4'
 'O' 'O' 0.0106 0.0060 'International Tables Vol C Tables 
4.2.6.8 and 6.1.1.4'
_space_group_crystal_system       'triclinic'
_space_group_IT_number            2
_space_group_name_H-M_alt         'P -1'
_space_group_name_Hall            '-P 1'
loop_
  _space_group_symop_id
  _space_group_symop_operation_xyz
 1 'x, y, z'
 2 '-x, -y, -z'
_cell_length_a                    9.3864(4)
_cell_length_b                    9.9323(4)
_cell_length_c                    11.3331(6)
_cell_angle_alpha                 69.308(4)
_cell_angle_beta                  80.860(4)
_cell_angle_gamma                 69.207(4)
1
_cell_volume                      923.36(7)
_cell_formula_units_Z             2
_cell_measurement_reflns_used     4358
_cell_measurement_temperature     110(2)
_cell_measurement_theta_max       31.9829
_cell_measurement_theta_min       2.9524
_exptl_absorpt_coefficient_mu     2.237
_exptl_absorpt_correction_T_max   0.440
_exptl_absorpt_correction_T_min   0.301
_exptl_absorpt_correction_type    analytical
_exptl_absorpt_process_details
;
CrysAlisPro, Agilent Technologies,
Version 1.171.35.15 (release 03-08-2011 CrysAlis171 .NET)
(compiled Aug  3 2011,13:03:54)
Analytical numeric absorption correction using a multifaceted 
crystal
model based on expressions derived by R.C. 
Clark & J.S. Reid.
(Clark, R. C. & Reid, J. S. (1995). Acta Cryst. A51, 887-897)
;
_exptl_crystal_colour             'pinkish colourless'
_exptl_crystal_colour_modifier    pinkish
_exptl_crystal_colour_primary     colourless
_exptl_crystal_density_diffrn     1.429
_exptl_crystal_density_meas       ?
_exptl_crystal_density_method     'not measured'
_exptl_crystal_description        block
_exptl_crystal_F_000              408
_exptl_crystal_size_max           0.1712
_exptl_crystal_size_mid           0.1642
_exptl_crystal_size_min           0.1105
_exptl_special_details
;
 ? 
;
_diffrn_reflns_av_R_equivalents   0.0204
_diffrn_reflns_av_unetI/netI      0.0410
_diffrn_reflns_limit_h_max        13
_diffrn_reflns_limit_h_min        -14
_diffrn_reflns_limit_k_max        12
_diffrn_reflns_limit_k_min        -14
_diffrn_reflns_limit_l_max        16
_diffrn_reflns_limit_l_min        -16
_diffrn_reflns_number             8860
_diffrn_reflns_theta_full         25.00
_diffrn_reflns_theta_max          32.06
_diffrn_reflns_theta_min          2.96
_diffrn_ambient_temperature       110.0
_diffrn_detector_area_resol_mean  16.1450
_diffrn_measured_fraction_theta_full 0.998
_diffrn_measured_fraction_theta_max 0.893
_diffrn_measurement_details
;
#__ type_ start__ end____ width___ exp.time_
  1 omega    6.00   95.00   1.0000   24.0000
omega____ theta____ kappa____ phi______ frames
2
    -       26.5735   57.0000  -90.0000 89
#__ type_ start__ end____ width___ exp.time_
  2 omega  -44.00   57.00   1.0000   24.0000
omega____ theta____ kappa____ phi______ frames
    -       26.5735  -77.0000  -60.0000 101
#__ type_ start__ end____ width___ exp.time_
  3 omega  -36.00   54.00   1.0000   24.0000
omega____ theta____ kappa____ phi______ frames
    -       26.5735  -77.0000   30.0000 90
#__ type_ start__ end____ width___ exp.time_
  4 omega   -3.00   97.00   1.0000   24.0000
omega____ theta____ kappa____ phi______ frames
    -       26.5735   77.0000  150.0000 100
;
_diffrn_measurement_device_type   'SuperNova, Single source at 
offset), Eos'
_diffrn_measurement_method        '\w scans'
_diffrn_orient_matrix_UB_11       0.0133329000
_diffrn_orient_matrix_UB_12       -0.0737616000
_diffrn_orient_matrix_UB_13       0.0449156000
_diffrn_orient_matrix_UB_21       0.0115947000
_diffrn_orient_matrix_UB_22       0.0270980000
_diffrn_orient_matrix_UB_23       0.0466279000
_diffrn_orient_matrix_UB_31       -0.0789367000
_diffrn_orient_matrix_UB_32       0.0182731000
_diffrn_orient_matrix_UB_33       0.0170567000
_diffrn_radiation_monochromator   mirror
_diffrn_radiation_type            'Mo K\a'
_diffrn_radiation_wavelength      0.7107
_diffrn_source                    'SuperNova (Mo) X-ray 
Source'
_diffrn_standards_decay_%         ?
_diffrn_standards_interval_count  ?
_diffrn_standards_interval_time   ?
_diffrn_standards_number          ?
_reflns_number_gt                 4995
_reflns_number_total              5751
_reflns_odcompleteness_completeness 99.13
_reflns_odcompleteness_iscentric  1
_reflns_odcompleteness_theta      30.01
_reflns_threshold_expression      >2sigma(I)
_computing_cell_refinement
;
CrysAlisPro, Agilent Technologies,
Version 1.171.35.15 (release 03-08-2011 CrysAlis171 .NET)
(compiled Aug  3 2011,13:03:54)
;
_computing_data_collection
;
CrysAlisPro, Agilent Technologies,
Version 1.171.35.15 (release 03-08-2011 CrysAlis171 .NET)
(compiled Aug  3 2011,13:03:54)
;
_computing_data_reduction
3
;
CrysAlisPro, Agilent Technologies,
Version 1.171.35.15 (release 03-08-2011 CrysAlis171 .NET)
(compiled Aug  3 2011,13:03:54)
;
_computing_molecular_graphics
;
O. V. Dolomanov, L. J. Bourhis, R. J. Gildea, J. A. K. Howard 
and H. Puschmann,
OLEX2: a complete structure solution, refinement and analysis 
program.
J. Appl. Cryst. (2009). 42, 339-341.
;
_computing_publication_material
;
O. V. Dolomanov, L. J. Bourhis, R. J. Gildea, J. A. K. Howard 
and H. Puschmann,
OLEX2: a complete structure solution, refinement and analysis 
program.
J. Appl. Cryst. (2009). 42, 339-341.
;
_computing_structure_refinement
;
XL, G.M. Sheldrick, Acta Cryst.
(2008). A64, 112-122
;
_computing_structure_solution
;
olex2.solve (L.J. Bourhis, O.V. Dolomanov, R.J. Gildea, J.A.K. 
Howard,
H. Puschmann, in preparation, 2011)
;
_refine_diff_density_max          1.301
_refine_diff_density_min          -0.484
_refine_diff_density_rms          0.085
_refine_ls_extinction_coef        ?
_refine_ls_extinction_method      none
_refine_ls_goodness_of_fit_ref    1.045
_refine_ls_hydrogen_treatment     constr
_refine_ls_matrix_type            full
_refine_ls_number_parameters      226
_refine_ls_number_reflns          5751
_refine_ls_number_restraints      0
_refine_ls_R_factor_all           0.0482
_refine_ls_R_factor_gt            0.0392
_refine_ls_restrained_S_all       1.045
_refine_ls_shift/su_max           0.000
_refine_ls_shift/su_mean          0.000
_refine_ls_structure_factor_coef  Fsqd
_refine_ls_weighting_details
'calc w=1/[\s^2^(Fo^2^)+(0.0429P)^2^+0.6465P] where P=(Fo^2^+
2Fc^2^)/3'
_refine_ls_weighting_scheme       calc
_refine_ls_wR_factor_gt           0.0929
_refine_ls_wR_factor_ref          0.0978
_refine_special_details
;
4
 H1, H1a and H1b were located in the difference map and their 
coordinates
 and isotropic displacement parameters restrained to ride on 
their 
 connecting atom.
 Refinement of F^2^ against ALL reflections.  The weighted R-
factor wR and 
 goodness of fit S are based on F^2^, conventional R-factors R 
are based 
 on F, with F set to zero for negative F^2^. The threshold 
expression of 
 F^2^ > 2sigma(F^2^) is used only for calculating R-factors
(gt) etc. and is 
 not relevant to the choice of reflections for refinement.  R-
factors based 
 on F^2^ are statistically about twice as large as those based 
on F, and R-
 factors based on ALL data will be even larger. 
;
_atom_sites_solution_hydrogens    geom
_atom_sites_solution_primary      direct
_atom_sites_solution_secondary    difmap
loop_
  _atom_site_label
  _atom_site_type_symbol
  _atom_site_fract_x
  _atom_site_fract_y
  _atom_site_fract_z
  _atom_site_U_iso_or_equiv
  _atom_site_adp_type
  _atom_site_occupancy
  _atom_site_symmetry_multiplicity
  _atom_site_calc_flag
  _atom_site_refinement_flags
  _atom_site_disorder_assembly
  _atom_site_disorder_group
 Br1 Br 0.35478(2) 0.30959(2) 0.51256(2) 0.02423(7) Uani 1 1 d 
. . .
 C2 C 0.0271(2) 0.9467(2) 0.66228(16) 0.0142(3) Uani 1 1 d . . 
.
 C3 C -0.0504(2) 1.0838(2) 0.68490(18) 0.0187(4) Uani 1 1 d . 
. .
 H3 H 0.0008 1.1507 0.6854 0.022 Uiso 1 1 calc R . .
 C4 C -0.2074(2) 1.1175(2) 0.7068(2) 0.0226(4) Uani 1 1 d . . 
.
 H4 H -0.2651 1.2097 0.7232 0.027 Uiso 1 1 calc R . .
 C5 C -0.2830(2) 1.0184(3) 0.7051(2) 0.0226(4) Uani 1 1 d . . 
.
 H5 H -0.3904 1.0461 0.7201 0.027 Uiso 1 1 calc R . .
 C6 C -0.2065(2) 0.8826(2) 0.68253(18) 0.0187(4) Uani 1 1 d . 
. .
 H6 H -0.2581 0.8164 0.6811 0.022 Uiso 1 1 calc R . .
 C7 C -0.0486(2) 0.8479(2) 0.66184(17) 0.0146(3) Uani 1 1 d . 
. .
 C8 C 0.0375(2) 0.5883(2) 0.62933(19) 0.0190(4) Uani 1 1 d . . 
5
.
 H8A H 0.1261 0.5342 0.5844 0.023 Uiso 1 1 calc R . .
 H8B H -0.0539 0.6207 0.5802 0.023 Uiso 1 1 calc R . .
 C9 C 0.0163(2) 0.4806(2) 0.75854(19) 0.0175(3) Uani 1 1 d . . 
.
 C10 C -0.1114(3) 0.4335(3) 0.7868(2) 0.0260(4) Uani 1 1 d . . 
.
 H10 H -0.1872 0.4722 0.7261 0.031 Uiso 1 1 calc R . .
 C11 C -0.1283(3) 0.3295(3) 0.9043(2) 0.0327(5) Uani 1 1 d . . 
.
 H11 H -0.2153 0.2967 0.9231 0.039 Uiso 1 1 calc R . .
 C12 C -0.0192(3) 0.2738(3) 0.9935(2) 0.0296(5) Uani 1 1 d . . 
.
 H12 H -0.0309 0.2025 1.0733 0.035 Uiso 1 1 calc R . .
 C13 C 0.1072(3) 0.3220(3) 0.9666(2) 0.0268(4) Uani 1 1 d . . 
.
 H13 H 0.1813 0.2851 1.0284 0.032 Uiso 1 1 calc R . .
 C14 C 0.1257(2) 0.4242(2) 0.8492(2) 0.0223(4) Uani 1 1 d . . 
.
 H14 H 0.2134 0.4559 0.8306 0.027 Uiso 1 1 calc R . .
 C15 C 0.3085(2) 0.9331(2) 0.63691(19) 0.0191(4) Uani 1 1 d . 
. .
 H15A H 0.2743 1.0454 0.6007 0.023 Uiso 1 1 calc R . .
 H15B H 0.3941 0.8917 0.5827 0.023 Uiso 1 1 calc R . .
 C16 C 0.3629(2) 0.8859(2) 0.76866(18) 0.0172(3) Uani 1 1 d . 
. .
 C17 C 0.4640(2) 0.7406(2) 0.8213(2) 0.0217(4) Uani 1 1 d . . 
.
 H17 H 0.4972 0.6711 0.7749 0.026 Uiso 1 1 calc R . .
 C18 C 0.5164(2) 0.6969(3) 0.9420(2) 0.0240(4) Uani 1 1 d . . 
.
 H18 H 0.5857 0.5978 0.9776 0.029 Uiso 1 1 calc R . .
 C19 C 0.4676(2) 0.7977(3) 1.0100(2) 0.0238(4) Uani 1 1 d . . 
.
 H19 H 0.5037 0.7680 1.0921 0.029 Uiso 1 1 calc R . .
 C20 C 0.3663(2) 0.9418(3) 0.9584(2) 0.0237(4) Uani 1 1 d . . 
.
 H20 H 0.3317 1.0103 1.0057 0.028 Uiso 1 1 calc R . .
 C21 C 0.3147(2) 0.9868(2) 0.8376(2) 0.0207(4) Uani 1 1 d . . 
.
 H21 H 0.2466 1.0865 0.8020 0.025 Uiso 1 1 calc R . .
 N1 N 0.18130(17) 0.87743(18) 0.63776(15) 0.0151(3) Uani 1 1 d 
. . .
 N2 N 0.06234(18) 0.72409(18) 0.63593(15) 0.0155(3) Uani 1 1 d 
. . .
 C1 C 0.1971(2) 0.7455(2) 0.62298(18) 0.0170(3) Uani 1 1 d . . 
.
 H1 H 0.2877 0.6803 0.6086 0.020 Uiso 1 1 d R . .
 O1 O 0.48452(19) 0.44528(19) 0.68588(14) 0.0288(3) Uani 1 1 d 
. . .
 H1A H 0.4648 0.3973 0.6680 0.035 Uiso 1 1 d R . .
 H1B H 0.5357 0.4765 0.6728 0.035 Uiso 1 1 d R . .
loop_
  _atom_site_aniso_label
  _atom_site_aniso_U_11
  _atom_site_aniso_U_22
6
  _atom_site_aniso_U_33
  _atom_site_aniso_U_23
  _atom_site_aniso_U_13
  _atom_site_aniso_U_12
 Br1 0.02397(11) 0.02083(11) 0.02819(12) -0.00962(8) -0.00177
(8) -0.00555(8)
 C2 0.0131(7) 0.0149(8) 0.0122(7) -0.0027(6) -0.0007(6) -
0.0033(6)
 C3 0.0207(9) 0.0153(8) 0.0182(9) -0.0046(7) -0.0021(7) -
0.0038(7)
 C4 0.0203(9) 0.0206(9) 0.0224(9) -0.0100(8) 0.0000(8) 0.0014
(8)
 C5 0.0149(8) 0.0274(10) 0.0215(9) -0.0076(8) 0.0002(7) -
0.0027(8)
 C6 0.0156(8) 0.0236(9) 0.0160(8) -0.0050(7) 0.0000(7) -0.0069
(7)
 C7 0.0147(8) 0.0138(8) 0.0130(8) -0.0025(6) -0.0020(6) -
0.0030(7)
 C8 0.0227(9) 0.0152(8) 0.0212(9) -0.0070(7) -0.0032(7) -
0.0063(7)
 C9 0.0184(8) 0.0138(8) 0.0209(9) -0.0075(7) 0.0006(7) -0.0047
(7)
 C10 0.0237(10) 0.0260(11) 0.0307(11) -0.0066(9) -0.0037(8) -
0.0123(9)
 C11 0.0304(11) 0.0354(13) 0.0369(13) -0.0083(10) 0.0057(10) -
0.0223(11)
 C12 0.0393(13) 0.0254(11) 0.0228(10) -0.0034(9) 0.0051(9) -
0.0160(10)
 C13 0.0289(11) 0.0254(11) 0.0222(10) -0.0037(8) -0.0038(8) -
0.0072(9)
 C14 0.0189(9) 0.0221(10) 0.0239(10) -0.0038(8) -0.0023(8) -
0.0072(8)
 C15 0.0163(8) 0.0235(9) 0.0201(9) -0.0062(7) 0.0003(7) -
0.0106(7)
 C16 0.0139(8) 0.0207(9) 0.0189(9) -0.0064(7) 0.0012(7) -
0.0085(7)
 C17 0.0192(9) 0.0211(9) 0.0256(10) -0.0086(8) -0.0012(8) -
0.0063(8)
 C18 0.0208(9) 0.0227(10) 0.0264(10) -0.0035(8) -0.0050(8) -
0.0073(8)
 C19 0.0219(9) 0.0304(11) 0.0217(9) -0.0055(8) -0.0024(8) -
0.0136(9)
 C20 0.0231(9) 0.0293(11) 0.0254(10) -0.0140(9) 0.0014(8) -
0.0121(9)
 C21 0.0180(8) 0.0206(9) 0.0246(10) -0.0083(8) -0.0009(7) -
0.0066(7)
 N1 0.0123(7) 0.0160(7) 0.0161(7) -0.0051(6) 0.0002(5) -0.0039
(6)
 N2 0.0161(7) 0.0133(7) 0.0162(7) -0.0044(6) -0.0007(6) -
0.0042(6)
 C1 0.0147(8) 0.0173(9) 0.0183(8) -0.0075(7) -0.0004(7) -
0.0025(7)
 O1 0.0300(8) 0.0245(8) 0.0237(8) -0.0083(6) -0.0004(6) 0.0012
(7)
_geom_special_details
;
7
 All esds (except the esd in the dihedral angle between two 
l.s. planes) 
 are estimated using the full covariance matrix.  The cell 
esds are taken 
 into account individually in the estimation of esds in 
distances, angles 
 and torsion angles; correlations between esds in cell 
parameters are only 
 used when they are defined by crystal symmetry.  An 
approximate (isotropic) 
 treatment of cell esds is used for estimating esds involving 
l.s. planes. 
;
loop_
  _geom_bond_atom_site_label_1
  _geom_bond_atom_site_label_2
  _geom_bond_distance
  _geom_bond_site_symmetry_2
  _geom_bond_publ_flag
 C2 C3 1.391(3) . ?
 C2 C7 1.403(2) . ?
 C2 N1 1.395(2) . ?
 C3 H3 0.9500 . ?
 C3 C4 1.392(3) . ?
 C4 H4 0.9500 . ?
 C4 C5 1.410(3) . ?
 C5 H5 0.9500 . ?
 C5 C6 1.377(3) . ?
 C6 H6 0.9500 . ?
 C6 C7 1.398(3) . ?
 C7 N2 1.390(2) . ?
 C8 H8A 0.9900 . ?
 C8 H8B 0.9900 . ?
 C8 C9 1.510(3) . ?
 C8 N2 1.476(2) . ?
 C9 C10 1.388(3) . ?
 C9 C14 1.395(3) . ?
 C10 H10 0.9500 . ?
 C10 C11 1.393(3) . ?
 C11 H11 0.9500 . ?
 C11 C12 1.382(3) . ?
 C12 H12 0.9500 . ?
 C12 C13 1.383(3) . ?
 C13 H13 0.9500 . ?
 C13 C14 1.389(3) . ?
 C14 H14 0.9500 . ?
 C15 H15A 0.9900 . ?
 C15 H15B 0.9900 . ?
 C15 C16 1.513(3) . ?
 C15 N1 1.481(2) . ?
 C16 C17 1.392(3) . ?
 C16 C21 1.392(3) . ?
 C17 H17 0.9500 . ?
 C17 C18 1.395(3) . ?
 C18 H18 0.9500 . ?
 C18 C19 1.383(3) . ?
 C19 H19 0.9500 . ?
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 C19 C20 1.384(3) . ?
 C20 H20 0.9500 . ?
 C20 C21 1.390(3) . ?
 C21 H21 0.9500 . ?
 N1 C1 1.333(2) . ?
 N2 C1 1.333(2) . ?
 C1 H1 0.8993 . ?
 O1 H1A 0.6675 . ?
 O1 H1B 0.6324 . ?
loop_
  _geom_angle_atom_site_label_1
  _geom_angle_atom_site_label_2
  _geom_angle_atom_site_label_3
  _geom_angle
  _geom_angle_site_symmetry_1
  _geom_angle_site_symmetry_3
  _geom_angle_publ_flag
 C3 C2 C7 121.89(17) . . ?
 C3 C2 N1 131.66(17) . . ?
 N1 C2 C7 106.45(16) . . ?
 C2 C3 H3 121.9 . . ?
 C2 C3 C4 116.17(18) . . ?
 C4 C3 H3 121.9 . . ?
 C3 C4 H4 119.2 . . ?
 C3 C4 C5 121.66(19) . . ?
 C5 C4 H4 119.2 . . ?
 C4 C5 H5 118.9 . . ?
 C6 C5 C4 122.27(18) . . ?
 C6 C5 H5 118.9 . . ?
 C5 C6 H6 121.9 . . ?
 C5 C6 C7 116.12(18) . . ?
 C7 C6 H6 121.9 . . ?
 C6 C7 C2 121.88(18) . . ?
 N2 C7 C2 106.46(15) . . ?
 N2 C7 C6 131.65(17) . . ?
 H8A C8 H8B 107.9 . . ?
 C9 C8 H8A 109.2 . . ?
 C9 C8 H8B 109.2 . . ?
 N2 C8 H8A 109.2 . . ?
 N2 C8 H8B 109.2 . . ?
 N2 C8 C9 112.20(16) . . ?
 C10 C9 C8 119.90(18) . . ?
 C10 C9 C14 119.35(19) . . ?
 C14 C9 C8 120.73(17) . . ?
 C9 C10 H10 120.0 . . ?
 C9 C10 C11 120.0(2) . . ?
 C11 C10 H10 120.0 . . ?
 C10 C11 H11 119.8 . . ?
 C12 C11 C10 120.3(2) . . ?
 C12 C11 H11 119.8 . . ?
 C11 C12 H12 120.0 . . ?
 C11 C12 C13 119.9(2) . . ?
 C13 C12 H12 120.0 . . ?
 C12 C13 H13 120.0 . . ?
 C12 C13 C14 120.1(2) . . ?
 C14 C13 H13 120.0 . . ?
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 C9 C14 H14 119.9 . . ?
 C13 C14 C9 120.29(19) . . ?
 C13 C14 H14 119.9 . . ?
 H15A C15 H15B 108.0 . . ?
 C16 C15 H15A 109.4 . . ?
 C16 C15 H15B 109.4 . . ?
 N1 C15 H15A 109.4 . . ?
 N1 C15 H15B 109.4 . . ?
 N1 C15 C16 111.31(15) . . ?
 C17 C16 C15 119.75(18) . . ?
 C21 C16 C15 120.80(18) . . ?
 C21 C16 C17 119.45(19) . . ?
 C16 C17 H17 119.9 . . ?
 C16 C17 C18 120.1(2) . . ?
 C18 C17 H17 119.9 . . ?
 C17 C18 H18 120.0 . . ?
 C19 C18 C17 120.0(2) . . ?
 C19 C18 H18 120.0 . . ?
 C18 C19 H19 120.0 . . ?
 C18 C19 C20 120.0(2) . . ?
 C20 C19 H19 120.0 . . ?
 C19 C20 H20 119.8 . . ?
 C19 C20 C21 120.3(2) . . ?
 C21 C20 H20 119.8 . . ?
 C16 C21 H21 120.0 . . ?
 C20 C21 C16 120.07(19) . . ?
 C20 C21 H21 120.0 . . ?
 C2 N1 C15 126.74(16) . . ?
 C1 N1 C2 108.11(15) . . ?
 C1 N1 C15 125.02(16) . . ?
 C7 N2 C8 126.22(16) . . ?
 C1 N2 C7 108.35(15) . . ?
 C1 N2 C8 125.38(17) . . ?
 N1 C1 N2 110.62(17) . . ?
 N1 C1 H1 123.4 . . ?
 N2 C1 H1 125.9 . . ?
 H1A O1 H1B 138.7 . . ?
loop_
  _geom_torsion_atom_site_label_1
  _geom_torsion_atom_site_label_2
  _geom_torsion_atom_site_label_3
  _geom_torsion_atom_site_label_4
  _geom_torsion
  _geom_torsion_site_symmetry_1
  _geom_torsion_site_symmetry_2
  _geom_torsion_site_symmetry_3
  _geom_torsion_site_symmetry_4
  _geom_torsion_publ_flag
 C2 C3 C4 C5 -0.4(3) . . . . ?
 C2 C7 N2 C8 178.18(16) . . . . ?
 C2 C7 N2 C1 0.7(2) . . . . ?
 C2 N1 C1 N2 0.2(2) . . . . ?
 C3 C2 C7 C6 0.8(3) . . . . ?
 C3 C2 C7 N2 179.76(17) . . . . ?
 C3 C2 N1 C15 3.9(3) . . . . ?
 C3 C2 N1 C1 179.9(2) . . . . ?
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 C3 C4 C5 C6 0.3(3) . . . . ?
 C4 C5 C6 C7 0.3(3) . . . . ?
 C5 C6 C7 C2 -0.9(3) . . . . ?
 C5 C6 C7 N2 -179.51(19) . . . . ?
 C6 C7 N2 C8 -3.0(3) . . . . ?
 C6 C7 N2 C1 179.49(19) . . . . ?
 C7 C2 C3 C4 -0.2(3) . . . . ?
 C7 C2 N1 C15 -175.73(17) . . . . ?
 C7 C2 N1 C1 0.2(2) . . . . ?
 C7 N2 C1 N1 -0.6(2) . . . . ?
 C8 C9 C10 C11 177.5(2) . . . . ?
 C8 C9 C14 C13 -178.2(2) . . . . ?
 C8 N2 C1 N1 -178.07(16) . . . . ?
 C9 C8 N2 C7 -76.2(2) . . . . ?
 C9 C8 N2 C1 100.8(2) . . . . ?
 C9 C10 C11 C12 0.6(4) . . . . ?
 C10 C9 C14 C13 0.0(3) . . . . ?
 C10 C11 C12 C13 0.3(4) . . . . ?
 C11 C12 C13 C14 -1.1(4) . . . . ?
 C12 C13 C14 C9 0.9(3) . . . . ?
 C14 C9 C10 C11 -0.8(3) . . . . ?
 C15 C16 C17 C18 179.10(18) . . . . ?
 C15 C16 C21 C20 -179.78(17) . . . . ?
 C15 N1 C1 N2 176.26(16) . . . . ?
 C16 C15 N1 C2 83.7(2) . . . . ?
 C16 C15 N1 C1 -91.6(2) . . . . ?
 C16 C17 C18 C19 0.3(3) . . . . ?
 C17 C16 C21 C20 -0.6(3) . . . . ?
 C17 C18 C19 C20 0.2(3) . . . . ?
 C18 C19 C20 C21 -0.9(3) . . . . ?
 C19 C20 C21 C16 1.1(3) . . . . ?
 C21 C16 C17 C18 -0.1(3) . . . . ?
 N1 C2 C3 C4 -179.73(19) . . . . ?
 N1 C2 C7 C6 -179.50(16) . . . . ?
 N1 C2 C7 N2 -0.57(19) . . . . ?
 N1 C15 C16 C17 81.9(2) . . . . ?
 N1 C15 C16 C21 -99.0(2) . . . . ?
 N2 C8 C9 C10 126.3(2) . . . . ?
 N2 C8 C9 C14 -55.4(2) . . . . ?
loop_
  _exptl_crystal_face_index_h
  _exptl_crystal_face_index_k
  _exptl_crystal_face_index_l
  _exptl_crystal_face_perp_dist
  _exptl_oxdiff_crystal_face_indexfrac_h
  _exptl_oxdiff_crystal_face_indexfrac_k
  _exptl_oxdiff_crystal_face_indexfrac_l
  _exptl_oxdiff_crystal_face_x
  _exptl_oxdiff_crystal_face_y
  _exptl_oxdiff_crystal_face_z
-12 -1 3 0.0444 -12.0139 -1.0157 2.9796 0.0486 -0.0279 0.9806
 12 2 -2 0.0807 12.0134 2.0160 -1.9799 -0.0775 0.1016 -0.9452
-2 -14 -8 0.0485 -1.9993 -14.0090 -8.0029 0.6472 -0.7760 -
0.2347
 5 14 8 0.1131 5.0023 14.0124 8.0074 -0.6072 0.8111 -0.0022
 1 3 -14 0.1054 1.0107 3.0087 -13.9890 -0.8368 -0.5590 -0.2634
11
-3 -3 13 0.0463 -3.0120 -3.0106 12.9865 0.7652 0.4890 0.4043
-12 1 -4 0.0506 -12.0089 0.9884 -4.0155 -0.4134 -0.2997 
0.8975
 12 0 0 0.0604 12.0118 0.0138 0.0182 0.1600 0.1405 -0.9476
-10 -10 -10 0.0521 -10.0051 -10.0146 -10.0125 0.1556 -0.8542 
0.4360
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APPENDIX C - Compound 222
data_ijsf1201
_audit_creation_date              2012-04-24
_audit_creation_method
;
  Olex2 1.1
  (compiled 2011.11.01 svn.r2039, GUI svn.r3906)
;
_publ_contact_author_address      ?
_publ_contact_author_email        ?
_publ_contact_author_name         ''
_publ_contact_author_phone        ?
_chemical_name_common             ?
_chemical_name_systematic
;
 ? 
;
_chemical_formula_moiety          'C21 H19 F3 N2 O3'
_chemical_formula_sum             'C21 H19 F3 N2 O3'
_chemical_formula_weight          404.38
_chemical_absolute_configuration  unk
_chemical_melting_point           ?
_chemical_oxdiff_formula          'C21 H19 F3 N2 O3'
_chemical_oxdiff_usercomment      'Toms TJW/5/143/450/1'
loop_
  _atom_type_symbol
  _atom_type_description
  _atom_type_scat_dispersion_real
  _atom_type_scat_dispersion_imag
  _atom_type_scat_source
 'C' 'C' 0.0033 0.0016 'International Tables Vol C Tables 
4.2.6.8 and 6.1.1.4'
 'H' 'H' 0.0000 0.0000 'International Tables Vol C Tables 
4.2.6.8 and 6.1.1.4'
 'N' 'N' 0.0061 0.0033 'International Tables Vol C Tables 
4.2.6.8 and 6.1.1.4'
 'O' 'O' 0.0106 0.0060 'International Tables Vol C Tables 
4.2.6.8 and 6.1.1.4'
 'F' 'F' 0.0171 0.0103 'International Tables Vol C Tables 
4.2.6.8 and 6.1.1.4'
_space_group_crystal_system       'monoclinic'
_space_group_IT_number            4
_space_group_name_H-M_alt         'P 1 21 1'
_space_group_name_Hall            'P 2yb'
loop_
  _space_group_symop_id
  _space_group_symop_operation_xyz
 1 'x, y, z'
 2 '-x, y+1/2, -z'
_cell_length_a                    8.7492(3)
_cell_length_b                    9.0043(3)
_cell_length_c                    24.1842(7)
_cell_angle_alpha                 90.00
_cell_angle_beta                  98.900(3)
1
_cell_angle_gamma                 90.00
_cell_volume                      1882.30(10)
_cell_formula_units_Z             4
_cell_measurement_reflns_used     5381
_cell_measurement_temperature     110.00(10)
_cell_measurement_theta_max       27.8109
_cell_measurement_theta_min       3.1089
_exptl_absorpt_coefficient_mu     0.116
_exptl_absorpt_correction_T_max   0.996
_exptl_absorpt_correction_T_min   0.963
_exptl_absorpt_correction_type    analytical
_exptl_absorpt_process_details
;
CrysAlisPro, Agilent Technologies,
Version 1.171.35.21 (release 20-01-2012 CrysAlis171 .NET)
(compiled Jan 23 2012,18:06:46)
Analytical numeric absorption correction using a multifaceted 
crystal
model based on expressions derived by R.C. 
Clark & J.S. Reid.
(Clark, R. C. & Reid, J. S. (1995). Acta Cryst. A51, 887-897)
;
_exptl_crystal_colour             'clear colourless'
_exptl_crystal_colour_lustre      clear
_exptl_crystal_colour_modifier    .
_exptl_crystal_colour_primary     colourless
_exptl_crystal_density_diffrn     1.427
_exptl_crystal_density_meas       ?
_exptl_crystal_density_method     'not measured'
_exptl_crystal_description        needle
_exptl_crystal_F_000              840
_exptl_crystal_size_max           0.3796
_exptl_crystal_size_mid           0.1807
_exptl_crystal_size_min           0.0328
_exptl_special_details
;
 ? 
;
_diffrn_reflns_av_R_equivalents   0.0306
_diffrn_reflns_av_unetI/netI      0.0489
_diffrn_reflns_limit_h_max        11
_diffrn_reflns_limit_h_min        -11
_diffrn_reflns_limit_k_max        11
_diffrn_reflns_limit_k_min        -11
_diffrn_reflns_limit_l_max        31
_diffrn_reflns_limit_l_min        -31
_diffrn_reflns_number             14377
_diffrn_reflns_theta_full         27.87
_diffrn_reflns_theta_max          27.87
_diffrn_reflns_theta_min          3.12
_diffrn_ambient_temperature       110.00(10)
_diffrn_detector_area_resol_mean  16.1450
_diffrn_measured_fraction_theta_full 0.996
_diffrn_measured_fraction_theta_max 0.996
_diffrn_measurement_details
;
#__ type_ start__ end____ width___ exp.time_
2
  1 omega  -97.00  -61.00   1.0000   70.0000
omega____ theta____ kappa____ phi______ frames
    -      -21.7365 -178.0000   60.0000 36
#__ type_ start__ end____ width___ exp.time_
  2 omega  -78.00  -51.00   1.0000   70.0000
omega____ theta____ kappa____ phi______ frames
    -      -21.7365 -178.0000 -120.0000 27
#__ type_ start__ end____ width___ exp.time_
  3 omega  -30.00   96.00   1.0000   70.0000
omega____ theta____ kappa____ phi______ frames
    -       22.8303    0.0000 -150.0000 126
#__ type_ start__ end____ width___ exp.time_
  4 omega   35.00   77.00   1.0000   70.0000
omega____ theta____ kappa____ phi______ frames
    -       22.8303 -141.0000  -29.0000 42
#__ type_ start__ end____ width___ exp.time_
  5 omega  -43.00    9.00   1.0000   70.0000
omega____ theta____ kappa____ phi______ frames
    -      -21.7365   57.0000   90.0000 52
#__ type_ start__ end____ width___ exp.time_
  6 omega  -92.00    8.00   1.0000   70.0000
omega____ theta____ kappa____ phi______ frames
    -      -21.7365  -77.0000  -30.0000 100
;
_diffrn_measurement_device_type   'SuperNova, Single source at 
offset), Eos'
_diffrn_measurement_method        '\w scans'
_diffrn_orient_matrix_UB_11       -0.0097380000
_diffrn_orient_matrix_UB_12       0.0026536000
_diffrn_orient_matrix_UB_13       -0.0296944000
_diffrn_orient_matrix_UB_21       -0.0294622000
_diffrn_orient_matrix_UB_22       0.0732094000
_diffrn_orient_matrix_UB_23       0.0005393000
_diffrn_orient_matrix_UB_31       0.0759031000
_diffrn_orient_matrix_UB_32       0.0287956000
_diffrn_orient_matrix_UB_33       0.0013631000
_diffrn_radiation_monochromator   mirror
_diffrn_radiation_type            'Mo K\a'
_diffrn_radiation_wavelength      0.7107
_diffrn_source                    'SuperNova (Mo) X-ray 
Source'
_diffrn_standards_decay_%         ?
_diffrn_standards_interval_count  ?
_diffrn_standards_interval_time   ?
_diffrn_standards_number          ?
_reflns_number_gt                 7201
_reflns_number_total              8188
_reflns_odcompleteness_completeness 99.65
_reflns_odcompleteness_iscentric  1
_reflns_odcompleteness_theta      27.82
_reflns_threshold_expression      >2sigma(I)
_computing_cell_refinement
3
;
CrysAlisPro, Agilent Technologies,
Version 1.171.35.21 (release 20-01-2012 CrysAlis171 .NET)
(compiled Jan 23 2012,18:06:46)
;
_computing_data_collection
;
CrysAlisPro, Agilent Technologies,
Version 1.171.35.21 (release 20-01-2012 CrysAlis171 .NET)
(compiled Jan 23 2012,18:06:46)
;
_computing_data_reduction
;
CrysAlisPro, Agilent Technologies,
Version 1.171.35.21 (release 20-01-2012 CrysAlis171 .NET)
(compiled Jan 23 2012,18:06:46)
;
_computing_molecular_graphics
;
O. V. Dolomanov, L. J. Bourhis, R. J. Gildea, J. A. K. Howard 
and H. Puschmann,
OLEX2: a complete structure solution, refinement and analysis 
program.
J. Appl. Cryst. (2009). 42, 339-341.
;
_computing_publication_material
;
O. V. Dolomanov, L. J. Bourhis, R. J. Gildea, J. A. K. Howard 
and H. Puschmann,
OLEX2: a complete structure solution, refinement and analysis 
program.
J. Appl. Cryst. (2009). 42, 339-341.
;
_computing_structure_refinement
;
XL, G.M. Sheldrick, Acta Cryst.
(2008). A64, 112-122
;
_computing_structure_solution
;
XS, G.M. Sheldrick, Acta Cryst.
(2008). A64, 112-122
;
_refine_diff_density_max          0.262
_refine_diff_density_min          -0.294
_refine_diff_density_rms          0.049
_refine_ls_abs_structure_details  'Flack H D (1983), Acta 
Cryst. A39, 876-881'
_refine_ls_abs_structure_Flack    -0.4(6)
_refine_ls_extinction_coef        ?
_refine_ls_extinction_method      none
_refine_ls_goodness_of_fit_ref    1.064
_refine_ls_hydrogen_treatment     mixed
_refine_ls_matrix_type            full
_refine_ls_number_parameters      535
_refine_ls_number_reflns          8188
_refine_ls_number_restraints      1
4
_refine_ls_R_factor_all           0.0572
_refine_ls_R_factor_gt            0.0480
_refine_ls_restrained_S_all       1.063
_refine_ls_shift/su_max           0.000
_refine_ls_shift/su_mean          0.000
_refine_ls_structure_factor_coef  Fsqd
_refine_ls_weighting_details
'calc w=1/[\s^2^(Fo^2^)+(0.0442P)^2^+0.5706P] where P=(Fo^2^+
2Fc^2^)/3'
_refine_ls_weighting_scheme       calc
_refine_ls_wR_factor_gt           0.1077
_refine_ls_wR_factor_ref          0.1135
_refine_special_details
;
 Refinement of F^2^ against ALL reflections.  The weighted R-
factor wR and 
 goodness of fit S are based on F^2^, conventional R-factors R 
are based 
 on F, with F set to zero for negative F^2^. The threshold 
expression of 
 F^2^ > 2sigma(F^2^) is used only for calculating R-factors
(gt) etc. and is 
 not relevant to the choice of reflections for refinement.  R-
factors based 
 on F^2^ are statistically about twice as large as those based 
on F, and R-
 factors based on ALL data will be even larger. 
;
_atom_sites_solution_hydrogens    geom
_atom_sites_solution_primary      direct
_atom_sites_solution_secondary    difmap
loop_
  _atom_site_label
  _atom_site_type_symbol
  _atom_site_fract_x
  _atom_site_fract_y
  _atom_site_fract_z
  _atom_site_U_iso_or_equiv
  _atom_site_adp_type
  _atom_site_occupancy
  _atom_site_symmetry_multiplicity
  _atom_site_calc_flag
  _atom_site_refinement_flags
  _atom_site_disorder_assembly
  _atom_site_disorder_group
 C1 C 0.1628(2) 0.3711(3) 0.53527(10) 0.0220(5) Uani 1 1 d . . 
.
 C2 C 0.0627(2) 0.2876(3) 0.48914(9) 0.0201(5) Uani 1 1 d . . 
.
 H2 H -0.0385 0.2700 0.5006 0.024 Uiso 1 1 calc R . .
 C3 C 0.1362(3) 0.1356(3) 0.47892(9) 0.0196(5) Uani 1 1 d . . 
.
 H3A H 0.1630 0.0850 0.5145 0.023 Uiso 1 1 calc R . .
 H3B H 0.0602 0.0753 0.4555 0.023 Uiso 1 1 calc R . .
 C4 C 0.2785(2) 0.1482(3) 0.45141(9) 0.0184(5) Uani 1 1 d . . 
.
 C5 C 0.2724(2) 0.1561(3) 0.39190(9) 0.0188(5) Uani 1 1 d . . 
5
.
 C6 C 0.1541(3) 0.1410(3) 0.34624(9) 0.0226(5) Uani 1 1 d . . 
.
 H6 H 0.0526 0.1247 0.3518 0.027 Uiso 1 1 calc R . .
 C7 C 0.1908(3) 0.1508(3) 0.29254(10) 0.0259(5) Uani 1 1 d . . 
.
 H7 H 0.1132 0.1394 0.2619 0.031 Uiso 1 1 calc R . .
 C8 C 0.3425(3) 0.1774(3) 0.28374(10) 0.0271(6) Uani 1 1 d . . 
.
 H8 H 0.3633 0.1850 0.2473 0.032 Uiso 1 1 calc R . .
 C9 C 0.4620(3) 0.1926(3) 0.32778(9) 0.0247(5) Uani 1 1 d . . 
.
 H9 H 0.5630 0.2097 0.3218 0.030 Uiso 1 1 calc R . .
 C10 C 0.4251(2) 0.1814(3) 0.38186(9) 0.0191(5) Uani 1 1 d . . 
.
 C11 C 0.4308(2) 0.1676(3) 0.47499(9) 0.0173(4) Uani 1 1 d . . 
.
 C12 C 0.5091(2) 0.1706(3) 0.53346(9) 0.0179(4) Uani 1 1 d . . 
.
 C13 C 0.6321(3) 0.2683(3) 0.54958(9) 0.0229(5) Uani 1 1 d . . 
.
 H13 H 0.6633 0.3318 0.5231 0.028 Uiso 1 1 calc R . .
 C14 C 0.7079(3) 0.2723(3) 0.60389(10) 0.0239(5) Uani 1 1 d . 
. .
 H14 H 0.7889 0.3386 0.6139 0.029 Uiso 1 1 calc R . .
 C15 C 0.6635(3) 0.1775(3) 0.64369(9) 0.0222(5) Uani 1 1 d . . 
.
 C16 C 0.5426(3) 0.0775(3) 0.62865(9) 0.0241(5) Uani 1 1 d . . 
.
 H16 H 0.5127 0.0138 0.6553 0.029 Uiso 1 1 calc R . .
 C17 C 0.4673(3) 0.0733(3) 0.57391(9) 0.0226(5) Uani 1 1 d . . 
.
 H17 H 0.3880 0.0052 0.5638 0.027 Uiso 1 1 calc R . .
 C18 C 0.2592(3) 0.3801(4) 0.63124(11) 0.0378(7) Uani 1 1 d . 
. .
 H18A H 0.3648 0.3762 0.6249 0.057 Uiso 1 1 calc R . .
 H18B H 0.2498 0.3291 0.6654 0.057 Uiso 1 1 calc R . .
 H18C H 0.2284 0.4818 0.6340 0.057 Uiso 1 1 calc R . .
 C19 C -0.0834(3) 0.3729(3) 0.40043(10) 0.0226(5) Uani 1 1 d . 
. .
 C20 C -0.0845(3) 0.4746(3) 0.35091(10) 0.0310(6) Uani 1 1 d . 
. .
 H20A H -0.0148 0.5559 0.3611 0.047 Uiso 1 1 calc R . .
 H20B H -0.1872 0.5122 0.3395 0.047 Uiso 1 1 calc R . .
 H20C H -0.0521 0.4205 0.3205 0.047 Uiso 1 1 calc R . .
 C21 C 0.7388(3) 0.1876(3) 0.70357(10) 0.0283(6) Uani 1 1 d . 
. .
 F1 F 0.88076(17) 0.2472(2) 0.70945(6) 0.0412(4) Uani 1 1 d . 
. .
 F2 F 0.65734(19) 0.2721(2) 0.73441(6) 0.0450(5) Uani 1 1 d . 
. .
 F3 F 0.7543(2) 0.0553(2) 0.72878(7) 0.0469(5) Uani 1 1 d . . 
.
 N1 N 0.0412(2) 0.3807(2) 0.44009(8) 0.0200(4) Uani 1 1 d . . 
.
 H1 H 0.1119 0.4445 0.4361 0.024 Uiso 1 1 calc R . .
 N2 N 0.5184(2) 0.1904(2) 0.43276(7) 0.0186(4) Uani 1 1 d . . 
6
.
 H2A H 0.620(3) 0.198(3) 0.4372(10) 0.019(6) Uiso 1 1 d . . .
 O1 O 0.1605(2) 0.3092(2) 0.58499(7) 0.0308(4) Uani 1 1 d . . 
.
 O2 O 0.23705(19) 0.4804(2) 0.52751(7) 0.0303(4) Uani 1 1 d . 
. .
 O3 O -0.19022(18) 0.2872(3) 0.40432(7) 0.0339(5) Uani 1 1 d . 
. .
 C22 C 0.1505(2) 0.7248(3) 0.02831(9) 0.0197(5) Uani 1 1 d . . 
.
 C23 C 0.0497(2) 0.6447(3) -0.01873(9) 0.0203(5) Uani 1 1 d . 
. .
 H23 H -0.0530 0.6311 -0.0081 0.024 Uiso 1 1 calc R . .
 C24 C 0.1167(2) 0.4893(3) -0.02893(9) 0.0205(5) Uani 1 1 d . 
. .
 H24A H 0.1369 0.4367 0.0064 0.025 Uiso 1 1 calc R . .
 H24B H 0.0396 0.4334 -0.0536 0.025 Uiso 1 1 calc R . .
 C25 C 0.2637(2) 0.4947(3) -0.05416(9) 0.0173(4) Uani 1 1 d . 
. .
 C26 C 0.2669(2) 0.4937(3) -0.11332(9) 0.0183(4) Uani 1 1 d . 
. .
 C27 C 0.1535(3) 0.4778(3) -0.16087(9) 0.0214(5) Uani 1 1 d . 
. .
 H27 H 0.0493 0.4720 -0.1573 0.026 Uiso 1 1 calc R . .
 C28 C 0.1994(3) 0.4709(3) -0.21307(10) 0.0243(5) Uani 1 1 d . 
. .
 H28 H 0.1252 0.4587 -0.2447 0.029 Uiso 1 1 calc R . .
 C29 C 0.3566(3) 0.4819(3) -0.21907(10) 0.0244(5) Uani 1 1 d . 
. .
 H29 H 0.3844 0.4771 -0.2546 0.029 Uiso 1 1 calc R . .
 C30 C 0.4699(3) 0.4997(3) -0.17332(9) 0.0214(5) Uani 1 1 d . 
. .
 H30 H 0.5735 0.5079 -0.1774 0.026 Uiso 1 1 calc R . .
 C31 C 0.4238(2) 0.5052(3) -0.12056(9) 0.0180(5) Uani 1 1 d . 
. .
 C32 C 0.4141(2) 0.5068(3) -0.02808(9) 0.0178(5) Uani 1 1 d . 
. .
 C33 C 0.4830(2) 0.5069(3) 0.03150(9) 0.0178(5) Uani 1 1 d . . 
.
 C34 C 0.6000(3) 0.6056(3) 0.05213(10) 0.0236(5) Uani 1 1 d . 
. .
 H34 H 0.6335 0.6750 0.0281 0.028 Uiso 1 1 calc R . .
 C35 C 0.6678(3) 0.6025(3) 0.10798(10) 0.0263(5) Uani 1 1 d . 
. .
 H35 H 0.7457 0.6696 0.1213 0.032 Uiso 1 1 calc R . .
 C36 C 0.6187(3) 0.4987(3) 0.14376(9) 0.0242(5) Uani 1 1 d . . 
.
 C37 C 0.5028(3) 0.3987(3) 0.12434(10) 0.0235(5) Uani 1 1 d . 
. .
 H37 H 0.4704 0.3293 0.1486 0.028 Uiso 1 1 calc R . .
 C38 C 0.4347(3) 0.4024(3) 0.06833(9) 0.0214(5) Uani 1 1 d . . 
.
 H38 H 0.3567 0.3352 0.0552 0.026 Uiso 1 1 calc R . .
 C39 C 0.2413(3) 0.7287(3) 0.12502(10) 0.0336(6) Uani 1 1 d . 
. .
 H39A H 0.2277 0.6775 0.1587 0.050 Uiso 1 1 calc R . .
 H39B H 0.2123 0.8310 0.1278 0.050 Uiso 1 1 calc R . .
7
 H39C H 0.3477 0.7228 0.1199 0.050 Uiso 1 1 calc R . .
 C40 C -0.0848(3) 0.7312(3) -0.10948(10) 0.0228(5) Uani 1 1 d 
. . .
 C41 C -0.0779(3) 0.8393(3) -0.15650(10) 0.0316(6) Uani 1 1 d 
. . .
 H41A H -0.0343 0.9314 -0.1415 0.047 Uiso 1 1 calc R . .
 H41B H -0.1805 0.8565 -0.1761 0.047 Uiso 1 1 calc R . .
 H41C H -0.0146 0.7989 -0.1819 0.047 Uiso 1 1 calc R . .
 C42 C 0.6867(3) 0.4952(3) 0.20451(10) 0.0316(6) Uani 1 1 d . 
. .
 F4 F 0.8198(2) 0.5696(2) 0.21585(7) 0.0550(5) Uani 1 1 d . . 
.
 F5 F 0.5953(2) 0.5546(4) 0.23679(7) 0.0842(9) Uani 1 1 d . . 
.
 F6 F 0.7218(3) 0.3589(2) 0.22285(8) 0.0643(6) Uani 1 1 d . . 
.
 N3 N 0.0344(2) 0.7404(2) -0.06716(8) 0.0213(4) Uani 1 1 d . . 
.
 H3 H 0.1046 0.8063 -0.0691 0.026 Uiso 1 1 calc R . .
 N4 N 0.5103(2) 0.5180(2) -0.06845(8) 0.0180(4) Uani 1 1 d . . 
.
 H4 H 0.608(3) 0.514(3) -0.0604(9) 0.010(6) Uiso 1 1 d . . .
 O4 O 0.1443(2) 0.6603(2) 0.07756(6) 0.0275(4) Uani 1 1 d . . 
.
 O5 O 0.22726(18) 0.8335(2) 0.02171(7) 0.0258(4) Uani 1 1 d . 
. .
 O6 O -0.19056(19) 0.6421(2) -0.10921(7) 0.0305(4) Uani 1 1 d 
. . .
loop_
  _atom_site_aniso_label
  _atom_site_aniso_U_11
  _atom_site_aniso_U_22
  _atom_site_aniso_U_33
  _atom_site_aniso_U_23
  _atom_site_aniso_U_13
  _atom_site_aniso_U_12
 C1 0.0175(10) 0.0241(13) 0.0251(12) -0.0022(10) 0.0052(9) 
0.0029(10)
 C2 0.0162(10) 0.0244(13) 0.0207(10) -0.0005(10) 0.0061(8) -
0.0020(9)
 C3 0.0192(10) 0.0199(13) 0.0200(10) 0.0009(9) 0.0040(8) -
0.0033(9)
 C4 0.0197(11) 0.0163(12) 0.0195(10) -0.0002(9) 0.0040(8) -
0.0012(9)
 C5 0.0207(11) 0.0151(12) 0.0209(11) -0.0015(9) 0.0042(8) 
0.0011(9)
 C6 0.0217(11) 0.0230(13) 0.0225(11) -0.0021(10) 0.0020(9) -
0.0001(10)
 C7 0.0273(12) 0.0290(15) 0.0194(11) -0.0030(10) -0.0025(9) 
0.0027(11)
 C8 0.0346(13) 0.0299(15) 0.0183(11) -0.0015(10) 0.0092(10) 
0.0035(11)
 C9 0.0237(11) 0.0284(14) 0.0232(11) -0.0011(10) 0.0079(9) 
0.0054(10)
 C10 0.0208(11) 0.0164(12) 0.0203(11) -0.0003(9) 0.0039(9) 
0.0028(9)
8
 C11 0.0193(10) 0.0136(11) 0.0201(10) 0.0006(9) 0.0065(8) 
0.0003(9)
 C12 0.0173(10) 0.0164(12) 0.0199(10) -0.0005(9) 0.0031(8) 
0.0020(9)
 C13 0.0249(11) 0.0199(13) 0.0238(12) 0.0055(10) 0.0033(9) -
0.0020(10)
 C14 0.0252(11) 0.0193(13) 0.0252(12) -0.0010(10) -0.0029(9) -
0.0048(10)
 C15 0.0266(12) 0.0190(12) 0.0201(11) 0.0000(10) 0.0011(9) 
0.0040(10)
 C16 0.0291(12) 0.0224(14) 0.0214(11) 0.0036(10) 0.0061(9) 
0.0000(10)
 C17 0.0243(11) 0.0201(13) 0.0235(12) 0.0012(10) 0.0039(9) -
0.0034(10)
 C18 0.0466(16) 0.0383(18) 0.0250(13) -0.0106(12) -0.0055(11) 
0.0026(14)
 C19 0.0193(11) 0.0270(14) 0.0230(11) -0.0027(10) 0.0080(9) 
0.0028(10)
 C20 0.0329(13) 0.0351(16) 0.0256(12) 0.0040(12) 0.0061(10) 
0.0035(12)
 C21 0.0326(13) 0.0266(15) 0.0239(12) 0.0013(11) -0.0011(10) 
0.0063(12)
 F1 0.0352(8) 0.0549(12) 0.0295(8) -0.0036(8) -0.0072(6) -
0.0062(9)
 F2 0.0519(10) 0.0575(13) 0.0254(8) -0.0109(8) 0.0055(7) 
0.0143(9)
 F3 0.0698(12) 0.0348(11) 0.0296(8) 0.0098(8) -0.0133(8) -
0.0008(9)
 N1 0.0165(9) 0.0215(11) 0.0226(10) 0.0016(8) 0.0049(7) -
0.0024(8)
 N2 0.0162(9) 0.0227(11) 0.0172(9) 0.0016(8) 0.0036(7) 0.0009
(8)
 O1 0.0363(10) 0.0349(12) 0.0200(8) -0.0031(8) 0.0011(7) -
0.0024(8)
 O2 0.0285(9) 0.0280(11) 0.0344(9) -0.0061(8) 0.0047(7) -
0.0075(8)
 O3 0.0189(8) 0.0506(13) 0.0317(9) 0.0076(9) 0.0028(7) -0.0080
(8)
 C22 0.0175(10) 0.0180(12) 0.0243(11) -0.0033(9) 0.0054(9) 
0.0030(9)
 C23 0.0179(10) 0.0224(13) 0.0216(11) -0.0026(10) 0.0063(9) -
0.0004(9)
 C24 0.0195(10) 0.0210(13) 0.0218(11) -0.0037(10) 0.0062(8) -
0.0059(10)
 C25 0.0201(10) 0.0126(11) 0.0197(10) -0.0019(9) 0.0049(8) -
0.0008(9)
 C26 0.0194(10) 0.0152(12) 0.0206(11) -0.0019(9) 0.0044(8) 
0.0018(9)
 C27 0.0191(11) 0.0203(13) 0.0245(11) -0.0021(10) 0.0023(9) -
0.0006(10)
 C28 0.0259(12) 0.0271(14) 0.0183(11) -0.0037(10) -0.0017(9) 
0.0019(11)
 C29 0.0282(12) 0.0287(14) 0.0167(11) -0.0009(10) 0.0045(9) 
0.0027(11)
 C30 0.0208(11) 0.0231(13) 0.0213(11) 0.0005(10) 0.0067(8) 
0.0007(10)
 C31 0.0182(10) 0.0165(12) 0.0193(10) 0.0003(9) 0.0032(8) 
9
0.0011(9)
 C32 0.0187(10) 0.0151(12) 0.0207(11) 0.0013(9) 0.0063(8) 
0.0012(9)
 C33 0.0206(10) 0.0149(12) 0.0177(10) -0.0006(9) 0.0024(8) 
0.0045(9)
 C34 0.0268(12) 0.0183(13) 0.0253(12) 0.0048(10) 0.0023(9) -
0.0015(10)
 C35 0.0275(12) 0.0228(14) 0.0266(12) 0.0000(10) -0.0024(10) -
0.0034(11)
 C36 0.0295(12) 0.0237(14) 0.0185(11) -0.0004(10) 0.0005(9) 
0.0070(11)
 C37 0.0298(12) 0.0209(13) 0.0209(11) 0.0026(10) 0.0069(9) 
0.0001(10)
 C38 0.0275(12) 0.0178(13) 0.0197(11) -0.0009(9) 0.0059(9) -
0.0006(10)
 C39 0.0420(15) 0.0351(17) 0.0210(12) -0.0053(11) -0.0037(10) 
-0.0008(13)
 C40 0.0201(11) 0.0235(14) 0.0252(11) -0.0061(10) 0.0053(9) 
0.0052(10)
 C41 0.0363(14) 0.0306(16) 0.0264(13) -0.0014(11) 0.0005(10) 
0.0002(12)
 C42 0.0369(14) 0.0352(17) 0.0214(12) 0.0015(12) 0.0000(10) 
0.0039(13)
 F4 0.0626(12) 0.0658(15) 0.0300(9) 0.0053(9) -0.0138(8) -
0.0197(11)
 F5 0.0674(13) 0.162(3) 0.0225(9) -0.0155(12) 0.0045(8) 0.0471
(15)
 F6 0.1032(16) 0.0395(12) 0.0381(10) 0.0153(9) -0.0268(10) -
0.0047(12)
 N3 0.0170(9) 0.0240(12) 0.0232(9) -0.0006(8) 0.0037(7) -
0.0028(8)
 N4 0.0143(9) 0.0206(11) 0.0193(9) 0.0003(8) 0.0033(7) -0.0003
(8)
 O4 0.0327(9) 0.0284(10) 0.0208(8) -0.0023(7) 0.0021(7) -
0.0031(8)
 O5 0.0217(8) 0.0274(10) 0.0285(9) -0.0052(7) 0.0044(7) -
0.0045(7)
 O6 0.0200(8) 0.0336(11) 0.0370(10) -0.0028(9) 0.0019(7) -
0.0033(8)
_geom_special_details
;
 All esds (except the esd in the dihedral angle between two 
l.s. planes) 
 are estimated using the full covariance matrix.  The cell 
esds are taken 
 into account individually in the estimation of esds in 
distances, angles 
 and torsion angles; correlations between esds in cell 
parameters are only 
 used when they are defined by crystal symmetry.  An 
approximate (isotropic) 
 treatment of cell esds is used for estimating esds involving 
l.s. planes. 
;
loop_
  _geom_bond_atom_site_label_1
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  _geom_bond_atom_site_label_2
  _geom_bond_distance
  _geom_bond_site_symmetry_2
  _geom_bond_publ_flag
 C1 C2 1.508(3) . ?
 C1 O1 1.329(3) . ?
 C1 O2 1.210(3) . ?
 C2 H2 0.9800 . ?
 C2 C3 1.548(3) . ?
 C2 N1 1.441(3) . ?
 C3 H3A 0.9700 . ?
 C3 H3B 0.9700 . ?
 C3 C4 1.505(3) . ?
 C4 C5 1.434(3) . ?
 C4 C11 1.377(3) . ?
 C5 C6 1.398(3) . ?
 C5 C10 1.413(3) . ?
 C6 H6 0.9300 . ?
 C6 C7 1.388(3) . ?
 C7 H7 0.9300 . ?
 C7 C8 1.397(3) . ?
 C8 H8 0.9300 . ?
 C8 C9 1.379(3) . ?
 C9 H9 0.9300 . ?
 C9 C10 1.398(3) . ?
 C10 N2 1.370(3) . ?
 C11 C12 1.473(3) . ?
 C11 N2 1.384(2) . ?
 C12 C13 1.397(3) . ?
 C12 C17 1.403(3) . ?
 C13 H13 0.9300 . ?
 C13 C14 1.377(3) . ?
 C14 H14 0.9300 . ?
 C14 C15 1.386(3) . ?
 C15 C16 1.393(3) . ?
 C15 C21 1.498(3) . ?
 C16 H16 0.9300 . ?
 C16 C17 1.385(3) . ?
 C17 H17 0.9300 . ?
 C18 H18A 0.9600 . ?
 C18 H18B 0.9600 . ?
 C18 H18C 0.9600 . ?
 C18 O1 1.451(3) . ?
 C19 C20 1.507(3) . ?
 C19 N1 1.338(3) . ?
 C19 O3 1.226(3) . ?
 C20 H20A 0.9600 . ?
 C20 H20B 0.9600 . ?
 C20 H20C 0.9600 . ?
 C21 F1 1.340(3) . ?
 C21 F2 1.345(3) . ?
 C21 F3 1.335(3) . ?
 N1 H1 0.8600 . ?
 N2 H2A 0.88(2) . ?
 C22 C23 1.511(3) . ?
 C22 O4 1.334(3) . ?
 C22 O5 1.211(3) . ?
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 C23 H23 0.9800 . ?
 C23 C24 1.551(3) . ?
 C23 N3 1.444(3) . ?
 C24 H24A 0.9700 . ?
 C24 H24B 0.9700 . ?
 C24 C25 1.507(3) . ?
 C25 C26 1.436(3) . ?
 C25 C32 1.373(3) . ?
 C26 C27 1.405(3) . ?
 C26 C31 1.414(3) . ?
 C27 H27 0.9300 . ?
 C27 C28 1.384(3) . ?
 C28 H28 0.9300 . ?
 C28 C29 1.409(3) . ?
 C29 H29 0.9300 . ?
 C29 C30 1.376(3) . ?
 C30 H30 0.9300 . ?
 C30 C31 1.397(3) . ?
 C31 N4 1.371(3) . ?
 C32 C33 1.473(3) . ?
 C32 N4 1.388(3) . ?
 C33 C34 1.389(3) . ?
 C33 C38 1.404(3) . ?
 C34 H34 0.9300 . ?
 C34 C35 1.389(3) . ?
 C35 H35 0.9300 . ?
 C35 C36 1.386(3) . ?
 C36 C37 1.383(3) . ?
 C36 C42 1.498(3) . ?
 C37 H37 0.9300 . ?
 C37 C38 1.393(3) . ?
 C38 H38 0.9300 . ?
 C39 H39A 0.9600 . ?
 C39 H39B 0.9600 . ?
 C39 H39C 0.9600 . ?
 C39 O4 1.454(3) . ?
 C40 C41 1.505(4) . ?
 C40 N3 1.346(3) . ?
 C40 O6 1.225(3) . ?
 C41 H41A 0.9600 . ?
 C41 H41B 0.9600 . ?
 C41 H41C 0.9600 . ?
 C42 F4 1.334(3) . ?
 C42 F5 1.315(3) . ?
 C42 F6 1.325(4) . ?
 N3 H3 0.8600 . ?
 N4 H4 0.85(2) . ?
loop_
  _geom_angle_atom_site_label_1
  _geom_angle_atom_site_label_2
  _geom_angle_atom_site_label_3
  _geom_angle
  _geom_angle_site_symmetry_1
  _geom_angle_site_symmetry_3
  _geom_angle_publ_flag
 O1 C1 C2 111.8(2) . . ?
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 O2 C1 C2 123.7(2) . . ?
 O2 C1 O1 124.4(2) . . ?
 C1 C2 H2 108.5 . . ?
 C1 C2 C3 110.54(19) . . ?
 C3 C2 H2 108.5 . . ?
 N1 C2 C1 107.8(2) . . ?
 N1 C2 H2 108.5 . . ?
 N1 C2 C3 112.80(17) . . ?
 C2 C3 H3A 108.9 . . ?
 C2 C3 H3B 108.9 . . ?
 H3A C3 H3B 107.7 . . ?
 C4 C3 C2 113.39(19) . . ?
 C4 C3 H3A 108.9 . . ?
 C4 C3 H3B 108.9 . . ?
 C5 C4 C3 122.9(2) . . ?
 C11 C4 C3 129.8(2) . . ?
 C11 C4 C5 107.03(18) . . ?
 C6 C5 C4 134.1(2) . . ?
 C6 C5 C10 118.95(19) . . ?
 C10 C5 C4 106.93(19) . . ?
 C5 C6 H6 120.6 . . ?
 C7 C6 C5 118.8(2) . . ?
 C7 C6 H6 120.6 . . ?
 C6 C7 H7 119.5 . . ?
 C6 C7 C8 121.1(2) . . ?
 C8 C7 H7 119.5 . . ?
 C7 C8 H8 119.2 . . ?
 C9 C8 C7 121.6(2) . . ?
 C9 C8 H8 119.2 . . ?
 C8 C9 H9 121.4 . . ?
 C8 C9 C10 117.2(2) . . ?
 C10 C9 H9 121.4 . . ?
 C9 C10 C5 122.3(2) . . ?
 N2 C10 C5 107.61(18) . . ?
 N2 C10 C9 130.1(2) . . ?
 C4 C11 C12 132.57(19) . . ?
 C4 C11 N2 108.91(18) . . ?
 N2 C11 C12 118.50(19) . . ?
 C13 C12 C11 120.2(2) . . ?
 C13 C12 C17 118.1(2) . . ?
 C17 C12 C11 121.7(2) . . ?
 C12 C13 H13 119.4 . . ?
 C14 C13 C12 121.3(2) . . ?
 C14 C13 H13 119.4 . . ?
 C13 C14 H14 120.0 . . ?
 C13 C14 C15 120.0(2) . . ?
 C15 C14 H14 120.0 . . ?
 C14 C15 C16 120.0(2) . . ?
 C14 C15 C21 120.3(2) . . ?
 C16 C15 C21 119.6(2) . . ?
 C15 C16 H16 120.1 . . ?
 C17 C16 C15 119.8(2) . . ?
 C17 C16 H16 120.1 . . ?
 C12 C17 H17 119.6 . . ?
 C16 C17 C12 120.8(2) . . ?
 C16 C17 H17 119.6 . . ?
 H18A C18 H18B 109.5 . . ?
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 H18A C18 H18C 109.5 . . ?
 H18B C18 H18C 109.5 . . ?
 O1 C18 H18A 109.5 . . ?
 O1 C18 H18B 109.5 . . ?
 O1 C18 H18C 109.5 . . ?
 N1 C19 C20 116.2(2) . . ?
 O3 C19 C20 122.2(2) . . ?
 O3 C19 N1 121.6(2) . . ?
 C19 C20 H20A 109.5 . . ?
 C19 C20 H20B 109.5 . . ?
 C19 C20 H20C 109.5 . . ?
 H20A C20 H20B 109.5 . . ?
 H20A C20 H20C 109.5 . . ?
 H20B C20 H20C 109.5 . . ?
 F1 C21 C15 112.9(2) . . ?
 F1 C21 F2 106.1(2) . . ?
 F2 C21 C15 112.2(2) . . ?
 F3 C21 C15 112.7(2) . . ?
 F3 C21 F1 106.4(2) . . ?
 F3 C21 F2 106.0(2) . . ?
 C2 N1 H1 118.4 . . ?
 C19 N1 C2 123.2(2) . . ?
 C19 N1 H1 118.4 . . ?
 C10 N2 C11 109.49(18) . . ?
 C10 N2 H2A 124.2(15) . . ?
 C11 N2 H2A 125.8(15) . . ?
 C1 O1 C18 115.0(2) . . ?
 O4 C22 C23 111.4(2) . . ?
 O5 C22 C23 123.9(2) . . ?
 O5 C22 O4 124.7(2) . . ?
 C22 C23 H23 108.3 . . ?
 C22 C23 C24 111.07(19) . . ?
 C24 C23 H23 108.3 . . ?
 N3 C23 C22 107.2(2) . . ?
 N3 C23 H23 108.3 . . ?
 N3 C23 C24 113.53(17) . . ?
 C23 C24 H24A 108.8 . . ?
 C23 C24 H24B 108.8 . . ?
 H24A C24 H24B 107.7 . . ?
 C25 C24 C23 113.74(19) . . ?
 C25 C24 H24A 108.8 . . ?
 C25 C24 H24B 108.8 . . ?
 C26 C25 C24 123.59(19) . . ?
 C32 C25 C24 129.34(19) . . ?
 C32 C25 C26 107.03(17) . . ?
 C27 C26 C25 134.09(19) . . ?
 C27 C26 C31 118.84(19) . . ?
 C31 C26 C25 106.99(19) . . ?
 C26 C27 H27 120.6 . . ?
 C28 C27 C26 118.9(2) . . ?
 C28 C27 H27 120.6 . . ?
 C27 C28 H28 119.5 . . ?
 C27 C28 C29 121.1(2) . . ?
 C29 C28 H28 119.5 . . ?
 C28 C29 H29 119.4 . . ?
 C30 C29 C28 121.2(2) . . ?
 C30 C29 H29 119.4 . . ?
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 C29 C30 H30 121.1 . . ?
 C29 C30 C31 117.7(2) . . ?
 C31 C30 H30 121.1 . . ?
 C30 C31 C26 122.2(2) . . ?
 N4 C31 C26 107.50(18) . . ?
 N4 C31 C30 130.3(2) . . ?
 C25 C32 C33 131.84(19) . . ?
 C25 C32 N4 108.97(19) . . ?
 N4 C32 C33 119.17(19) . . ?
 C34 C33 C32 121.2(2) . . ?
 C34 C33 C38 118.6(2) . . ?
 C38 C33 C32 120.2(2) . . ?
 C33 C34 H34 119.5 . . ?
 C35 C34 C33 121.1(2) . . ?
 C35 C34 H34 119.5 . . ?
 C34 C35 H35 120.2 . . ?
 C36 C35 C34 119.6(2) . . ?
 C36 C35 H35 120.2 . . ?
 C35 C36 C42 120.8(2) . . ?
 C37 C36 C35 120.6(2) . . ?
 C37 C36 C42 118.6(2) . . ?
 C36 C37 H37 120.2 . . ?
 C36 C37 C38 119.7(2) . . ?
 C38 C37 H37 120.2 . . ?
 C33 C38 H38 119.8 . . ?
 C37 C38 C33 120.5(2) . . ?
 C37 C38 H38 119.8 . . ?
 H39A C39 H39B 109.5 . . ?
 H39A C39 H39C 109.5 . . ?
 H39B C39 H39C 109.5 . . ?
 O4 C39 H39A 109.5 . . ?
 O4 C39 H39B 109.5 . . ?
 O4 C39 H39C 109.5 . . ?
 N3 C40 C41 114.7(2) . . ?
 O6 C40 C41 123.1(2) . . ?
 O6 C40 N3 122.2(2) . . ?
 C40 C41 H41A 109.5 . . ?
 C40 C41 H41B 109.5 . . ?
 C40 C41 H41C 109.5 . . ?
 H41A C41 H41B 109.5 . . ?
 H41A C41 H41C 109.5 . . ?
 H41B C41 H41C 109.5 . . ?
 F4 C42 C36 113.1(2) . . ?
 F5 C42 C36 112.8(2) . . ?
 F5 C42 F4 105.4(3) . . ?
 F5 C42 F6 108.0(3) . . ?
 F6 C42 C36 112.6(2) . . ?
 F6 C42 F4 104.3(2) . . ?
 C23 N3 H3 118.5 . . ?
 C40 N3 C23 122.9(2) . . ?
 C40 N3 H3 118.5 . . ?
 C31 N4 C32 109.40(18) . . ?
 C31 N4 H4 126.9(15) . . ?
 C32 N4 H4 122.4(15) . . ?
 C22 O4 C39 114.9(2) . . ?
loop_
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  _geom_torsion_atom_site_label_1
  _geom_torsion_atom_site_label_2
  _geom_torsion_atom_site_label_3
  _geom_torsion_atom_site_label_4
  _geom_torsion
  _geom_torsion_site_symmetry_1
  _geom_torsion_site_symmetry_2
  _geom_torsion_site_symmetry_3
  _geom_torsion_site_symmetry_4
  _geom_torsion_publ_flag
 C1 C2 C3 C4 -71.3(2) . . . . ?
 C1 C2 N1 C19 -152.2(2) . . . . ?
 C2 C1 O1 C18 177.6(2) . . . . ?
 C2 C3 C4 C5 -86.2(3) . . . . ?
 C2 C3 C4 C11 87.3(3) . . . . ?
 C3 C2 N1 C19 85.5(2) . . . . ?
 C3 C4 C5 C6 -7.3(4) . . . . ?
 C3 C4 C5 C10 174.5(2) . . . . ?
 C3 C4 C11 C12 5.8(5) . . . . ?
 C3 C4 C11 N2 -173.0(2) . . . . ?
 C4 C5 C6 C7 -177.8(3) . . . . ?
 C4 C5 C10 C9 178.9(2) . . . . ?
 C4 C5 C10 N2 -0.8(3) . . . . ?
 C4 C11 C12 C13 -143.1(3) . . . . ?
 C4 C11 C12 C17 39.2(4) . . . . ?
 C4 C11 N2 C10 -1.9(3) . . . . ?
 C5 C4 C11 C12 -179.9(2) . . . . ?
 C5 C4 C11 N2 1.3(3) . . . . ?
 C5 C6 C7 C8 -0.9(4) . . . . ?
 C5 C10 N2 C11 1.6(3) . . . . ?
 C6 C5 C10 C9 0.3(4) . . . . ?
 C6 C5 C10 N2 -179.4(2) . . . . ?
 C6 C7 C8 C9 1.0(4) . . . . ?
 C7 C8 C9 C10 -0.4(4) . . . . ?
 C8 C9 C10 C5 -0.3(4) . . . . ?
 C8 C9 C10 N2 179.4(3) . . . . ?
 C9 C10 N2 C11 -178.0(3) . . . . ?
 C10 C5 C6 C7 0.3(4) . . . . ?
 C11 C4 C5 C6 178.0(3) . . . . ?
 C11 C4 C5 C10 -0.3(3) . . . . ?
 C11 C12 C13 C14 -179.5(2) . . . . ?
 C11 C12 C17 C16 179.8(2) . . . . ?
 C12 C11 N2 C10 179.2(2) . . . . ?
 C12 C13 C14 C15 0.5(4) . . . . ?
 C13 C12 C17 C16 2.1(3) . . . . ?
 C13 C14 C15 C16 0.4(4) . . . . ?
 C13 C14 C15 C21 -176.3(2) . . . . ?
 C14 C15 C16 C17 0.0(4) . . . . ?
 C14 C15 C21 F1 -24.4(3) . . . . ?
 C14 C15 C21 F2 95.4(3) . . . . ?
 C14 C15 C21 F3 -145.0(2) . . . . ?
 C15 C16 C17 C12 -1.2(4) . . . . ?
 C16 C15 C21 F1 159.0(2) . . . . ?
 C16 C15 C21 F2 -81.2(3) . . . . ?
 C16 C15 C21 F3 38.4(3) . . . . ?
 C17 C12 C13 C14 -1.7(4) . . . . ?
 C20 C19 N1 C2 -177.8(2) . . . . ?
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 C21 C15 C16 C17 176.6(2) . . . . ?
 N1 C2 C3 C4 49.4(3) . . . . ?
 N2 C11 C12 C13 35.6(3) . . . . ?
 N2 C11 C12 C17 -142.1(2) . . . . ?
 O1 C1 C2 C3 -70.4(2) . . . . ?
 O1 C1 C2 N1 165.95(18) . . . . ?
 O2 C1 C2 C3 109.0(3) . . . . ?
 O2 C1 C2 N1 -14.7(3) . . . . ?
 O2 C1 O1 C18 -1.7(3) . . . . ?
 O3 C19 N1 C2 2.0(4) . . . . ?
 C22 C23 C24 C25 -70.1(2) . . . . ?
 C22 C23 N3 C40 -156.4(2) . . . . ?
 C23 C22 O4 C39 178.6(2) . . . . ?
 C23 C24 C25 C26 -90.6(3) . . . . ?
 C23 C24 C25 C32 86.7(3) . . . . ?
 C24 C23 N3 C40 80.6(2) . . . . ?
 C24 C25 C26 C27 -5.3(4) . . . . ?
 C24 C25 C26 C31 177.9(2) . . . . ?
 C24 C25 C32 C33 5.4(4) . . . . ?
 C24 C25 C32 N4 -175.8(2) . . . . ?
 C25 C26 C27 C28 -175.1(3) . . . . ?
 C25 C26 C31 C30 176.6(2) . . . . ?
 C25 C26 C31 N4 -2.0(3) . . . . ?
 C25 C32 C33 C34 -137.6(3) . . . . ?
 C25 C32 C33 C38 44.7(4) . . . . ?
 C25 C32 N4 C31 -3.2(3) . . . . ?
 C26 C25 C32 C33 -177.0(2) . . . . ?
 C26 C25 C32 N4 1.9(3) . . . . ?
 C26 C27 C28 C29 -1.0(4) . . . . ?
 C26 C31 N4 C32 3.2(3) . . . . ?
 C27 C26 C31 C30 -0.7(4) . . . . ?
 C27 C26 C31 N4 -179.4(2) . . . . ?
 C27 C28 C29 C30 0.1(4) . . . . ?
 C28 C29 C30 C31 0.6(4) . . . . ?
 C29 C30 C31 C26 -0.3(4) . . . . ?
 C29 C30 C31 N4 178.1(3) . . . . ?
 C30 C31 N4 C32 -175.3(3) . . . . ?
 C31 C26 C27 C28 1.3(4) . . . . ?
 C32 C25 C26 C27 176.8(3) . . . . ?
 C32 C25 C26 C31 0.1(3) . . . . ?
 C32 C33 C34 C35 -178.1(2) . . . . ?
 C32 C33 C38 C37 177.9(2) . . . . ?
 C33 C32 N4 C31 175.8(2) . . . . ?
 C33 C34 C35 C36 0.4(4) . . . . ?
 C34 C33 C38 C37 0.2(3) . . . . ?
 C34 C35 C36 C37 -0.2(4) . . . . ?
 C34 C35 C36 C42 -178.4(2) . . . . ?
 C35 C36 C37 C38 0.0(4) . . . . ?
 C35 C36 C42 F4 -16.9(4) . . . . ?
 C35 C36 C42 F5 102.7(3) . . . . ?
 C35 C36 C42 F6 -134.8(3) . . . . ?
 C36 C37 C38 C33 0.0(3) . . . . ?
 C37 C36 C42 F4 164.8(2) . . . . ?
 C37 C36 C42 F5 -75.6(3) . . . . ?
 C37 C36 C42 F6 47.0(3) . . . . ?
 C38 C33 C34 C35 -0.4(3) . . . . ?
 C41 C40 N3 C23 -179.0(2) . . . . ?
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 C42 C36 C37 C38 178.2(2) . . . . ?
 N3 C23 C24 C25 50.8(3) . . . . ?
 N4 C32 C33 C34 43.6(3) . . . . ?
 N4 C32 C33 C38 -134.0(2) . . . . ?
 O4 C22 C23 C24 -68.8(2) . . . . ?
 O4 C22 C23 N3 166.62(17) . . . . ?
 O5 C22 C23 C24 110.9(2) . . . . ?
 O5 C22 C23 N3 -13.7(3) . . . . ?
 O5 C22 O4 C39 -1.1(3) . . . . ?
 O6 C40 N3 C23 1.4(3) . . . . ?
loop_
  _exptl_crystal_face_index_h
  _exptl_crystal_face_index_k
  _exptl_crystal_face_index_l
  _exptl_crystal_face_perp_dist
  _exptl_oxdiff_crystal_face_indexfrac_h
  _exptl_oxdiff_crystal_face_indexfrac_k
  _exptl_oxdiff_crystal_face_indexfrac_l
  _exptl_oxdiff_crystal_face_x
  _exptl_oxdiff_crystal_face_y
  _exptl_oxdiff_crystal_face_z
 0 0 -1 0.0164 -0.0000 -0.0000 -0.9999 0.0297 -0.0005 -0.0014
 0 0 1 0.0164 0.0000 0.0000 0.9999 -0.0297 0.0005 0.0014
 1 0 0 0.0867 1.0001 0.0001 -0.0001 -0.0097 -0.0295 0.0759
-1 0 0 0.0867 -1.0001 -0.0001 0.0001 0.0097 0.0295 -0.0759
 0 -1 0 0.1938 0.0000 -1.0000 -0.0001 -0.0027 -0.0732 -0.0288
 0 1 0 0.1858 -0.0000 1.0000 0.0001 0.0027 0.0732 0.0288
 2 -1 0 0.1409 2.0001 -0.9999 -0.0003 -0.0221 -0.1321 0.1230
18
Appendix C - Compound 230
data_ijsf1202
_audit_creation_date              2012-04-13
_audit_creation_method
;
  Olex2 1.1
  (compiled 2011.11.01 svn.r2039, GUI svn.r3906)
;
_publ_contact_author_address      ?
_publ_contact_author_email        ?
_publ_contact_author_name         ''
_publ_contact_author_phone        ?
_chemical_name_common             ?
_chemical_name_systematic
;
 ? 
;
_chemical_formula_moiety          'C20 F N2 O3'
_chemical_formula_sum             'C20 H19 F N2 O3'
_chemical_formula_weight          354.37
_chemical_absolute_configuration  unk
_chemical_melting_point           ?
_chemical_oxdiff_formula          'C20 H19 F1 N2 O3'
_chemical_oxdiff_usercomment      'Tom Williams 
TJW/5/173/465/1'
loop_
  _atom_type_symbol
  _atom_type_description
  _atom_type_scat_dispersion_real
  _atom_type_scat_dispersion_imag
  _atom_type_scat_source
 'C' 'C' 0.0033 0.0016 'International Tables Vol C Tables 
4.2.6.8 and 6.1.1.4'
 'H' 'H' 0.0000 0.0000 'International Tables Vol C Tables 
4.2.6.8 and 6.1.1.4'
 'F' 'F' 0.0171 0.0103 'International Tables Vol C Tables 
4.2.6.8 and 6.1.1.4'
 'N' 'N' 0.0061 0.0033 'International Tables Vol C Tables 
4.2.6.8 and 6.1.1.4'
 'O' 'O' 0.0106 0.0060 'International Tables Vol C Tables 
4.2.6.8 and 6.1.1.4'
_space_group_crystal_system       'trigonal'
_space_group_IT_number            146
_space_group_name_H-M_alt         'R 3'
_space_group_name_Hall            'R 3'
loop_
  _space_group_symop_id
  _space_group_symop_operation_xyz
 1 'x, y, z'
 2 '-y, x-y, z'
 3 '-x+y, -x, z'
 4 'x+2/3, y+1/3, z+1/3'
 5 '-y+2/3, x-y+1/3, z+1/3'
 6 '-x+y+2/3, -x+1/3, z+1/3'
 7 'x+1/3, y+2/3, z+2/3'
1
 8 '-y+1/3, x-y+2/3, z+2/3'
 9 '-x+y+1/3, -x+2/3, z+2/3'
_cell_length_a                    21.0404(11)
_cell_length_b                    21.0404(11)
_cell_length_c                    10.4652(7)
_cell_angle_alpha                 90.00
_cell_angle_beta                  90.00
_cell_angle_gamma                 120.00
_cell_volume                      4012.2(6)
_cell_formula_units_Z             9
_cell_measurement_reflns_used     3569
_cell_measurement_temperature     110.00(10)
_cell_measurement_theta_max       32.0836
_cell_measurement_theta_min       2.9596
_exptl_absorpt_coefficient_mu     0.096
_exptl_absorpt_correction_T_max   0.990
_exptl_absorpt_correction_T_min   0.986
_exptl_absorpt_correction_type    analytical
_exptl_absorpt_process_details
;
CrysAlisPro, Agilent Technologies,
Version 1.171.35.19 (release 27-10-2011 CrysAlis171 .NET)
(compiled Oct 27 2011,15:02:11)
Analytical numeric absorption correction using a multifaceted 
crystal
model based on expressions derived by R.C. 
Clark & J.S. Reid.
(Clark, R. C. & Reid, J. S. (1995). Acta Cryst. A51, 887-897)
;
_exptl_crystal_colour             'clear colourless'
_exptl_crystal_colour_lustre      clear
_exptl_crystal_colour_modifier    .
_exptl_crystal_colour_primary     colourless
_exptl_crystal_density_diffrn     1.320
_exptl_crystal_density_meas       ?
_exptl_crystal_density_method     'not measured'
_exptl_crystal_description        irregular
_exptl_crystal_F_000              1674
_exptl_crystal_size_max           0.2168
_exptl_crystal_size_mid           0.1531
_exptl_crystal_size_min           0.1393
_exptl_special_details
;
 ? 
;
_diffrn_reflns_av_R_equivalents   0.0271
_diffrn_reflns_av_unetI/netI      0.0498
_diffrn_reflns_limit_h_max        31
_diffrn_reflns_limit_h_min        -23
_diffrn_reflns_limit_k_max        23
_diffrn_reflns_limit_k_min        -31
_diffrn_reflns_limit_l_max        15
_diffrn_reflns_limit_l_min        -15
_diffrn_reflns_number             9531
_diffrn_reflns_theta_full         30.01
_diffrn_reflns_theta_max          32.16
2
_diffrn_reflns_theta_min          2.96
_diffrn_ambient_temperature       110.00(10)
_diffrn_detector_area_resol_mean  16.1450
_diffrn_measured_fraction_theta_full 0.999
_diffrn_measured_fraction_theta_max 0.920
_diffrn_measurement_details
;
#__ type_ start__ end____ width___ exp.time_
  1 omega  -69.00   48.00   1.0000   12.8400
omega____ theta____ kappa____ phi______ frames
    -      -25.1672   19.0000  -30.0000 117
#__ type_ start__ end____ width___ exp.time_
  2 omega  -65.00  -35.00   1.0000   12.8400
omega____ theta____ kappa____ phi______ frames
    -      -25.1672 -178.0000  -30.0000 30
#__ type_ start__ end____ width___ exp.time_
  3 omega   31.00   77.00   1.0000   12.8400
omega____ theta____ kappa____ phi______ frames
    -       26.4172 -128.0000   -7.0000 46
#__ type_ start__ end____ width___ exp.time_
  4 omega   39.00  100.00   1.0000   12.8400
omega____ theta____ kappa____ phi______ frames
    -       26.4172 -178.0000  -90.0000 61
#__ type_ start__ end____ width___ exp.time_
  5 omega   31.00   62.00   1.0000   12.8400
omega____ theta____ kappa____ phi______ frames
    -       26.4172   56.0000  117.0000 31
;
_diffrn_measurement_device_type   'SuperNova, Single source at 
offset), Eos'
_diffrn_measurement_method        '\w scans'
_diffrn_orient_matrix_UB_11       -0.0179086000
_diffrn_orient_matrix_UB_12       -0.0357576000
_diffrn_orient_matrix_UB_13       0.0267633000
_diffrn_orient_matrix_UB_21       -0.0296459000
_diffrn_orient_matrix_UB_22       -0.0103234000
_diffrn_orient_matrix_UB_23       -0.0430230000
_diffrn_orient_matrix_UB_31       0.0175359000
_diffrn_orient_matrix_UB_32       -0.0111921000
_diffrn_orient_matrix_UB_33       -0.0453332000
_diffrn_radiation_monochromator   mirror
_diffrn_radiation_type            'Mo K\a'
_diffrn_radiation_wavelength      0.7107
_diffrn_source                    'SuperNova (Mo) X-ray 
Source'
_diffrn_standards_decay_%         ?
_diffrn_standards_interval_count  ?
_diffrn_standards_interval_time   ?
_diffrn_standards_number          ?
_reflns_number_gt                 5157
_reflns_number_total              5613
_reflns_odcompleteness_completeness 99.89
_reflns_odcompleteness_iscentric  1
3
_reflns_odcompleteness_theta      30.01
_reflns_threshold_expression      >2sigma(I)
_computing_cell_refinement
;
CrysAlisPro, Agilent Technologies,
Version 1.171.35.19 (release 27-10-2011 CrysAlis171 .NET)
(compiled Oct 27 2011,15:02:11)
;
_computing_data_collection
;
CrysAlisPro, Agilent Technologies,
Version 1.171.35.19 (release 27-10-2011 CrysAlis171 .NET)
(compiled Oct 27 2011,15:02:11)
;
_computing_data_reduction
;
CrysAlisPro, Agilent Technologies,
Version 1.171.35.19 (release 27-10-2011 CrysAlis171 .NET)
(compiled Oct 27 2011,15:02:11)
;
_computing_molecular_graphics
;
O. V. Dolomanov, L. J. Bourhis, R. J. Gildea, J. A. K. Howard 
and H. Puschmann,
OLEX2: a complete structure solution, refinement and analysis 
program.
J. Appl. Cryst. (2009). 42, 339-341.
;
_computing_publication_material
;
O. V. Dolomanov, L. J. Bourhis, R. J. Gildea, J. A. K. Howard 
and H. Puschmann,
OLEX2: a complete structure solution, refinement and analysis 
program.
J. Appl. Cryst. (2009). 42, 339-341.
;
_computing_structure_refinement
;
XL, G.M. Sheldrick, Acta Cryst.
(2008). A64, 112-122
;
_computing_structure_solution
;
Palatinus, L. & Chapuis, G. (2007).
SUPERFLIP - a computer program for the solution of crystal 
structures
 by charge flipping in arbitrary dimensions.
J. Appl. Cryst. 40, 786-790.
;
_refine_diff_density_max          0.313
_refine_diff_density_min          -0.229
_refine_diff_density_rms          0.045
_refine_ls_extinction_coef        ?
_refine_ls_extinction_method      none
_refine_ls_goodness_of_fit_ref    1.036
_refine_ls_hydrogen_treatment     mixed
_refine_ls_matrix_type            full
4
_refine_ls_number_parameters      245
_refine_ls_number_reflns          5613
_refine_ls_number_restraints      1
_refine_ls_R_factor_all           0.0479
_refine_ls_R_factor_gt            0.0424
_refine_ls_restrained_S_all       1.036
_refine_ls_shift/su_max           0.000
_refine_ls_shift/su_mean          0.000
_refine_ls_structure_factor_coef  Fsqd
_refine_ls_weighting_details
'calc w=1/[\s^2^(Fo^2^)+(0.0412P)^2^+1.5669P] where P=(Fo^2^+
2Fc^2^)/3'
_refine_ls_weighting_scheme       calc
_refine_ls_wR_factor_gt           0.0946
_refine_ls_wR_factor_ref          0.0995
_refine_special_details
;
 Refinement of F^2^ against ALL reflections.  The weighted R-
factor wR and 
 goodness of fit S are based on F^2^, conventional R-factors R 
are based 
 on F, with F set to zero for negative F^2^. The threshold 
expression of 
 F^2^ > 2sigma(F^2^) is used only for calculating R-factors
(gt) etc. and is 
 not relevant to the choice of reflections for refinement.  R-
factors based 
 on F^2^ are statistically about twice as large as those based 
on F, and R-
 factors based on ALL data will be even larger. 
The hydrogens on the nitrogens were found by difference map.
;
_atom_sites_solution_hydrogens    geom
_atom_sites_solution_primary      iterative
_atom_sites_solution_secondary    difmap
loop_
  _atom_site_label
  _atom_site_type_symbol
  _atom_site_fract_x
  _atom_site_fract_y
  _atom_site_fract_z
  _atom_site_U_iso_or_equiv
  _atom_site_adp_type
  _atom_site_occupancy
  _atom_site_symmetry_multiplicity
  _atom_site_calc_flag
  _atom_site_refinement_flags
  _atom_site_disorder_assembly
  _atom_site_disorder_group
 C1 C 0.54326(9) 0.29788(9) 0.51985(15) 0.0237(3) Uani 1 1 d . 
. .
 C2 C 0.52022(9) 0.34868(9) 0.52482(15) 0.0233(3) Uani 1 1 d . 
. .
 H2 H 0.5149 0.3667 0.6028 0.028 Uiso 1 1 calc R . .
 C3 C 0.50511(8) 0.37238(9) 0.41058(14) 0.0196(3) Uani 1 1 d . 
. .
5
 H3 H 0.4891 0.4063 0.4120 0.024 Uiso 1 1 calc R . .
 C4 C 0.51388(8) 0.34549(8) 0.29391(13) 0.0157(3) Uani 1 1 d . 
. .
 C5 C 0.53818(8) 0.29447(8) 0.29351(14) 0.0191(3) Uani 1 1 d . 
. .
 H5 H 0.5446 0.2767 0.2161 0.023 Uiso 1 1 calc R . .
 C6 C 0.55282(9) 0.27007(9) 0.40693(16) 0.0229(3) Uani 1 1 d . 
. .
 H6 H 0.5686 0.2359 0.4067 0.027 Uiso 1 1 calc R . .
 C7 C 0.49634(8) 0.36751(8) 0.17097(13) 0.0151(2) Uani 1 1 d . 
. .
 C8 C 0.51401(8) 0.43501(8) 0.12255(13) 0.0146(2) Uani 1 1 d . 
. .
 C9 C 0.55844(8) 0.50912(7) 0.18290(14) 0.0161(3) Uani 1 1 d . 
. .
 H9A H 0.5455 0.5056 0.2726 0.019 Uiso 1 1 calc R . .
 H9B H 0.5458 0.5429 0.1428 0.019 Uiso 1 1 calc R . .
 C10 C 0.64169(7) 0.54050(8) 0.17169(13) 0.0139(2) Uani 1 1 d 
. . .
 H10 H 0.6561 0.5114 0.2248 0.017 Uiso 1 1 calc R . .
 C11 C 0.66116(8) 0.53645(8) 0.03302(13) 0.0153(3) Uani 1 1 d 
. . .
 C12 C 0.68382(11) 0.46603(11) -0.11590(16) 0.0309(4) Uani 1 1 
d . . .
 H12A H 0.6398 0.4503 -0.1647 0.046 Uiso 1 1 calc R . .
 H12B H 0.6970 0.4285 -0.1176 0.046 Uiso 1 1 calc R . .
 H12C H 0.7228 0.5103 -0.1522 0.046 Uiso 1 1 calc R . .
 C13 C 0.75258(8) 0.65834(8) 0.20747(13) 0.0162(3) Uani 1 1 d 
. . .
 C14 C 0.78405(9) 0.73524(9) 0.25806(17) 0.0258(3) Uani 1 1 d 
. . .
 H14A H 0.8185 0.7433 0.3250 0.039 Uiso 1 1 calc R . .
 H14B H 0.7452 0.7418 0.2912 0.039 Uiso 1 1 calc R . .
 H14C H 0.8086 0.7697 0.1902 0.039 Uiso 1 1 calc R . .
 C15 C 0.48395(8) 0.42278(8) -0.00434(13) 0.0154(3) Uani 1 1 d 
. . .
 C16 C 0.48216(8) 0.46893(8) -0.09995(15) 0.0187(3) Uani 1 1 d 
. . .
 H16 H 0.5061 0.5195 -0.0880 0.022 Uiso 1 1 calc R . .
 C17 C 0.44428(9) 0.43801(9) -0.21186(15) 0.0219(3) Uani 1 1 d 
. . .
 H17 H 0.4429 0.4682 -0.2754 0.026 Uiso 1 1 calc R . .
 C18 C 0.40778(9) 0.36167(9) -0.23109(15) 0.0220(3) Uani 1 1 d 
. . .
 H18 H 0.3818 0.3421 -0.3064 0.026 Uiso 1 1 calc R . .
 C19 C 0.40995(8) 0.31516(9) -0.13967(15) 0.0211(3) Uani 1 1 d 
. . .
 H19 H 0.3867 0.2648 -0.1531 0.025 Uiso 1 1 calc R . .
 C20 C 0.44815(8) 0.34650(8) -0.02694(14) 0.0165(3) Uani 1 1 d 
. . .
 F1 F 0.55774(7) 0.27429(7) 0.63125(9) 0.0371(3) Uani 1 1 d . 
. .
 N1 N 0.67922(7) 0.61582(7) 0.21652(12) 0.0174(2) Uani 1 1 d . 
. .
 H1 H 0.6540(13) 0.6359(13) 0.241(2) 0.039(6) Uiso 1 1 d . . .
 N2 N 0.45744(7) 0.31386(7) 0.08007(12) 0.0179(2) Uani 1 1 d . 
. .
6
 H2A H 0.4351(13) 0.2686(14) 0.093(2) 0.036(6) Uiso 1 1 d . . 
.
 O1 O 0.66376(6) 0.57685(6) -0.05103(10) 0.0198(2) Uani 1 1 d 
. . .
 O2 O 0.67144(6) 0.47957(6) 0.01536(10) 0.0205(2) Uani 1 1 d . 
. .
 O3 O 0.79097(6) 0.63528(6) 0.16024(10) 0.0196(2) Uani 1 1 d . 
. .
loop_
  _atom_site_aniso_label
  _atom_site_aniso_U_11
  _atom_site_aniso_U_22
  _atom_site_aniso_U_33
  _atom_site_aniso_U_23
  _atom_site_aniso_U_13
  _atom_site_aniso_U_12
 C1 0.0238(8) 0.0237(8) 0.0176(6) 0.0079(6) 0.0016(6) 0.0075
(6)
 C2 0.0235(8) 0.0262(8) 0.0161(6) 0.0013(6) 0.0049(6) 0.0095
(6)
 C3 0.0186(7) 0.0193(7) 0.0205(6) 0.0010(5) 0.0040(5) 0.0092
(6)
 C4 0.0140(6) 0.0127(6) 0.0171(6) 0.0018(5) 0.0007(5) 0.0042
(5)
 C5 0.0216(7) 0.0163(6) 0.0174(6) -0.0010(5) -0.0006(5) 0.0079
(6)
 C6 0.0261(8) 0.0184(7) 0.0249(7) 0.0035(6) -0.0013(6) 0.0117
(6)
 C7 0.0134(6) 0.0151(6) 0.0151(6) -0.0008(5) 0.0007(5) 0.0058
(5)
 C8 0.0129(6) 0.0143(6) 0.0159(6) -0.0011(5) 0.0006(5) 0.0063
(5)
 C9 0.0151(6) 0.0130(6) 0.0190(6) -0.0014(5) 0.0014(5) 0.0060
(5)
 C10 0.0138(6) 0.0130(6) 0.0157(6) -0.0014(5) 0.0003(5) 0.0073
(5)
 C11 0.0135(6) 0.0134(6) 0.0167(6) -0.0021(5) 0.0000(5) 0.0050
(5)
 C12 0.0442(11) 0.0346(9) 0.0200(7) -0.0044(7) 0.0067(7) 
0.0243(9)
 C13 0.0149(6) 0.0161(6) 0.0171(6) -0.0005(5) -0.0003(5) 
0.0074(5)
 C14 0.0184(7) 0.0182(7) 0.0362(9) -0.0081(6) -0.0005(6) 
0.0057(6)
 C15 0.0137(6) 0.0156(6) 0.0163(6) -0.0003(5) 0.0012(5) 0.0067
(5)
 C16 0.0166(6) 0.0167(6) 0.0229(7) 0.0021(5) 0.0011(5) 0.0084
(6)
 C17 0.0194(7) 0.0268(8) 0.0200(7) 0.0056(6) 0.0005(6) 0.0119
(6)
 C18 0.0182(7) 0.0280(8) 0.0178(7) -0.0021(6) -0.0029(5) 
0.0101(6)
 C19 0.0192(7) 0.0194(7) 0.0218(7) -0.0029(6) -0.0033(6) 
0.0074(6)
 C20 0.0151(6) 0.0152(6) 0.0183(6) -0.0005(5) -0.0003(5) 
0.0068(5)
7
 F1 0.0498(7) 0.0456(7) 0.0197(5) 0.0118(5) 0.0005(5) 0.0268
(6)
 N1 0.0136(5) 0.0147(6) 0.0236(6) -0.0054(5) 0.0011(5) 0.0068
(5)
 N2 0.0187(6) 0.0121(6) 0.0193(6) -0.0016(5) -0.0032(5) 0.0050
(5)
 O1 0.0206(5) 0.0171(5) 0.0196(5) 0.0029(4) 0.0010(4) 0.0079
(4)
 O2 0.0281(6) 0.0215(5) 0.0168(5) -0.0020(4) 0.0027(4) 0.0160
(5)
 O3 0.0161(5) 0.0202(5) 0.0240(5) -0.0031(4) 0.0006(4) 0.0101
(4)
_geom_special_details
;
 All esds (except the esd in the dihedral angle between two 
l.s. planes) 
 are estimated using the full covariance matrix.  The cell 
esds are taken 
 into account individually in the estimation of esds in 
distances, angles 
 and torsion angles; correlations between esds in cell 
parameters are only 
 used when they are defined by crystal symmetry.  An 
approximate (isotropic) 
 treatment of cell esds is used for estimating esds involving 
l.s. planes. 
;
loop_
  _geom_bond_atom_site_label_1
  _geom_bond_atom_site_label_2
  _geom_bond_distance
  _geom_bond_site_symmetry_2
  _geom_bond_publ_flag
 C1 C2 1.378(3) . ?
 C1 C6 1.377(2) . ?
 C1 F1 1.3600(18) . ?
 C2 H2 0.9300 . ?
 C2 C3 1.392(2) . ?
 C3 H3 0.9300 . ?
 C3 C4 1.396(2) . ?
 C4 C5 1.401(2) . ?
 C4 C7 1.4755(19) . ?
 C5 H5 0.9300 . ?
 C5 C6 1.388(2) . ?
 C6 H6 0.9300 . ?
 C7 C8 1.373(2) . ?
 C7 N2 1.3876(18) . ?
 C8 C9 1.4989(19) . ?
 C8 C15 1.4377(19) . ?
 C9 H9A 0.9700 . ?
 C9 H9B 0.9700 . ?
 C9 C10 1.5366(19) . ?
 C10 H10 0.9800 . ?
 C10 C11 1.5218(19) . ?
 C10 N1 1.4503(18) . ?
 C11 O1 1.2052(18) . ?
8
 C11 O2 1.3312(18) . ?
 C12 H12A 0.9600 . ?
 C12 H12B 0.9600 . ?
 C12 H12C 0.9600 . ?
 C12 O2 1.4526(19) . ?
 C13 C14 1.505(2) . ?
 C13 N1 1.3458(19) . ?
 C13 O3 1.2345(17) . ?
 C14 H14A 0.9600 . ?
 C14 H14B 0.9600 . ?
 C14 H14C 0.9600 . ?
 C15 C16 1.408(2) . ?
 C15 C20 1.411(2) . ?
 C16 H16 0.9300 . ?
 C16 C17 1.383(2) . ?
 C17 H17 0.9300 . ?
 C17 C18 1.406(2) . ?
 C18 H18 0.9300 . ?
 C18 C19 1.386(2) . ?
 C19 H19 0.9300 . ?
 C19 C20 1.394(2) . ?
 C20 N2 1.3778(19) . ?
 N1 H1 0.87(2) . ?
 N2 H2A 0.84(3) . ?
loop_
  _geom_angle_atom_site_label_1
  _geom_angle_atom_site_label_2
  _geom_angle_atom_site_label_3
  _geom_angle
  _geom_angle_site_symmetry_1
  _geom_angle_site_symmetry_3
  _geom_angle_publ_flag
 C6 C1 C2 123.01(14) . . ?
 F1 C1 C2 118.73(15) . . ?
 F1 C1 C6 118.26(15) . . ?
 C1 C2 H2 120.7 . . ?
 C1 C2 C3 118.53(14) . . ?
 C3 C2 H2 120.7 . . ?
 C2 C3 H3 119.8 . . ?
 C2 C3 C4 120.38(15) . . ?
 C4 C3 H3 119.8 . . ?
 C3 C4 C5 119.07(13) . . ?
 C3 C4 C7 122.07(13) . . ?
 C5 C4 C7 118.84(13) . . ?
 C4 C5 H5 119.5 . . ?
 C6 C5 C4 120.97(14) . . ?
 C6 C5 H5 119.5 . . ?
 C1 C6 C5 118.04(15) . . ?
 C1 C6 H6 121.0 . . ?
 C5 C6 H6 121.0 . . ?
 C8 C7 C4 131.75(13) . . ?
 C8 C7 N2 109.46(12) . . ?
 N2 C7 C4 118.73(13) . . ?
 C7 C8 C9 128.77(13) . . ?
 C7 C8 C15 106.77(12) . . ?
 C15 C8 C9 124.41(13) . . ?
9
 C8 C9 H9A 108.9 . . ?
 C8 C9 H9B 108.9 . . ?
 C8 C9 C10 113.51(11) . . ?
 H9A C9 H9B 107.7 . . ?
 C10 C9 H9A 108.9 . . ?
 C10 C9 H9B 108.9 . . ?
 C9 C10 H10 109.3 . . ?
 C11 C10 C9 109.25(11) . . ?
 C11 C10 H10 109.3 . . ?
 N1 C10 C9 109.00(11) . . ?
 N1 C10 H10 109.3 . . ?
 N1 C10 C11 110.79(11) . . ?
 O1 C11 C10 125.11(13) . . ?
 O1 C11 O2 124.20(13) . . ?
 O2 C11 C10 110.62(12) . . ?
 H12A C12 H12B 109.5 . . ?
 H12A C12 H12C 109.5 . . ?
 H12B C12 H12C 109.5 . . ?
 O2 C12 H12A 109.5 . . ?
 O2 C12 H12B 109.5 . . ?
 O2 C12 H12C 109.5 . . ?
 N1 C13 C14 115.58(13) . . ?
 O3 C13 C14 122.74(13) . . ?
 O3 C13 N1 121.68(13) . . ?
 C13 C14 H14A 109.5 . . ?
 C13 C14 H14B 109.5 . . ?
 C13 C14 H14C 109.5 . . ?
 H14A C14 H14B 109.5 . . ?
 H14A C14 H14C 109.5 . . ?
 H14B C14 H14C 109.5 . . ?
 C16 C15 C8 133.95(14) . . ?
 C16 C15 C20 118.84(13) . . ?
 C20 C15 C8 107.18(12) . . ?
 C15 C16 H16 120.5 . . ?
 C17 C16 C15 119.03(14) . . ?
 C17 C16 H16 120.5 . . ?
 C16 C17 H17 119.5 . . ?
 C16 C17 C18 121.06(15) . . ?
 C18 C17 H17 119.5 . . ?
 C17 C18 H18 119.5 . . ?
 C19 C18 C17 121.06(14) . . ?
 C19 C18 H18 119.5 . . ?
 C18 C19 H19 121.1 . . ?
 C18 C19 C20 117.72(14) . . ?
 C20 C19 H19 121.1 . . ?
 C19 C20 C15 122.26(13) . . ?
 N2 C20 C15 107.62(12) . . ?
 N2 C20 C19 130.10(13) . . ?
 C10 N1 H1 119.8(16) . . ?
 C13 N1 C10 121.37(12) . . ?
 C13 N1 H1 118.4(16) . . ?
 C7 N2 H2A 125.4(15) . . ?
 C20 N2 C7 108.94(12) . . ?
 C20 N2 H2A 124.3(15) . . ?
 C11 O2 C12 115.68(12) . . ?
loop_
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  _geom_hbond_atom_site_label_D
  _geom_hbond_atom_site_label_H
  _geom_hbond_atom_site_label_A
  _geom_hbond_distance_DH
  _geom_hbond_distance_HA
  _geom_hbond_distance_DA
  _geom_hbond_angle_DHA
  _geom_hbond_site_symmetry_A
 N1 H1 O1 0.87(2) 2.06(2) 2.9155(16) 170(2) 6_565
loop_
  _geom_torsion_atom_site_label_1
  _geom_torsion_atom_site_label_2
  _geom_torsion_atom_site_label_3
  _geom_torsion_atom_site_label_4
  _geom_torsion
  _geom_torsion_site_symmetry_1
  _geom_torsion_site_symmetry_2
  _geom_torsion_site_symmetry_3
  _geom_torsion_site_symmetry_4
  _geom_torsion_publ_flag
 C1 C2 C3 C4 -0.6(2) . . . . ?
 C2 C1 C6 C5 -0.2(2) . . . . ?
 C2 C3 C4 C5 -0.1(2) . . . . ?
 C2 C3 C4 C7 178.13(14) . . . . ?
 C3 C4 C5 C6 0.6(2) . . . . ?
 C3 C4 C7 C8 47.4(2) . . . . ?
 C3 C4 C7 N2 -135.53(15) . . . . ?
 C4 C5 C6 C1 -0.5(2) . . . . ?
 C4 C7 C8 C9 0.3(3) . . . . ?
 C4 C7 C8 C15 177.89(14) . . . . ?
 C4 C7 N2 C20 -179.18(13) . . . . ?
 C5 C4 C7 C8 -134.34(16) . . . . ?
 C5 C4 C7 N2 42.70(19) . . . . ?
 C6 C1 C2 C3 0.7(2) . . . . ?
 C7 C4 C5 C6 -177.66(14) . . . . ?
 C7 C8 C9 C10 80.64(18) . . . . ?
 C7 C8 C15 C16 178.36(15) . . . . ?
 C7 C8 C15 C20 0.43(16) . . . . ?
 C8 C7 N2 C20 -1.52(16) . . . . ?
 C8 C9 C10 C11 50.88(16) . . . . ?
 C8 C9 C10 N1 172.07(11) . . . . ?
 C8 C15 C16 C17 -176.53(15) . . . . ?
 C8 C15 C20 C19 177.08(14) . . . . ?
 C8 C15 C20 N2 -1.35(16) . . . . ?
 C9 C8 C15 C16 -4.0(2) . . . . ?
 C9 C8 C15 C20 178.12(13) . . . . ?
 C9 C10 C11 O1 75.70(17) . . . . ?
 C9 C10 C11 O2 -101.15(13) . . . . ?
 C9 C10 N1 C13 -174.53(13) . . . . ?
 C10 C11 O2 C12 174.64(13) . . . . ?
 C11 C10 N1 C13 -54.29(17) . . . . ?
 C14 C13 N1 C10 -179.88(13) . . . . ?
 C15 C8 C9 C10 -96.52(16) . . . . ?
 C15 C16 C17 C18 0.1(2) . . . . ?
 C15 C20 N2 C7 1.77(16) . . . . ?
 C16 C15 C20 C19 -1.2(2) . . . . ?
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 C16 C15 C20 N2 -179.65(13) . . . . ?
 C16 C17 C18 C19 -1.4(2) . . . . ?
 C17 C18 C19 C20 1.4(2) . . . . ?
 C18 C19 C20 C15 -0.1(2) . . . . ?
 C18 C19 C20 N2 177.96(15) . . . . ?
 C19 C20 N2 C7 -176.50(15) . . . . ?
 C20 C15 C16 C17 1.2(2) . . . . ?
 F1 C1 C2 C3 -179.67(14) . . . . ?
 F1 C1 C6 C5 -179.82(14) . . . . ?
 N1 C10 C11 O1 -44.40(19) . . . . ?
 N1 C10 C11 O2 138.75(12) . . . . ?
 N2 C7 C8 C9 -176.90(13) . . . . ?
 N2 C7 C8 C15 0.65(16) . . . . ?
 O1 C11 O2 C12 -2.2(2) . . . . ?
 O3 C13 N1 C10 0.3(2) . . . . ?
loop_
  _exptl_crystal_face_index_h
  _exptl_crystal_face_index_k
  _exptl_crystal_face_index_l
  _exptl_crystal_face_perp_dist
  _exptl_oxdiff_crystal_face_indexfrac_h
  _exptl_oxdiff_crystal_face_indexfrac_k
  _exptl_oxdiff_crystal_face_indexfrac_l
  _exptl_oxdiff_crystal_face_x
  _exptl_oxdiff_crystal_face_y
  _exptl_oxdiff_crystal_face_z
-2 1 0 0.0998 -2.0000 0.9990 -0.0002 0.0001 0.0490 -0.0462
 2 -1 0 0.1128 2.0000 -0.9990 0.0002 -0.0001 -0.0490 0.0462
 0 0 1 0.0890 -0.0001 -0.0002 0.9992 0.0267 -0.0430 -0.0453
 0 0 -1 0.0736 0.0001 0.0002 -0.9992 -0.0267 0.0430 0.0453
 1 -1 -1 0.0662 0.9999 -0.9990 -0.9991 -0.0089 0.0237 0.0740
-1 1 1 0.0732 -0.9999 0.9990 0.9991 0.0089 -0.0237 -0.0740
-1 0 -1 0.0746 -1.0001 -0.0000 -0.9993 -0.0088 0.0726 0.0278
 1 0 1 0.0746 1.0001 0.0000 0.9993 0.0088 -0.0726 -0.0278
 1 -2 0 0.0574 0.9996 -1.9986 -0.0001 0.0536 -0.0090 0.0399
-1 2 0 0.0854 -0.9996 1.9986 0.0001 -0.0536 0.0090 -0.0399
-1 -1 0 0.0706 -1.0004 -0.9996 -0.0002 0.0537 0.0400 -0.0063
 1 1 0 0.0826 1.0004 0.9996 0.0002 -0.0537 -0.0400 0.0063
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